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Abstract 
 
Research into cocrystals is just a small field within crystallography, though the significant rise 
of investigation into cocrystals has made it an exciting area of research. This thesis initially 
introduces the phenomenon of cocrystals, including the design, formation, structure solution 
and the properties of cocrystals.  
This thesis presents a number of new multi-component crystalline adducts that have been 
synthesised using dicarboxylic acids as coformers with isonicotinamide, nicotinamide or 
adenine.  The first results chapter discusses a number of molecular adducts that contain 
distinct hydrogen bonding networks and includes the discovery of a new polymorph and the 
potential of adenine to tautomerise. The following two results chapters focus on molecular 
structures of nicotinamide and isonicotinamide with the dicarboxylic acids in which trends in 
crystal packing, cocrystal property studies and twisting of the acid backbone are discussed in 
detail.  
In conjunction with the crystal structure and property studies, several powder X-ray 
diffraction datasets were collected from a synchrotron source. The final results chapter shows 
that a cocrystal structure, such as nicotinamide : succinic acid,  can be solved without the need 
of single crystal X-ray diffraction data.  
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 1. Introduction 
1.1 Introduction 
The work presented and discussed within this thesis is focussed on small molecule 
crystallography and the design of new crystalline molecular materials. Some chapters are 
based on crystal engineering in which crystal structures and their bulk properties are tuned 
and predicted whilst other chapters focus on the ability to solve crystal structures from 
powder X-ray diffraction. The aim of this chapter is to introduce the fundamentals of 
crystallography (from reference 1) and to give a background into molecular cocrystals, their 
properties, synthon design and discuss the advantages of using powder X-ray diffraction in 
the structural analysis of these materials. 
 
1.2 Cocrystals; what are they? 
Both the word ‘cocrystal’ and the definition of this term have been the subject of much 
debate; should the word cocrystal be hyphenated? What is the difference between a cocrystal 
and a solvate? I will not delve any further into this as the potential uses and benefits of a 
cocrystal/co-crystal warrant discussion much more than a grammatical term, the definition 
however is important. Aakeroy et al2 came up with the following, in which the industry seems 
settled; ‘A cocrystal is a structurally homogeneous crystalline material that contains two or 
more neutral building blocks that are present in stoichiometric amounts’. This is now often 
extended to the definition that these building blocks are solid at room temperature. 
Cocrystals have many uses, such as electronic and optical materials3,4 and within the paint and 
agrochemical industry, although their main potential use and the primary focus of this project 
is their use as an alternative formulation of active pharmaceutical ingredients (APIs) within 
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the pharmaceutical industry5. The pharmaceutical industry has become increasingly interested 
in the use of cocrystals as API formulations because they have the ability to provide optimal 
physical properties whilst retaining the chemical properties of the individual cocrystal 
components6,7. Physicochemical properties such as melting point, stability and solubility of an 
API can be tuned through cocrystal formation8 and a number of examples are given in section 
1.7. 
There are a number of synthetic methods for attempting cocrystallisation experiments, with 
solvent evaporation being the most common. For solution cocrystallisation to be successful, 
the solubilities of all starting materials need to be similar to avoid the recrystallisation of one 
cocrystal former before cocrystallisation has occurred9. The ternary phase diagram below 
(figure 1.1) shows the importance of the coformers having similar solubilities and clearly 
indicates that the area relating to cocrystal formation being thermodynamically favourable 
significantly reduces when the relative solubilities of the coformers have a larger difference. 
 
Figure 1.1: A ternary phase diagram for solvent mediated cocrystallisation. A) shows similar 
solubilities of the coformers whilst B) represents solubilities between the coformers with a 
greater difference. Region A represents coformer 1, region B represents coformer 1 and 
cocrystal, region C represents cocrystal, region D represents coformer 2 and cocrystal, region 
E represents coformer 2 and region F represents solution. Figure taken from reference 9 
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Other possible cocrystallisation methods are available such as liquid assisted grinding (LAG), 
dry grinding and sonic slurry, some of which can reduce the issue of non-comparable 
solubilities between the coformers.  
Dry grinding and LAG is becoming increasingly popular. It is a ‘greener’ method as it uses 
only a few drops of solvent, but more importantly it can lead to formation of new 
polymorphic forms (section 1.3), alternative stoichiometries or a solvent free adduct10,11. The 
technique involves grinding stoichiometric amounts of the coformers by hand, using a pestle 
and mortar or using a ball mill. It has been found that the presence of a small amount of 
solvent (LAG) can increase the kinetics of the cocrystallisation and gives more polymorphic 
control10,12. The sonic slurry method also reduces the amount of solvent required for 
cocrystallisation and removes the problem of coformers having a large difference in 
solubilities. This method involves suspending the coformers in a small amount of solvent 
which undergoes intense bursts of heat and pressure. This allows the growth and collapse of 
‘bubbles’ giving rise to a new cocrystalline phase13. The ability to form heteromeric synthons 
(synthetic building blocks) is the key to cocrystallisation as this has to be more energetically 
favourable than remaining as a mixture of coformers2. 
Whilst cocrystals are the desired result of a cocrystallisation experiment, there are other 
possible outcomes14. Not only could the materials recrystallise as a mixture of the coformers, 
salt formation or the production of hydrates and solvates are also possible. A salt results when 
a proton is transferred between the two coformers15. Hydrates and solvates form when either 
water or solvent molecules are present within the crystalline structure12. All of these different 
forms exhibit different physical properties to that of an anhydrous neutral cocrystal12. 
 All of the above will be discussed and explored in much more detail further in the chapter. 
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1.3 Polymorphism 
A crystalline polymorph is defined as a crystal with more than one crystalline arrangement of 
molecules or structure. In terms of a cocrystal, a polymorphic cocrystal has the same 
stoichiometry but a different structure16. Polymorphic cocrystals attracts extensive study due 
to its ability to change the physicochemical properties such as melting point, density and 
solubility the material17,18. Whilst at times the changes in these properties may be beneficial, it 
can also reduce desired properties such as good bioavailability, e.g. the antiretroviral drug 
ritonavir19,20 there is also the possibility of it having a much more dangerous affect for 
example increasing the toxicity18. There are many examples of both single component 
systems and cocrystals forming polymorphs. Carbamazepine, for example, has multiple 
polymorphic forms as a single component21 and also as a cocrystal with isonicotinamide, 
which forms the 1:1 cocrystal structure shown in figure 1.2 (a) and whilst the second 1:1 
polymorphic form has yet to have its structure solved it is believed to be isostructural to that 
of carbamazepine : nicotinamide, figure 1.2 (b)22.  
  
(a) 
 
(b) 
Figure 1.2:  The crystal structures of (a) 1:1 carbamazepine : isonicotinamide and (b) 
carbamazepine : nicotinamide believed to be isostructural to the second polymorphic form of 
carbamazepine : isonicotinamide. Figures taken from reference 22 
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An extensive CSD (Cambridge Structural Database) search carried out by Aitipamula et al in 
2010 found that 1.2% of the 3624 cocrystals in the database are polymorphic23. As a 
consequence, pharmaceutical companies have required vigorous polymorph screening of 
single components to take place before they select an active pharmaceutical ingredient. This 
screening involves several stages including crystallisation using a wide variety of 
experimental techniques and reaction conditions, followed by subjecting the samples to a 
number of analytical techniques. Property comparisons are then made before the polymorph 
selection24. This is a process that will be used routinely in cocrystal screening as these 
materials become more widespread. 
Solvent evaporation (the most common cocrystallisation technique) is a technique also used 
within polymorph screening, utilising various different solvents and solvent mixtures as this 
can affect nucleation and crystal growth. The resultant crystals are examined whilst they 
remain wet and in the solvent and once dried24,25. Different reaction vessels should be utilised 
within a vigorous polymorph screen, for example, capillary crystallisation provides a wide 
range of supersaturation levels, which in turn can affect the nucleation24. Along with the 
solvent evaporation technique, other experimental methods such as grinding, 
thermomicroscopy, compression, sublimation and vapour and heat stressing of crystalline 
forms should be employed24. Upon crystal formation, full characterization of the adduct is 
required often using multiple techniques such as powder X-ray diffraction and Raman 
spectroscopy, both being efficient as neither requires a large sample size24,25. 
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1.4 Cocrystals and salts 
Cocrystals and salts are both multi component crystalline materials, though a salt is formed if 
proton transfer occurs between the two components e.g. an acid and an amide (figure 1.3). 
Study of the pKa difference between the coformers can often indicate whether proton transfer 
is likely, with a difference of greater than 2 - 3 often resulting in salt formation15. 
 
Figure 1.3: An example of a cocrystal (a) and a salt (b) in which proton transfer has occurred 
 
The question of whether the position of this hydrogen atom affects the physical properties and 
the reliability of the crystalline material has attracted much attention, with Aakeroy et al 
investigating the reliability and predictability of salts versus cocrystals25. This study involved 
the inspection of 85 crystalline structures of which 65 were cocrystals and the remaining 20 
salts. Of this sample selection, 45% of the salts showed either an unexpected stoichiometry or 
lattice combination (including the presence of solvates) compared to 5% of the cocrystals. 
This trend was continued in the CSD searches that they carried out, demonstrating a 
significant advantage of cocrystals over salts in reliability and predictability of design within 
the pharmaceutical industry25. 
However, the location of the hydrogen atom is not always clear cut; a salt-cocrystal 
continuum exists in which the hydrogen could be disordered or partially occupy multiple 
sites15. Physical effects such as temperature, solvent choice and stoichiometric ratio of the 
1. Introduction Page 7 
 
coformers are also known to have an effect on this salt-cocrystal continuum. In one case, a 
variable temperature neutron diffraction study of pentachlorophenol : 4-methylpyridine (ΔpKa 
= 0.77) showed that as the temperature increases the adduct becomes more cocrystal ‘like’ 
with the shared hydrogen moving closer towards the pentachlorophenol oxygen (figure 
1.4)15,26.  
 
Figure 1.4: The location of the hydrogen atom at varying temperatures in the 
pentachlorophenol : 4-methylpyridine complex measured using neutron diffraction. Figure 
taken from reference 15 
 
Proton migration to become more cocrystal like in character at elevated temperatures is a 
behaviour also seen in the 1:1 salt of urea : phosphoric acid in which the proton moved 
towards the phosphate oxygen to become more centered between the two components. The 
choice of solvent used in the cocrystallisation synthesis can also influence the extent of proton 
transfer, with the use of more polar solvents favouring proton transfer27. 2,3-lutidine : fumaric 
acid is an example of a crystalline system that can form both cocrystal and salt forms by 
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variation of the stoichiometric ratio of starting materials. A 1:2 salt is obtained from a 1:1 
ratio of coformers, whereas a 2:1 cocrystal is formed from a 2:1 lutidine : fumaric acid 
starting material ratio (figure 1.5)28.  
 
 
 
 
 
 
 
Figure 1.5: The crystal structure of (a) 2,3-lutidine : fumarate salt, 1:2 and (b) 2,3-lutidine : 
fumaric acid 2:128 
 
These examples clearly indicate the importance of being able to locate the acidic proton. 
Structure solution of the multi-component materials discussed in this thesis was carried out 
using both single crystal and powder X-ray diffraction analysis, although these techniques are 
not always sufficient to fully classify the new crystalline adducts as either cocrystals or salts. 
As a result, complementary techniques will be employed, such as inspection of certain bond 
lengths and angles of the atoms involved and comparison with other known structures. 
Infrared spectroscopy is also a technique that can aid classification of these materials based on 
the observation of O-H, N-H, C-O and C=O bands29. Neutron diffraction is suitable for the 
investigation of the position of light atoms such as hydrogen atoms, but the requirement of 
deuteration by recrystallisation limits the application of this technique when materials are 
available only from solvent free synthetic methods30. 
(a) (b) 
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1.5 Hydrates and solvates 
The stability and other physical properties of both hydrates and solvates differ from that of the 
unsolvated forms, and can be either detrimental or beneficial to a pharmaceutical product12. 
The majority of cocrystallisation experiments are from solution, so the presence of solvent 
within the crystal lattice is not surprising. Water molecules are small and can form multiple 
hydrogen bonds and hence inclusion as a hydrate within a crystal structure is frequently 
observed31. The CSD database search carried out by Aitipamula et al also investigated the 
number of cocrystal structures that exist as either solvates or hydrates23. The results of this 
search showed that ~12% of the 3624 entries were hydrates with a further ~11% being 
solvates (with methanol, ethanol and acetonitrile being the most common solvate to be 
incorporated into the structure)23.  
It has been reported that in certain systems where there is an imbalance of donor and acceptor 
molecules, that the presence of water can stabilize the structure32.33. Work carried out by 
Aakeroy et al33 on the cocrystallisation of two hydrazones (which have limited hydrogen bond 
donor sites) with a range of carboxylic acids showed that all twelve of the adducts formed 
were hydrates indicating that the inclusion of water within the structure is driven by the desire 
to even out the donor/acceptor balance. The thermal stability of a range of hydrated cocrystals 
was investigated by Clarke et al32 which observed that the more tightly bound the water 
molecules, the higher the temperature required before the water is lost. For example the 
samples in which the water was held in channels was lost at temperatures less than 100ºC, 
though temperatures greater than 120ºC were required before dehydration of the samples in 
which the water was tightly bound within the crystalline lattice33. 
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1.6 Synthon formation and crystal engineering  
Cocrystal formation relies on the formation of heteromeric synthons, with this supramolecular 
assembly being energetically more favourable than the existence of the pure coformers2,7 
Several homomeric and heteromeric synthons have been identified as ‘strong’, ‘stable’ and 
‘robust’ and are frequently observed in many cocrystal structures. Examples of 
supramolecular synthons that are applicable to this thesis are acid-heterocyclic nitrogen, acid-
amide, amide-amide and acid-acid and amide-heterocyclic nitrogen7,34-37 (figure 1.6) 
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Figure 1.6: Five robust synthons formed between isonicotinamide and a carboxylic acid; (a) 
an acid-heterocyclic nitrogen synthon reinforced by a C-H...O=C to form a ring motif, (b) an 
acid-amide synthon, (c) an amide-amide synthon, (d) an acid-acid synthon and (e) an amide-
pyridine synthon again reinforced by a soft C-H...O=C to form a ring motif 
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These robust synthons exist as they contain strong hydrogen bond donor and acceptor sites 
and they follow guidelines set out by Etter38, suggesting a hierarchy of hydrogen bond 
formation (see list below): 
 
1. All good proton donors and acceptors are used in hydrogen bonding 
2. Six-membered ring intramolecular bonds form in preference to intermolecular 
hydrogen bonds 
3. The best proton donors and acceptors remaining after intramolecular hydrogen bond        
formation form intermolecular hydrogen bonds to one another 
 
Synthon energy studies were carried out by Vishweshwar et al39 in which it was found that 
the heterosynthons (a, b and c in figure 1.6) are more likely to be formed before the 
homosynthons (d and e in figure 1.6). 
Crystal engineering is the term used for ‘crystal design’ by studying such synthons and 
supramolecular interactions with the aim of being able to control the crystalline state along 
with its physical properties7,34,35,40,41. Potential hydrogen bond donor and acceptor sites and 
the possibility of robust synthon formation has been explored in detail for the coformers 
selected in this thesis, and their behaviour will be discussed further in the relevant chapters. 
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1.7 Properties of cocrystals 
Both academic and industrial study and research into cocrystals has increased significantly in 
the last few years, owing mainly to the fact that cocrystals have the ability to change the 
physical properties of a material whilst a coformer retains its chemical properties, giving the 
potential to tune certain desirable bulk properties6,8,42-44. These potential uses and tunability of 
properties of cocrystals arise because crystalline materials obtain their physical properties 
from the molecular arrangement and the relative placement of the interactions between 
molecules8. There are a number of physical properties that are especially important when 
selecting an API, including melting point, solubility, dissolution, stability, bioavailability, 
compressability and wettability8,43. 
The melting point is important as it is directly related to the solubility with a higher melting 
point implying that the new material is thermodynamically stable8. There are several studies 
that have investigated the melting points of cocrystals and compared them to that of their 
coformers. Dicarboxylic acids, for example, display alternating melting point with increasing 
or decreasing chain length due to conformational packing differences between those with an 
even number of carbon atoms and those with an odd number, a trend which remains when 
these acids are cocrystallised with another material29,41. For example, melting point 
measurements on ten AMG cocrystals showed that the melting point of each cocrystal was 
related to the coformer45, further indicating that if an API was required with a specific melting 
point, selection of a cocrystal former with a melting point in the desired range would be a 
solution. What is not clear however, is whether the melting point of the cocrystal can be 
predicted as above both coformers, below both coformers or between the two, with reports 
illustrating all of these possibilities8,29,39,46. 
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Many APIs have poor solubility and one of the primary interests in cocrystal research is to 
investigate the potential of improving this situation. Solubility is a property with many 
considerations, including the hydrogen bonding strength and melting point of the cocrystal 
along with the temperature and polarity of the solvent45. Cocrystal studies that have involved 
the measurement of solubility have found that upon cocrystallisation of an API the solubility 
does in most cases increase43,45. 
The dissolution of an API is directly related to the solubility and when considering drugs for 
oral consumption, a good dissolution rate is key. A study by McNamare et al47 investigated 
the cocrystallisation of glutaric acid with the poorly soluble 2-[4-(4-chloro-2-
fluorophenoxy)phenyl]pyrimidine-4-carboxamide, which is a potential candidate for treating 
surgical, chronic and neuropathic pain. Upon cocrystallisation dissolution rate experiments 
were carried out in pure water, with the intrinsic dissolution rate of the cocrystal being about 
18 times faster than the coformer47. 
Both chemical and physical stability is also an important factor when selecting APIs as it 
effects properties such as shelf life in which it is important that the API is in the most stable 
form (i.e. not undergoing polymorphism). Stability measurements can be carried out in 
stability chambers, for example, the AMG 517 (an antagonist of the protein TRPV1) 
cocrystals which showed no change after being subjected to the chamber for a month45, along 
with looking at moisture sorption measurements6, 45.  
Bioavailability is the measure of both the rate and extent of the activity of the drug when 
reaching systematic circulation8, another highly important factor to consider during API 
selection. The study by McNamara et al not only found better dissolution rates when the API 
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was cocrystallised with glutaric acid but also that the bioavailability increased when testing 
the drug in dogs47. 
These are just a few examples highlighting the significant advantages that cocrystals can 
provide to the pharmaceutical industry, specifically due to the ability to ‘select’ the optimum 
properties and obtain them via cocrystallisation. 
 
1.8 Structure solution of cocrystals 
Structure solution is an integral part of cocrystal research; it confirms (or not!) synthon design 
principles, it allows the determination of whether the adduct is a salt or cocrystal, it aids the 
discovery of solvent or water molecules that may be present within the crystal lattice and 
facilitates the determination of structure-property relationships. Single crystal X-ray 
diffraction is currently the most widely used technique for cocrystal structure solution, though 
NMR spectroscopy and solid state IR spectroscopy are all techniques used to complement this 
method. Powder X-ray diffraction and neutron diffraction are also used within this field. 
Powder X-ray diffraction is used more as a ‘screening’ technique for new materials although 
it does have the potential for full structure analysis.  
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1.9 Crystallography; the fundamentals 
X-ray crystallography is a powerful technique with the ability to determine the crystal 
structure of both molecular and inorganic crystalline solids. It can provide details such as the 
contents of the sample, packing of the atoms or molecules and structural details such as bond 
lengths and angles. This technique involves placing the crystalline material in a beam of X-
rays, which then diffracts in all directions (figure 1.7). The diffracted beams are collected by a 
detector generating a unique diffraction fingerprint (no two distinct crystalline solids will 
have the same diffraction pattern). 
 
 
Figure 1.7: A schematic of the X-ray diffraction experiment 
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1.9.1 The crystalline material 
In order for X-ray crystallography to be successful the sample must be crystalline; i.e. have 
periodic long range order. A crystal lattice is formed of unit cells; a unit cell contains the 
smallest repeating unit and is connected to other identical unit cells in three dimensions. It has 
parameters which define both the axes (a, b and c) and the angles (α, β, and γ). This labelling 
of parameters is the standardised scheme for a unit cell (figure 1.8). 
 
 
Figure 1.8: A unit cell 
 
The contents of the unit cell can often be reduced to sub-units known as the asymmetric unit. 
Each asymmetric unit is related to others by symmetry elements (rotation, reflection, 
inversion etc) to form the complete crystal structure. Sets of imaginary planes can also be 
defined, running through the crystal lattice. The planes within a set are parallel and 
equidistant (interplanar distance known as d-spacing) and are labelled by Miller indices 
(h,k,l); integer values which are mathematically related to the unit cell parameters.  
The combination of various different symmetries places restrictions on the unit cell 
parameters. There are seven different crystal systems (table 1.1) and in addition to this there 
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are four different lattice types; primitive (P), body-centred (I), face-centred (F) and base-
centred (A,B or C) shown in figure 1.9. 
 
Table 1.1: The seven crystal systems 
Crystal system Restrictions on Unit Cell parameters Possible Bravais lattice types 
Cubic a = b = c 
α = β = γ = 90º 
P, I, F 
Hexagonal a = b ≠ c 
α = β = 90º  γ = 120º 
P 
Trigonal a = b = c 
α = β = γ ≠ 90º 
R 
Tetragonal a = b ≠ c 
α = β = γ = 90º 
P, I 
Orthorhombic a ≠ b ≠ c 
α = β = γ = 90º 
P, I, F, A, B, C 
Monoclinic a ≠ b ≠ c 
α = γ = 90º  β ≠ 90º 
P, C 
Triclinic a ≠ b ≠ c 
α ≠ β ≠ γ ≠ 90º 
P 
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Figure 1.9: The four Bravais lattice types; (i) Body centered, (ii) primitive, (iii) A centered 
and (iv) face centered48 
 
A crystal structure is assigned a space group which represents all of the symmetry elements 
within the system. The combination of possible symmetry elements, the seven crystal systems 
and fourteen Bravais lattices mean there are only 230 different space groups. The possible 
symmetry elements include inversion, rotation, reflection, screw axes and glide planes. 
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1.9.2 The diffraction experiment 
Wilhelm Conrad Röntgen first discovered X-rays in 1895, receiving a Nobel prize for his 
work49. The X-ray crystallography experiment is possible because X-rays have wavelengths 
of the same order as intramolecular bond lengths. 
During the X-ray experiment, the crystalline sample is irradiated with X-rays, which get 
diffracted in all directions. The diffracted beams are measured by a detector to give a 
diffraction pattern. In single crystal X-ray diffraction, the sample is one crystallite, with 
minimum dimension normally 0.01 mm. 
Braggs law explains how diffraction patterns are produced (equation 1.1 and figure 1.10) 
 
2dsinθ = nλ 
Equation 1.1: Bragg’s law 
 
 
Figure 1.10: Bragg’s law 
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The derivation of Bragg’s law is a mathematical construct in which diffraction can be thought 
of in terms of reflection of the incident beam from the lattice planes. For constructive 
interference to occur, and thus intensity observed on the detector, beams A and B (figure 
1.10) must be in phase when they reach the detector. The difference in path length from 
source to detector of beams A and B is equal to AB + BC (figure 1.10) and for the beams to 
be in phase this must be equal to nλ (where n is an integer and λ is the X-ray wavelength). 
Using trigonometry, AB + BC is found to be equal to twice the d-spacing multiplied by sinθ 
where θ is the angle of incidence, hence Bragg’s law (equation 1.1). As the X-ray diffraction 
experiment can be easily understood in terms of reflection, it is common for diffraction peaks 
to be referred to as reflections. 
X-rays are produced when an excited electron relaxes back to its ground state. In a standard 
X-ray crystallography experiment, X-rays are produced in a sealed tube in which an electron 
beam is generated by an electric current and accelerated towards a metal target (usually 
copper or molybdenum dependent on wavelength requirements). The X-ray beam is produced 
as a by-product of this collision. Three wavelengths of radiation are produced; Kα1, Kα2 and 
Kβ. A monochromator can be used to remove some of the unwanted Kα2 and Kβ radiation to 
produce a monochromatic beam.  
A peak (reflection) occurs when a set of lattice planes (hkl) satisfies Bragg’s law. Each set of 
planes gives rise to one diffraction peak. The relative intensities of the peaks and the peak 
positions (2 values figure 1.7) give information on the contents of the unit cell, the cell 
parameters and crystal system. The first stage is indexing in which each measured peak is 
assigned (hkl) values. The d-spacing of the (hkl) reflection (calculated using Bragg’s law) can 
be related to the unit cell parameters allowing them to be calculated. The Bravais lattice type 
1. Introduction Page 22 
 
and space group are determined by investigation of absences within the diffraction pattern 
which occur because of symmetry related atoms. There are two types of absence, a general 
absence relating to Bravais lattice type and a systematic absence relating to translational space 
group symmetry. The different lattice types place different conditions of when there will be a 
general absence, for example, an absence will occur for a body centred lattice if h + k + l is 
odd. Systematic absences only occur for translational space group symmetry and pose similar 
conditions. For example a 21 screw axis in the a direction will have a systematic absence at (h, 
0, 0) where h is odd and absent. This information allows the symmetry to be determined and a 
space group to be assigned. 
 
1.9.3 Structure solution and refinement 
Each peak in the diffraction pattern has a structure factor, Fhkl which is related to the relative 
intensity (equation 1.2). 
Ihkl  |    |
2 
Equation 1.2: Relationship between structure factors and intensities 
The structure factors are related to the electron density which is required for structure 
solution. The diffraction pattern is a Fourier transform of electron density, although before the 
electron density map can be obtained the phase problem has to be overcome. Electron density, 
ρ(xyz) is obtained by summing all of the structure factors and phase angles (equation 1.3).  
 (   )   
 
  
 ∑  (   )          (        ) 
     
 
Equation 1.3: Reverse Fourier transform of the diffraction pattern 
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The phase problem exists because only the intensities can be recorded in the diffraction 
pattern and not the phases. The most traditional method of overcoming this is by using direct 
methods in which possible phase angles are estimated. This approach is used mainly for small 
molecules without heavy metals. Patterson methods are also available, these use trial 
structures; once a ‘trial’ structure is obtained it undergoes refinement to compare it with the 
experimental data, refining lattice parameters, atomic positions etc. Once an initial structure 
solution has been obtained the most common method of refinement is the least squares 
method which gives a numerical representation of the ‘goodness’ of fit between the 
experimental data and the structure. 
 
1.10 Single crystal X-ray diffraction 
Single crystal X-ray diffraction (SXRD) is the most commonly used technique to determine a 
crystal structure50, however it does come with certain requirements. This method is reliant on 
the quality of crystal; small crystals are often poorly diffracting and data collections can be 
quite time consuming30. SXRD is routinely carried out at low temperatures as it can yield 
better quality data than at room temperature50; this approach is potentially vital for reliable 
location of hydrogen atoms in a crystal structure. 
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1.10.1 Potential problems in single crystal analysis 
Disorder and twining both provide challenges and problems in the structure refinement stage. 
Disorder occurs when atoms are in different orientations or positions in neighbouring unit 
cells and hence a perfect translational repeat is not obeyed. The percentage occupancy of 
these different orientations can be variable, particularly with changes in temperature. The 
refined crystal structure will contain all orientations of the disordered groups and is derived 
from diffraction data from all the unit cells in the sample as this is the diffraction average. 
Twinning occurs when a single dataset includes more than one diffraction pattern 
superimposed on one another. There are two types; firstly merohedral twinning which occurs 
when the symmetry of a crystal lattice is such that unit cells can be orientated in two ways 
leading to datasets that overlap exactly. It normally arises from systems in which the unit cell 
parameters are very close to higher symmetry values (such as a monoclinic unit cell with  
very close to 90). Non-merohedral twinning occurs when two orientations of a crystal lattice 
are present in the same sample and give rise to superimposed diffraction patterns which do not 
overlap.  Polymorphism (section 1.3) is another phenomenon that can cause crystallographers 
further challenges.  
 
1.10.2 Structure validation 
Once a crystal structure has been solved, there are several parameters and visual inspections 
that can be used to validate that the structure is chemically sensible and correct. The first 
values to consider are the R factors and the goodness-of-fit. The R factor is a measure of 
agreement between the diffraction pattern calculated from the model and experimental data 
and, ideally should be less than 5 % but is normally acceptable if less than 10 %. The 
weighted R factor (wR2), which will have a higher value, though still be less than 25 %, takes 
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into account the precision of the measured quantities by weighting them accordingly. The 
goodness-of-fit is another weighted statistical measure of the agreement between the 
calculated and raw data. This value should be close to 1 with the range 0.8 - 2 being 
acceptable. The completeness of data (the percentage of the unique reflections that have been 
measured out to the maximum diffraction angle) is another value used to validate the crystal 
structure with > 97% being ideal. The final parameter to check is the remaining difference 
electron density, (electron density that has not been assigned in the model) with values below 
0.6 e-/Ǻ3 for organic structures indicating that all atoms have been assigned. 
Visual checks of the bond lengths and angles should be made to ensure that they are all within 
sensible parameters for that bond type. The thermal parameters should also be visually 
checked as comparatively large or small ellipsoids will highlight any potential disorder or 
incorrect atom assignment. 
All of these checks along with the use PLATON51 will validate the structure and highlight any 
issues. 
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1.11 Powder diffraction 
Powder X-ray diffraction data contains the same structural information as single crystal X-ray 
data, though whereas the latter is in three dimensions, powder data is compressed into one 
dimension30. In powder diffraction, many crystallites satisfy the Bragg criterion for diffraction 
from planes (hkl). Therefore cone-shaped Debye rings are formed (figure 1.11). 
 
Figure 1.11: The diffraction cones formed from the scattered X-rays in powder X-ray 
diffraction 
 
The diffraction data is collected by taking a slice through the Debye ring along 2θ and is then 
compressed into one dimension. This leads to both systematic and accidental peak overlap 
within a powder diffraction pattern and is particularly a problem when the structure has either 
a large unit cell or low symmetry as this gives rise to a higher density of peaks52. The ability 
to be able to solve structures from powder diffraction data is important when single crystals of 
suitable quality or size are difficult to obtain. As in single crystal X-ray diffraction challenges 
do arise, although for the powder method, preferred orientation is the most common sample 
preparation issue. Preferred orientation occurs when the crystallites favour certain orientations 
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as opposed to being randomly oriented. It can potentially be avoided or minimised if a 
capillary tube is used for sample mounting during data collection as opposed to a disc 
especially if the crystallites show a plate-like morphology. 
To solve a crystal structure from powder diffraction data the following process is followed30; 
1. Indexing to obtain lattice parameters, crystal system and space group 
2. Structure solution by producing an approximate model with atomic positions 
3. Structure refinement 
Unlike in single crystal structure determination, these steps are often complex due to the lack 
of data.  
Crystal structure solution from powder diffraction data is limited. Synchrotron data can be 
used to give a better signal/noise ratio and with higher resolution can be used to resolve peak 
overlap to an extent30. Direct space methods are now the most common approach to the 
solution of molecular structures from PXRD. These differ significantly from traditional 
structure solution methods as they approach the problem by movement of a structural model 
around the unit cell, using some form of optimisation algorithm and identify the correct 
structure by agreement with the experimental data. These methods do not use integrated 
intensities directly and utilize information gained from knowledge of the chemical structure 
(more details in chapter 2)53.  
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1.12 Neutron diffraction 
Neutron diffraction data can also be used in the determination of crystal structures and can be 
advantageous when investigating the position of light atoms or distinguishing between 
isotopes. However the requirement of deuteration by recrystallisation can limit the application 
of this technique particularly when investigating cocrystal structures30. As discussed 
previously in this chapter, recrystallisation of crystals can lead to other polymorphic forms 
and the recrystallisation of cocrystals could lead to the formation of alternative 
stoichiometries, or potentially solvated forms of the adduct (particularly if the cocrystal was 
formed using a technique such as grinding where solvent was not required). Another problem 
with neutron diffraction is that it requires a much larger sample size. 
 
1.13 Other complementary techniques 
Solution state 1H NMR spectroscopy is a useful technique in this area as it has the ability to 
indicate the cocrystal stoichiometry by looking at the relevant integration of the different 
hydrogen environments. The NMR spectra will also identify any solvent peaks. Whilst 
solvent could be present in a sample that is not properly dry, it could be that the solvent is 
located within the crystal lattice and forms part of the structure. Solid state NMR 
spectroscopy is a technique that can be used to aid location of hydrogen atoms and crystal 
symmetry, a technique used in many polymorphic studies54. 
Solid state infra-red spectroscopy is a technique that is regularly used to provide vital 
information on the salt vs cocrystal issue, based on the observation of O-H, N-H, C-O and 
C=O bands29 with a direct comparison of the adduct and its coformers indicating whether 
proton transfer could have occurred. 
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1.14 Aims and materials used 
The work reported in this thesis is based upon molecular crystallography and cocrystal design 
with several aims. The field of crystal engineering has expanded significantly within recent 
years and this project aims to provide more structures and results towards the prediction of 
hydrogen bond networks and the relation of properties between coformers and molecular 
adducts. The other primary aim was to develop the ability to solve the structures of multi-
component molecular adducts by powder diffraction and other complementary techniques. 
This would be a significant advantage to the pharmaceutical industry, not only making the 
process quicker and cheaper but enabling the use of alternative methods of cocrystallisation 
such as grinding in which single crystal X-ray diffraction analysis is not always possible. The 
determination of accurate packing and even the determination of salt or cocrystal form from 
powder diffraction is the goal. 
This research focuses on the potential crystalline adducts that can be formed using 
dicarboxylic acids (HO2C(CH2)n-2CO2H) as a series of coformers (table 1.2). These 
dicarboxylic acids were chosen due to their potential to form strong hydrogen bonds at each 
end of the acid and their ability to form the strong synthons discussed in section 1.7. 
Isonicotinamide, nicotinamide and adenine (table 1.2) were selected as the other coformer for 
adduct formation. All three have pKa values that will enhance the probability of obtaining a 
cocrystal rather than a salt with the majority of the acids.  Nicotinamide and isonicotinamide 
contain a heterocyclic nitrogen and an amide group which will form strong hydrogen bonds 
and the adenine molecule provides three strong hydrogen bond acceptor and two strong 
hydrogen bond donor sites. 
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Table 1.2: A table of the coformers studied in this project with their relative pKa values
55. 
pKa
1 refers to the first deprotonation and pKa
2 the second deprotonation. 
 
 
Coformer 
 
 
Molecular structure 
 
 
 
 
 
pKa
 1 
 
 
pKa
 2 
 
Oxalic acid 
n = 2 
 
 
1.27 
 
4.29 
 
 
 
Malonic acid 
n = 3 
 
 
2.85 
 
 
 
5.70 
 
 
Succinic acid 
n = 4 
 
 
4.21 
 
 
 
 
 
5.64 
 
 
Fumaric acid 
n = 4 
 
 
3.02 
 
 
 
 
 
4.38 
 
Maleic acid 
n = 4 
 
 
1.97 
 
 
 
6.24 
 
Glutaric acid 
n = 5 
 
 
 
4.34 
 
 
 
5.41 
 
 
Adipic acid 
n = 6 
 
 
4.43 
 
 
 
 
5.41 
 
Pimelic acid 
n = 7  
 
4.50 
 
 
 
5.43 
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9 
 
 
Suberic acid 
n = 8 
 
 
4.53 
 
 
 
 
 
5.50 
 
Azelaic acid 
n = 9  
 
4.55 
 
 
 
5.50 
 
 
Sebacic acid 
n = 10 
 
 
4.72 
 
 
 
 
5.45 
Undecanedioic 
acid 
n = 11  
 
4.48 
 
 
Isonicotinamide 
 
Heterocyclic 
N: 3.4 
 
Amide: 13.7 
Nicotinamide 
 
Heterocyclic 
N: 3.6 
 
Amide: 13.3 
 
 
Adenine 
 
N1 - 4.1 
 
N9 - 9.8 
 
 
 
 
 
 
 
1 
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2. Methodology 
 
2.1 Single crystal structure solution and refinement 
Structure solution and refinement, by a full-matrix least-squares procedure on F2, were carried 
out using SHELXS97 and SHELXL97 respectively1. All non-hydrogen atoms were refined 
with anisotropic displacement parameters. Electron density maps were used to locate the 
positions of the carboxyl hydrogen atoms, confirming that the crystalline adduct is either in 
neutral cocrystal form or protonated salt form. H atoms were then added at calculated 
positions and refined by use of a riding model with isotropic displacement parameters based 
on the equivalent isotropic displacement parameter (Ueq) of the parent atom. The hydrogen 
atoms that are part of the water molecules in the hydrated structures were manually added and 
fixed as they could not be treated in the same way. WinGX2 was used to prepare the material 
for discussion in the following results chapters for all structures except adenine : pimelic acid 
in which OLEX23 was used. Details of intermolecular interactions occurring in all structures 
were analysed with the aid of PLATON4. DIAMOND5 and ORTEP36 were used to produce all 
of the figures displaying the crystal packing. Details of data collection are given in chapter 3. 
 
2.2 Structure solution from powder diffraction data 
2.2.1: Data handling 
Powder X-ray diffraction data were collected as RAW files and converted to a UXD format 
using Diffract file exchange [XCH], with an in-house Perl-based converter used to create XY, 
GSA and XDD files required for other crystallographic software used later in the structure 
solution process. 
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Information about previously published crystal structures was downloaded from the 
Cambridge Structural Database (CSD) in crystallographic information file (CIF) format7. 
 
2.2.2: Unit cell and space group determination 
The unit cell is determined from the X-ray powder diffraction pattern by means of indexing, 
which generates possible sets of lattice parameters from the selected peak positions with a 
figure of merit used to rank the results. The first 20 peaks in the diffraction pattern were 
selected using XFIT8 and this information was used as an input in CRYSFIRE9. CRYSFIRE 
runs a series of indexing programs using the selected peak positions and collates a summary 
file detailing possible sets of lattice parameters including a figure of merit and unit cell 
volume. Chekcell10 was then used to verify that the peak selection from XFIT and the results 
from CRYSFIRE matched.  The space group was determined by examining the systematic 
absences in the diffraction pattern, using the international crystallographic tables and 
Chekcell10. 
 
2.2.3: Pattern decomposition 
Pattern decomposition was carried out following identification of the unit cell and space 
group in both GSAS11 via the EXPGUI12 platform to create a Le Bail fit13, and in Topas14 to 
create a Pawley fit14. Pattern decomposition is a ‘structureless’ refinement, used in this work 
to achieve more accurate lattice parameters, zero-point and peak shape before structure 
solution is attempted. In this stage of the process, the peak intensities are treated as variables 
to be refined. An R factor (% Rwp) is produced and represents a target agreement that the 
structure solution and refinement steps later in the process aim to achieve.  
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2.2.4: Direct space methods 
Traditional and direct space methods are two distinct approaches that can be used to solve a 
crystal structure once the lattice parameters and space group have been assigned. Traditional 
methods involve extracting individual intensities, I(hkl), from each individual reflection and 
whilst this approach has been successful in solving crystal structures from powder X-ray 
diffraction15-17 the issue of peak overlap in powder X-ray diffraction (section 1.11) makes it 
more difficult to extract reliable intensities from the individual peaks.  
Direct space methods, which have been utilised within this project (chapter 7), are techniques 
in which a ‘trial’ structure is produced. Trial structures are evaluated using the experimental 
diffraction pattern and assigned a figure of merit (% Rwp) or in some cases evaluated using 
chi-squared. The R-factor is a measure of similarity between the ‘trial’ structure and the 
experimental data, comparing the whole diffraction pattern point by point (equation 2.1). 
          √
∑                    
∑            
 
Equation 2.1: % Rwp, where yiobs is the experimentally observed intensity at a value of 2 and 
yicalc is the calculated intensity at 2 
 
A number of variables or structural parameters need to be considered when defining a 
problem using direct space methods. These are commonly categorized in three groups; the 
position of the molecule(s) or fragment(s) within the unit cell (x,y,z), the orientation of the 
molecule(s) or fragment(s) (,Φ,Ψ) and any freely rotating sections within the molecule(s) 
(τ1-τn). The dimensionality of hypersurface of Rwp is then defined by these variables. 
Incorporation of prior crystallographic and chemical knowledge reduces the dimensionality 
and makes this process more efficient, e.g. prior chemical knowledge of benzene means only 
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6 parameters need to be considered as opposed to 18 if treated as six individual atoms. In this 
project, the molecular model was created in Chem 3D pro18 and then converted and described 
by a list of elements. POSSUM19 (a cross-platform suite program package) was used to input 
the different variables defining the structural model (such as the number of freely rotating 
bonds in the molecules), starting points for the calculation and other data before undergoing 
an optimisation. 
A number of optimisation techniques are available for direct space methods including Monte 
Carlo20,21, simulated annealing22,23, genetic algorithms24,25 and grid searches26. This study uses 
the differential evolution method, an evolutionary algorithm using a population based 
optimisation technique (described further in section 2.2.5). 
 
2.2.5: Differential evolution 
Differential evolution (DE) is a population based optimisation technique that maintains a 
number of trial structures which produce offspring through a combination of mutation and 
recombination (equation 2.2).  
 
Offspring = Parent + K (Random1 – Parent) + F (Random2 – Random3) 
Equation 2.2: The creation of a trial structure from members of the previous population. K is 
the recombination factor and F the mutation factor 
 
The calculation begins with trial structures spread across the hypersurface, each described by 
a set of elements with the structural parameters (x,y,z,,Φ,Ψ,τ1-τn) chosen at random. Each 
member of the population is a trial structure whose fitness is measured by % Rwp (comparison 
of the trial structure to the experimental data). Each member then produces an offspring 
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structure using equation 2.2. If the offspring is fitter than its parent, i.e. has a lower Rwp, it 
replaces the parent structure which is then discarded; if not the parent remains in the 
population and the offspring is discarded. This process continues with the mean % Rwp of each 
generation and the best individual % Rwp been monitored. Convergence is achieved when 
these two values are equal. The process is fast and relatively efficient although local minima 
are sometimes located rather than the global minimum (figure 2.1) 
 
Figure 2.1: An example of local minimum and the global minimum on an energy 
hypersurface. Figure taken from reference 27 
  
To try and avoid this problem, a diverse initial population is used. The initial recombination 
and mutation vectors between the population are likely to be large due to the random diverse 
distribution, and will consequently produce diverse offspring. Progression of the calculation 
will result in the population becoming less diverse, leading to a shortening of vectors, and 
eventually convergence of the calculation (figure 2.2). 
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Figure 2.2: Production of an offspring trial structure using a combination of variables of the 
parent and randomly selected individuals (R1, R2 and R3) 
 
The recombination vector K, represents the difference between genetic material from the 
parent to one random member, R1. The mutation vector F, represents the difference in 
parameters between two random members of the population, R2 and R3. The mutation 
component establishes significant differences between the child and its original parent to 
avoid premature convergence in local minima. The scaling of these vectors (values of K and 
F) can be defined in POSSUM19 along with other data. A vector that is too large may miss 
narrow minima, whereas if it is too small, convergence may lead to a local minima. The DE 
calculation also uses boundary conditions to keep the search within a defined space, using 
prior crystallographic knowledge to direct the search. The DE process can be used to give a 
structure solution that is used as the starting point for Rietveld refinement28 in which more 
flexible structural features are introduced. 
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2.2.6: Rietveld refinements 
Rietveld refinement uses a least-squares approach to obtain an optimal fit between an 
observed experimental diffraction pattern and a calculated diffraction pattern simulated from 
the model structure such as that obtained from DE. The refinement considers every point in 
the powder diffraction pattern as an individual intensity and compares it to the simulated data, 
again using % Rwp as a figure of merit. Variables relating to both the crystal structure and 
instrumentation are adjusted to achieve the optimal fit28. To ensure refinements are chemically 
acceptable, geometric restraints can be applied to the bond lengths and angles based upon 
prior chemical knowledge and standard molecular geometries29.  Rietveld refinement can be 
carried out using a number of different software packages. In this project GSAS11 and Topas14 
were the programs of choice. 
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3. Experimental  
 
3.1 Synthesis by solvent-mediated crystallisation 
Stoichiometric amounts of the cocrystal components (approximately 0.1 g) were dissolved in 
a suitable solvent added dropwise (approximately 20 ml, though when dissolving adenine 
significantly more solvent was required, approximately 50 ml). The solutions were heated and 
stirred until all starting material had dissolved and the solutions were both filtered (through 
hot filtration) into the same conical flask. The solution was allowed to crystallise over time 
before being dried under suction for approximately one hour. All experiments were carried 
out at room temperature and pressure. The experiments were repeated using a different 
solvent. This experimental procedure was followed for all systems presented in this thesis 
using both methanol and ethanol as initial and repeat choice of solvent unless otherwise 
stated. The length of time for cocrystallisation varies from two days to two months with the 
longer chain acid cocrystals taking the longest. 
 
3.2 Synthesis by solvent-mediated crystallisation using multi-reaction rack 
Stoichiometric amounts (approximately 0.05 g) of the cocrystal components were added to a 
20ml vial suitable for use in a multi-reaction rack. The Anachem Reactarray Microvate multi-
reaction rack, model RAR-12 can hold 24 samples and allows accurate temperature control 
over each strip of four holders with a global stirring control. A suitable solvent (methanol) 
was added dropwise and the vial placed into the rack. The multi-reaction rack was 
programmed to heat from room temperature to 60 ºC at a ramp rate of 5 ºC per minute, to hold 
for 1 hour allowing the starting materials to dissolve and then to drop to 25 ºC at a ramp rate 
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of 5 ºC per minute, with stirring for the first 75 minutes. The resultant solution was left over 
time to crystallise and was then dried under suction for approximately one hour. All 
experiments were carried out at room temperature and pressure. 
 
3.3 Powder X-ray diffraction 
3.3.1 Laboratory diffraction data 
Datasets were collected using a Bruker AXS D8 high resolution powder diffractometer in 
transmission mode. The sample was mounted on clear transparent tape and held in place on a 
PMMA transmission sample ring as a thin disc of approxiamately 8mm diameter. The 
wavelength used was λ = 1.5406 Å (CuKα1) generated by a sealed-tube X-ray source and 
selected using a germanium crystal monochromator. A 1mm exit slit and 1° mototrised 
divergence slit were used and the detector was a solid-state LynxEye position sensitive 
detector (PSD) covering 3º in 2. The data were collected over a 2 range of 5º <2 <70º and 
the step size was 0.0198º. The data were collected over 20 minutes. 
 
3.3.2 High resolution diffraction data 
The high resolution synchrotron X-ray powder diffraction data was obtained from beamline 
I11 at Diamond Light Source over a 2θ range of 0.955˚– 151.74˚ (λ = 1.035467 Å). Data were 
collected at room temperature at various positions of the sample to avoid beam damage (three 
positions at 4mm intervals if the amount of sample permitted) with the datasets combined. 
The data were collected for either 10 minutes or 15 minutes at each position. 
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3.4 Single crystal X-ray diffraction 
Single crystal X-ray diffraction data collection has been carried out using five different 
diffractometers, including one at a synchrotron source. Details of the instruments used and a 
list of which diffractometer was used for each data collection are given overleaf (table 3.1). 
 
3.4.1 Diffractometer 1; Bruker APEX II CCD  
Data were collected from suitable crystals on a Bruker APEX II CCD diffractometer at the 
window of a Bruker FR591 rotating anode (λMo-Kα = 0.71073 Å) at 120 K by the UK National 
Crystallography Service1. The data collections were driven by COLLECT2 and processed by 
DENZO3. Absorption corrections were applied using SADABS4. Structure solution and 
refinement details are given in chapter 2. 
 
3.4.2 Diffractometer 2; Bruker CCD  
Data were collected from suitable crystals on a Bruker CCD diffractometer at the window of a 
Bruker FR591 rotating anode (λMo-Kα = 0.71073 Å) at 120 K by the UK National 
Crystallography Service1. The data collections were driven by COLLECT2 and processed by 
DENZO3. Absorption corrections were applied using SADABS4. Structure solution and 
refinement details are given in chapter 2. 
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3.4.3 Diffractometer 3; Bruker SMART 6000  
Data were collected from suitable crystals on a Bruker SMART 6000 diffractometer (λCu-Kα = 
1.54184 Å) at 120 K in the School of Chemistry at the University of Birmingham. The data 
collections were driven by SMART5 and processed by SAINT6. Absorption corrections were 
applied using SADABS4. Structure solution and refinement details are given in chapter 2. 
 
3.4.4 Diffractometer 4; Rigaku Kappa 3 circle 
Data were collected from suitable crystals on a Kappa 3 circle diffractometer equipped with a 
Rigaku Saturn 724 CCD detector (λ = 0.71075 Å) at the UK National Crystallography 
Service1. The data were collected at 100 K, and the data collections were driven and 
processed by CrystalClear-SM Expert 2.0r77. Absorption corrections were applied using 
CrystalClear-SM Expert 2.0r77. Structure solution and refinement details are given in chapter 
2. 
 
3.4.5 Diffractometer 5; Synchrotron 4-circle  
Data were collected from a suitable crystal on a Crystal Logic 4-circle kappa diffractometer 
equipped with a Rigaku Saturn 724 CCD detector using synchrotron radiation (λ = 0.68890 Å) 
at beamline I19 at Diamond Light Source by the UK National Crystallography Service1. The 
data were collected at 100 K, and the data collection was driven and processed by 
CrystalClear-SM Expert 2.0r58. Structure solution and refinement details are given in chapter 
2. 
 
 
 
3. Experimental Page 49 
 
Table 3.1: Details of the single crystal diffractometers used for data collection of specific 
crystal structures  
System Chapter Diffractometer 
Adeninium : malonate 4 Diffractometer 3; Bruker SMART 6000 
Adenine : succinic acid 4 Diffractometer 1; Bruker APEX II CCD 
Adenine : fumarate 4 Diffractometer 1; Bruker APEX II CCD 
Adeninium : hydrogen maleate 4 Diffractometer 5; Synchrotron 4-circle 
Adeninium : hydrogen maleate 
methanolate 
4 Diffractometer 3; Bruker SMART 6000 
Adenine : pimelic acid 4 Diffractometer 4; Rigaku Kappa 3 circle 
Adenine : suberic acid 4 Diffractometer 4; Rigaku Kappa 3 circle 
Azelaic acid 4 Diffractometer 3; Bruker SMART 6000 
Adenine : sebacic acid 4 Diffractometer 3; Bruker SMART 6000 
Isonicotinamide : pimelic acid 5 Diffractometer 2; Bruker CCD 
Isonicotinamide :suberic acid 5 Diffractometer 1; Bruker APEX II CCD 
Isonicotinamide : azelaic acid 5 Diffractometer 1; Bruker APEX II CCD 
Nicotinamide : succinic acid 6 Diffractometer 1; Bruker APEX II CCD 
Nicotinamide : undecanedioic acid 6 Diffractometer 3; Bruker SMART 6000 
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3.5 Solution 1H NMR Spectroscopy 
The solution state 1H NMR spectra were recorded on a Bruker AVIII300 spectrometer. The 
spectra were recorded at 300.18 MHz with a 5 mm quad probe using residual solvent as a 
reference. A small amount of each sample (approximately 5 – 25 mg) was used, dissolved in 
d6 DMSO. 
 
3.6 Melting point measurements 
Melting point measurements were made on a Stuart Scientific Melting Point SMP1 machine. 
The sample were placed into a 100 mm long capillary tube with inner dimension of 1.3 mm 
before being inserted into the melting point machine along with a standard thermometer that 
measures up to 360°. The melting point machine was turned on to heat gently and the melting 
point read. Each melting point was measured twice with an average taken.  
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4. Adenine: tautomerism, cocrystallisation, salt formation and 
solvation  
 
4.1 Introduction 
 
  
(a) (b) 
Figure 4.1: (a) The most stable tautomer of adenine, showing the numbering scheme used 
when discussing tautomeric forms and (b) the adenine-thymine base pair 
 
Adenine (figure 4.1 (a)), a nucleobase with several uses in biochemistry1, is an integral part of 
both DNA and RNA. Adenine hydrogen bonds with thymine (figure 4.1 (b)) to form a base 
pair stabilising the DNA double helix (along with a guanine-cytosine base pair) and forms a 
base pair with uracil in RNA, aiding protein synthesis2,3. Not only does it play an important 
part within the structure of DNA, it has multiple hydrogen bond donor and acceptor sites, 
giving it the opportunity to form strong heteromeric synthons between itself and other 
molecules. 
Adenine exists in fourteen different tautomeric forms which can be problematic, for example 
it can cause spontaneous mutations in DNA4,5. Investigation of twelve of these different 
tautomers, focussing on the relative stabilities and ionisation energies found that the natural 
form of adenine, tautomer 9H (figure 4.2), is the most stable, followed by tautomers 3H and 
7H respectively5. 
Adenine: tautomerism, cocrystallisation, salt formation and solvation Page 52 
 
  
 
 
 
 
 
Whilst there is limited previous research into adenine complexes, it has been identified as a 
good cocrystal former as it contains a number of strong hydrogen bond donor and acceptor 
sites and is known to form crystalline complexes, for example with metal ions6 and hydrated 
crystalline complexes such as adenine : riboflavin7. Appendix 1.1 and 1.2 contain tables 
displaying the results of a CSD (Cambridge Structural Database) of all known adenine 
complexes to date (both neutral and protonated adeninium ion forms) and their relative 
tautomeric form. Previous publications have reported that adenine has formed crystalline 
complexes with three dicarboxylic acids; oxalic acid8, maleic acid1,9 and adipic acid10 and 
these will be discussed in detail later in the chapter. 
This chapter focuses on the synthesis and characterisation of a number of crystalline adducts 
formed by adenine and a range of dicarboxylic acids, HO2C(CH2)n-2CO2H with a carbon 
chain length (n) between two and ten.  There are a few cocrystals and salts reported for 
adenine but relatively few of these contain dicarboxylic acids. As such, no trend in structure 
or properties has yet been established for adenine : dicarboxylic acid adducts, although a 
number of possible motifs between adenine and the dicarboxylic acid along with possible 
dimer formations of adenine have been identified for the most stable three tautomers of 
adenine as shown in table 4.1. 
Figure 4.2: The three most stable tautomers of adenine; (a) 9H, (b) 3H and (c) 7H 
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Table 4.1: Possible adenine - acid and adenine - adenine bonding motifs  
9H tautomer 
Adenine - acid 
 
 
 
 
9H-I 
 
 
9H-II 
 
 
9H-III 
 
 
 
 
9H-IV 
 
 
9H-V 
 
 
 
9H-VI 
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9H-VII 
 
 
9H-VIII 
 
 
9H-IX 
Adenine dimers 
 
 
 
9H-X 
 
 
9H-XI 
 
 
9H-XII 
 
 
 
9H-XIII 
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9H-XV 
 
 
 
9H-XVI 
 
 
3H tautomer 
Adenine - acid 
 
 
 
3H-I 
 
 
3H-II 
 
 
3H-III 
 
 
 
 
3H-IV 
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3H-V 
 
 
 
3H-VI 
 
 
3H-VII 
 
 
 
3H-VIII 
 
 
3H-IX 
Adenine dimers 
 
 
 
3H-X 
 
 
3H-XI 
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3H-XII 
 
 
 
3H-XIII 
 
 
 
3H-XIV 
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7H tautomer 
Adenine - acid 
 
 
 
 
7H-I 
 
 
7H-II 
 
 
 
7H-III 
 
 
 
 
7H-IV 
 
 
7H-V 
 
 
 
7H-VI 
 
 
 
7H-VII 
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Adenine dimers 
 
 
7H-VIII 
 
 
7H-IX 
 
 
 
7H-X 
 
 
It is clear from this table that there are many possible motifs for the different tautomers, 
including a number of dimer options, with additional alternatives possible for the adeninium 
form. From the study of both previously reported adenine complexes and the structure of 
adenine itself it is found that an adenine dimer motif is very popular1,2,6,7,9,10. Structure 
descriptions of adenine complexes are often described using base pairs, Watson-Crick and 
Hoogsteen edges. Figure 4.3 shows an example of carboxylic acids bonding to an adenine 
molecule on the base (B), Watson-Crick edge (W-C) and the Hoogsteen edge (H).  
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Figure 4.3: An example of adenine molecule as the 9H tautomer forming motifs with 
carboxylic acids on the base (b), Watson-Crick (WC) and Hoogsteen (H) edges 
 
The consideration of possible hydrogen bonding motifs is not the only variable in prediction 
of the structure of a crystalline adduct; the pKa difference of the coformers can also give 
insight into whether proton transfer is likely to occur, thus resulting in salt (in this case 
adeninium) rather than cocrystal formation. A pKa difference greater than 2 - 3 is often used 
to indicate that salt formation will dominate11, although there are anomalies to this ‘rule’. The 
pKa values of all of the coformers investigated in this chapter are given in table 4.2. 
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9 
Table 4.2: A table of pKa values for the coformers investigated
12. pKa
1 refers to the pKa of the 
first acid deprotonation and pKa
2 then refers to that of the second. 
Coformer Chemdraw pKa 
 
 
Adenine 
 
N1 - 4.1 
 
N9 - 9.8 
 
 
 
 pKa
1 pKa
2 
   
 
Oxalic acid 
 
 
1.27 4.29 
 
 
 
 
Malonic acid 
 
2.85 
 
 
 
5.70 
 
 
Succinic acid 
 
4.21 
 
 
 
 
 
5.64 
 
 
Fumaric acid 
 
3.02 
 
 
 
 
 
4.38 
 
Maleic acid 
 
1.97 
 
 
 
6.24 
 
Glutaric acid 
 
4.34 
 
 
 
5.41 
 
 
Adipic acid 
 
4.43 
 
 
 
 
5.41 
1 
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Pimelic acid 
 
4.50 
 
 
 
5.43 
 
 
Suberic acid 
 
4.53 
 
 
 
 
 
5.50 
 
Azelaic acid 
 
4.55 
 
 
 
5.50 
 
 
Sebacic acid 
 
4.72 
 
 
 
 
5.45 
 
Undecanedioic 
acid 
 
 
4.48 
 
 
 
These pKa values suggest that cocrystal formation will predominate for adducts of adenine 
with carboxylic acids with n≥5, and that cocrystals will most likely be formed with malonic, 
succinic acid and fumaric acid, but that for oxalic and maleic acid, salt formation is the most 
likely outcome. 
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4.2 Previously known structures 
There are five previously reported adenine adducts with dicarboxylic acids from the set of 
coformers considered here; two adeninium : oxalate (n = 2) salts, one of which is chlorinated 
and the other hydrated8, an adeninium : adenine : maleate (n = 4) hydrated salt1, a second 
adeninium : maleate hydrated salt (incorrectly reported in the literature as adeninium : 
succinate)9 and an adenine : adipic acid (n = 6) 2:1 solvated cocrystal10. As comparison of the 
motifs and hydrogen bonded networks of both published and new structures is essential the 
crystal packing found within these published adducts along with the structure of pure adenine 
will be discussed in detail first. 
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4.2.1 – Adenine 
 
Figure 4.4: A view of the pure adenine structure, displaying the two adenine dimer motifs 
present which form infinite sheets. Hydrogen bonds are shown as dashed lines. 
 
The structure of adenine has been published by Mahaptra et al2, though it has since been 
found to be disordered by a Tremayne and co-workers who successfully solved the structure 
from powder X-ray diffraction13 (figure 4.4). Infinite hydrogen bonded sheets are formed 
through two different adenine dimer motifs, which stack to form the adenine structure. The 
dimers present in this structure are based on the 9H tautomer motifs 9H-X and 9H-XIII, both 
of which are observed in the structures presented later in this chapter. 
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4.2.2 – Adeninium : oxalate : chlorine solvate 2:1:2 
 
Figure 4.5: A view of the chlorinated adeninium : oxalate salt8. Hydrogen bonds are shown as 
dashed lines 
 
The chlorinated adeninium : oxalate salt has a 2:1:2 adeninium : oxalate : chlorine 
stoichiometry in which the oxalic acid has been bideprotonated (figure 4.5). The pKa 
difference between these two coformers is greater than two, therefore the formation of a salt 
as opposed to a cocrystal was to be expected, although surprisingly the structure does not 
contain adenine dimers as seen in many other adenine and adeninium structures. With both of 
the carboxyl groups on the oxalic acid deprotonated, the adeninium ions exist in the 
1H,7H,9H tautomeric form. The adeninium and oxalate molecules link to form )8(22R ring 
motifs14 based on motif 9H-VII but in an alternative tautomeric form. A secondary ring motif 
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is formed where N9 acts as a double donor, donating to two oxygen molecules to the oxalates. 
The chlorine molecules bond only to the adeninium molecules and not to the oxalates8.  
 
4.2.3 – Adeninium : hydrogen oxalate : oxalate : hydrate 2:2:1:2 
 
Figure 4.6: A view of the hydrated adeninium : oxalate salt structure8. Hydrogen bonds are 
shown as dashed lines 
 
The hydrated adeninium : hydrogen oxalate salt structure is similar to the chlorinated structure 
in that no adenine dimer is present. The adeninium molecules exist in the 1H,9H tautomeric 
form with the asymmetric unit containing one adeninium cation, one hydrogen oxalate anion, 
half an oxalic acid and a disordered water molecule (figure 4.6). The structure consists of a 
)9(22R acid-Hoogsteen ring motif between the adeninium and the oxalate based on motif 9H-
IX but with a protonated adeninium. A second ring motif is present similar to one seen in the 
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chlorinated structure in which N9 acts as a double donor. Like the chlorine molecules in the 
previous oxalate structure, the water molecules bond solely to the adeninium ions8.  
 
4.2.4 – Adeninium : adenine : hydrogen maleate : hydrate 2:2:1:2 
 
Figure 4.7: A view of the adeninium : hydrogen maleate hydrated structure1 with a mixture of 
neutral and protonated adenine units, hydrogen bonding to the hydrogen maleate anions1. 
Hydrogen bonds are shown as dashed lines 
 
The McHugh et al hydrated salt of adeninium : adenine : hydrogen maleate has an asymmetric 
unit containing two adeninium cations, two hydrogen maleate anions, one neutral adenine and 
two water molecules. The neutral adenine molecule exists in a less stable tautomeric form 
than the adenine starting material (not 9H but 7H) with the adeninium cations existing as the 
1H,9H tautomer (figure 4.7). The structure is built up of trimer units of adenine and 
adeninium, based on a )10(22R ring motif between the two adeninium cations (motif 9H-XII) 
and a second )8(22R ring motif formed between the neutral 7H adenine molecule and a 1H,9H 
adeninium dimer using a protonated Watson-Crick to adenine base synthon. As this adenine-
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adeninium dimer motif is formed between molecules of different tautomeric form, this motif 
is not displayed in table 4.1 with the other adenine dimer synthons. This trimer unit is linked 
to another trimer through the formation of an adenine – adenine )8(22R dimer, 7H-IX, and is 
surrounded by maleate ions bonded either via )9(22R or )8(
2
2R ring motifs or as a chain. There 
is a water molecule interacting with each maleate ion but never to an adenine unit1.  
 
4.2.5 – Adeninium : hydrogen maleate : hydrate 1:1:1 
 
Figure 4.8: A view of the adeninium : maleate hydrated salt structure8 with adeninium dimer 
units hydrogen bonding to hydrogen maleate anions. Hydrogen bonds are shown as dashed 
lines 
 
The Sridhar et al hydrated adeninium : hydrogen maleate structure is a 1:1:1 salt with the 
adeninium in the most stable 1H,9H tautomeric form (figure 4.8). The structure contains an 
adeninium based )10(22R dimer, motif 9H-XII (table 4.1), with each adeninium ion interacting 
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with two hydrogen maleates. One linkage is an acid-amide )8(22R ring motif, motif 9H-VII, 
whereas the other is an acid-pyridine chain motif, motif 9H-VI. Again the water molecules are 
involved in hydrogen bonds only to the maleate ions9.  
 
4.2.6 – Adenine : adipic acid : methanolate 2:1:2 
 
Figure 4.9: A view of the solvated adenine : adipic acid : methanolate cocrystal structure10. 
Hydrogen bonds are shown as dashed lines 
 
The adenine : adipic acid : methanolate structure (2:1:2) contains adenine as the 9H tautomer. 
Two adenine molecules form an adenine )8(22R dimer, motif 9H-XI, with a third adenine 
molecule interacting with the dimer through two methanol molecules in a )12(44R  ring (figure 
4.9). The solvate molecules essentially disrupt the formation of a second adenine dimer (9H-
X). These units are capped at each end by adipic acid molecules which form adenine-acid 
)9(22R ring motifs (motif 9H-IX). The overall structure forms a large )42(
10
10R  ring motif
10. 
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 4.3 Adenine : oxalic acid 
With both a hydrated and chlorinated adeninium : oxalate salt structure already known, the 
focus of this study was to synthesise an anhydrous, neutral cocrystal. The experimental 
procedure followed is described in chapter 3, using methanol, ethanol and ethyl acetate as 
solvents. Figure 4.10 shows the powder X-ray diffraction patterns for the products of 
crystallisation, compared with those of the starting materials and the published salt structures. 
 
 
Figure 4.10: Powder diffraction patterns of the products of crystallisation compared to those 
of the starting materials and published salt structures 
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From this comparison it can be easily identified that none of the three adducts formed are the 
same as the published structures or the starting materials. Whilst the resultant adducts from 
methanol and ethanol are the same, that synthesised from ethyl acetate is different, suggesting 
the formation of two distinct materials, though those from methanol and ethanol may be a 
very poor quality adenine. Solution 1H NMR analysis on the product of ethyl acetate 
crystallisation has not been possible to date, but is the next stage of structure solution on what 
may be another new and exciting system. The published materials were synthesised in a 
similar way, using hydrochloric acid as the solvent for the chloride structure and water as the 
solvent for the hydrated form8. 
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4.4 Adeninium : hydrogen malonate  
Adenine was crystallised with malonic acid following the synthetic procedure detailed in 
chapter 3 and produced a new material as confirmed by powder X-ray diffraction below 
(figure 4.11). 
 
Figure 4.11: Powder X-ray diffraction data for the product of adenine and malonic acid 
cocrystallisation and the starting materials 
The data shows that both products of crystallisation differ from the starting materials. The 
diffraction pattern of the product from ethanol displays small peaks at 10 - 15° in 2-theta that 
are not apparent in the pattern of the sample obtained from methanol. This could indicate that 
two new materials have formed or that one sample is a mixture. Solution 1H NMR 
spectroscopy was carried out on both samples (appendix 2.1) and it was found that both 
consisted of both adenine and malonic acid, both with a 1:1 stoichiometry, though the ratios 
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obtained from the NMR signals for the sample crystallised in ethanol are not as exact as in the 
methanol sample, providing further indication of the ethanol sample being a mixture. 
A crystal of suitable quality from the sample synthesised in ethanol was identified and 
selected for structure determination by single crystal diffraction. The structure solution 
established this adduct as an anhydrous 1:1 salt crystallising in a triclinic cell with space 
group P-1 (table 4.3). However, the quality of the dataset was poor and consequently the 
structure has a low completeness and a high excess of electron density, although it is good 
enough to enable study of the hydrogen bond motifs and the crystal packing.  
 
Table 4.3: Cell parameters for adeninium : hydrogen malonate, 1:1 
Compound Adeninium :hydrogen malonate 1:1 
a (Å) 4.8942(3) 
b (Å) 8.1034(4) 
c (Å) 12.5052(6) 
α (°) 82.944(3) 
β (°) 86.677(3) 
γ (°) 79.855(4) 
Volume (Å3) 484.17(4) 
Z 
T (K) 
Reflections collected 
Independent reflections 
R(int) 
2 
120(2) 
4730 
1725 
0.0288 
Goodness of fit 1.168 
R1 (observed) 0.0991 
R1 (all) 0.1097 
wR2 (observed) 0.12512 
wR2 (all) 0.2680 
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The position of the hydrogen atoms were determined by an electron density map confirming 
the structure to be a salt, since proton transfer occurred from the malonic acid to the adenine. 
The diffraction pattern simulated from the structure solved by single crystal methods is the 
same as that of the experimental laboratory powder X-ray diffraction pattern confirming that 
the crystal chosen is representative of the bulk material (appendix 2.2). Table 4.4 lists the nine 
intermolecular and intramolecular hydrogen bonds, whilst table 4.5 details selected bond 
lengths and angles (full crystallographic details and intramolecular bonds are given in 
appendix 2). Figure 4.12 shows the numbering scheme used.  
 
 
Figure 4.12: The independent molecules of adeninium : hydrogen malonate acid showing the 
atom-numbering scheme and the hard intermolecular hydrogen-bonds (shown as dashed 
lines). Displacement ellipsoids are drawn at 50% probability level 
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Table 4.4: Hydrogen bond table for adeninium : hydrogen malonate, 1:1  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
O12-H12...O10 0.84 1.68 2.461(3) 154.0 
N2-H2...N4i 0.88 2.10 2.926(4) 157.2 
N2-H2...O13ii 0.88 2.65 3.074(4) 110.6 
N6-H6...O10 0.88 1.78 2.662(4) 176.6 
N7-H7A...O11 0.88 1.93 2.807(4) 174.5 
N7-H7B...N9iii 0.88 2.01 2.872(4) 164.3 
C1-H1...O13ii 0.95 2.36 2.977(5) 121.8 
C5-H5...O12ii 0.95 2.37 3.297(5) 165.0 
C5-H5...O13ii 0.95 2.44 3.222(4) 139.8 
Symmetry transformations used to generate equivalent atoms: 
(i) –x-1, -y+1, -z+1    (ii) x-1, y, z-1   (iii) -x+1, -y, -z+1  
 
Table 4.5: Selected intramolecular bond lengths (Å) and angles (°) for adeninium : hydrogen 
malonate, 1:1 
Bond lengths (Å) Bond angles (°) Torsion angles (°) 
C10-O10 1.267(4) O10-C10-O11 124.4(3) O10-C10-C12-O12 -0.4(3) 
C10-O11 1.248(4) O12-C12-O13 120.7(3) O11-C10-C13-O14 -1.6(9) 
C12-O12 1.319(4) C1-N9-C8 104.0(3) H7B-N7-C7-N6 -180.0(3) 
C12-O13 1.205(5) C1-N2-C3 106.5(3) H7B-N7-C7-C8 0.4(6) 
  C3-N4-C5 112.2(3) O10-C10-C12-O12 -0.4(3) 
  C5-N6-C7 124.0(3)   
  C1-N9-C8 104.0(3)   
  C1-N2-C3 106.5(3)   
 
The asymmetric unit contains an adeninium cation along with a hydrogen malonate anion. 
The adeninium exists in its most stable 9H tautomeric form, with protonation on the 1H 
position; the 1H,9H tautomer is commonly seen in other molecular salts as can be seen from 
the table displayed in appendix 1.2. The coformers hydrogen bond to one another to form a 
Adenine: tautomerism, cocrystallisation, salt formation and solvation Page 76 
 
popular )8(22R ring motif (motif 9H-VII) on the Watson-Crick edge. The C10-O10 and C10-
O11 bond lengths show no clear distinction, indicative of a deprotonated carboxyl, suggesting 
the deprotonation of the hydrogen to the adenine molecule, further confirmed by the larger 
endocyclic angle around the protonated site; C5-N6-C7 of 124.0(3)°, approximately 4° larger 
than in a neutral adenine structure. 
The coformers are linked by the amide N7 donating H7A to O11 and the heterocyclic N6 
donating H6 to O10. There is one further hydrogen bond within the asymmetric unit, an 
intermolecular interaction between the carboxyl groups on the hydrogen malonate, donated by 
O12 through H12 to O10 (figure 4.12). The adeninium forms a chain with neighbouring 
adeninium molecules, the first linkage formed through a complementary hydrogen bond 
donated by N7 to N9 via H7B, creating an )10(22R  ring motif (motif 9H-XII) and the second, 
motif 9H-X, formed by a complementary bond being donated by N2 to N4 via H2, resulting 
in an )8(22R ring motif. This can be viewed as a unit of repeating adeninium dimers creating 
an infinite chain of adeninium cations which are linked to other adeninium chains through 
hydrogen malonate molecules to form a planar sheet. These linkages arise through the 
adeninium : malonate )8(22R ring motif within the asymmetric unit along with a further two 
hydrogen bond motifs. The first of these is an )5(12R ring formed by combination of a hard 
hydrogen bond donated by the heterocyclic N2 via H2 to O13 and a soft hydrogen bond, also 
accepted by O13, but formed by donation of H1 by heterocyclic C1. The second utilises the 
heterocyclic C5 as a double donor of H5 to both O12 and O13, forming an )5(21R ring motif 
(figure 4.13). All strong hydrogen bond donors and acceptors are used within this structure, 
with N2 and C5 being double donors and O13 an acceptor of three hydrogen bonds. 
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Figure 4.13: A view of adeninium : hydrogen malonate, 1:1. Hydrogen bonds are shown as 
dashed lines 
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4.5 Adenine : succinic acid 
Adenine was cocrystallised with succinic acid following the experimental procedure outlined 
in chapter 3, to produce a new material as confirmed by powder X-ray diffraction below 
(figure 4.14). 
 
Figure 4.14: Powder X-ray diffraction data for the product of adenine and succinic acid 
cocrystallisation and the starting materials 
 
It is clear from the above powder diffraction patterns that a new material has been formed, 
with a stoichiometry of 1:1 of both coformers determined by 1H NMR spectroscopy 
(appendix 3.1). 
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Single crystal X-ray diffraction data were collected at the UK National Crystallography 
Service15 and the adduct was found to crystallise in a monoclinic cell with a space group of 
P21/n (table 4.6).  
Table 4.6: Cell parameters for adenine : succinic acid, 1:1 
Compound Adenine : succinic acid 1:1 
a (Å) 9.4902(4) 
b (Å) 5.3041(3) 
c (Å) 21.2846(8) 
α (°) 90 
β (°) 92.398(3) 
γ (°) 90 
Volume (Å3) 
T (K) 
1070.46(9) 
120(2) 
Z 
Reflections collected 
Independent reflections 
R(int) 
4 
8933 
2426 
0.0485 
Goodness of fit 1.114 
R1 (observed) 0.0586 
R1 (all) 0.0817 
wR2 (observed) 0.1123 
wR2 (all) 0.1257 
 
The position of the hydrogen atoms were determined by an electron density map confirming 
the structure to be a cocrystal, since no proton transfer occurred from the acid to the adenine. 
The powder diffraction pattern simulated from the structure solved from single crystal data is 
the same as that of the experimental laboratory powder X-ray diffraction pattern confirming 
that the crystal chosen is representative of the bulk material (appendix 3.2). Table 4.7 lists the 
seven intermolecular hydrogen bonds that make up the cocrystal structure; Table 4.8 details 
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selected bond lengths and angles and figure 4.15 shows the numbering scheme used. Full 
crystallographic details and intramolecular bonds and angles can be found in appendix 3. 
 
Figure 4.15: The independent molecules of adenine : succinic acid showing the atom-
numbering scheme and the hard intermolecular hydrogen-bonds (shown as dashed lines). 
Displacement ellipsoids are drawn at 50% probability level 
 
 
 Table 4.7: Intermolecular hydrogen bonding (Å) for adenine : succinic acid, 1:1  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
N2-H2...N4i 0.88 1.96 2.825(3) 166.4 
N7-H7A...O11ii 0.88 2.04 2.875(2) 157.3 
N7-H7B...O11 0.88 2.05 2.924(3) 171.7 
O10-H10...N9  0.84 1.80 2.630(3) 167.0 
O13-H13...N6iii 0.84 1.87 2.686(2) 162.9 
C1-H1...O14iv 0.95 2.38 3.077(3) 129.9 
C5-H5...O14v 0.95 2.43 3.213(2) 139.9 
Symmetry transformations used to generate equivalent atoms: 
(i) –x, -y+3, -z    (ii) –x+0.5, y+0.5, -z+0.5  (iii) –x+0.5, y+1.5, -z+0.5  
(iv) –x+1, -y+1, -z    (v) x-1, y+2, z 
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Table 4.8: Selected bond lengths (Å) and angles (°) for  adenine : succinic acid, 1:1 
Bond lengths (Å) Bond angles (°) Torsion angles (°) 
C10-O10 1.304(3) O10-C10-O11 122.8(2) O10-C10-C13-O13 -176.4(2) 
C10-O11 1.220(3) O13-C13-O14 120.0(2) O11-C10-C13-O14 -177.0(2) 
C13-O13 1.330(3) C1-N9-C8 103.6(2) H7B-N7-C7-N6 -180.0(2) 
C13-O14 1.206(3) C1-N2-C3 106.7(2) H7B-N7-C7-C8 -180.0(2) 
 C3-N4-C5 111.1(2) O10-C10-C13-O13 -176.4(2) 
C5-N6-C7 119.2(2)  
O10-C10-O11 122.8(2) 
 O13-C13-O14 120.0(2) 
 
In the crystal structure of adenine : succinic acid, the asymmetric unit consists of one neutral 
adenine molecule in the most stable and expected 9H tautomeric form and one succinic acid 
(figure 4.15). There is clear discrimination between the length of the C-OH and C=O bonds in 
the succinic acid molecule (table 4.7) indicating that both carboxyl groups have retained their 
acidic protons, and the endocyclic C-N-C angles further confirm the presence of the 9H 
tautomer with C1-N2-C3 of 106.7(2)° approximately 3° larger than the unprotonated nitrogen 
site (C1-N9-C8 of 103.6(2)°) (table 4.8).  
The two coformer molecules are hydrogen bonded through two hard hydrogen bonds; the first 
formed by the amide N7 acting as a donor via H7B to O11 and the second in which the 
heterocyclic nitrogen N9 acts as an acceptor of H10 donated by O10, together creating an
)9(22R  ring formed along the Hoogsteen edge of the adenine molecule (9H-IX).  Each adenine 
forms a dimer through complementary hydrogen donation from N2 via H2 to N4 on the 
neighbouring adenine molecule, resulting in an )8(22R ring.  This dimer motif (9H-X) is 
common to other crystalline adenine structures, and acts to form a small supramolecular 
building block of four molecules containing alternating ring motifs (figure 4.16).  
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Figure 4.16: A view of the chain units formed by an adenine dimer capped at each end by a 
succinic acid molecule. Hydrogen bonds are shown as dashed lines 
 
These units are linked to others through two soft hydrogen bonds in which O14 acts as a 
double acceptor (C1 on one adenine acts as a donor via H1 while C5 on the neighbouring 
adenine, within the dimer, acts as the second donor via H5) forming )8(23R rings above and 
below the adenine dimer (figure 4.17).  The result is the formation of an infinite hydrogen-
bonded ribbon running in the [-120] direction.   
 
 
Figure 4.17: The infinite hydrogen-bonded ribbon of adenine dimers and alternating succinic 
acid molecules.  Hydrogen bonds are shown as dashed lines 
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Each ribbon is then linked to two others running in the same direction through a ‘layer’ of 
other ribbons running in the [120] direction in a sandwich-type arrangement containing 
alternating layers of ribbons (figure 4.18).   
 
Figure 4.18: The extensive hydrogen bonded network of alternating perpendicular layers of 
infinite hydrogen-bonded ribbons of adenine and succinic acid molecules. Hydrogen bonds 
are shown as dashed lines 
 
This architecture is formed by the two remaining hard hydrogen bonds; one formed by 
donation of H7A from N7 to O11 and the second from O13 via H13 to N6.  In this extensive 
hydrogen bond network (table 4.7), each adenine molecule is involved in eight intermolecular 
interactions with five succinic acid and one adenine molecule, such that all hydrogen bond 
donors and acceptor sites on the adenine are used.  Each succinic acid molecule is hydrogen 
bonded to five adenine molecules with both carboxylic OH groups acting as donors and both 
C=O groups as double acceptors. In this structure, parallel ribbons are stacked with an 
interplanar distance of 3.56 Å, with each ribbon also cross-linked by eight others (figure 
4.19).   
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Figure 4.19: A view showing the stacking and cross-linking of ribbons in the crystal structure 
of adenine : succinic acid, 1:1 
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4.6 Adeninium : hydrogen fumarate  
Adenine was cocrystallised with fumaric acid following the synthetic procedure described in 
chapter 3, to produce a new crystalline material as confirmed by powder X-ray diffraction 
below (figure 4.20). 
 
Figure 4.20: Powder X-ray diffraction data for the product of adenine and fumaric acid 
cocrystallisation and the starting materials 
 
The diffraction patterns show that both products of crystallisation are the same and differ 
from the starting materials. Solution 1H NMR spectroscopy was used to confirm both adenine 
and fumaric acid are present in the new material in a 1:1 stoichiometry (appendix 4.1). 
A crystal of suitable quality for single crystal structural analysis was selected from the sample 
synthesised in methanol, with a dataset then being collected at the UK National 
Crystallography Service15 (chapter 3). The dataset exhibited merohedral twinning; 
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consequently this structure was solved by Dr Louise Male. The structure of the new material 
is a 1:1 salt, crystallising in the monoclinic cell with space group, P21/c (table 4.9).  
 
Table 4.9: Cell parameters for adeninium : hydrogen fumarate, 1:1 
Compound Adeninium : hydrogen 
fumarate 1:1 
a (Å) 3.61600(10) 
b (Å) 13.0730(6) 
c (Å) 22.0296(9) 
α (°) 90 
β (°) 94.633(3) 
γ (°) 90 
Volume (Å3) 
T (K) 
1037.98(7) 
120(2) 
Z 
Reflections collected 
Independent reflections 
R(int) 
4 
10663 
1872 
0.0778 
Goodness of fit 1.114 
R1 (observed) 0.0574 
R1 (all) 0.0813 
wR2 (observed) 0.1071 
wR2 (all) 0.1206 
 
The position of the hydrogen atoms was determined by an electron density map confirming 
the structure to be a salt, since proton transfer occurred from the fumaric acid to the adenine. 
The powder diffraction pattern simulated from the structure solved by single crystal analysis 
is the same as that of the experimental laboratory powder X-ray diffraction pattern confirming 
that the crystal chosen is representative of the bulk material (appendix 4.2). Table 4.10 lists 
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the seven intermolecular hydrogen bonds that make up the salt structure, with table 4.11 
detailing selected intramolecular bond lengths and angles. Figure 4.21 shows the numbering 
scheme used. Appendix 4 contains a full table of intramolecular bond lengths and angles and 
crystallographic details. 
 
Figure 4.21: The independent molecules of adeninium : hydrogen fumarate showing the atom-
numbering scheme and the hard intermolecular hydrogen-bonds (shown as dashed lines). 
Displacement ellipsoids are drawn at 50% probability level 
 
Table 4.10: Intermolecular hydrogen bonding (Å) for adeninium : hydrogen fumarate, 1:1 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
N2-H2...N4i 0.88 2.06 2.892(4) 158.5 
N7-H7A...O11 0.88 1.92 2.795(4) 170.9 
N7-H7B...O11ii 0.88 2.07 2.809(4) 140.8 
N6-H10...O10  0.88 1.77 2.604(3) 171.3 
O13-H13...O10iii 0.84 1.76 2.577(4) 172.0 
C5-H5...O14iv 0.95 2.52 3.175(5) 135.5 
C5-H5...O14v 0.95 2.55 3.244(5) 130.9 
Symmetry transformations used to generate equivalent atoms: 
(i) –x-1, -y+2, -z+1   (ii) –x+1, -y+1, -z+1  (iii) –x+1, y-0.5, -z+0.5  
(iv) –x, y+0.5, -z+0.5   (v) –x+1, y+0.5, -z+0.5 
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Table 4.11: Selected bond lengths (Å) and angles (°) for adeninium : hydrogen fumarate, 1:1 
Bond length (Å) Bond angle (°) Torsion angles (°) 
C10-O10 1.280(4) O10-C10-O11 123.5(3) O10-C10-C13-O13 -149.5(4) 
C10-O11 1.246(4) O13-C13-O14 123.8(3) O11-C10-C13-O14 -161.3(3) 
C13-O13 1.324(4) O10-C10-O11 123.5(3) H7B-N7-C7-N6 180.0(3) 
C13-O14 1.215(4) C1-N9-C8 103.3(3) H7B-N7-C7-C8 180.0(3) 
  C1-N2-C3 106.1(3)   
  C3-N4-C5 111.9(3)   
  C5-N6-C7 123.8(3)   
 
The asymmetric unit of the adeninium : hydrogen fumarate structure shows that in this case, 
proton transfer has taken place so that the crystal structure contains an adeninium ion in the 
9H tautomeric form protonated at the 1H position, again forming the most common 1H,9H 
adeninium tautomer (appendix 1.2).  The adeninium is hydrogen bonded to the hydrogen 
fumarate ion through the formation of a )8(22R ring on the Watson-Crick edge (9H-VII).  The 
intramolecular geometry of the adeninium ion again confirms the presence of this tautomer 
with a larger endocyclic angle around the protonated nitrogen N2 site and the C5-N6-C7 
angle of 123.8 approximately 4 larger than that in the unprotonated adenine : succinic acid 
cocrystal. There is clear discrimination again between the C-OH and C=O bond lengths at the 
protonated C13 end of the hydrogen fumarate ion, but much less so at the carboxylate end 
(table 4.11).  
The coformers are linked by a hard hydrogen bond from the amide N7 acting as a donor via 
H7A to O11, with the ring motif completed by the formation of an acid-pyridine interaction 
from the protonated heterocyclic nitrogen N6 within the adeninium six-membered ring via H6 
to the carboxylate O10 as shown in figure 4.21.  The adeninium dimer )8(22R ring motif, 9H-X 
is also present in this structure, formed by complementary hydrogen bond donation from N2 
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to N4 via H2.  This creates a small supramolecular building block of four molecules 
containing alternating acid-adeninium and adeninium-adeninium ring motifs (figure 4.22).  
 
Figure 4.22: The infinite hydrogen-bonded chain of adeninium dimers and alternating 
hydrogen fumarate molecules in this cocrystal structure. Hydrogen bonds are shown as dashed 
lines 
 
 These supramolecular units are then linked together to form an infinite chain by a 
complementary hydrogen bond donated by N7 via H7B to O11 creating an additional )8(24R  
ring (figure 4.22). Unlike in the crystal structure of adenine : succinic acid, N9 and C1 in the 
adenine unit are not involved in any significant intermolecular interactions.  The hydrogen 
fumarate ion that could be in a position to form these additional interactions is instead bent 
out of plane, such that half the fumarate is either above or below the plane of the chain shown 
in figure 4.22, with intramolecular carboxylate-to-carboxyl torsion angles O10-C10-C13-O13 
and O11-C10-C13-O14 of -149.5° and -161.3° respectively (table 4.11).  The result is an 
infinite hydrogen-bonded non-planar chain running in the [-210] direction.  A reason for this 
marked geometric distortion of the hydrogen fumarate ion becomes clear after consideration 
of how these chains are then linked to others.  Each fumarate ion links to three other chains 
running in the [210] direction (figure 4.23); in the first case, the fumarate acts as both a 
hydrogen bond donor from O13 via H13 to O10 and as an acceptor of a soft hydrogen bond 
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from C5 via H5 to O14 forming two interactions which in combination create a further )9(33R  
ring; O14 acts as a double acceptor as an interaction is also formed between a second 
adeninium dimer in a neighbouring chain, also denoted as C5-H5...O14 but with a slightly 
shorter H...A distance of 2.42 Å; finally, a complementary O13-H13...O10 hydrogen bond in 
which O10 of the fumarate ion under consideration acts as an acceptor forms the interaction 
with a third chain.   
 
Figure 4.23: A view of part of the extensive hydrogen bond network formed by the adeninium 
dimers and hydrogen fumarate molecules showing a number of the criss-cross chains that 
form the alternating layer structure. Hydrogen bonds are shown as dashed lines 
Each adeninium is involved in seven interactions including a bifurcated C-H donation, but 
both the strong acceptor N9 and the weak donor C1 are not used.  Each hydrogen fumarate 
ion is also involved in seven interactions; all three unprotonated oxygens act as double 
acceptors with the carboxylic OH acting as a donor.  In a similar way to adenine : succinic 
acid, these chains form a sandwich-type structure in which there are alternating ‘layers’ of 
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chains running in opposing directions, with each asymmetric unit pair of coformers within a 
chain, involved in interactions with four others.  However, in this structure the ribbons 
themselves are bent above and below the plane (due to the fumarate conformation discussed 
earlier) and parallel ribbons are stacked with an interplanar distance of 3.62 Å (figure 4.24).   
 
 
Figure 4.24: A view showing the stacking and cross-linking of ribbons in the crystal structure 
of the adeninium : hydrogen fumarate salt. Hydrogen bonds are shown as dashed lines 
 
Whilst the structure of adeninium : hydrogen fumarate exhibits similarities to that of the 
adenine : succinic acid structure, the architecture of these two cocrystals is clearly distinct. 
They both contain neutral adenine molecules in its most stable tautomeric form and contain 
the common adenine dimer motif, motif 9H-X. Both structures consist of small four molecule 
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units that bond to form either infinite chains or ribbons, which in turn form a sandwich type 
layer structure, however the networks present in these structures are very different. 
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4.7 Adeninium : hydrogen maleate 
Two adeninium : hydrogen maleate structures have previously been reported as hydrated salts, 
so adenine was cocrystallised with maleic acid following the experimental procedure outlined 
in chapter 3 to investigate the possibility of an anhydrous, neutral adenine : maleic acid 
adduct. Powder X-ray diffraction was used to confirm that a new material had been formed 
(figure 4.25). 
 
 
Figure 4.25: Powder X-ray diffraction data for the product of adenine and maleic acid 
cocrystallisation, the starting materials and the published materials 
 
The powder diffraction patterns of the two products of crystallisation are not only different 
from the powder patterns of the published structures, but also differ from both the starting 
materials and each other, indicating the formation of a further two new crystalline materials. 
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The powder diffraction pattern of the product from ethanol shows the presence of some 
excess maleic acid. The reported hydrated salt published by Sridhar et al9(9) was crystallised 
using water as the solvent, the other published maleate salt does not report the solvent used. 
1H NMR spectra of the product crystallised in methanol indicates a 1:1 stoichiometry of 
adenine and maleic acid, along with the presence of methanol. 1H NMR spectra of the product 
crystallised from ethanol indicates a 1:3 adenine : maleic acid stoichiometry, but with maleic 
acid starting material present in the diffraction pattern, a reliable stoichiometry cannot be 
obtained in this way. The spectra also show impurity peaks at ~1.25ppm which are currently 
unidentified (appendix 5.1). 
Single crystal X-ray diffraction data were collected on suitable crystals of both products, 
confirming that the product crystallised from ethanol (1) is an unsolvated salt which 
crystallises in a monoclinic cell with space group P21/c, and the product from methanol (2) is 
a solvated salt crystallising in the triclinic cell with space group P -1. Due to the small size of 
the crystals (0.09 x 0.01 x 0.01) of (1), the data were collected on beamline I19 at the 
Diamond Light Source15 (chapter 3). Table 4.12 shows the cell parameters for both (1) and 
(2). 
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Table 4.12: Cell parameters for both adeninium : hydrogen maleate salts 
Compound Adeninium : 
hydrogen maleate 
(1) 
Adeninium : 
hydrogen maleate 
methanolate (2) 
a (Å) 3.610(3) 5.28150(10) 
b (Å) 13.323(11) 10.0506(2) 
c (Å) 22.187(19) 22.0125(4) 
α (°) 90 78.1910(10) 
β (°) 92.258(7) 85.1600(10) 
γ (°) 90 80.0170(10) 
Volume (Å3) 
T (K) 
1066.3(15) 
100(2) 
1124.98(4) 
120(2) 
Z 
Reflections collected 
Independent reflections 
R(int) 
4 
10172 
2401 
0.0556 
4 
7965 
3745 
0.0212 
Goodness of fit 1.052 1.067 
R1 (observed) 0.0416 0.0345 
R1 (all) 0.0582 0.0404 
wR2 (observed) 0.1020 0.0900 
wR2 (all) 0.1108 0.0937 
 
The position of the hydrogen atoms were determined by an electron density map confirming 
both structures to be salts, since proton transfer occurred from the maleic acid molecules to 
the adenine. The powder diffraction patterns simulated from the structures solved from the 
single crystal diffraction data is the same as that of the experimental laboratory powder X-ray 
diffraction pattern confirming that the crystals chosen are representative of the bulk material 
(appendix 5.2). Table 4.13 lists the intermolecular and intramolecular hydrogen bonds that 
make up the salt structures, whilst table 4.14 details selected bond lengths and angles. Figure 
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4.26 shows the numbering schemes used. Appendix 5 includes full crystallographic details 
and intramolecular bonds and angles for both (1) and (2). 
 
 
Figure 4.26: The independent molecules of anhydrous adeninium : maleate, 1:1 (1) and the 
independent molecules of adeninium : maleate : methanolate, 2:2:1 (2) showing the atom-
numbering scheme and the hard intermolecular hydrogen-bonds (shown as dashed lines). 
Displacement ellipsoids are drawn at 50% probability level 
(2) 
(1) 
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Table 4.13: Intermolecular hydrogen bonding (Å) for both adeninium : maleate salts 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
(1) 
O13-H13...O11 0.84 1.62 2.464(2) 177.4 
N7-H7A...O10 0.88 2.07 2.946(3) 171.3 
N7-H7B...O11i 0.88 2.07 2.922(2) 163.2 
N9-H9...O10i 0.88 1.87 2.721(2) 161.6 
N9-H9...O11i 0.88 2.56 3.288(2) 140.1 
N4-H4...N2ii 0.88 1.95 2.808(2) 162.9 
C11-H11...N6 0.9496(16) 2.4325(22) 3.374(3) 170.936(116) 
C5-H5...O14iii 0.9493(16) 2.7549(20) 3.054(3) 99.213(98) 
C1-H1...O13 0.9505(16) 2.8564 (20) 3.417(3) 118.739(104) 
(2) 
N7A-H7AA...O10A 0.88 1.93 2.799(2) 169.3 
N7A-H7AB...O14Aiv 0.88 2.01 2.865 (2) 163.8 
N6A-H6A...O11A 0.88 1.90 2.772(2) 174.3 
N2A-H2A...N9B  0.88 2.05 2.921(2) 171.5 
O13A-H13A...O10A 0.84 1.59 2.430(1) 173.0 
N7B-H7BA...O10 0.88 2.00 2.873(2) 170.1 
N7B-H7BB...O14Bv 0.88 1.97 2.808(2) 158.1 
N6B-H6B...O11B 0.88 1.82 2.687(2) 168.9 
N2B-H2B...O16 0.88 1.83 2.696(2) 168.4 
O13B-H13B...O10B 0.84 1.61 2.448(2) 174.6 
O16-H16...O14Avi 0.84 1.82 2.659(2) 173.4 
C5A-H5A...O11Avi 0.95 2.39 3.330(2) 172.4 
C1A-H1A...O14Bv 0.95 2.33 3.130(2) 141.7 
C5B-H5B...O11Bvii 0.95 2.35 3.293(2) 169.7 
Symmetry transformations used to generate equivalent atoms: 
(i) –x+5, -y+1, -z+1  (ii) x+2, y+1/2, -z+1/2  (iii) x+1, -y+1, -z  
(iv) –x+1, -y, -z  (v) -x, -y+2, -z   (vi) –x+3, -y+2, -z+1 
(vii) –x+2, -y+1, -z     
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Table 4.14: Selected bond lengths (Å) and bond angles (°) for both adeninium : maleate salts 
 (1) (2) 
molecules A 
(2) 
molecules B 
C10-O10 1.254(2) 1.275(2) 1.281(2) 
C10-O11 1.280(2) 1.248(2) 1.249(2) 
C13-O13 1.309(2) 1.288(2) 1.303(2) 
C13-O14 1.226(2) 1.241(2) 1.230(2) 
O10-C10-O11 122.4(2) 121.1(1) 121.3(1) 
O13-C13-O14 121.2(1) 123.4(1) 123.05(1) 
O10-C10-C13-O13 177.6(2) 1.0(1) 2.9(1) 
O11-C10-C13-O14 2.4(3) 7.5(9) 7.4(8) 
H7B-N7-C7-N6 180.0(2) 180.0(1) 180.0(1) 
H7B-N7-C7-C8 180.0(2) 0.2(2) -1.1(3) 
C1-N9-C8 106.4(1) 103.2(1) 103.6(1) 
C1-N2-C3 103.4(1) 106.4(1) 106.1(1) 
C3-N4-C5 116.2(1) 111.9(1) 111.8(1) 
C5-N6-C7 120.1(1) 123.6(1) 123.8(1) 
 
4.7.1 Crystal structure of adeninium : hydrogen maleate, (1) 
In this crystal structure, proton transfer has taken place, giving an asymmetric unit containing 
an adeninium cation and a hydrogen maleate anion.  The hydrogen maleate anion displays the 
planar conformation commonly found in other hydrogen maleate structures1,9 (1, 9) stabilised 
by formation of a short intramolecular hydrogen bond O13-H13...O11 involving the 
remaining carboxyl proton (figure 4.26 (1)).  Comparison of the carboxylate C-O bond 
lengths again indicates the presence of the acidic proton (involved in the intramolecular 
hydrogen bond) on O13 and loss of a proton from the other carboxylate end of the hydrogen 
maleate.  However, the adeninium ion in is in the less common 3H,7H tautomeric form, with 
the endocyclic angles C1-N9-C8 and C1-N2-C3 reversed so that the protonated N9 site is 
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approximately 3 larger than N2. Protonation of N4 also results in an endocyclic angle 
significantly larger than the other structures reported in this chapter (table 4.14).   
The two components interact through a hard hydrogen bond formed by the amide N7 acting as 
a donor via H7A to O10 and a soft hydrogen bond formed by C11 via H11 in which the 
heterocyclic N6 acts as the acceptor (figure 4.26 (1)).  The adeninium and hydrogen maleate 
ions combine to form a )8(22R  ring on the Watson-Crick site, similar to that seen in the 
fumarate structure although the synthon itself is clearly formed by an alternative combination 
of interactions with a soft interaction forming part of the motif (based on motif 7H-VII).  In 
this structure, the adeninium dimer )8(22R motif is formed through complementary donation 
from N4 via H4 to N2.  Although the supramolecular effect of this adeninium synthon is 
similar to the succinic acid and fumarate structures, the nature of this dimer differs due to the 
alternative tautomeric form giving the motif 3H-X.  Each adeninium is hydrogen bonded to a 
second hydrogen maleate through formation of an )9(22R ring motif on the Hoogsteen edge of 
the adeninium ion (this motif is similar to that of 9H-IX but with a different tautomeric form); 
hard hydrogen bonds are formed by N7 acting as a donor via H7B to O11 and N9 via H9 to 
O10, with a further reinforcing hydrogen bond between N9 and O11 also via H9 (but not 
shown on the crystal packing diagram) (figure 4.27).  This results in the formation of chains 
of alternating adeninium and hydrogen maleate ions linked through alternating hydrogen 
bonded rings in the Watson-Crick and Hoogsteen modes, running parallel to the b-axis.   
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Figure 4.27: A view of the crystal structure showing the chains of alternating )8(22R  and  
)9(22R rings linked together in an infinite sheet with an extensive hydrogen-bonded network. 
Hydrogen bonds are shown as dashed lines 
 
These chains are linked together by the adeninium dimers to give an infinite hydrogen bonded 
sheet lying in the (211) plane (figure 4.27).  While the carboxylate end of the hydrogen 
maleate is involved in the strong hydrogen bonds discussed above, the protonated end lies 
either above or below the plane and is involved in the formation of soft hydrogen bonds with 
adeninium dimers in neighbouring layers.  The first of these is formed by C1 of one 
adeninium acting as a donor via H1 to O13 and the second by C5 on the other adeninium 
within the dimer, via H5 to O14 generating a puckered )10(33R  ring (Figure 4.28).   
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Figure 4.28: The intermolecular interactions surrounding each 3H7H adeninium molecule in 
(1).  This view shows the adeninium dimer and chains of alternating )8(22R and )9(
2
2R rings 
within a layer (green dashed lines) with soft hydrogen bonds between the dimer and hydrogen 
maleate anions above and below this plane shown as dashed pink and blue lines 
 
All strong hydrogen bond donors and acceptors are used in this structure, with each 
adeninium ion involved in nine intermolecular interactions including N9 acting as a bifurcated 
donor and both weak C-H donors also used.  Each hydrogen maleate ion interacts with four 
adeninium ions and is involved in eight hydrogen bonds such that O10 acts as a double 
acceptor, O11 as a triple acceptor (including the intramolecular interaction) and O13 as both a 
donor and acceptor.  
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4.7.2 Crystal structure of adeninium : hydrogen maleate : methanolate, (2) 
The crystal structure shows that proton transfer has again taken place, but that in this case, the 
asymmetric unit contains two symmetrically independent adeninium cations, both in the more 
common 1H,9H tautomeric form, and two symmetrically independent hydrogen maleate 
anions, with one methanol molecule also present (figure 4.26 (2)).  The intramolecular 
geometry of both adeninium ions (A and B with atom labels a and b respectively) is similar, 
with the endocyclic angles C1-N2-C3 again larger than the unprotonated N9 site, and the C5-
N6-C7 angle significantly larger than in the unprotonated N6 structures (table 4.14).  Both 
adeninium cations (A and B) are hydrogen bonded to the hydrogen maleate anions (A and B 
respectively) through the formation of )8(22R  rings on each Watson-Crick site.  The hydrogen 
maleate ions are again planar, stabilised by the short intramolecular hydrogen bonds formed 
by O13-H13…O10.  The C-O bond lengths in maleate B again indicate the presence or not of 
the acidic proton (as in structure (1)), although this distinction is not clear in maleate A.  
The distinctive )8(22R  rings between the coformers in this structure are formed by a 
combination of the amide N7 acting as a donor via H7A to O10 and a second hard hydrogen 
bond in which the protonated heterocyclic nitrogen N6 acts as a donor of H6 to the 
carboxylate O11 in each pair.  This motif (9H-VII) is similar to that seen in the adeninium 
hydrogen fumarate structure rather than the anhydrous maleate structure (1).  The two 
adeninium ions are linked through the formation of a hard hydrogen bond donated by N2A on 
adeninium A via H2A to N9B on adeninium B (with a soft reinforcing interaction, not shown 
in figure 4.26, formed between C1B-H1B and N4A), and hence the typical dimer motif seen 
in many other adenine adduct structures is not formed here.  The eighth hard hydrogen bond 
found within the asymmetric unit of this crystal structure is formed between adeninium B and 
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the methanol molecule, by donation of H2B from the remaining strong donor N2B to the 
methanol hydroxyl O16 acting as an acceptor.  
The asymmetric unit is linked to others by a combination of hard and soft hydrogen bonds 
generating an infinite hydrogen bonded sheet lying in the (123) plane.  This structure can be 
viewed as parallel ladders of )8(22R  rings formed independently by the adeninium and 
hydrogen maleate A and B pairs (figure 4.29).  
 
 
Figure 4.29: A view of the crystal structure showing the hydrogen-bonded sheet formed by 
the crystallographically independent adeninium (A and B) and the hydrogen maleate (A and 
B) ions with methanol.  Intermolecular hydrogen bonds are shown as dashed lines 
 
In the ‘A’ ladder, the amide N7 on adeninium A acts as a donor via H7B to form a hydrogen 
bond with the O14 acceptor on the hydrogen maleate A; generation of the complementary 
hydrogen bond around an inversion centre forms a )16(46R  ring. The C5 on adeninium A acts 
as a donor of H5 forming a soft hydrogen bond with O11 which then acts as a double 
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acceptor; generation of the complementary hydrogen bond around an inversion centre forms a 
)10(24R  ring.  The overall effect is the formation of a ladder running in the [2-10] direction 
comprised of )8(22R  rings interspersed by alternating )16(
6
6R  and )10(
2
4R  rings (figure 4.29).  
A similar architecture is generated by the adeninium and hydrogen maleate B ions in which 
complementary hydrogen bonds N7-H7...O14 and C5-H5...O11 form the 16-membered and 
10-membered rings.  There are two further interactions that link the ‘A’ and ‘B’ ladders to 
form an infinite sheet.  The first of these is a soft hydrogen bond formed by C1 of adeninium 
A via H1 to O14 of the neighbouring hydrogen maleate B; the second is an O-H...O hydrogen 
bond formed by donation of H16 by O16 of the methanol to the hydrogen maleate A O14 
making it a double acceptor (figure 4.29).  As in previous structures, the adeninium and 
hydrogen maleate ions are involved in an extensive hydrogen bonding network.  All the 
acceptors in both hydrogen maleate ions act as double acceptors with the carboxyl donor 
involved in a strong intramolecular interaction.  Both adeninium ions are involved in six 
intermolecular interactions that are marked on the structure packing diagram, however, the 
remaining N acceptors and weak C-H donors are all in the correct geometry to be involved in 
weak C-H...N interactions with neighbouring maleates, adeniniums and the methanol 
hydrogens, although these are not discussed in any more detail. 
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4.8 Adenine : glutaric acid 
Adenine and glutaric acid were cocrystallised following the experimental procedure outlined 
in chapter 3. Powder X-ray diffraction was used to confirm the formation of a new material 
below (figure 4.30).  
 
Figure 4.30: Powder X-ray diffraction data for the product of adenine and glutaric acid 
cocrystallisation and the starting materials 
 
The two products of crystallisation from different solvents have identical patterns differing 
from those of the coformers indicating the formation of a new material. As the product 
obtained from methanol is much less crystalline, further study on this adduct was carried out 
on the sample formed from ethanol. Solution NMR spectroscopy was used to identify that 
both adenine and glutaric acid are present in a 1:1 stoichiometry (appendix 6.1).  
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The single crystals in this sample of the adenine : glutaric acid adduct are very small, so while 
a suitable crystal is not available for single crystal diffraction analysis, indexing was carried 
out using the powder X-ray diffraction data to identify the unit cell. Indexing provides a list of 
various possible unit cells for the crystalline material providing unit cell parameters, the 
volume of the cell and each option is given a figure of merit. The unit cell selected (table 
4.15) was chosen because it has the correct volume for a 1:1 triclinic cell if it has space group 
P-1 and has sensible cell parameters. It also has the highest figure of merit of all of the results 
given (shown in appendix 6.2). Further work on this material includes attempting to solve the 
crystal structure from the powder X-ray diffraction data by firstly doing either a le bail or 
pawley fit (chapter 2)  
 
Table 4.15: Cell parameters obtained for adenine : glutaric acid, 1:1 
Parameter Adenine : glutaric acid  
a (Å) 5.2672 
b (Å) 11.1084 
c (Å) 18.1065 
α (°) 137.836 
β (°) 84.602 
γ (°) 89.534 
Volume (Å3) 703.162 
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4.9 Adenine : adipic acid 
A solvated adenine : adipic acid cocrystal has previously been reported10, however unsolvated 
forms of cocrystals and salts are preferable when designing materials for the pharmaceutical 
industry, so following the experimental procedure outlined in chapter 3 the synthesis of an 
anhydrous adenine : adipic acid material was attempted. Powder X-ray diffraction of the 
resultant adducts was used to confirm that a new material has been formed (figure 4.31). 
 
Figure 4.31: Powder X-ray diffraction data for the product of adenine and adipic acid 
cocrystallisation, the simulated powder pattern from the published solvated cocrystal 
structure10 and the starting materials 
 
The powder diffraction patterns show that the product from crystallisation from methanol is 
different to that of the published solvated cocrystal and the starting materials. The diffraction 
pattern of the product of crystallisation from ethanol is similar to that obtained from methanol 
but less crystalline. A 1:1 stoichiometry for this new material (synthesised in methanol) was 
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determined from 1H NMR spectroscopy. The spectrum shows only peaks relating to the 
coformers and the DMSO (the solvent in which the NMR spectra were obtained from). The 
lack of a methanol solvent peak in the NMR spectrum suggests that the new material is 
anhydrous (appendix 7.1).  
The crystal structure has yet to be solved, however indexing from the powder diffraction data 
has been carried out. The indexing results are given in appendix 7.2, though the unit cell 
selected is shown in table 4.16. This unit cell was chosen due to it having the correct volume 
for a 1:1 crystal structure of adenine : adipic acid if it has space group P-1. It also has sensible 
unit cell parameters and a relatively high figure of merit. Single crystals of adenine : adipic 
acid have since been grown and are awaiting single crystal X-ray diffraction analysis. 
 
Table 4.16: Cell parameters obtained for adenine : adipic acid, 1:1 
Parameter Adenine : adipic acid  
a (Å) 11.5146 
b (Å) 11.8849 
c (Å) 6.483 
α (°) 100.388 
β (°) 103.01 
γ (°) 65.44 
Volume (Å3) 782.437 
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4.10 Adenine : pimelic acid 
Adenine was cocrystallised with pimelic acid following the synthetic procedure described in 
chapter 3. Powder X-ray diffraction was used to identify whether the resultant product is a 
new material (figure 4.32). 
 
Figure 4.32: Powder X-ray diffraction data for the product of adenine and pimelic acid 
cocrystallisation and the starting materials 
 
This synthesis was repeated a number of times and of the four adducts synthesised, two new 
materials have formed. The first of these is the final product of crystallisation from methanol 
(black line) in which the diffraction pattern shows the formation of a new material without 
any excess of starting material. The second new material formed is that of the product from 
ethanol (green line) although this sample does contain peaks indicating the presence of some 
starting material. The other two products formed from methanol show either a mixture of the 
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two new materials (purple line) or a mixture of the new product from methanol and pimelic 
acid (blue line) and in both cases show reduced crystallinity. Further work on the new product 
from ethanol has not yet been carried out, although 1H NMR spectroscopy has been used to 
determine the stoichiometry of the new material from methanol. Whilst this NMR spectrum is 
not absolutely conclusive, it does suggest a 1:1 stoichiometry (appendix 8.1). 
A suitable crystal was identified and selected from the sample synthesised in methanol (black 
line in figure 4.32) for analysis by single crystal X-ray diffraction, though due to the poor 
quality of these crystals and the difficulty of the sample, both the data collection and the 
structure solution were carried out by Dr Mateusz Pitaz at the UK National Crystallography 
Service15. The adenine : pimelic acid adduct was found to form a 1:1 cocrystal, crystallising in 
a monoclinic cell with space group P21/c. The cell parameters are given in table 4.17. 
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Table 4.17: Cell parameters for adenine : pimelic acid, 1:1 
Compound Adenine : pimelic acid 1:1 
a (Å) 12.438(11) 
b (Å) 31.49(3) 
c (Å) 7.237(6) 
α (°) 90 
β (°) 102.635(13) 
γ (°) 90 
Volume (Å3) 
T (K) 
2766(4) 
100(2) 
Z 
Reflections collected 
Independent reflections 
R(int) 
8 
11224 
4802 
0.1653 
Goodness of fit 0.832 
R1 (observed) 0.0757 
R1 (all) 0.2554 
wR2 (observed) 0.1443 
wR2 (all) 0.2055 
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The positions of the hydrogen atoms were determined by an electron density map confirming 
that the structure is a cocrystal, since no proton transfer occurred from the pimelic acid to the 
adenine. The powder diffraction pattern simulated from the structure solved by single crystal 
analysis is the same as that of the experimental laboratory powder X-ray diffraction pattern 
confirming that the crystal chosen is representative of the bulk material (appendix 8.2). Table 
4.18 lists the 14 intermolecular hydrogen bonds that make up the cocrystal structure, whilst 
table 4.19 details selected bond lengths and angles. Figure 4.33 shows the numbering scheme 
used. Full crystallographic details and tables of all intramolecular bonds and angles are given 
in appendix 8. 
 
Figure 4.33: The independent molecules of adenine and pimelic acid showing the atom-
numbering scheme. Displacement ellipsoids are drawn at 50% probability level 
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Table 4.18: Intermolecular hydrogen bonding (Å) for adenine : pimelic acid, 1:1 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
N2A-H2A...O11A 0.88 1.96 2.777(7) 152.9 
N7A-H7AB...O17Aiv 0.86 2.26 3.048(7) 152.8 
N7A-H7AA...O17Biii 0.86 2.52 3.090(7) 124.6 
O10A-H10A...N4A 0.84 1.87 2.693(7) 168.0 
O16A-H16A...N9Aii 0.84 1.87 2.696(6) 159.2 
C1A-H1A...O10Biv 0.95 2.41 3.265(8) 149.0 
C5A-H5A...O11Biii 0.95 2.81 3.765(9) 178.9 
N2B-H2B...O11B 0.88 1.92 2.752(7) 156.7 
N7B-H7BA...O17Aii 0.86 2.57 3.145(7) 125.2 
N7B-H7BB...O17Bi 0.86 2.35 3.047(7) 137.3 
O10B-H10B...N4B 0.84 1.88 2.707(7) 166.1 
O16B-H16B...N9Biii 0.84 1.83 2.633(7) 160.1 
C1B-H1B...O10Ai 0.95 2.46 3.339(8) 153.8 
C5B-H5B...O11Aii 0.95 2.81 3.720(8) 160.1 
Symmetry transformations used to generate equivalent atoms: 
(i) –x+2, y-0.5, -z+0.5     (ii)–x+1, y-0.5, -z-0.5             (iii) –x+2, y+0.5, -z+0.5     
(iv) –x+1, y+0.5, -z-0.5                                    
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Table 4.19: Selected bond lengths (Å) and angles (°) for adenine : pimelic acid, 1:1  
Bond lengths (Å) Bond angles (°) 
 Molecules 
A 
Molecules 
B 
 Molecules 
A 
Molecules 
B 
C10-O10 1.344(7) 1.319(7) O10-C10-O11 122.3(6) 124.1(6) 
C10-O11 1.237(7) 1.239(7) O16-C16-O17 122.6(6) 122.9(6) 
C16-O16 1.327(7) 1.333(7) O10-C10-O11 122.3(6) 124.1(6) 
C16-O17 1.236(7) 1.243(7) O16-C16-O17 122.6(6) 122.9(6) 
   C1-N9-C8 105.0(5) 104.8(6) 
   C1-N2-C3 107.1(5) 106.9(6) 
   C3-N4-C5 112.1(6) 110.6(6) 
   C5-N6-C7 117.2(6) 119.7(6) 
   O10-C10-C16-O16 9.1(9) 4.3(9) 
   O11-C10-C16-O17 0.5(6) -0.9(6) 
   H7B-N7-C7-N6 -160.5(6) -144.0(7) 
   H7B-N7-C7-C8 22.5(9) -40.2(9) 
 
In the crystal structure of adenine : pimelic acid, the asymmetric unit contains two 
symmetrically independent neutral adenine molecules in the most stable 9H tautomeric form 
and two symmetrically independent pimelic acid molecules (figure 4.33). The intramolecular 
geometry of both adenine molecules (A and B with atom labels a and b respectively) is 
similar in terms of the endocyclic angles C1-N2-C3 are approximately 2° larger than the 
unprotonated N9 site and there is clear discrimination between the bond lengths of the C-OH 
and C=O bonds in both pimelic acid molecules indicating that all four carboxyl groups in the 
asymmetric unit have retained their acidic protons (table 4.19). In this structure there is a 
slight difference in the O10-O16 angles in the different pimelic acid molecules and a large 
difference in the adenine amide group to the adenine ring angle in the two independent 
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molecules with a difference of ~20º (torsion angles H7B-N7-C7-N6 and H7B-N7-C7-C8 in 
table 4.19). 
Both adenine molecules A and B are hydrogen bonded to the pimelic acid molecules A and B 
respectively through two hard hydrogen bonds; the first formed by the heterocyclic N2 acting 
as a donor via H2 to O11 and the second in which O10 on the acid donates H10 to N4, 
creating a )8(22R ring based on motif 9H-VIII (figure 4.33).  
A second ring motif is formed between the adenine and a second pimelic acid molecule via 
the donation of H7B from the amide N7 to O17 and the heterocyclic N9 acting as an acceptor 
of H16 from O16 forming a )9(22R  ring, motif 9H-IX. The combination of these two rings 
form infinite zigzag chains of either entirely A or B adenine and pimelic acid molecules 
(figure 4.34). 
 
Figure 4.34: A view of the infinite sheet formed through the linking of the adenine : pimelic 
acid chains. Hydrogen bonds are shown as dashed lines 
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The chains are linked into an infinite sheet involving both hard and soft hydrogen bonds. An 
)8(24R ring motif is formed between the chains; two interactions as part of the A and B chains 
respectively and the two complementary hydrogen bonds formed by donation from 
heterocyclic N7A via H7AA to O17B and from N7B via H7BA to O17A. Formation of this 
sheet is reinforced by four soft hydrogen bonds; the first pair of interactions are formed 
between C1B and O10A via H1B and C5A and O11B via H5A, these create another ring 
motif, )10(24R , when combined with hard interactions already discussed as part of the A and B 
chains. An equivalent ring is formed taking into account the other soft hydrogen bonds; C5B 
and O11A via H5B and C1A and O10B via H1A. 
The NH2 group in both the adenine molecules in this structure are out of the plane of the ring, 
in turn causing the sheets in this structure to deviate from planar. The full crystal structure of 
this adenine : pimelic acid cocrystal is generated by the stacking of these sheets, however no 
hard hydrogen bond interactions are formed between them, the only linkages are short contact 
bonds between the carbons in the pimelic acid chain and a short linkage between the bent NH2 
and the carbon chain in the acid. The majority of strong hydrogen bond donors and acceptors 
are used in this structure with the exception of one heterocyclic N acceptor N6 on both the A 
and B adenine molecules. Whilst this cocrystal structure exhibits favourable adenine : acid 
ring motifs, the lack of an adenine dimer is surprising. The majority of previously published 
crystalline adenine complexes, and those reported here, involve either the formation of an 
adenine dimer, or at least the formation of hydrogen bond interactions between adenine 
molecules. The lack of this supramolecular feature is especially surprising in a solvent free 
structure. 
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4.11 Adenine : suberic acid 
Adenine and suberic acid were cocrystallised following the synthetic procedure detailed in 
chapter 3. Powder X-ray diffraction was used to identify that the resultant adducts are new 
materials (figure 4.35). 
 
Figure 4.35: Powder X-ray diffraction data for the product of adenine and suberic acid 
cocrystallisation and the starting materials 
 
The above powder diffraction patterns show that both adducts obtained from methanol and 
ethanol are the same and do not contain any starting materials. 1H NMR spectroscopy was 
used to confirm the presence of both adenine and suberic acid in a 1:1.5 ratio (appendix 9.1). 
Attempts were made to index the powder diffraction pattern to obtain a possible unit cell for 
this adenine : suberic acid structure as the crystals obtained are of poor quality, making 
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structure determination from single crystal X-ray diffraction data difficult. Appendix 9.2 gives 
the results of this indexing although a reliable unit cell could not be identified. 
A selection of crystals was sent to the UK National Crystallography Service15 as it was hoped 
that the more powerful diffractometer would enable a single crystal dataset to be collected 
from the smaller crystals. It was reported that the sample was formed of a large crystal made 
up of a number of smaller ones intergrown together, with some microcrystalline crystals 
grown on the surface. Upon smashing this cluster, small fragments were identified, though 
they gave poor and smeared diffraction and not a single diffraction pattern (figure 4.36). The 
service did however manage to obtain a suitable single crystal from the sample synthesised in 
ethanol, allowing a dataset to be collected from which structure solution and refinement was 
possible, though with poor R factors. The structure was found to be a neutral 1:1:1 hydrated 
cocrystal, crystallising in a triclinic unit cell with space group P-1. Table 4.20 gives the cell 
parameters and refinement values for this cocrystal. 
 
Figure 4.36: A screen shot showing the poor diffraction obtained from the small fragments of 
the large adenine : suberic acid cluster-like crystals 
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Table 4.20: Cell parameters and refinement values for adenine : suberic acid : hydrate, 1:1:1 
Compound Adenine : suberic acid : water 1:1:1 
a (Å) 8.080(17) 
b (Å) 9.76(2) 
c (Å) 10.49(2) 
α (°) 104.43(4) 
β (°) 99.88(4) 
γ (°) 92.014(19) 
Volume (Å3) 
T (K) 
786(3) 
100 
Z 
Reflections collected 
Indepentdent reflections 
R(int) 
2 
4634 
2343 
0.2197 
Goodness of fit 1.479 
R1 (observed) 0.1415 
R1 (all) 0.1600 
wR2 (observed) 0.3573 
wR2 (all) 0.3840 
 
This cell was not identified from the powder diffraction data, although comparison of the 
simulated powder X-ray diffraction pattern from the single crystal data and the experimental 
laboratory powder data confirms that the single crystal chosen was representative of the bulk 
(appendix 9.3). The 1:1.5 stoichiometry assumed from the 1H NMR spectrum is incorrect as 
the cocrystal has a 1:1:1 adenine : suberic acid : hydrate stoichiometry. This discrepancy 
could be caused by the hydration of the cocrystal. The position of the hydrogen atoms were 
determined by an electron density map confirming the structure to be a cocrystal, since no 
proton transfer occurred from the suberic acid to the adenine. Table 4.21 gives details on the 
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eight intermolecular bonds, with figure 4.37 showing the atom numbering scheme used. 
Appendix 9 contains a full list of intermolecular bond lengths and angles, though selected 
ones are given in table 4.22. 
 
Figure 4.37: The independent molecules of adenine and suberic acid, showing the atom-
numbering scheme. Displacement ellipsoids are drawn at 50% probability level 
 
Table 4.21: Intermolecular hydrogen bonding (Å) for adenine : suberic acid : hydrate, 1:1:1 
D-H...A d(D-H) d(H...A) d(D...A)  <(DHA) 
N2-H2...N4i 0.88 2.03 2.909(8) 172.8 
N7-H7A...O15 0.88 2.16 3.035(7) 172.1 
N7-H7B...N6ii 0.88 2.23 3.108(8) 173.2 
O10-H10...O18 0.84 1.78 2.604(7) 168.2 
O14-H14...N9 0.84 1.82 2.647(6) 138.3 
O18-H18A...O11iii 0.86(2) 1.97(2) 2.818(8) 170(6) 
O18-H18B...O15iv 0.86(2) 1.92(2) 2.768(7) 172(6) 
C1-H1...O11iv 0.95 2.16 3.045(9) 155 
Symmetry transformations used to generate equivalent atoms: 
(i) –x, -y+1, -z+1    (ii) –x, -y, -z   (iii) –x, -y+2, -z+1 
(iv) x, y+1, z+1 
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Table 4.22: Selected intermolecular bond lengths (Å) and angles (°) for adenine : suberic acid 
: hydrate, 1:1:1 
Bond lengths (Å) Bond lengths (°) Torsion lengths (°) 
C10-O10 1.289(8) O10-C10-O11 122.0(6) O10-C10-C10i-O10i -180.0(5) 
C10-O11 1.202(7) O14-C15-O15 123.3(5) O11-C10-C10i-O11i -180.0(6) 
C14-O14 1.307(7) C1-N9-C8 103.6(5) O14-C14-C14i-O14i 180.0(6) 
C14-O15 1.223(6) C1-N2-C3 108.2(4) O15-C14-C14i-O15i 180.0(4) 
  C3-N4-C5 109.4(4) H7A-N7-C7-N6 179.8(5) 
  C5-N6-C7 119.3(5) H7A-N7-C7-C8 0.01(9) 
    O10-C10-C11-C12 -80.2(7) 
    O11-C10-C11-C12 97.0_8) 
    O14-C14-C15-C16 179.6(5) 
    O15-C14-C15-C16 -0.6(8) 
 
The size and shape of the ellipsoids (figure 4.37) are both large and elongated suggesting 
disorder within the structure. The ellipsoids in the adenine molecule and one of the acids are 
all elongated in the c direction and the other acid has very large ellipsoids for the carbon 
atoms. The asymmetric unit consists of one neutral adenine molecule, in the most stable 9H 
tautomeric form, two half symmetrically independent suberic acid molecules and a molecule 
of water. As can be seen from table 4.22 there is clear distinction between the C-OH and C=O 
bonds in the suberic acid molecules, indicating that both the carboxyl groups have retained 
their acidic protons, and the endocyclic adenine C-N-C angles further confirm the presence of 
the 9H tautomer with C1-N2-C3 having a bond angle significantly larger than that of the 
unprotonated N9 site. It is clear from table 4.22 that whilst one of the acid molecules is planar 
(O14-C14-C15-C16 and O15-C14-C15-C16) the other is twisted (O10-C10-C11-C12 and 
O11-C10-C11-C12). There are three hard hydrogen bonds within the asymmetric unit of this 
structure. The first is between the twisted suberic acid molecules and the water moleucule and 
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is formed by donation of H10 from O10 to O18. The other two hydrogen bonds form a 
linkage between the adenine and the second, more planar suberic acid molecule, forming the 
popular adenine : acid )9(22R ring motif, 9H-IX, on the Watson-Crick edge. This ring motif is 
formed by N7 acting as a donor of H7A to O15 and the heterocyclic N9 acting as an acceptor 
of H14 donated by O14.  
The adenine molecule forms a dimer with a neighbouring adenine through a complementary 
hydrogen bond donated by N2 to N4 via H2 to form the 9H-X motif, common in other 
adenine crystalline structures. This interaction creates infinite chains of alternating adenine 
dimers and planar suberic acid molecules. These chains are linked together through the 
formation of a further adenine - adenine )8(22R ring, motif 9H-XI created by a further 
complementary hydrogen bond donated by N7 to N6 via N7B. This part of the structure 
combines to create an infinite hydrogen bonded sheet (figure 4.38) in which infinite chains of 
adenine molecules are a distinct supramolecular feature.  
 
Figure 4.38: A view of part of the crystal structure of adenine : suberic acid showing the 
infinite chains that link to form sheets of adenine and planar suberic acid components. 
Hydrogen bonds are shown as dashed lines 
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The twisted suberic acid moiety that is linked to the water molecules also form hydrogen 
bond chains which cross and link to the adenine : suberic acid sheets. Each of these chains is 
formed by two of the twisted suberic acid molecules linked by two water molecules to create 
a large )12(44R ring motif. This motif is formed by a complementary hydrogen bond donated 
by O18 through H18A to O11 in combination with the O10-H10...O18 suberic acid : water 
hydrogen bond present in the asymmetric unit, hence the water acts as both a hydrogen bond 
donor and acceptor. These acid : water chains link to the adenine : acid chains through a 
further hard hydrogen bond donated by the water to the more suberic acid by O18 to O15 via 
H18B, and a soft hydrogen bond donated from the adenine C1 via H1 to O11 on the twisted 
suberic acid. 
 
Figure 4.39: A view to show the crossing of the adenine : acid with the acid : water chains. 
Hydrogen bonds are shown as dashed lines 
 
This structure utilises all strong hydrogen bond donor and acceptor sites and contains both 
common adenine dimers and a common adenine :  acid ring motif. 
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4.12 Adenine : azelaic acid 
The experimental procedure described in chapter 3 was followed as part of a BSc project in 
which the project student attempted to cocrystallise an adenine and azelaic acid crystalline 
adduct16. Powder X-ray diffraction was used to confirm the formation of an new material 
(figure 4.40) 
 
Figure 4.40: Powder X-ray diffraction data for the product of adenine and azelaic acid 
cocrystallisation and the starting materials 
 
From the powder diffraction patterns above it can be determined that a new material has been 
formed. The two diffraction patterns are very similar, although there is an unidentified peak at 
~5° in the pattern of the product synthesised in methanol16. 1H NMR spectroscopy was used 
to identify what coformers are present and in what ratio they exist. In this case it is clear from 
the NMR data (appendix 10.1), that there is a minimal amount of adenine present and that 
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azelaic acid is the only coformer present in any meaningful amount. A suitable crystal was 
therefore selected for single crystal X-ray diffraction analysis from the sample synthesised in 
ethanol, and a dataset collected. It was found that the resultant adduct was in fact a different, 
previously unpublished azelaic acid polymorph, with no adenine present in the crystal 
structure. The structure crystallises in the monoclinic cell with space group P21/c.  Table 4.23 
gives the cell parameters for this azelaic acid polymorph. 
 
Table 4.23: Cell parameters for azelaic acid polymorph 
Compound Azelaic acid 
a (Å) 5.51140(10) 
b (Å) 9.4563(2) 
c (Å) 18.8814(4) 
α (°) 90 
β (°) 95.994(2) 
γ (°) 90 
Volume (Å3) 
T( K) 
978.67(3) 
120(2) 
Z 
Reflections collected 
Independent reflections 
R(int) 
4 
13150 
1697 
0.0358 
Goodness of fit 1.069 
R1 (observed) 0.0472 
R1 (all) 0.0525 
wR2 (observed) 0.1217 
wR2 (all) 0.1288 
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The position of the hydrogen atoms was determined by an electron density map. The powder 
diffraction pattern simulated from the structure solved by single crystal analysis is essentially 
the same as that of the experimental laboratory powder X-ray diffraction pattern although 
there may be some impurity or preferred orientation. However, this does confirm that the 
crystal chosen is representative of the bulk material (appendix 10.2). Table 4.24 lists the three 
intermolecular hydrogen bonds that are formed in the crystal structure, table 4.25 list selected 
bond lengths and angles, whilst Figure 4.41 shows the numbering scheme used. Full bond 
lengths and angles are shown in appendix 10. 
 
Figure 4.41: The asymmetric unit of the azelaic acid polymorph showing the atom-numbering 
scheme. Displacement ellipsoids are drawn at 50% probability level 
 
Table 4.24: Intermolecular hydrogen bonding and weak interactions (Å) for the azelaic acid 
polymorph 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
O2-H2...O1i 0.84 1.84 2.672(1) 169.2 
O3-H3...O4ii 0.84 1.82 2.659(1) 175.7 
C2-H2B...O4iii 0.99 2.68 3.343(2) 124.8 
C8-H8A...O1iv 0.99 2.42 3.388(2) 167 
Symmetry transformations used to generate equivalent atoms: 
(i) -x+4,-y+1,-z+1    (ii) -x,-y+1,-z      (iii) –x+2, y-0.5, -z+0.5  
(iv) x-1, -y+0.5, z-0.5   
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Table 4.25: Selected intramolecular bond lengths (Å) and angles (°) for the azleaic acid 
polymorph 
Bond lengths (Å) Bond lengths (°) Torsion lengths (°) 
C1-O1 1.230(2) O1-C1-O2 122.8(1) O1-C1-C9-O4 104.1(2) 
C1-O2 1.308(2) O3-C9-O4 123.0(1) O2-C1-C9-O3 132.5(2) 
C9-O4 1.221 (2)   O1-C1-C2-C3 145.8(2) 
C9-O3 1.321(2)   O2-C1-C2-C3 -36.5(2) 
    O7-C8-C9-O4 -1.9(1) 
    O7-C8-C9-O3 178.7(1) 
 
There is a clear distinction between the C-OH and C=O bond lengths (table 4.25) further 
confirming the correct placing of the carboxyl hydrogen. The azelaic acid molecules in this 
structure are twisted (table 4.25), a feature common within the longer chain acids with an odd 
number of carbon atoms17. In previously published structures, this twisting is a consequence 
of the packing observed within the structures, which consist of chains involving carboxy 
dimers, which are in close proximity to the carboxy dimers in the chains either side of it. The 
twisting occurs to reduce repulsion between these dimers. This is a property also seen in 
azelaic acid cocrystals, for example isonicotinamide : azelaic acid18. 
The overall crystal structure is formed of infinite chains of azelaic acid molecules, hydrogen 
bonding together to form infinite sheets, with soft hydrogen bonds linking the sheets together. 
The azelaic acid chains are built up of )8(22R acid dimers formed at each end of the molecule. 
The first consists of a hydrogen bond donated by O2 via H2 to O1 with propagation around an 
inversion centre creating an )8(22R ring motif. The second is formed by donation of H3 from 
O3 to O4, again with propagation around an inversion centre forming an )8(22R  ring motif. 
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These infinite chains are then linked together via a soft hydrogen bond donated by C2 to O4 
through H2B (figure 4.42).  
 
 
Figure 4.42: A view of the chain units bonding to form an infinite sheet. Hydrogen bonds are 
shown by dashed lines 
 
A soft bond donated by C8 to O1 via H8A completes this structure to bond the infinite sheets 
as seen in figure 4.43.  
 
Figure 4.43: A view of the infinite sheets linking via a soft hydrogen bond. Hydrogen bonds 
are shown by dashed lines 
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There are five previously published azelaic acid polymorph structures17,19,20, differing from 
the structure reported here in a number of ways. All are monoclinic, though four of the five 
have the space group C2/c, the fifth is in P21/c. The other polymorphs of azelaic acid also 
differ to this one as the two C-OH groups on the carboxyl are on the same side (figure 4.44) 
as compared to the structure reported here where they are on opposing sides (figure 4.41). 
Whilst there are differences between these polymorphic structures, there are some similarities, 
for example all of them form infinite chains, though they do not all contain strong hydrogen 
bonds linking these chains to form sheets. The twisting present in this polymorph is a feature 
seen in all of them. 
 
Figure 4.44: A view of a differing azelaic acid polymorph, showing the C-OH groups on the 
same side 
 
Polymorph screening is very important within the pharmaceutical industry as different 
polymorphs exhibit different properties, with numerous examples of drugs having multiple 
forms and becoming problematic with potentially dangerous results21. The most common 
method of polymorph screening is simple recrystallisation of the single component from a 
wide range of different solvents or using differing experimental conditions22. To discover a 
different polymorph through an attempted cocrystallisation experiment is rare, but it opens up 
a whole new method of polymorph screening available to the pharmaceutical industry. 
Since no adenine was present in the result of the initial cocrystallisation attempt, a repeat of 
the synthesis outlined in chapter 3 was carried out in the hope of forming an adenine : azelaic 
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acid crystalline adduct. Powder X-ray diffraction was used to determine whether a new adduct 
material had been formed (figure 4.45). 
 
Figure 4.45: Powder X-ray diffraction data for the product of adenine and azelaic acid 
cocrystallisation compared with the powder pattern of the azelaic acid polymorph and the 
starting materials 
 
The diffraction patterns above show that upon repeating the synthesis, a new material which is 
differs from both the azelaic acid polymorph and the starting materials has been formed. 
Solution 1H NMR spectroscopy of these new materials confirm the presence of both adenine 
and azelaic acid and indicate a 1:1 adenine : azelaic acid stoichiometry. This suggests that an 
adenine : azelaic acid adduct has also been formed (appendix 10.6).  Single crystal X-ray 
diffraction analysis has not yet been attempted, though indexing the powder X-ray diffraction 
pattern has been carried out. A table of results is shown in appendix 10.7, though the cell 
selected is given in table 4.26. This cell was selected because the volume is correct for a 1:1 
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adenine : azelaic acid adduct with monoclinic symmetry. Whilst the figure of merit for the 
chosen cell is low, cells with much higher figures of merit have volumes that would not be 
correct being either too low for a triclinic cell or having a volume representative of 
monoclinic but unit cell parameters representative of triclinic. The low figure of merit does 
suggest that this may not be correct but it is a good basis. Single crystals of this adduct have 
been obtained and are awaiting single crystal x-ray diffraction analysis.  
 
Table 4.26: Cell parameters obtained from indexing of adenine : azelaic acid, 1:1 
Parameter Adenine : azelaic acid  
a (Å) 18.2318 
b (Å) 4.6715 
c (Å) 16.3596 
α (°) 90 
β (°) 111.414 
γ (°) 90 
Volume (Å3) 1297.161 
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4.13 Adenine : sebacic acid 
Adenine was cocrystallised with sebacic acid following the experimental procedure described 
in chapter 3. Powder X-ray diffraction was used to confirm the formation of a new material. 
As can be seen from the diffraction patterns below in figure 4.46, the products of 
crystallisation are different from different solvents as well as from the coformers, suggesting 
that two new materials have been formed, although the product from ethanol looks like it may 
also contain some of the product obtained from methanol. 
 
Figure 4.46: Powder X-ray diffraction data for the product of adenine and sebacic acid 
cocrystallisation and the starting materials 
 
Solution 1H NMR spectroscopy was carried out on both of these crystalline adducts (appendix 
11.1), suggesting that adenine and sebacic acid are present in both of these new materials in a 
1:1 ratio from ethanol but a 4:3 adenine : acid ratio from methanol. 
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Single crystal X-ray diffraction analysis has been used to solve the crystal structure of the new 
material from methanol, although a suitable crystal of the product from ethanol has not been 
obtained. The dataset collected for the product of crystallisation from methanol resulted in a 
hydrated cocrystal structure in a 4:3:4 adenine : sebacic acid : water stoichiometry. The 
structure crystallises in a triclinic cell with a space group of P -1. Table 4.27 gives the cell 
parameters for this hydrated structure. 
 
Table 4.27: Cell parameters for adenine : sebacic acid : hydrate 4:3:4 
Compound Adenine : sebacic acid : hydrate 4:3:4 
a (Å) 10.3417(2) 
b (Å) 12.4896(3) 
c (Å) 12.7894(3) 
α (°) 101.134(2) 
β (°) 107.272(2) 
γ (°) 104.6200(10) 
Volume (Å3) 
T (K) 
1460.72(6) 
120(2) 
Z 
Reflections collected 
Indepentdent reflections 
R(int) 
2 
14245 
5019 
0.0254 
Goodness of fit 1.044 
R1 (observed) 0.0360 
R1 (all) 0.0429 
wR2 (observed) 0.0877 
wR2 (all) 0.0918 
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The position of the hydrogen atoms was determined by an electron density map confirming 
that the structure is a cocrystal, since no proton transfer has occurred from the sebacic acid to 
the adenine. The powder diffraction pattern simulated from the structure solved by single 
crystal analysis is similar to that of the experimental laboratory powder X-ray diffraction 
pattern although the peaks at 25 - 27° in 2-theta may suggest that there is some anisotropic 
thermal behaviour evident in this comparison. (appendix 11.2). The crystal is however 
assumed to be representative of the bulk material. Table 4.28 lists the 15 intermolecular 
interactions that are formed in this cocrystal structure, whilst figure 4.47 shows the numbering 
scheme used. A full table of intramolecular bonds and angles can also be found in appendix 
11, with selected values given in table 4.29. 
 
Figure 4.47: The independent molecules of adenine : sebacic acid : hydrate 4:3:4 synthesised 
from methanol showing the atom-numbering scheme and the hard intermolecular hydrogen-
bonds (shown as dashed lines). Displacement ellipsoids are drawn at 50% probability level 
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Table 4.28: Intermolecular hydrogen bonding (Å) for adenine : sebacic acid : hydrate 4:3:4 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
N2-H2...O36 0.88 1.91 2.782(2) 168.6 
N7-H7A...N29 0.88 2.14 3.018(2) 178.5 
N7-H7B...O11 0.88 2.04 2.909(2) 171.5 
O10-H10...N9 0.84 1.84 2.669(2) 167.8 
O19-H19...N26ii 0.84 1.76 2.589(2) 169.3 
N21-H21...N24iii 0.88 2.03 2.869(2) 160.3 
N27-H27A...O20iv 0.88 2.08 2.940(2) 164.3 
N27-H27B...N6 0.88 2.11 2.958(2) 161.3 
O30-H30...O35 0.84 1.76 2.601(1) 177.0 
O35-H35A...O11v 0.87 (2) 1.92 (2) 2.776(2) 165.3(19) 
O35-H35B...N4 0.88 (2) 2.04(2) 2.852(2) 153.0(18) 
O36-H36A...O31 0.85(2) 2.02(2) 2.851(2) 169.6(19) 
O36-H36B...O20 0.86(2) 1.94(2) 2.772(2) 164(2) 
C20-H20...O35 0.95 2.50 3.335(2) 146.0 
C25-H25...O31 0.95 2.42 3.257(2) 146.0 
Symmetry transformations used to generate equivalent atoms: 
(i) -x, -y+2, -z+1        (ii) x+2, y, z+1      (iii) - x+2, -y, -z                
(iv) x-2, y, z-1               (v) -x+2, -y+1, -z+1  
 
 
 
 
 
 
 
 
Adenine: tautomerism, cocrystallisation, salt formation and solvation Page 136 
 
Table 4.29: Selected intramolecular bond lengths (Å) and angles (°) for adenine : sebacic acid 
: hydrate, 4:3:4 
Bond lengths (Å) Bond lengths (°) Torsion lengths (°) 
C10-O10 1.309(2) O10-C10-O11 113.5(1) O10-C10-C19-O19 179.4(2) 
C10-O11 1.222(2) O19-C20-O19 123.4(1) O11-C10-C19-O20 -176.6(1) 
C19-O19 1.302(2) O30-C30-O31 123.0(1) O30-C30-C30i-O30i -180.0(1) 
C19-O20 1.226(2) C1-N9-C8 103.8(1) O31-C31-C31i-O31i 180.0(2) 
C30-O30 1.312(2) C1-N2-C3 106.6(1) H7B-N7-C7-N6 -180.0(1) 
C30-O31 1.222(2) C3-N4-C5 110.5(1) H7B-N7-C7-C8 0.2(3) 
  C5-N6-C7 118.8(1) H27B-N27-C27-N6 180.0(1) 
  C20-N29-C28 103.6(1) H27B-N27-C27-C28 -0.3(3) 
  C20-N21-C22 106.7(1)   
  C22-N24-C25 111.1(1)   
  C25-N26-C27 120.7(1)   
 
The asymmetric unit of the adenine : sebacic acid hydrated cocrystal, 4:3:4 contains two 
symmetrically independent adenine molecules, both in the most stable 9H tautomeric form, 
one complete and one half symmetrically independent sebacic acid molecule with two 
molecules of water (figure 4.47). There is clear discrimination between the length of the C-
OH and C=O bonds in both the sebacic acid molecules (table 4.27) indicating that all carboxyl 
groups have retained their acidic protons, and the endocyclic C-N-C angles further confirming 
the presence of the 9H tautomer with C1-N2-C3 and C20-N21-C22 having angles 
approximately 3° larger than the unprotonated nitrogen sites (C1-N9-C8 and C20 N29 C28) 
(table 4.27). The intramolecular angles between the two independent molecules are similar, 
however it is believed that zꞌ for this structure is two because it may be the only way to 
accomodate the water molecules. 
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The coformer molecules hydrogen bond to form an adenine dimer and two adenine : acid ring 
motifs within the asymmetric unit. One of which also integrates both water molecules (figure 
4.48). One of the most common adenine dimers, 9H-XIII, is formed by the amide groups on 
the two adenine molecules N7 and N27 acting as hydrogen bond donors of H7A and H27B to 
N29 and N6 respectively to give an )9(22R ring. The first of the adenine : acid ring motifs is 
formed on the Hoogsteen edge of one adenine by the amide N7 donating its second hydrogen 
H7B, to O11, with the adenine heterocyclic N9 also accepting a hydrogen bond from O10 via 
H10 resulting in another )9(22R ring, (motif 9H-IX). The second adenine : acid ring motif 
(formed by the same adenine molecule) also encompasses the water molecules. This motif is 
formed by the heterocyclic N2 donating H2 to O36 on one water molecule, which in turn 
donates H36A to the sebacic acid acceptor O31. The adenine also accepts a hydrogen bond at 
N4 donated by O35 via H35B on the second water molecule, which in turn accepts H30 from 
O30 from the sebacic acid, altogether creating a large )12(44R ring motif, similar to motif 9H-
VIII shown in table 4.1.  
The adenine dimer unit is hydrogen bonded to three sebacic acid molecules; the two present in 
the asymmetric unit and a third )8(22R motif formed by the donation of H27A from amide N27 
O20, with heterocyclic N26 acting as an acceptor for H19 donated from O19. This seven unit 
architecture (two adenine molecules, three sebacic acid molecules and two water molecules) 
links to a further unit through the formation of a second adenine dimer to create  a small chain 
unit of four adenine molecules. This dimer is formed through a complementary hydrogen 
bond donated by N21 to N24 via H21, forming an )8(22R  ring, motif 9H-X.  
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Figure 4.48: A view of the adenine : sebacic acid cocrystal structure showing the adenine 
dimer units as small four unit chains. Hydrogen bonds are shown as dashed lines 
 
The adenine : sebacic acid structure consists of multiple layers with the water molecules 
acting as a step and linking these layers together (figure 4.49). The water molecules each 
hydrogen bond to further sebacic acid molecules; the first donated by O35 through H35A to 
O11 and the second formed by O36 donating a hydrogen bond via H36B to O20. The 
structure is completed by the presence of two soft hydrogen bonds, one of which donated by 
C20 to O35 via H20 and the second donated by C25 via H25 to O31. 
 
Figure 4.49: A view of the layered structure of adenine : sebacic acid. Hydrogen bonds are 
shown as dashed lines 
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This cocrystal structure utilises all strong hydrogen bond donor and acceptor sites, containing 
adenine dimer units commonly found in a number of adenine structures along with three 
different adenine : acid ring motifs. 
 
4.14 Adenine : undecanedioic acid 
Adenine was synthesised with undecanedioic acid following the experimental procedure 
outlined in chapter 3. Currently no crystals have formed in the solution; further work includes 
repeating this procedure using a range of different solvents along with investigating possible 
other methods of synthesis such as solvent drop grinding.  
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4.15 Discussion 
In this chapter we have presented the structures of eight new adenine : dicarboxylic acid 
adducts in addition to a new polymorphic form of an acid and introduced the structures of five 
previously published adenine : dicarboxylic acid adducts. Of the new adenine adducts 
reported, four are cocrystals and four are salts. When predicting the possibility of proton 
transfer by investigation of their pKa values, it was correctly predicted that malonic acid and 
maleic acid are more likely to form a salt as opposed to a cocrystal. However, the adeninium : 
hydrogen fumarate salt is an anomaly to the generic rule that a pKa difference of less than 3 
would suggest cocrystal formation (table 4.2). This shows that although the difference in pKas 
may be an indicator of adduct form when values are at the extremes, a more robust solid-state 
parameterisation is required if this prediction of solid state form is to be more reliable. 
In addition to the study of electron density maps for location of the proton in question, 
detailed investigation of the carboxyl bond lengths can be utilised to confirm whether these 
adducts are cocrystal or salt. From table 4.30 it can be seen that if the structure is a salt, only 
one of the C-OH carboxyl bond lengths is ~1.3 Å, the other is much shorter and more 
representative of a C=O bond, confirming the deprotonation.  
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Table 4.30: Carboxylic acid bond lengths in the adenine : dicarboxylic acid adducts. The 
highlighted cells show the much shorter C-OH bond lengths in the salt structures 
 C=O C-OH C=O C-OH 
Adenine : hydrogen malonate 1.205(5) 1.319(4) 1.248(4) 1.267(4) 
Adenine : succinic acid 1.220(3) 1.304(3) 1.206(3) 1.330(3) 
Adenine : hydrogen fumarate 1.215(4) 1.324(4) 1.246(4) 1.280(4) 
Adenine : hydrogen maleate 1.226(2) 1.309(2) 1.280(2) 1.254(2) 
Adenine : hydrogen maleate : malonate     Mol A 1.241(2) 1.288(2) 1.248(2) 1.275(2) 
                                                             Mol B 1.230(2) 1.303(2) 1.249(2) 1.281(2) 
Adenine : pimelic acid 1.236(7) 1.327(7) 1.237(7) 1.344(7) 
Adenine : suberic acid 1.223(6) 1.307(7) 1.202(7) 1.289(8) 
Adenine : sebacic acid 1.226(2) 1.302(2) 1.222(2) 1.309(2) 
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Investigation of the intramolecular geometry within the adenine molecule can also be used. 
Table 4.31 shows the bond angles within the adenine molecule. It can be seen that when a 
nitrogen atom in adenine is protonated, the angle becomes approximately 3° larger. This 
observation helps with both the confirmation of whether there has been proton transfer from 
the acid as well as confirming the existence of a specific tautomer.  
The anhydrous adeninium : hydrogen maleate structure for example contains adeninium 
cations in the less stable 3H,7H tautomeric form, and the table clearly shows that for this 
structure the bond angles around N9 and N4 are greater than in the other structures based on 
the more stable 9H or 1H,9H tautomers. 
Table 4.31: Selected intramolecular bond angles around the heterocyclic nitrogen of the 
adenine : dicarboxylic acid adducts. The protonated nitrogen positions are highlighted in 
orange 
 C1-N9-C8 C1-N2-C3 C3-N4-C5 C5-N6-C7 
Adenine : hydrogen malonate 104.0(3) 106.5(3) 112.2(3) 124.0(3) 
Adenine : succinic acid 103.6(2) 106.7(2) 111.1(2) 119.2(2) 
Adenine : hydrogen fumarate 103.3(3) 106.1(3) 111.9(3) 123.8(3) 
Adenine : hydrogen maleate 106.4(1) 103.4(1) 116.2(1) 120.1(1) 
Adenine : hydrogen maleate : 
malonate      
103.2(1) 106.4(1) 119.1(1) 123.6(1) 
 Adenine : pimelic acid                                                       105.0(5) 107.1(5) 112.1(6) 117.2(6) 
Adenine : suberic acid 103.6(5) 108.2(4) 109.4(4) 119.3(5) 
Adenine : sebacic acid 103.8(1) 106.6(1) 110.5(1) 118.8(1) 
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The study by Guerra et al5 established that the three most stable tautomers of neutral adenine 
are 9H > 3H > 7H. All four structures in which there are neutral adenine molecules detailed in 
this chapter exist in its most stable 9H tautomeric form. As can be seen in appendix 1.1, in the 
previously reported adenine adducts in which the adenine molecule is neutral, all exist in the 
9H form except for four in the 7H tautomeric form. 
In the four salt structures formed, three contain adeninium cations in the most common 1H,9H 
tautomeric form (as shown in appendix 1.2). The anhydrous adeninium : hydrogen maleate 
structure however contains adeninium cations in the 3H,7H tautomeric form. There are only 
two adeninium complexes previously reported containing this tautomeric form23, both 
containing metal ions. This adeninium : hydrogen maleate structure is the first purely organic 
adduct to contain 3H,7H adeninium cations. DFT (density functional theory) calculations 
have been reported on various adeninium tautomeric forms24 and it was concluded that the 
1H,9H form is the most stable followed by the 3H,7H. The remaining adeninium tautomer 
options have the following stabilities 3H,9H > 7H,9H > 1H,7H > 6H,9H > 6H,7H, though of 
the structures currently known, there are only examples of 1H,7H and 6H,9H (appendix 1.2). 
The hydrogen bonding network in adenine : hydrogen maleate results in a crystalline 
arrangement that stabilizes this uncommon tautomer. The lack of protonation at the N2 
adeninium position enables the formation of a C-H...N interaction on the Watson- 
Crick site enabling the hydrogen maleate in this structure to form an additional intermolecular 
interaction. The presence of a hydrogen on N4 necessitates movement of the proton from N2 
to N9 so the expected adeninium dimer (3H-X, figure 4.1) can from. The overall combination 
of these structural requirements results in the adoption and stabilization of the unusual 3H,7H 
tautomer. 
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The vast majority of adenine : dicarboxylic crystalline adducts reported contain the adenine 
dimer motif as shown in table 4.1. The exceptions are the previously published adeninium : 
oxalate structures, the adenine : pimelic acid cocrystal reported here and the solvated 
adeninium : hydrogen maleate salt (although this latter structure does contain strong hydrogen 
bonds between the adenine molecules). Two of the cocrystal structures discussed in this 
chapter (adenine : suberic acid and adenine : sebacic acid) contain ribbons of adenine 
molecules, a supramolecular feature formed by dimers linked together forming chains, similar 
to the structure of pure adenine. The adenine : acid ring motifs are also popular within this set 
of crystalline adducts with all of these structures involving at least one of these networks. 
Table 4.32 lists the different motifs present in both the previously known structures and those 
reported here. 
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Table 4.32: The motifs found in the adenine structures discussed  
Structure Tautomer Adenine motifs Adenine-acid motifs Adenine-acid 
single bond 
Adenine 9H 9H-X  
9H-XIII 
B-B 
H-WC 
  
Adeninium : 
oxalate : chlorine8  
1H9H  9H-VIIa 
 
WC-acid 
 
N9H-O=C 
)5(12R  
Adeninium : 
hydrogen oxalate : 
oxalate : hydrate8  
1H9H  9H-IX 
 
H-acid N9H-O=C 
)5(12R  
Adeninium : 
adenine : hydrogen 
maleate : hydrate1  
7H 
1H9H 
9H-XII 
7H-IX 
9H-XVIa 
H-H 
WC-WC 
B-WC 
9H-IX 
9H-VIIa 
 
H-acid 
WC-acid 
 
9H-VI 
N9H-O-C 
Adeninium : 
hydrogen maleate : 
hydrate9  
1H9H 9H-XII 
 
H-H 9H-VIIa 
 
WC-acid 9H-VI 
N9H-O=C 
Adenine : adipic 
acid : 
methanolate10 
9H 9H-XI 
 
WC-WC 9H-IX 
 
H-acid  
Adenine : 
hydrogen malonate 
1H9H 9H-XII 
9H-X 
 
H-H 
B-B 
 
9H-VIIa 
 
WC-acid 9H-VI 
N9H-O=C 
Adenine : succinic 
acid 
9H 9H-X 
 
B-B 9H-IX 
 
H-acid 9H-IV 
9H-III 
N1-CO2H
 
NH-C=O 
Adenine : 
hydrogen fumarate 
1H9H 9H-X 
 
B-B 9H-VIIa 
 
WC-acid 9H-III 
NH-C=O 
Adenine : 
hydrogen maleate 
(1) 
3H7H 3H-X 
 
B-B 9H-IXa 
7H-VII 
H-acid 
WC-acid 
 
Adenine : 
hydrogen maleate : 
methanolate (2) 
1H9H  9H-VIIa 
 
WC-acid  
Adenine : pimelic 
acid 
9H  9H-VIII 
9H-IX 
B-acid 
H-acid 
9H-II 
9H-III 
NH-C=O 
NH-C=O 
Adenine : suberic 
acid 
9H 9H-X 
9H-XI 
B-B 
WC-WC 
9H-IX H-acid  
Adenine : sebacic 
acid 
9H 9H-XIII 
9H-X 
 
H-WC 
B-B 
 
9H-VIII 
9H-IX 
B-acid 
H-acid 
 
B – base of adenine or adeninium, WC – Watson-Crick edge, H – Hoogsteen edge 
a – based on this motif, though with either different tautomeric forms or adeninium cations as 
opposed to neutral adenine molecules 
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Whilst there are some similarities between the structures presented in this chapter (for 
example the existence of an adenine-acid ring motif), it is clear from the above table that 
many of the hydrogen bonding networks are distinct. There are six possible adenine dimer 
motifs (B-B, H-H, WC-WC, B-H, B-WC, H-WC) and whilst the base-Hoogsteen dimer does 
not occur in these structures, the remaining options are similarly represented, with a slight 
emphasis on a base-base pair arising from adenine : acid linkages on the Watson-Crick and 
Hoogsteen sites. An adenine-acid ring motif is present in all structures discussed here, with all 
three options (B-acid, H-acid and WC-acid) represented.  These adenine structures all exhibit 
extensive hydrogen bonded networks that do not show an obvious trend, however some 
common features have emerged. All anhydrous adducts have a B-B adenine dimer and a H-
acid linkage whilst all hydrated forms contain a H-H adenine dimer. When studying the 
cocrystal motifs as a comparison to the salt structures, it was noted that the H-acid linkage is 
present in all cocrystals whereas the salt structures contain the WC-acid motif, with the B-acid 
linkage not occurring. Further structures within this series would be required to determine 
whether these patterns would continue to allow prediction of the packing and hydrogen 
bonding networks of future adenine structures.  
The synthesis of new materials and a preference for the neutral anhydrous forms of these 
adducts is for their potential use within the pharmaceutical industry. Adenine is a nucleobase, 
but as reported in both previous work and the work reported here, its ability to tautomerise 
can be problematic. In addition to its very high melting point and poor solubility adenine is 
not an ideal solid state material for pharmaceutical application. Cocrystal formation provides 
a potential route for tuning certain physicochemical properties such as melting point, 
solubility and stability of an active pharmaceutical ingredient, whilst retaining the chemical 
properties of the cocrystal formers. Melting point studies of these materials has been started, 
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although further work is needed for completion of this, and investigation into relative 
solubilities is also needed. As can be seen from Table 4.33, the melting points of the 
crystalline adducts are significantly lower than that of adenine and in some cases lower than 
its pure acid as well, an advantage when considering adenine for pharmaceutical application. 
The melting points of the other adenine adducts not included in this table was attempted, 
however at 360ºC the samples had not melted implying that these samples may have degraded 
and not be fully representative. This analysis was attempted significantly later than the 
preparation of the sample, in some cases, more than a year. 
  
Table 4.33: The melting points of a selection of adenine : dicarboxylic acids and their 
coformer materials 
Material Melting point (˚C) 
Adenine > 360  
Maleic acid 141-143 
Succinic acid 179-181 
Fumaric acid 286 – 288 
Adenine : succinic acid 241 – 244 
Adeninium : fumarate 242 – 244 
Adeninium : maleate  132 – 136 
Adeninium : maleate: methanolate 192 - 195 
 
Further work into this series of cocrystals will involve attempts to synthesise neutral, 
anhydrous cocrystal forms of adenine with all of the materials in this set including 
investigating different methods of synthesis and alternative stoichiometries. Solvent drop 
grinding is another possible experimental method and should be utilised as it creates the 
possibility for solvent free forms to be obtained. It could also yield adenine adducts of 
differing stoichiometries to those discussed and it would be interesting to determine whether 
tautomerisation occurs using this technique as opposed to from solution. Study into the 
properties of these new materials also requires further work; solubility and reliable melting 
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point measurements for the whole set of materials are to be taken. There are also a number of 
materials that were not fully characterised so structure solution from powder diffraction data 
would prove beneficial where the quality of these crystals for single crystal X-ray diffraction 
is poor.  
 
4.16 Footnote 
1. Since submission of this thesis, two further adenine adduct structures have been solved; an 
adenine : adipic acid cocrystal (that differs from the published solvated structure10) and an 
adenine : azelaic acid cocrystal structures. Both of these structures follow the patterns 
highlighted in the above discussion (appendix12). 
2. The adenine : succinic acid, adenine : hydrogen fumarate, adenine : hydrogen maleate and 
adenine : hydrogen maleate : malonate structures discussed within this chapter have been 
drafted into a paper for publication to be entitled ‘The supramolecular behaviour of adenine 
with succinic, fumaric and maleic acids; tautomerisation, cocrystallisation, salt formation and 
solvation’ (appendix 13) 
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5. The Crystal Structures and Melting Point Properties of 
Isonicotinamide Cocrystals with Alkanediacids  
 
5.1 Introduction 
Isonicotinamide (pyridine-4-carboxamide, figure 5.1) has also been identified as a good 
candidate for cocrystallisation with the alkanediacids used in chapter 4 for the adenine 
complexes. This molecule also has a number of strong hydrogen bond donor and acceptor 
sites present and demonstrates a propensity to form crystalline adducts with other materials. 
The strong hydrogen bond donor and acceptor sites present in this structure make it ideal for 
forming the robust acid-pyridine heteromeric synthon seen in many of the amide-acid 
cocrystal combinations discussed later in this chapter. 
 
 
Figure 5.1: Isonicotinamide 
 
Previously published isonicotinamide : dicarboxylic acids adduct structures include 2:1 
cocrystals of isonicotinamide : oxalic acid1, isonicotinamide : malonic acid (cocrystal and salt 
mix)1, isonicotinamide : succinic acid1, isonicotinamide : fumaric acid2, isonicotinamide : 
glutaric acid1 and isonicotinamide : adipic acid1. Isonicotinamide : glutaric acid and 
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isonicotinamide : adipic acid also exist in a 1:1 stoichiometry. All of these published 
structures contain a dicarboxylic acid HO2C(CH2)n-2CO2H with a carbon chain length (n) of 
between two and six carbon atoms.  
This chapter focuses on the cocrystallisation of six new potential isonicotinamide : 
dicarboxylic acid adducts; isonicotinamide with maleic acid, pimelic acid, suberic acid, 
azelaic acid, sebacic acid and undecanedioic acid. Maleic acid, like succinic acid and fumaric 
acid, has a carbon chain length of four carbon atoms, whilst the remaining acids have much 
longer chain lengths with n being between seven and eleven respectively (table 5.1). The 
hydrogen bonding patterns of these potential complexes were predicted by studying the 
possible hydrogen bonding motifs and networks that these structures could form along with 
an understanding of the packing of similar isonicotinamide : diacid complexes. The pKa 
values of these coformers were also examined to monitor the possibility of the formation of 
salts rather than cocrystals (see section 1.4).  
Three possible hydrogen bonding motifs were identified for these materials, including an 
isonicotinamide dimer, and two heteromeric motifs, one of which contains the very strong 
acid-pyridine synthon, (figure 5.2). 
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Figure 5.2: Possible hydrogen bonding motifs for isonicotinamide : dicarboxylic acids; (I) 
acid-pyridine, (II) acid-amide and (III) amide-amide. 
 
In appendix 14, the hydrogen bond motifs and packing diagrams for all of the previously 
reported isonicotinamide : dicarboxylic acid cocrystals are shown. As can be seen from these 
figures, a clear trend exists. All these structures contain the acid-pyridine hydrogen bonding 
motif I (shown in figure 5.2) with the 1:1 complexes exhibiting the acid : amide motif II and 
the 2:1 complexes containing the amide dimer synthon III.  
The relative pKa values of all these materials are given in table 5.1Table 5.1: . From this data 
we can predict that the new materials formed and presented in this chapter will be in cocrystal 
form as the pKa difference is less than 2 - 3 (perhaps with the exemption of maleic acid as this 
pKa difference is close to the borderline). Using our knowledge of motifs we would predict 
that all will contain motif I and either II or III dependent on the stoichiometry. 
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Table 5.1: A table of pKa values for the coformers investigated
3. pKa
1 refers to the first 
deprotonation and pKa
2 the second deprotonation. 
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In addition to the synthesis and crystal structure determination of these materials, a melting 
point study of all the isonicotinamide : dicarboxylic acid adducts and their respective 
coformers was undertaken with the aim of enhancing the understanding of how the physical 
properties of a cocrystal relate to the two different coformers, and consequently aide the 
tuning of physical properties of materials by cocrystallisation. The melting point of the pure 
acids shows an alternating pattern with the acids containing an odd number of carbon atoms in 
the chain length having a lower melting point (figure 5.3). This alternation is well 
documented4 and is discussed in detail later in this chapter. The melting point study here will 
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address whether the cocrystals have the same alternating pattern and the relative placing of 
these melting points with respect to their coformers. 
 
Figure 5.3: Melting point of the coformers used in this study 
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5.2 Isonicotinamide : hydrogen maleate 
An isonicotinamide : hydrogen maleate salt structure has been previously identified by a 
member of our research group5 (see appendix 14.5). However, maleic acid has been reported 
to isomerise to fumaric acid6 during cocrystal formation, for example in the cocrystallisation 
of nicotinamide and maleic acid as discussed in chapter 6. 
With this in mind, a range of experimental techniques were employed by myself and an 
undergraduate project student to investigate the possibility of maleic acid isomerising to give 
an isonicotinamide : fumaric acid cocrystal structure. Isonicotinamide was cocrystallised with 
maleic acid following the procedure outlined in section 3.2 (multi-reaction rack) and powder 
X-ray diffraction was used to identify whether new the adduct formed was isonicotinamide : 
maleic acid, isonicotinamide : fumaric acid or an alternative material (figure 5.4). 
 
Figure 5.4: Powder X-ray diffraction patterns of the isonicotinamide : hydrogen maleate, 
isonicotinamide : fumaric acid, the new adduct formed and the corresponding coformers. 
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The powder diffraction patterns above show that the product of crystallisation is a mixture of 
both isonicotinamide : hydrogen maleate and isonicotinamide : fumaric acid with a possibility 
of a small amount of starting material also present. This indicates that some of the maleic acid 
did indeed isomerise to fumaric acid in the cocrystal process. This research was then taken 
further by the project student who investigated the outcome of standard cocrystallisation using 
a wide range of solvents. His research employed eight different solvents and yielded some 
very interesting results (table 5.2) in which a study of the crystallisation process (how long 
before crystals formed etc) allowed prediction of the resulting material (maleate or fumaric 
acid adduct)7. 
 
Table 5.2: Resultant adducts from the isonicotinamide : maleic acid cocrystallisation 
experiments with a variation of solvents7 
Solvent Resultant material 
Methanol Isonicotinamide : fumaric acid 
Ethanol Mixture of isonicotinamide : hydrogen maleate 
and isonicotinamide : fumaric acid 
Propan-1-ol Isonicotinamide : hydrogen maleate 
Ethyl acetate Isonicotinamide : hydrogen maleate 
Butan-1-ol Isonicotinamide : hydrogen maleate 
Methyl acetate Isonicotinamide : hydrogen maleate 
Acetonitrile Isonicotinamide : hydrogen maleate 
Dimethylsulfoxide No product reported 
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 5.3 Isonicotinamide : pimelic acid 
Isonicotinamide was cocrystallised with pimelic acid following the experimental procedure 
outlined in chapter 3.1. Powder X-ray diffraction was used to confirm that a new material had 
been formed (figure 5.5). 
 
Figure 5.5: Powder X-ray diffraction data for the product of isonicotinamide and pimelic acid 
cocrystallisation and the starting materials 
 
The diffraction patterns above show that the product of crystallisation is a new material 
though there may be a small amount of excess pimelic acid starting material also present, 
indicated by the presence of a peak at ~19°. 1H NMR spectroscopy was used to confirm the 
presence of both isonicotinamide and pimelic acid in this material and to identify a 1:1 
stoichiometry (with a small amount of excess pimelic acid present), appendix 15.1.  
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Single crystal X-ray diffraction analysis was carried out on a crystal of suitable quality. The 
data collection was carried out at the UK National Crystallography Service8, with structure 
solution completed by myself. The structure solution of this anhydrous, neutral 1:1 cocrystal 
shows crystallisation in a monoclinic cell with space group P2/c. Table 5.3 Table 5.3gives the 
cell parameters for this structure. 
 
Table 5.3: Cell parameters for isonicotinamide : pimelic acid, 1:1 
Compound Isonicotinamide : pimelic acid 1:1 
a (Å) 8.2223(5) 
b (Å) 5.1437(3) 
c (Å) 33.38946(2) 
α (°) 90 
β (°) 93.873(3) 
γ (°) 90 
Volume (Å3) 
T (K) 
1408.9(2) 
120(2) 
Z 
Reflections collected 
Independent reflections  
R(int) 
4 
13904 
2480 
0.0742 
Goodness of fit 1.077 
R1 (observed) 0.0557 
R1 (all) 0.0901 
wR2 (observed) 0.1184 
wR2 (all) 0.1337 
 
The positions of the hydrogen atoms were determined by an electron density map confirming 
the structure to be a cocrystal, as no proton transfer occurred from the acid to the 
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isonicotinamide. The diffraction pattern simulated from the single crystal structure is the same 
as the laboratory experimental powder diffraction pattern confirming that the crystal selected 
was representative of the bulk material (appendix 15.2). Table 5.4 gives details of the six 
intermolecular hydrogen bonds that are formed in this structure whilst table 5.5 lists selected 
intramolecular bonds and angles in the structure. The numbering scheme used for the 
structure description is shown in figure 5.6. For full crystallographic details and 
intramolecular bonds and angles see appendix 15. 
 
Figure 5.6: The independent molecules in the asymmetric unit isonicotinamide : pimelic acid 
showing the atom-numbering scheme and the hard intermolecular hydrogen-bonds (showed as 
dashed lines) 
 
Table 5.4: Hydrogen bonding (Å) for isonicotinamide : pimelic acid, 1:1 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
N7-H7A...O9 0.88 2.05 2.917(2) 168 
N7-H7B...O15i 0.88 2.08 2.927(3) 162 
O8-H8...O7 0.84 1.77 2.586(2) 165 
O14-H14...N1ii  0.84 1.80 2.634(2) 174 
C5-H5...O15i 0.95 2.38 3.310(3) 166 
C6-H6...O15iii 0.95 2.56 3.221(3) 127 
Symmetry transformations used to generate equivalent atoms: 
(i) –x+1, y-1, z-0.5    (ii) x-1, -y, -z-0.5  (iii) x+1, -y, z+0.5  
 
5. The Crystal Structures and Melting Point Properties of Isonicotinamide Cocrystals with 
Alkanediacids Page 161 
 
 
 
 
Table 5.5: Selected bond lengths (Å) and angles (°) for isonicotinamide : pimelic acid, 1:1 
Bond length Bond length (Å) Torsion angle Torsion angle (°) 
C7-O7 1.246(3) C3-C4-C7-N7 -179.0(2) 
C7-N7 1.322(3) O8-C8-C9-C10 -169.6(2) 
C8-O8 1.322(3) C12-C13-C14-O14 35.4(3) 
C8-O9 1.209(3) O8-C8-C14-O14 -116.6(3) 
 
The crystal structure of isonicotinamide : pimelic acid, 1:1 consists of infinite chains of 
alternating isonicotinamide and acid molecules linked together by the acid-pyridine and acid-
amide synthons (I and II respectively) expected for a 1:1 cocrystal structure of this type with 
these coformers.  
 
Figure 5.7: A view of the chain formed by alternating isonicotinamide and pimelic acid 
molecules. Hydrogen bonds are shown as dashed lines 
 
The distinctive supramolecular chain motif (figure 5.7) is formed by alternating 
isonicotinamide and pimelic acid molecules involved in four intermolecular interactions; two 
hard hydrogen bonds N-H...C=O and O-H...C=O, one hard O-H...N(heterocyclic) interaction 
and one soft C-H...O=C interaction. The heterocyclic nitrogen N1 acts as a hydrogen bond 
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acceptor of H14 donated by O14 from the pimelic acid and is reinforced by a soft hydrogen 
bond from C6 via H6 to the other carboxyl oxygen O15 creating an )7(22R ring. Each 
isonicotinamide molecule interacts with a second pimelic acid molecule to form an )8(22R  
acid-amide synthon in which the amide nitrogen N7 acts as a donor via H7A to the carboxyl 
oxygen O9, while the amide oxygen O7 accepts a second hydrogen bond from the other 
carboxyl oxygen O8 via H8. All the isonicotinamide molecules within a chain face in the 
same direction along the c-axis but the orientation of the amide group alternates up and down 
along the chain. Although the isonicotinamide molecules themselves are planar, the chain 
motif is crinkled due to the twisted conformation of the pimelic acid molecules (Table 5.5: ). 
The interplanar angles between the alkyl chain and the acid groups at both ends O8-C8-C9-
C10 and C12-C13-C14-O14 are -162.6(2)° and 35.4(3)° respectively, with the full extent of 
the twisting illustrated by an interplanar angle between the two acid groups O8-C8-C14-O14 
of -116.6(3)°. 
The hydrogen bonded chains are cross-linked via a further N-H...O=C hydrogen bond donated 
by N7 through H7B to O15 of a pimelic acid in the chain above, and reinforced by another 
soft hydrogen bond from C5 via H5 to O15 (figure 5.8).  
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Figure 5.8: A view of the chains cross-linked by N-H...O hydrogen bonds. Hydrogen bonds 
are shown as dashed lines. The weak C5-H5...O15 hydrogen bond has been omitted from this 
figure 
The chains are aligned in alternate directions such that the isonicotinamide molecules in each 
chain are stacked above and below each other, and with the twisted conformation of the acid 
in the chain, this cross-linking results in the formation of a ‘step-like’ sheet in which 
complementary pairs of isonicotinamide and pimelic acid molecules form )16(24R rings in 
alternating orientations. All strong hydrogen bonding donor and acceptor sites are involved in 
the hydrogen bonding network in this structure. 
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5.4 Isonicotinamide : suberic acid 
Isonicotinamide was cocrystallised with suberic acid following the experimental procedure 
outlined in chapter 3.1. Powder X-ray diffraction was used to confirm the production of a new 
material (figure 5.9). 
 
Figure 5.9: Powder X-ray diffraction data for the product of isonicotinamide and suberic acid 
cocrystallisation and the starting materials 
 
The above diffraction patterns show that a new material has been formed although there is 
indication that it also contains a small amount of isonicotinamide and suberic acid starting 
material. 1H NMR spectroscopy was used to obtain the stoichiometry of the new material 
formed; it shows that both isonicotinamide and suberic acid are present in a 1:1 stoichiometry 
(with a small amount of excess suberic acid present), appendix 16.1.  
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A crystal of suitable quality was isolated for single crystal analysis and a dataset collected at 
the UK National Crystallography Service8. Structure determination was carried out and it was 
found to be an anhydrous neutral cocrystal with a 1:1 stoichiometry, however, unlike 
isonicotinamide : pimelic acid, this structure has triclinic symmetry with space group P-1. 
Crystallographic details are given in table 5.6. 
  
Table 5.6: Cell parameters for isonicotinamide : suberic acid , 1:1 
Compound Isonicotinamide : suberic acid 1:1 
a (Å) 8.943(2) 
b (Å) 9.537(1) 
c (Å) 10.135(2) 
α (°) 86.653(1) 
β (°) 66.031(7) 
γ (°) 66.571(1) 
Volume (Å3) 
T (K) 
719.1(2) 
120(2) 
Z 
Reflections collected 
Independent reflections 
R(int) 
2 
9503 
2516 
0.0719 
Goodness of fit 1.105 
R1 (observed) 0.0724 
R1 (all) 0.1055 
wR2 (observed) 0.1604 
wR2 (all) 0.1837 
 
The positions of the hydrogen atoms were determined by an electron density map confirming 
this structure to be a cocrystal, as no proton transfer occurred from the acid to the 
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isonicotinamide. The diffraction pattern simulated from the single crystal structure is the same 
as that of the laboratory experimental powder diffraction pattern confirming that the crystal 
selected was representative of the bulk material (although there are clearly starting materials 
also present), appendix 16.2. Table 5.7 gives details of the six intermolecular hydrogen bonds 
that are formed in this structure whilst table 5.8 details selected intramolecular bonds and 
angles in the structure. The numbering scheme used for the structure description is shown in 
figure 5.10 Figure 5.10: with full crystallographic details given in appendix 16. 
 
 
Figure 5.10: The independent molecules in the asymmetric unit of isonicotinamide : suberic 
acid showing the atom-numbering scheme and the hard intermolecular hydrogen-bonds 
(showed as dashed lines) 
 
 
Table 5.7: Hydrogen bonding (Å) for isonicotinamide : suberic acid, 1:1 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
N7-H7A...O9 0.88 2.10 2.963(4) 167 
N7-H7B...O16i 0.88 2.08 2.939(4) 165 
O8-H8...O7 0.84 1.76 2.583(3) 164 
O15-H15...N1ii  0.84 1.84 2.648(4) 162 
C2-H2...O9iii 0.95 2.60 3.379(3) 140 
C5-H5...O16ii 0.95 2.40 3.304(5) 160 
Symmetry transformations used to generate equivalent atoms: 
5. The Crystal Structures and Melting Point Properties of Isonicotinamide Cocrystals with 
Alkanediacids Page 167 
 
(i) x, y+1, z+1    (ii) x-1, y-1, z-1  (iii) x+1, y, z  
 
 
Table 5.8: Selected bond lengths (Å) and angles (°) for isonicotinamide : suberic acid, 1:1 
Bond length Bond length (Å) Torsion angle Torsion angle (°) 
C7-O7 1.241(4) C3-C4-C7-N7 172.2(3) 
C7-N7 1.325(5) O8-C8-C9-C10 179.2(3) 
C8-O8 1.321(5) C13-C14-C15-O15 176.8(3) 
C8-O9 1.213(4) O8-C8-C15-O15 168.8 (4) 
 
The crystal structure of isonicotinamide : suberic acid, 1:1 is also formed of chains that 
consist of alternating isonicotinamide and acid molecules. The structure has a 1:1 
stoichiometry, and as expected the molecules are linked by acid-amide and acid-pyridine 
interactions (I and II), but the more planar conformation of the suberic acid molecules (table 
5.8) means that the chain itself differs to that of the isonicotinamide : pimelic acid chain 
structure (figure 5.11). 
 
Figure 5.11: A view of the chain formed of alternating isonicotinamide and suberic acid 
molecules. Hydrogen bonds are shown as dashed lines 
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Within each chain, each isonicotinamide molecule faces in the same direction with the amide 
group in the same orientation, and is involved in the formation of three hard hydrogen bonds. 
Two of these, N-H...O=C and O-H...O=C form the same acid-amide )8(22R  motif seen in the 
isonicotinamide : pimelic acid structure, with the third a hard O-H...N(heterocyclic) 
interaction in which N1 acts as a hydrogen bond acceptor of H15 donated by O15 from the 
other suberic acid molecule. However, the planar conformation of the suberic acid molecule 
and the relative orientation of the acid and amide within the chains in this structure are not 
conducive to the formation of the )7(22R ring motif seen in the isonicotinamide : pimelic acid 
structure. The way in which these chains pack is also distinct from the other structure, as in 
this case the adjacent chains are aligned in the same direction and staggered. An N-H...O=C 
bond is formed between adjacent chains from N7 through H7B to O16 of a suberic acid 
molecule in the chain above and reinforced by two soft hydrogen bonds, one from C5 via H5 
also to O16 in the chain above and the other from C2 via H2 to O9 of a suberic acid molecule 
in the chain below. The overall result is a planar hydrogen bonded sheet in the (011) plane 
(figure 5.12). All strong hydrogen bond donors and acceptors are involved in the 
intermolecular network displayed in this structure. 
 
Figure 5.12: A view of the planar hydrogen bonded sheet. Hydrogen bonds are shown as 
dashed lines. The weak C5-H5...O16 hydrogen bond has been omitted from this figure 
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5.5 Isonicotinamide : azelaic acid 
Isonicotinamide was cocrystallised with azelaic acid following the experimental procedure 
detailed in chapter 3.1. Powder X-ray diffraction was used to confirm the formation of a new 
material (figure 5.13). 
 
Figure 5.13: Powder X-ray diffraction data for the product of isonicotinamide and azelaic acid 
cocrystallisation and the starting materials 
 
The X-ray powder diffraction patterns shown above prove that a new material has formed 
without any excess starting material. Solution 1H NMR spectroscopy was used to identify the 
1:1 stoichiometry of this new isonicotinamide : azelaic acid material (appendix 17.1).  
A crystal of suitable quality was identified and a single crystal dataset collected on this 
sample at the UK National Crystallography Service8. The crystal structure determination 
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(completed by myself) identified that the material is a 1:1 cocrystal in a monoclinic cell with 
space group P2/c. Table 5.9 shows the cell parameters and certain crystallographic details. 
 
Table 5.9: Cell parameters for isonicotinamide : azelaic acid, 1:1 
Compound Isonicotinamide : azelaic acid 1:1 
a (Å) 8.2118(1) 
b (Å) 5.0680(7) 
c (Å) 38.683(5) 
α (°) 90 
β (°) 93.264(6) 
γ (°) 90 
Volume (Å3) 
T (K) 
1607.3(4) 
120(2) 
Z 
Reflections collected 
Independent reflections 
R(int) 
4 
11278 
2761 
0.0748 
Goodness of fit 1.283 
R1 (observed) 0.0872 
R1 (all) 0.1217 
wR2 (observed) 0.1966 
wR2 (all) 0.2217 
 
The positions of the hydrogen atoms were determined by an electron density map confirming 
that this structure was also a cocrystal, as no proton transfer occurred from the acid to the 
isonicotinamide. The diffraction pattern simulated from the single crystal structurea is the 
same as that of the laboratory experimental powder diffraction pattern confirming that the 
crystal selected was representative of the bulk material, al there is clearly a shift in peak 
positions arising from the different temperatures at which the data is ‘collected’ (appendix 
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17.2). Table 5.10 gives details of the six intermolecular hydrogen bonds that form this 
structure whilst table 5.11 lists selected intramolecular bonds and angles in this structure. The 
numbering scheme used for structure description is shown in figure 5.14 and full 
crystallographic details are given in appendix 17. 
 
 
Figure 5.14: The independent molecules in the asymmetric unit of isonicotinamide : azelaic 
acid showing the atom-numbering scheme and the hard intermolecular hydrogen-bonds 
(showed as dashed lines) 
 
Table 5.10: Hydrogen bonding (Å) for isonicotinamide : azelaic acid, 1:1 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
N7-H7A...O9 0.88 2.03 2.899(5) 169 
N7-H7B...O17i 0.88 2.06 2.905(5) 162 
O8-H8...O7 0.84 1.77 2.586(4) 164 
O16-H16...N1ii  0.84 1.79 2.626(4) 175 
C5-H5...O17ii 0.95 2.37 3.296(5) 166 
C6-H6...O17iii 0.95 2.53 3.192(5) 127 
Symmetry transformations used to generate equivalent atoms: 
(i) –x+1, y+1, -z+0.5    (ii) x-1, -y+2, z-0.5  (iii) x+1, -y+2, z+0.5  
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Table 5.11: Selected bond lengths (Å) and angles (°) for  isonicotinamide : azelaic acid, 1:1  
Bond length Bond length (Å) Torsion angle Torsion angle (°) 
C7-O7 1.248(5) C3-C4-C7-N7 178.4(4) 
C7-N7 1.322(5) O8-C8-C9-C10 -171.5(4) 
C8-O8 1.318(5) C14-C15-C16-O16 30.6(6) 
C8-O9 1.216(6) O8-C8-C16-O16 -115.0 (5) 
 
 
Isonicotinamide : azelaic acid, 1:1 is essentially isostructural to isonicotinamide : pimelic 
acid, 1:1. It is formed of infinite chains of alternating isonicotinamide and acid molecules 
(figure 5.15) and includes the predicted acid-pyridine and acid-amide motifs (I and II) 
forming both the )8(22R and )7(
2
2R ring motifs expected in a 1:1 stoichiometry. 
 
Figure 5.15: A view of the alternating isonicotinamide and azelaic acid molecules to form the 
infinite chain. Hydrogen bonds are shown as dashed lines 
 
The azelaic acid molecules in this structure (figure 5.16) also exhibit the twisting seen in the 
pimelic acid cocrystal (table 5.11) giving rise to crinkled chains, that form the same cross-
linked hydrogen bonded network seen in the isonicotinamide : pimelic acid structure. All 
strong hydrogen bond donors and acceptors are used in this structure. 
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Figure 5.16: A view of the cross-linked isonicotinamide : azelaic acid sheet. Hydrogen bonds 
are shown as dashed lines. The weak C5-H5...O17 hydrogen bond has been omitted from this 
figure 
 
 
 
 
 
 
 
 
 
 
 
 
5. The Crystal Structures and Melting Point Properties of Isonicotinamide Cocrystals with 
Alkanediacids Page 174 
 
5.6 Isonicotinamide : sebacic acid 
Isonicotinamide was cocrystallised with sebacic acid following the experimental procedure 
described in chapter 3. Powder X-ray diffraction was used to identify whether a new material 
had been formed (figure 5.17). 
 
Figure 5.17: Powder X-ray diffraction data for the product of isonicotinamide and sebacic 
acid cocrystallisation and the starting materials 
 
It can be seen from the diffraction patterns above that a new material has been formed from 
both methanol and ethanol. The product from methanol also contains a significant amount of 
starting material (sebacic acid) whereas that from ethanol seems a higher purity material.  1H 
NMR spectroscopy confirmed the presence of both isonicotinamide and sebacic acid in this 
material and determined the stoichiometry as 2:1 isonicotinamide : sebacic acid (appendix 
18.1). Several crystals were selected for single crystal X-ray diffraction analysis, however, the 
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crystals were so small and weakly diffracting that it was not possible even to obtain a unit 
cell. Further work on this material would include further attempt at the synthesis of a crystal 
of suitable quality for single crystal X-ray diffraction by growth in an incubator with 
controlled conditionss during the solvent evaporation step of the experimental procedure. 
Structure solution from powder diffraction data is unlikely to be successful in this case as 
there is little diffraction data available for a relatively complex structure. 
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5.7 Isonicotinamide : undecanedioic acid 
Isonicotinamide was cocrystallised with undecanedioic acid following the experimental 
procedure detailed in chapter 3. Powder X-ray diffraction was used to identify whether a new 
material had been formed (figure 5.18). 
 
Figure 5.18: Powder X-ray diffraction data for the product of isonicotinamide and 
undecanedioic acid cocrystallisation and the starting materials 
 
The diffraction patterns in figure 5.18 confirm that a new material has been formed ant that no 
starting materials are present. 1H NMR spectroscopy was used to confirm the presence of 
isonicotinamide and undecanedioic acid in this material in a 1:1 stoichiometry 
(appendix19.1). However, in a similar way to isonicotinamide : sebacic acid, 2:1, crystals of 
this adduct have been placed on the single crystal X-ray diffractometer but they were not of 
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suitable quality to enable data collection. Attempts have not been made to solve the structure 
of this material from powder diffraction data. 
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5.8 Discussion 
The published isonicotinamide : alkanediacid adducts were reported as cocrystals as opposed 
to salts. A further three cocrystal structures and a salt structure have been discussed in this 
chapter; correctly predicted earlier in the chapter when studying the relative pKa values 
displayed in table 5.1. 
The hydrogen bonding networks in crystalline structures in this series of cocrystal materials 
are similar. As previously discussed, all the previously known structures contain the acid-
pyridine synthon I, with synthon II present in 1:1 structures and synthon III present in the 2:1 
structures (figure 5.2); a trend that is continued in the isonicotinamide: diacid crystalline 
structures presented here. The structures all contain infinite hydrogen bonded chains 
consisting of alternating isonicotinamide and dicarboxylic acid molecules in the 1:1 structures 
and alternating isonicotinamide dimers and dicarboxylic acid molecules in the 2:1 structures. 
These infinite chains then link via further hydrogen bonds to create an infinite sheet. 
The three new cocrystal structures with the longer chain acids (isonicotinamide : pimelic acid, 
isonicotinamide : suberic acid and isonicotinamide : azelaic acid) all have a 1:1 stoichiometry. 
Before the structure solution was undertaken, the hydrogen bond network was correctly 
predicted involving both the acid-pyridine and acid-amide heteromeric synthons. Although 
the predicted heteromeric synthons are present in all three of these structures, the chain motifs 
and resultant crystal packing in both the pimelic acid and azelaic acid cocrystal structures 
differ significantly from other published isonicotinamide : alkanediacid cocrystals. The 
twisted conformation of the acid molecules in the pimelic and azelaic acid structures is a 
feature not observed in other isonicotinamide : alkanediacid materials in which a geometry 
more like that found in the isonicotinamide : suberic acid structure is adopted, regardless of 
whether the acid has an odd or even chain length. Twisting of the alkyl chain is a feature that 
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has been reported in the pure α,ω-alkanedicarboxylic acids4 in which it was related to the 
melting point behaviour of these materials. Although lower chain length diacids display 
significant polymorphic behaviour, it was found that those with a chain length greater than 
five displayed packing regularities. The longer chain acids with an even number of carbon 
atoms adopt a fully extended all-trans planar conformation, whereas the odd acids display 
twisted conformations (table 5.12). 
 
Table 5.12: Selected torsion angles (°) of the pimelic, suberic and azelaic acid cocrystals with 
isonicotinamide and the related angles in the pure acid structures 
    Pure acida 
Isonicotinamide : pimelic acid O8-C8-C9-C10 -169.6(2)  -163.14(8) 
 C12-C13-C14-O14 35.4(3)  -163.14(8) 
 O8-C8-C14-O14 -116.6(3)  70.2(1) 
Isonicotinamide : suberic acid O8-C8-C9-C10 179.2(3)  178.33(8) 
 C13-C14-C15-O15 176.8(3)  178.33(8) 
 O8-C8-C15-O15 168.8(4)  180 
Isonicotinamide : azelaic acid O8-C8-C9-C10 -171.5(4)  -163.33(6) 
 C14-C15-C16-O16 30.6(6)  -163.33(6) 
 O8-C8-C16-O16 -115.0(5)  68.08(9) 
a Data taken from4  
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In all cases, the pure diacid molecules are linked together through dimers to form an infinite 
hydrogen bonded chain, but it is the different backbone conformation and different packing of 
these chains between odd and even acids that has been related to the melting point properties. 
In the even members of the series, adjacent chains are shifted, resulting in an offset so that the 
carboxy dimers are not in repulsive proximity. This shift is not adopted by the odd numbered 
acids4 and so the alkyl chain twists to accommodate the alternate orientations of the carboxy 
groups. This results in the formation of the energetically unfavourable conformations and 
hence the odd acids display lower melting points than the even members seen in figure 5.34. 
The melting points of the isonicotinamide cocrystals (both these previously published and 
those synthesised in this project) were recorded and compared against their starting materials 
(figure 5.19). 
 
Figure 5.19: Melting point (°C) of the isonicotinamide : diacid cocrystals and their respective 
coformers 
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It can be seen from figure 5.20 that the melting points of the cocrystals mimic the alternation 
behaviour of the pure acids. The melting points of the 1:1 cocrystals are higher than the pure 
acids but lower than the 2:1 cocrystals. Both this study and others1,9,10 demonstrate that the 
melting point alternation behaviour of pure α,ω-alkanedicarboxylic acids is a reliable property 
that is retained within each homologous series after cocrystallisation. However, the relative 
placement of each melting point series i.e. pure acid vs 1:1 cocrystal vs 2:1 cocrystal is not 
easy to rationalise. It could be expected that both the 1:1 and 2:1 cocrystal series have higher 
melting points than both the pure components as the strong intermolecular interactions that 
are formed in preference to those between molecules of individual components stabilise the 
cocrystal structure and raise the melting point. Whilst this behaviour is observed in some 
cases1,11, including most of the 2:1 and the odd 1:1 cocrystal adducts discussed here, there are 
many other examples of cocrystals with melting points between those of the pure 
components12 and others in which the melting point is significantly lower than both9,11. 
Melting point behaviour of cocrystals containing one of these dicarboxylic acids in which the 
alternating trend is reversed has also been reported13. This case involves cocrystallisation with 
1,2-bis(4-pyridyl)propane and reports that cocrystals with dicarboxylic acids with an odd 
number of carbons have higher melting points than those with an even carbon chain length13. 
Melting point is clearly linked to crystal packing, intermolecular forces and molecular 
conformation (as demonstrated by pure odd diacids4, the isonicotinamide : pimelic acid and 
isonicotinamide : azelaic acid adducts discussed here), but other factors such as entropy 
considerations make any correlation complicated; even more so when considering the relative 
melting points of cocrystal systems with differing stoichiometries, in which there seems to be 
no correlation between the strength of hydrogen bonds and which cocrystal stoichiometry is 
formed. When studying the crystal density and packing fraction (calculated using platon13) of 
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the isonicotinamide cocrystals with pimelic, suberic and azelaic acids we found no direct 
relationship between these properties and the relative placement of the melting point series 
(figure 5.20). For a table of these values see appendix 20. 
 
Figure 5.20: Packing fraction of the isonicotinamide cocrystals and their respective coformers 
 
Although the 2:1 isonicotinamide : diacid cocrystals show a good correlation between these 
parameters within a series in respect of the packing fraction, both the pure acids and our 1:1 
cocrystal results show that this is not always the case i.e. the increase in melting point 
between isonicotinamide : pimelic acid to isonicotinamide : azelaic acid is matched by a 
relative decrease rather than an increase in packing fraction (figure 5.20). Consideration of the 
relative strength of intermolecular hydrogen-bond interactions within the supramolecular unit 
of isostructural systems within a series also gives disparate results. The 2:1 cocrystals 
containing even diacids show a decrease in melting point with an increasing number of carbon 
atoms that correlates with a decrease in intermolecular hydrogen-bond strength quantified by 
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an increase in total H...A distance within the supramolecular building block defining the 
cocrystal unit (appendix 20). In the case of isonicotinamide : pimelic acid and isonicotinamide 
: azelaic acid, in which there was no correlation with packing fraction, the increase in melting 
point is mirrored by an increase in relative hydrogen-bond strength. Unfortunately, similar 
analysis of pure diacid components, whether within the odd or even series, shows a 
contradictory almost systematic increase of hydrogen-bond strength with decrease in melting 
point. Hence, whilst it has not been possible to rationalise the relative placements of the 
melting points, it has been found that the reliable melting point alternation of the pure 
alkanediacids can be used as a potential tool in the tunability of the properties of new 
crystalline materials through cocrystal formation within a homologous series and that in the 
structures reported here at least, the key structural feature displayed by the twisting of odd 
acids is retained in the isonicotinamide cocrystal with longer chain acids. 
 
5.9 Footnote 
The results presented in this chapter (structures and properties of isonicotinamide : pimelic 
acid, isonicotinamide : suberic acid and isonicotinamide : azelaic acid) have been published in 
L.J.Thompson, R.S.Voguri, L.Male, M.Tremayne, CrystEngComm., 2011, 13(12), 4188 
(appendix 20) 
 
 
 
 
 
5. The Crystal Structures and Melting Point Properties of Isonicotinamide Cocrystals with 
Alkanediacids Page 184 
 
5.10 References 
1. P. Vishweshwar, A. Nangia and V. M. Lynch, Cryst. Growth. Des., 2003, 3, 783 
 
2. C. B. Aakeroy, A. M. Beatty and B. A. Helfrich, J. Am. Chem. Soc., 2002, 124, 14425 
 
3. R. M. C. Dawson, D. C. Elliott, W. H. Elliott and K. M. Jones, Data for biochemical 
research, 2 ed, Oxford Clarendon Press, 1969 
 
4. V. R. Thalladi, M. Nusse and R.Boese, J. Am. Chem. Soc., 2000, 122, 9227 
 
5. A. Cowell, An investigation into the synthesis, structural characterisation, thermal 
and polymorphic behaviour of organic crystalline materials, PhD thesis, University of 
Birmingham, 2011 
 
6. S. Chatterjee, V. R. Pedireddi and C. N. R. Rao, Tetrahedron Lett., 1998, 39, 2843 
 
7. G. Cutts,  Synthesis and structure determination of molecular cocrystals, M.Sci 
project report, University of Birmingham, 2011 
 
8. S. J. Coles and P. A. Gale, Chem. Sci., 2012, 3(3), 683 
 
9. D. Braga, L. Maini, G. de Sanctis, K. Rubini, F. Grepioni, M.R. Chierotti and R. 
Gobetto, Chem.-Eur. J., 2003, 9, 5538 
 
10. C. B. Aakeroy, I. Hussain and J. Desper, Cryst. Growth. Des.,  2006, 6, 474 
 
11. L. S. Reddy, A. Nangia and V. M. Lynch, Cryst. Growth. Des.,  2004, 4, 89 
 
12. N. Schultheiss and A. Newman, Cryst. Growth. Des., 2009, 9, 2950 
 
13. D. Braga, E. Dichiarante, G. Palladino, F. Grepioni, M. R. Chierotti, R. Gobetto and L. 
Pellegrino, CrystEngComm, 2010, 12, 3534 
 
14. A. L. Spek, PLATON, Bijvoet Centre for Biochemical Research, Vakgroep Kristal-en 
Structure-Chemie, University of Utrecht, Netherlands 
 
 
 
 
 
 
6. The Crystal Structures of Nicotinamide Cocrystals with Alkanediacids  Page 185 
 
 6. The Crystal Structures of Nicotinamide Cocrystals with 
Alkanediacids 
 
6.1 Introduction 
Nicotinamide (3-pyridinecarboxamide, vitamin B3) is “generally recognized as safe” 
(GRAS), a term used and requires for materials used within both food and pharmaceutical 
products. It has a molecular structure similar to that of isonicotinamide, with the amide on the 
3-position as opposed to the 4-position, and is also a good candidate for cocrystallisation with 
the alkanediacids used in chapters 4 and 5 for the adenine and isonicotinamide adducts (figure 
6.1).  
 
Figure 6.1: Nicotinamide 
 
In a similar way to isonicotinamide, nicotinamide contains both strong hydrogen bond donors 
and acceptors and has shown a propensity to form crystalline complexes with a number of 
materials including the dicarboxylic acids studied in this project. Previously published 
nicotinamide : dicarboxylic acids include 1:1 and 2:1 cocrystal stoichiometries for 
nicotinamide : fumaric acid1, nicotinamide : adipic acid2 and nicotinamide : suberic acid2. 2:1 
cocrystal structures have been reported for nicotinamide : malonic acid2 and nicotinamide : 
sebacic acid2 with 1:1 cocrystal structures known for nicotinamide : glutaric acid2, 
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nicotinamide : pimelic acid2 and nicotinamide : azelaic acid2. A 1:1 nicotinamide : oxalic acid 
salt has also been reported3 along with a 2:1 nicotinamide : oxalic adduct, in which the 
structure was unable to be solved2. All these published structures contain a dicarboxylic acid 
with a carbon chain length, n (HO2C(CH2)n-2CO2H) of between two and ten carbon atoms.  
This chapter focuses on the cocrystallisation of three new potential nicotinamide : 
dicarboxylic acid adducts; nicotinamide with succinic acid, maleic acid and undecanedioic 
acid. The structure of these potential complexes can again possibly be predicted by studying 
the possible hydrogen bonding motifs and networks that these structures could form based on 
an understanding of similar nicotinamide : diacid complexes. The pKa values of these 
coformers can also be examined to identify the possibility of the formation of a salt or a 
cocrystal (section 1.4).  
Three possible hydrogen bonding motifs were identified for these adduct materials, including 
a nicotinamide dimer and two acid : amide motifs, including the very strong acid pyridine 
motif (figure 6.2). These are similar to those formed by isonicotinamide, although there is 
now a possibility of alternate packing arrangements of nicotinamide adopting either the anti 
or syn, amide-pyridine N conformation. 
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Figure 6.2: Possible hydrogen bonding motifs for nicotinamide : dicarboxylic acids; (I) acid-
pyridine, (II) acid-amide and (III) amide-amide 
 
Appendix 22 contains crystal packing diagrams and synthon figures for all the previously 
reported nicotinamide : dicarboxylic acid cocrystal structures. These figures show a clear 
trend; all structures contain the strong acid-pyridine hydrogen bonding motif shown in figure 
6.2 (I), however, the 1:1 complexes exhibit the acid : amide motif (II), whilst the amide dimer 
(III) can be seen in all 2:1 complexes. The exception to this are the salt structures 
(nicotinamide : hydrogen oxalate and nicotinamide : hydrogen maleate) in which the 
nicotinamide dimer is present despite its 1:1 stoichiometry. With this knowledge, we can 
predict that all three adducts studied in this chapter will contain the strong acid-pyridine 
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synthon (I) along with one of the other motifs dependent upon the stoichiometry. The 
published nicotinamide : azelaic acid (n = 9) structure displays twisting of the acid 
conformation. This compares favourably with the conclusion from the isonicotinamide series, 
and would be expected as it has an odd chain length, however, the nicotinamide : pimelic acid 
structure does not exhibit the same twisting.  There are no melting point values reported for 
these nicotinamide cocrystal structures, so no further structure-property relationships can be 
discussed. 
The relative pKa values of all these materials are given in table 6.1. From these values we can 
predict that cocrystals are likely to predominate for the nicotinamide : acid adducts in this 
series although the ΔpKa for nicotinamide with maleic acid and oxalic acid is in the less 
predictable region. 
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Table 6.1: A table of pKa values for the coformers investigated
4. pKa
1 refers to the first 
deprotonation and pKa
2 the second deprotonation. 
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6.2 Nicotinamide : succinic acid 
Nicotinamide was cocrystallised with succinic acid following the experimental procedure 
outlined in chapter 3.1. Powder X-ray diffraction was used to identify whether the resulting 
material was distinct from the starting components (figure 6.3). 
 
Figure 6.3: Powder X-ray diffraction data for the product of nicotinamide and succinic acid 
cocrystallisation and the starting materials 
 
The diffraction patterns above show that both products of crystallisation are the same new 
material with no starting material present. 1H NMR spectroscopy was carried out to determine 
the stoichiometry of the new nicotinamide : succinic acid adduct and to confirm the presence 
of both coformers in the material. The resultant spectrum shown in appendix 23.1 suggests a 
2:1 nicotinamide : succinic acid stoichiometry.  
Single crystal X-ray diffraction analysis was attempted several times on crystals selected from 
these samples, however the crystals were not of suitable quality to obtain a unit cell and allow 
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data collection. This was a problem reported by other researchers who also attempted the 
structure solution of this 2:1 nicotinamide : succinic acid adduct2. Consequently 
cocrystallisation was repeated using a more controlled experimental procedure as detailed in 
chapter 3.2, with the aim of producing better quality crystals. Powder X- ray diffraction was 
again used to determine the outcome of this new experimental method, figure 6.4. 
 
Figure 6.4: Powder X-ray diffraction data for the product of nicotinamide and succinic acid 
cocrystallisation using the two different cocrystallisation methods and their respective starting 
materials 
 
 It can be seen from this figure that the crystalline adduct formed when using the different 
experimental method 3.2, that a second new material has been formed, again with no traces of 
the 2:1 adduct or the starting materials present. The 1H NMR spectra of this second adduct 
suggests a 1:1 stoichiometry (appendix 23.2). Crystals of suitable quality were selected for 
single crystal X-ray diffraction, a dataset was collected at the UK National Crystallography 
Service5 and the structure solution undertaken. However, this resulted in the structure a 2:1 
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cocrystal even though the 1H NMR spectra of this sample had implied a 1:1 stoichiometry. A 
powder diffraction pattern was simulated from this structure and compared to the laboratory 
powder diffraction pattern, (figure 6.5). It can be seen the crystal chosen for single crystal 
analysis was not representative of the bulk material obtained from the experimental procedure 
3.2, but does match the bulk pattern obtained from experiment 3.1 from which no crystals 
could be obtained. 
 
Figure 6.5: The diffraction pattern simulated from the single crystal structure compared to that 
of the laboratory experimental powder diffraction patterns of the products of crystallisation 
using experimental methods 3.1 and 3.2 
 
It was not possible to obtain a crystal structure for the 1:1 nicotinamide : succinic adduct by 
single crystal X-ray diffraction, so it was solved from high quality powder diffraction data 
collected at a synchrotron source. Full details of this procedure and the structure description 
are discussed in chapter 7.  
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6.2.1 Nicotinamide : succinic acid, 2:1 structure description 
The single crystal dataset for the 2:1 crystal was collected at the national crystallography 
service (chapter 3). Structure solution confirmed the adduct to be a cocrystal, crystallising in a 
triclinic cell with space group P-1. Table 6.2 gives the cell parameters for the 2:1 
nicotinamide : succinic acid structure. 
 
Table 6.2: Cell parameters for nicotinamide : succinic acid, 2:1 
Compound Nicotinamide : succinic acid 2:1 
a (Å) 5.0872(2) 
b (Å) 11.5569(5) 
c (Å) 14.2784(5) 
α (°) 77.433(2) 
β (°) 86.726(2) 
γ (°) 89.418(2) 
Volume (Å3) 
T (K) 
818.01(6) 
120(2) 
Z 
Reflections collected 
Independent reflections 
R(int) 
2 
12664 
3205 
0.0610 
Goodness of fit 1.106 
R1 (observed) 0.0555 
R1 (all) 0.0803 
wR2 (observed) 0.1162 
wR2 (all) 0.1320 
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The positions of the hydrogen atoms were determined by an electron density map, confirming 
the structure to be a cocrystal with no proton transfer from the succinic acid to the 
nicotinamide. Table 6.3 lists the eight intermolecular hydrogen bond interactions that are 
formed in this cocrystal structure, whilst table 6.4 gives selected intramolecular bond lengths 
and angles. Figure 6.6 shows the numbering scheme used in the discussion. Full 
crystallographic details are given in appendix 23. 
 
Figure 6.6: The independent molecules of nicotinamide : succinic acid, 2:1 showing the atom-
numbering scheme and the hard intermolecular hydrogen-bonds (shown as dashed lines). 
Displacement ellipsoids are drawn at 50% probability level 
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Table 6.3: Intermolecular hydrogen bonding (Å) for nicotinamide : succinic acid, 2:1 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
O8A-H8A...N1A 0.84 1.85 2.691(3) 174.1 
C6A-H6A...O9A 0.95 2.52 3.206(3) 129.5 
N7A-H7AA...O7Ai 0.88 2.10 2.953(2) 164.1 
N7A-H7AB...O7Aii 0.88 2.15 2.899(3) 142.2 
O8B-H8B...N1B 0.84 1.84 2.682(3) 176.0 
C6B-H6B...O9B 0.95 2.61 3.268(3) 126.9 
N7B-H7BA...O7Biii 0.88 2.06 2.941(3)) 173.6 
N7B-H7BB...O7Bii 0.88 2.22 2.947(3) 139.1 
Symmetry transformations used to generate equivalent atoms: 
(i) –x+1, -y+2, -z+2   (ii) x-1, y, z  (iii) –x+2, -y+1, -z+2 
 
Table 6.4: Selected bond lengths (Å) and angles (°) for nicotinamide : succinic acid, 2:1 
 Bond lengths (Å)  Bond angles (º) 
 Molecules A Molecules B  Molecules A Molecules B 
C7-O7 1.241(3) 1.242(3) O7-C7-N7 121.8(2) 122.2(2) 
C7-N7 1.332(3) 1.331(3) O9-C8-O8 123.6(2) 123.3(2) 
C8-O9 1.213(3) 1.212(3) C6-C5-C7-N7 151.9(2) 26.5(3) 
C8-O8 1.328(3) 1.334(3) O8-C8-C9-C10 174.6(2)i -176.6(2)ii 
Symmetry transformations used to generate equivalent atoms: 
(i) –x+3, -y+2, -z+1   (ii) -x, -y+1,-z+1   
 
The crystal structure of  2:1 nicotinamide : succinic acid displays an extended hydrogen bond 
network generated by the acid-pyridine and amide-amide synthons (I and III) expected in a 
cocrystal of this composition in a 2:1 stoichiometry, but unlike other nicotinamide : acid 
cocrystals, this one contains two crystallographically different nicotinamide molecules with 
different conformations. Nicotinamide molecule A (donated by ‘a’ in figure 6.6) adopts an 
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anti conformation with the heterocyclic N and the amide N on opposite sides of the molecule 
whereas nicotinamide molecule B (denoted by ‘b’ in figure 6.6) adopts a syn conformation. 
Each nicotinamide molecule (A and B) is involved in four intermolecular hydrogen bonds 
with A and B molecules respectively; one hard O-H...N(heterocyclic) interaction and one soft 
C-H...O=C hydrogen bond to a succinic acid molecule, and two hard N-H...O=C hydrogen 
bonds to other nicotinamide molecules of the same conformation. More specifically, the 
carboxyl O8A acts as a hydrogen-bond donor via H8A to heterocyclic N1A of nicotinamide 
molecule A at (x, y, z) with the acid-pyridine packing motif (figure 6.2 (I)) reinforced by a 
C6A in the nicotinamide acting as a soft hydrogen-bond donor through H6A to the other 
carboxyl oxygen O9A at (x, y, z). Propagation of this motif through inversion within the 
succinic acid molecule generates the 2:1 nicotinamide : succinic acid unit in which the 
succinic acid A is capped at both ends by molecules of nicotinamide A. These units are then 
linked together through the complementary amide dimer )8(22R  motif, figure 6.2 (III) formed 
by N7A via H7AA to O7A at (1-x, 2-y, 2-z) to generate a chain running in the       
direction. The chains are linked through a second complementary N-H...O interaction formed 
by N7A through H7AB to O7A resulting in the formation of ladders of alternating )8(24R and 
)8(22R rings and the generation of an extended corrugated hydrogen-bonded sheet in the ac 
plane, figure 6.7. 
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Figure 6.7: A view of the corrugated hydrogen-bonded sheet in the ac plane formed by 
nicotinamide A and succinic acid A molecules. Hydrogen bonds are shown as dashed lines 
 
Nicotinamide B is involved in a similar set of intermolecular interactions with succinic acid B 
and other nicotinamide B molecule, generating the same synthons and motifs as nicotinamide 
A. The formation of a dimer with nicotinamide B at (2-x, 1-y, -z) generates a chain linking the 
nicotinamide B succinic acid B units, which in this case runs in the [201] direction. These 
chains are linked to others to give a second corrugated hydrogen-bonded sheet also in the ac 
plane. Hence, the structure contains alternating sheets comprised purely of A molecules and 
then purely of B molecules in which the chains run in opposing directions. There are no 
strong interactions between alternating sheets and all strong hydrogen-bond donors and 
acceptors are used in the hydrogen-bond network. Figure 6.8 shows a stereoview of this 
crystal structure showing the chains formed by nicotinamide A and succinic acid A running 
along [20-1] and nicotinamide B and succinic acid B running along [201]. 
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Figure 6.8: A stereoview of part of the crystal structure of nicotinamide : succinic acid 2:1 
showing the chains formed by nicotinamide A and succinic acid A running along [20-1] 
(right) and nicotinamide B and succinic acid B running along [201] (left).  Hydrogen bonds 
are shown as dashed lines 
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6.3 Nicotinamide : maleic acid 
Cocrystallisation of nicotinamide and maleic acid has yielded some more interesting findings, 
resulting in extensive further work carried out by myself, a previous group member and an 
undergraduate project student. Nicotinamide was cocrystallised with maleic acid using the 
solvent evaporation experimental method (chapter 3) from both methanol and ethanol but 
resulting in different crystalline materials. From methanol, a nicotinamide : hydrogen maleate 
salt was formed, with the maleate undergoing isomerisation to form a 1:1 nicotinamide : 
fumaric acid cocrystal if the initial crystals were left to redissolve in the solvent. The crystals 
of the maleate salt were white and able to be isolated for single crystal X-ray diffraction 
analysis6 whereas the fumaric cocrystal crystals were yellow. From ethanol, the yellow 
nicotinamide : fumaric acid cocrystal formed without appearance of the maleate crystals first. 
Isomerisation of maleic acid to fumaric acid in cocrystallisation has previously been 
reported7, in which it was suggested that the use of a highly polar solvent was the cause of 
this isomerisation. Consequently, investigation of solvent effect was undertaken, initially 
using dichloromethane and acetone to identify whether the isomerisation occurs using aprotic 
solvents. Powder X-ray diffraction was used to compare and identify the adducts formed from 
these solvents (figure 6.9). Appendix 22.3 shows the crystal structure and packing motif for 
the hydrogen maleate salt structure6 and the fumaric acid cocrystal structures1. 
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Figure 6.9: Powder X-ray diffraction pattern of the products of crystallisation from the aprotic 
solvents compared to those of the starting materials, the nicotinamide : hydrogen maleate 1:1 
salt and nicotinamide : fumaric acid 1:1 cocrystal 
 
The powder diffraction patterns above clearly show that the product of crystallisation from 
acetone is the nicotinamide : hydrogen maleate salt. The diffraction pattern of the product of 
crystallisation from dichloromethane indicates the formation of a further new material with 
the pattern consisting of peaks which clearly differ to those of the adduct structures and 
starting materials. 
A undergraduate student took this project further and investigated a range of other solvents 
including propan-1-ol, ethyl acetate, butan-1-ol, methyl acetate, acetonitrile and 
dimethylsulfoxide8. The nicotinamide : hydrogen maleate salt formed in all of these solvents, 
except for dimethylsulfoxide, which produced no crystalline material. The product of 
crystallisation from propan-1-ol also contained the nicotinamide : fumaric acid cocrystal. The 
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project concluded that the length of time taken for the crystals to form allowed some 
prediction of the resultant product. It was found that the white nicotinamide hydrogen maleate 
crystals form quickly (less than 1 day) as opposed to the yellow nicotinamide : fumaric acid 
crystals which took up to a month to form8. Both the cocrystal and the salt adducts formed in 
these polar protic and polar aprotic solvents, and hence further work will include the use of 
non polar solvents to investigate the effect on this isomerisation. 
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6.4 Nicotinamide : undecanedioic acid 
Nicotinamide was cocrystallised with undecanedioic acid following the experimental 
procedure discussed in chapter 3.1. Powder X-ray diffraction was used to determine whether 
the resultant adduct was a new material, figure 6.10. 
 
Figure 6.10: Powder X-ray diffraction data for the product of nicotinamide and undecanedioic 
acid cocrystallisation and the respective starting materials 
 
The diffraction patterns above show that a new material has been formed. The adducts from 
methanol and ethanol are the same, although there may be some differences due to prefererred 
orientation or some impurity in the sample from ethanol. 1H NMR spectroscopy was used to 
confirm the presence of both nicotinamide and undecanedioic acid in this new material in a 
1:1 stoichiometry (appendix 24.1). 
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A suitable crystal was selected for single crystal X-ray diffraction analysis, a unit cell was 
determined and a dataset collected. The structure crystallises in a triclinic with space group P-
1, table 6.5 gives the cell parameters for the nicotinamide : undecanedioic acid 1:1 structure. 
 
Table 6.5: Cell parameters for nicotinamide : undecanedioic acid, 1:1 
Compound Nicotinamide : undecanedioic  acid 1:1 
a (Å) 9.1939(1) 
b (Å) 11.6336(2) 
c (Å) 17.6109(3) 
α (°) 106.738(1) 
β (°) 90.588(1) 
γ (°) 105.479(1) 
Volume (Å3) 
T (K) 
Z 
Reflections collected 
Independent reflections 
R(int) 
1730.63(5) 
120(2) 
4 
15786 
5925 
0.0288 
R1 (observed) 0.0442 
R1 (all) 0.0373 
wR2 (observed) 0.0985 
wR2 (all) 0.1047 
 
 The position of the hydrogen atoms were determined by an electron density map confirming 
the structure as a cocrystal, since no proton transfer occurred from the acid to the 
nicotinamide. The diffraction pattern simulated from the single crystal structure matches the 
experimental powder X-ray diffraction pattern confirming that the crystal chosen is 
representative of the bulk material (appendix 24.2). Table 6.6 lists the eight intermolecular 
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hydrogen bonds in this structure, whilst table 6.7 lists selected bond lengths and angles (full 
crystallographic details are given in appendix 24. Figure 6.11 shows the numbering scheme 
used in this discussion.  
 
Figure 6.11: The independent molecules of nicotinamide and undecanedioic acid showing the 
atom-numbering scheme and the hard intermolecular hydrogen-bonds (shown as dashed 
lines). Displacement ellipsoids are drawn at 50% probability level 
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Table 6.6: Hydrogen bond table for nicotinamide : undecanedioic acid, 1:1 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
N7A-H7AA...O7Ai 0.88 2.08 2.952(2) 173 
N7A-H7AB...O19Bii 0.88 2.09 2.954(2) 168 
O8A-H8A...N1A 0.84 1.78 2.613(1) 173 
O18A-H18A...O9B 0.84 1.83 2.662(4) 174 
C6A-H6A...O19Biii 0.95 2.34 3.277(2) 170 
N7B-H7BA...O7Biv 0.88 2.10 2.975(2) 170 
N7B-H7BB...O19A 0.88 2.10 2.963(2) 165 
O8B-H8B...N1B 0.84 1.79 2.622(1) 171 
O18B-H18B...O9Av 0.84 1.84 2.673(1) 175 
C6B-H6B...O19Avi 0.95 2.37 3.292(2) 164 
Symmetry transformations used to generate equivalent atoms: 
(i) -x+3, -y+1, -z+1   (ii) x+1, y-1, z+1  (iii) x+1, y, z 
(iv) –x, -y+1, -z+1  (v) x-1, y+1, z-1  (vi) –x+2, -y+1, -z+1 
 
Table 6.7: Selected intramolecular bond lengths (Å) and angles (°) for nicotinamide : 
undecanedioic acid, 1:1 
 Bond lengths (Å)  Bond angles (°) 
 Molecules 
A 
Molecules 
B 
 Molecules 
A 
Molecules 
B 
C7-O7 1.238(2) 1.237(2) O7-C7-N7 122.8(1) 122.5(1) 
C7-N7 1.329(2) 1.329 (2) O9-C8-O8 122.2(1) 122.4(1) 
C8-O9 1.214(2) 1.220(2) O19-C18-O18 122.6(1) 122.6(1) 
C8-O8 1.316(2) 1.309(2) C6-C5-C7-N7 -177.0(1) -177.7(1) 
C18-O18 1.335(2) 1.334(2) O8-C8-C9-C10 178.7(1) -170.4(1) 
C18-O19 1.207(2) 1.209(2) O18-C18-C19-C20 174.1(1) 175.6(1) 
   O8-C8-C18-O18 -15.7(2) 10.7(2) 
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The asymmetric unit of nicotinamide : undecanedioic acid, 1:1 contains two symmetrically 
independent undecanedioic acid molecules (A and B) and two symmetrically independent 
nicotinamide molecules (A and B), though unlike the nicotinamide : succinic acid 2:1 
structure, both nicotinamide molecules adopt the syn conformation, figure 6.11. It is clear 
from the bond lengths and angles listed in table 6.7 that nicotinamide molecules A and B have 
the same conformation with the bond lengths and angles similar. The same cannot be said for 
the acid molecules in which the torsion angles O8-C8-C9-C10, O18-C18-C19-C20 and O8-
C8-C18-O18 are very different in molecule B compared to molecule A. From the C-OH and 
C=O bond angles given in table 6.7, it can be seen that there is a clear distinction between 
them, confirming again that this is a cocrystal as all carboxyl groups have retained their acidic 
protons. 
Each nicotinamide molecule (A and B) is involved in two intermolecular hydrogen bonds to 
molecules of the same type; one hard O-H...N(heterocyclic) interaction and a self 
complementary N-H...O=C hydrogen bond. More specifically the heterocyclic N1 acts as a 
hydrogen bond acceptor of H8 donated by the carboxyl O8 to form the acid-pyridine motif I, 
as expected in a cocrystal structure composed of these coformers. Propagation of this motif 
through the nicotinamide dimer (packing motif III) formed by a complementary bond donated 
by the amide N7 through H7A to O7, creates the four unit chains that can be viewed as the 
basic building block of this crystalline structure. Figure 6.12 shows an example of this 
supramolecular unit formed from molecules B; molecules A form a similar unit with the same 
bonding and motifs. 
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Figure 6.12: A view of the small four unit chains formed by the acid-pyridine and amide-
amide packing motifs I and III 
 
Each nicotinamide molecule (A and B) is involved in three hard intermolecular hydrogen 
bonds and one reinforcing weak hydrogen bond; one hard O-H...N(heterocyclic) interaction 
between respective molecules and a hard self complementary N-H...O=C hydrogen bond are 
present. The final two hydrogen bonds are a hard N-H...O interaction and a soft reinforcing C-
H...O linkage formed between an acid and an amide of differeing types. More specifically the 
heterocyclic N1 acts as a hydrogen bond acceptor of H8 donated by the carboxyl O8 to form 
the acid-pyridine motif I, as expected in a cocrystal structure composed of these coformers. 
Propagation of this motif through the nicotinamide dimer (packing motif III) formed by a 
complementary bond donated by the amide N7 through H7A to O7, creates the four unit 
chains that can be viewed as the basic building block of this crystalline structure. Figure 6.12 
shows an example of this supramolecular unit formed from molecules B; molecules A form a 
similar unit with the same bonding and motifs. 
These units form hydrogen bonds to other units of the opposite type (A or B) via two strong 
hydrogen bonds and a reinforcing soft bond, including the nicotinamide using amide N7 as a 
donor to the carboxyl O9 as an acceptor with the undecanedioic molecules on the second 
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chain. Specifically N7 will donate H7B to O19 on the opposite type chain, with the acids from 
different chains also interacting through the donation of H18 from O18 to the acceptor O9 ion 
the neighbouring chain unit. The amide-acid linkage is reinforced by the soft hydrogen bond 
donated by C6 via H6 to O19 creating a )7(12R ring motif, though the two hard interactions in 
combination with the acid-pyridine linkage form a much larger )14(33R ring motif (figure 
6.13). Each supramolecular chain unit of molecules A forms hydrogen bond interactions to 
four chains of molecules B, which in turn are linked to four units of molecule A etc to form 
the overall crystal structure shown in figure 6.13. 
 
Figure 6.13: A view of the hydrogen bonding network of the nicotinamide : undecanedioic 
acid cocrystal. Hydrogen bonds are shown as dashed lines with the pink lines referring to 
bonding between the A molecules, green lines between the B molecules and the blue lines 
represent the hydrogen bonds that link these chains together. 
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All strong hydrogen bond donors and acceptors are utilised within this cocrystal structure 
forming an extensive hydrogen bonded network that differs significantly from other 
nicotinamide and isonicotinamide cocrystals with dicarboxylic acids. The first major 
difference is that whilst this has a 1:1 stoichiometry, the amide-amide synthon (III) is present 
whereas the amide-acid synthon (II) is not. In other cases the dimer is only formed in the 2:1 
cocrystal structures. The other packing feature that is different in this structure is that it 
consists of small four-unit chains rather than the infinite chains formed in other cocrystals of 
this series. 
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6.5 Discussion 
The published nicotinamide : dicarboxylic acid cocrystals follow the same trend in packing 
motifs as the isonicotinamide : dicarboxylic acid cocrystals; all contain the strong acid-
pyridine synthon and then either an acid-amide motif for 1:1 adducts or the amide-amide 
linkage in the 2:1 adducts. This trend is followed by the nicotinamide : succinic acid 2:1 
cocrystal, however the two nicotinamide molecules within this structure exist in two different 
conformations. A study of the Cambridge Structural Database9 revealed that not only is this a 
feature unobserved in other cocrystals within this series, but it has not been previously 
reported in other  nicotinamide adducts which display only one conformation. Results from 
the database highlighted that there are more examples of structures adopting the anti rather 
than the syn conformation, as indicated by the structures discussed in this chapter, with  the 
hydrogen-bonded sheet formed by nicotinamide A in the anti conformation being the 
common supramolecular unit found in other 2:1 nicotinamide dicarboxylic acid cocrystals 
such as nicotinamide : adipic acid, nicotinamide : suberic acid and nicotinamide : sebacic 
acid2. There are no other reports of the syn conformation in this series of cocrystals, although 
it is found in the 1:1 structures within this series; nicotinamide : glutaric acid and 
nicotinamide : pimelic acid2. 
The nicotinamide : undecanedioic acid cocrystal structure presented in this chapter goes 
against all of the trends previously discussed. The structure does contain the acid-pyridine 
packing motif, however, the acid-amide synthon that is expected in the 1:1 cocrystals is not 
present; instead the amide-amide packing motif, usually seen in the 2:1 cocrystal structures is 
formed. The short four-unit supramolecular chains are another feature not observed in the 
other structures within this series, all of which contain infinite chains that link to form infinite 
sheets.  
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In the isonicotinamide chapter, twisting of the acid conformations is seen within the longer 
chain dicarboxylic acids containing an odd number of carbon atoms. The isonicotinamide : 
pimelic and isonicotinamide : azelaic acid 1:1 (n = 7 and 9 respectively) structures contained 
similar twisting to that seen in the pure acids; however only the published nicotinamide : 
azelaic acid cocrystal exhibits this twisting and not the pimelic acid adduct2. Undecanedioic 
acid contains eleven carbon atoms on its backbone and hence it would be predicted that 
twisting would be present. The O8-C8-O18-C18 torsion angles shown in table 6.7 show that 
twisting is present in this structure, though not to the same extent as the pure acids or the 
isonicotinamide : pimelic and isonicotinamide : azelaic acid 1:1 structures. The reason for this 
can be rationalised by study of the structure. The twisting is present in the pure acids to avoid 
repulsion between the carboxy dimers10 and is present in the cocrystal structures to avoid 
repulsion between the acid-amide ring motifs11. The twisting is energetically unfavourable 
and with this structure not following the packing trends; the motifs are not within a close 
enough range for repulsion so the acid molecules do not need to twist.  
A melting point of 106-108 ºC has been obtained for nicotinamide : undecanedioic, this is in 
the same range as the acid which was recorded to melt at 107ºC. Unfortunately the published 
nicotinamide : dicarboxylic acids did not report the melting points so it has not been possible  
to determine whether the alternating trend displayed by the pure acids and isonicotinamide 
cocrystals is followed in this series of cocrystals.  
Further work would include further attempts at obtaining a structure for isonicotinamide : 
undecanedioic acid to see whether the structure would be similar to the nicotinamide : 
undecanedioic acid structure or whether it follows the initial trend set out by all other 
crystalline adducts within the series of materials studied within this project.  
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Study into the formation of hydrogen maleate salt structures from cocrystallisation 
experiments with both nicotinamide and isonicotinamide also yielded some exciting results. It 
was found that within both systems, the maleic acid would isomerise to fumaric acid within 
the crystal structure when using certain solvents. Table 6.8 lists the different solvents used 
and the resultant material formed when both isonicotinamide and nicotinamide are 
cocrystallised with maleic acid. It is clear from this table that the hydrogen maleate structure 
is more common. 
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Table 6.8: A table listing the resultant crystalline adducts when maleic acid is cocrystallised 
with isonicotinamide and nicotinamide8 
Solvent Resultant material with 
isonicotinamide 
Resultant material with 
nicotinamide 
 
Methanol 
 
Isonicotinamide : fumaric acid 
 
Nicotinamide : hydrogen maleate 
that recrystallises to nicotinamide : 
fumaric acid 
 
Ethanol Mixture of isonicotinamide : 
hydrogen maleate and 
isonicotinamide : fumaric acid 
 
Nicotinamide : fumaric acid 
Propan-1-ol Isonicotinamide : hydrogen 
maleate 
Mixture of nicotinamide : 
hydrogen maleate and nicotinamide 
: fumaric acid 
 
Butan-1-ol Isonicotinamide : hydrogen 
maleate 
 
Nicotinamide : hydrogen maleate 
Acetonitrile Isonicotinamide : hydrogen 
maleate 
 
Nicotinamide : hydrogen maleate 
Methylacetate Isonicotinamide : hydrogen 
maleate 
 
Nicotinamide : hydrogen maleate 
Ethyl acetate Isonicotinamide : hydrogen 
maleate 
 
Nicotinamide : hydrogen maleate 
Dimethylsulfoxide No product reported 
 
No product reported 
 
6.6 Footnote 
The results presented in this chapter (structure of nicotinamide : succinic acid 2:1) have been 
published in L.J.Thompson, R.S.Voguri, A. Cowell, L.Male, M.Tremayne, Acta Crystallogr. 
C, 2010, C66, 0421 (appendix 25) 
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7. Structure solution from X-ray powder diffraction 
 
7.1 Introduction 
This chapter focuses on the structure solution of crystalline adducts from powder diffraction 
using high resolution X-ray diffraction data  collected on beamline I11 at Diamond Light 
Source (section 3.3.2). The unknown nicotinamide : succinic acid 1:1 structure (as discussed 
in chapter 6) has successfully been solved using this data and a variation of methods has been 
used on both a room temperature and low temperature dataset of the known nicotinamide : 
fumaric acid structure1. 
 
7.2 Nicotinamide : succinic acid 
It was found in chapter 6 that different experimental cocrystallisation methods (section 3.1 
and 3.2) form nicotinamide : succinic acid crystalline adducts of different stoichiometry; 2:1 
and 1:1 respectively, though single crystals could only be formed for the 2:1 adduct. 
Therefore high quality powder diffraction data was collected on these crystals with the 
primary aim to solve the structure without needing good quality single crystals. 
 
7.2.1 Unit cell and space group determination 
The laboratory X-ray diffraction pattern of the 1:1 nicotinamide : succinic acid adduct (figure 
7.1) shows that the crystalline sample contains no starting material with solution 1H NMR 
spectroscopy confirming the presence of both nicotinamide and succinic acid in a 1:1 
stoichiometry (appendix 23.2). 
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Figure 7.1: Powder X-ray diffraction data for the product of nicotinamide and succinic acid 
cocrystallisation using the cocrystallisation experimental method 3.2 and the respective 
starting materials 
 
As discussed in section 1.11, high resolution X-ray diffraction data collected from a 
synchrotron source can be used to give better signal/noise ratio and can resolve peak overlap 
to an extent2. Diffraction data were collected on beamline I11 at Diamond Light Source at 
room temperature (section 3.3.2) and indexed (section 2.2.2) allowing a unit cell to be 
determined (table 7.1).  
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Table 7.1: The selected unit cell for nicotinamide : succinic acid, 1:1 from the initial indexing 
results 
Parameter Nicotinamide : succinic acid, 1:1 
a (Å) 8.8832 
b (Å) 25.4316 
c (Å) 5.0191 
α (º) 90 
β (º) 93.761 
γ (º) 90 
V 1131.44 
 
7.2.2 Pattern decomposition 
A le bail fit on the high resolution diffraction data was formed in GSAS3 (section 2.2.3). As 
can be seen from the screenshot below (figure 7.2), the le bail fit is very poor with both peak 
height and peak width fitting badly. The poor fit is believed to be caused by anisoptropic 
peak broadening, a feature often found to be present in X-ray powder diffraction data sets 
collected from synchrotron light sources4. 
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Figure 7.2: A screenshot of the le bail fit of nicotinamide : succinic acid 1:1. The 
experimental pattern is represented by the red crosses, the calculated pattern by the green line 
and the pink line represents the difference of the two 
 
Since anisotropic peak broadening could not be overcome in GSAS, a le bail fit was carried 
out on the laboratory X-ray diffraction pattern using the unit cell obtained from indexing the 
high resolution data. This yielded a slightly better fit (figure 7.3) and did allow for a basic 
structure solution, though not good enough for publication. However, structure solution with 
both reliable and publishable results has been obtained by using Topas5 in which a good 
quality pawley fit was achieved (figure 7.4). 
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Figure 7.3: Le bail fit of the nicotinamide : succinic acid laboratory X-ray diffraction data. 
The experimental pattern is represented by the red crosses, the calculated pattern by the green 
line and the pink line represents the difference of the two 
 
 
Figure 7.4: Pawley fit of nicotinamide : succinic acid on the high resolution synchrotron data. 
The experimental pattern is represented by the blue line, the calculated pattern by the redline 
and the grey line represents the difference of the two 
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7.2.3 Structure solution 
A basic structure solution was obtained from the le bail fit of the laboratory X-ray diffraction 
pattern. Whilst it did not yield results good enough for publication, it did provide a good 
understanding of the crystal packing and molecular arrangement within the structure. The 
structure solution which yielded reliable results was solved from the pawley fit of the high 
resolution synchrotron data by inputting all of the different possible conformations for the 
nicotinamide : succinic acid 1:1 adduct as Z matrices. These models were refined to obtain an 
R-factor (measure of agreement between the model and the experimental data). Sixteen 
different possible conformations were identified; eight cocrystals and eight salts with the 
amide group and the heterocyclic nitrogen on the nicotinamide and carboxylic acid groups on 
the acid being altered (figure 7.5). 
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Figure 7.5: The sixteen possible cocrystal and salt conformations for nicotinamide : succinic 
acid 1:1 
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Restraints were applied to all bond lengths and angles to ensure the results were chemically 
sensible. Table 7.2 shows the resultant R factors for all sixteen conformational models.  
 
Table 7.2: A table of R factors for all sixteen nicotinamide : succinic acid 1:1 conformations 
Model 
 
R
wp
  Model R
wp
 
Cocrystal 1 
 
3.96  Salt 1 4.04 
Cocrystal 2 
 
4.77  Salt 2 4.95 
Cocrystal 3 
 
5.02  Salt 3 4.81 
Cocrystal 4 
 
5.63  Salt 4 5.46 
Cocrystal 5 
 
3.99  Salt 5 4.13 
Cocrystal 6 
 
4.64  Salt 6 4.81 
Cocrystal 7 
 
4.91  Salt 7 4.76 
Cocrystal 8 
 
5.37  Salt 8 5.46 
 
Inspection of these results was initially done in groups of four (conformations 1-4 and 5-8) to 
enable the conformation of the nicotinamide molecule to be confirmed, in which the amide 
group and the position of the heterocyclic nitrogen was different (nicotinamide conformation 
the same for 1 and 5, 2 and 6, 3 and 7 and 4 and 8). The R factors for models 1 and 5 are the 
lowest in all four cases. Further confirmation of this being the correct nicotinamide model 
was obtained from removing the bond length restraints on the amide and pyridine ring with 
the results displayed in table 7.3. 
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Table 7.3: The amide and pyridine bond lengths for the different conformations of the 
nicotinamide molecule once the restraints on bond lengths were removed 
Model Amide bond 
length (Å) 
Pyridine bond length (Å) Conformation 
 
 
Cocrystal 
1 
 
 
C=O 
 
C-N 
 
 
1.250 
 
1.396 
 
C-C 
 
C-C 
 
C-C 
 
1.481 
 
1.390 
 
1.365 
 
C-N 
 
C-N 
 
1.300 
 
1.341 
 
 
 
Cocrystal 
2 
 
 
C=O 
 
C-N 
 
 
1.422 
 
1.162 
 
 
 
 
Cocrystal 
3 
  
C-C 
 
C-C 
 
C-C 
 
1.275 
 
1.299 
 
1.380 
 
C-N 
 
C-N 
 
1.435 
 
1.411 
 
  
It was found that removing the bond length restraints for the amide group for model 2 that the 
C=O bond length elongated to a length more representative of a C-N and the opposite 
happens to the C-N, which contracts to a length more representative of a C=O. A similar 
elongation and contraction occurs to the C-N and C-C bond lengths around the pyridine ring 
in cocrystal 3 upon removal of the restraints in which the C-N bond lengths elongate to be 
more representative of C-C and the relevant two C-C bonds contract to be more 
representative of C-N. 
The conformation of the succinic acid molecule was then able to be confirmed in a similar 
manner. From inspection of the R factors, cocrystal and salt 1 have lower values than the 
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respective cocrystal and salt 5 models. Removal of the bond length restraints found a 
contraction of C-OH and an elongation of C=O, table 7.4. 
 
Table 7.4: The carboxylic acid bond lengths for the different conformations of the succinic 
acid molecule once the restraints on bond lengths were removed 
Model Carboxylic acid bond 
length (Å) 
Conformation 
 
 
Cocrystal 1 
 
 
 
C=O 
 
C-OH 
 
 
1.200 
 
1.270 
 
 
 
 
 
Cocrystal 5 
 
 
C=O 
 
C-OH 
 
 
1.302 
 
1.161 
 
 
 
 
The remaining unknown with this structure is whether it is a cocrystal or salt? Inspection of 
the R factors indicate that it is a cocrystal, however when removing the restraints on this 
hydrogen atom, it sits equidistant to both the nicotinamide and succinic acid molecules. Solid 
state infrared spectroscopy data were collected although it was inconclusive. When 
considering all factors including the trend in all other nicotinamide : dicarboxylic acid 
adducts and the pKa difference between the coformers (chapter 6, table 6.1) it has been 
deduced that the correct structure is that of model cocrystal 1.  
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7.2.4 Rietveld refinement 
Rietveld refinement (section 2.2.6) was carried out after the structure solution, obtaining fully 
refined cell parameters, thermal parameters and bond lengths and angles (section 7.2.5).  
Rietveld refinement was also carried out on the basic structure solution obtained from the le 
bail fit. The models were then manually changed so to ‘test’ the possible different 
conformations and obtain an R factors (table 7.5). The R factors for these results are all very 
close, and the lowest of indicates cocrystal 2 to be the correct model.  
 
Table 7.5: Comparison of the R factors relating to each possible conformational model 
collected from the lab data 
Model Rwp 
Cocrystal 1 0.1132 
Cocrystal 2 0.1114 
Cocrystal 3 0.1135 
Cocrystal 4 0.1116 
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7.2.5 Structure description 
An example of the numbering system used in this description can be seen in figure 7.6 with 
the crystallographic details, hydrogen bonding and selected bond lengths and angles given in 
tables 7.6, 7.7 and 7.8 respectively. 
 
Figure 7.6: The numbering scheme used for the nicotinamide : succinic acid 1:1 structure 
description 
 
Table 7.6: Refined cell parameters for nicotinamide : succinic acid, 1:1 
Cocrystal Nicotinamide : succinic acid 
Formula (C6H6N2O)(C4H6O4) 
Mr 240.21 
T (K) 298 
Crystal system Monoclinic 
Space group P21/n 
a (Å) 10.49   (0.00014) 
b (Å) 25.44   (0.00032) 
c (Å) 5.02     (0.00006) 
α (˚) 90 
β (˚) 122.31  (0.00066) 
γ (˚) 90 
Z 2 
2θ (˚)  3.37 - 25.02 
Goodness of fit 1.077 
Final R1 and wR2 0.0557, 0.1184 
R1 (all data) 0.0901 
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Table 7.7: Intermolecular hydrogen bonding (Å and ˚) in nicotinamide : succinic acid, 1:1 
D-H...A D(D-H) D(H...A) D(D...A)   <(DHA) 
O8-H0...N1 0.84 1.86 2.70 177 
N7-H7...O11i 0.88 2.11 2.94 159 
O12-H11...O7i 0.84 1.78 2.7 167 
N7-H8...O9ii 0.88 2.14 2.99 165 
 
Table 7.8: Selected intramolecular bond lengths and angles in nicotinamide : succinic acid, 
1:1 
Bond length Bond length (Å) Angle Angle (°) 
C7-O7 1.250 O7-C7-N7 126.82 
C7-N7 1.371 O9-C8-O8 125.00 
C8-O8 1.377 O11-C11-O12 125.95 
C8-O9 1.150 C4-C5-C7-O7 170.01 
C11-O11 1.200 O9-C8-C9-C10 170.00 
C11-O12 1.207 O12-C11-C10-C9 170.69 
 
The distinctive supramolecular chain motif is formed by alternating nicotinamide and 
succinic acid molecules involved in three intermolecular interactions; one of which is a hard 
hydrogen bond between the heterocyclic nitrogen and the acid, more specifically O8 acts as a 
hydrogen bond donor via H0 to N1. Each nicotinamide molecule interacts with a second 
succinic acid molecule to form a )8(22R  acid-amide synthon in which the amide nitrogen N7 
acts as a donor via H7 to the carboxyl oxygen O11, whilst the amide oxygen O7 accepts a 
second hydrogen bond from the other carboxyl oxygen O12 via H11 (figure 7.7). The 
nicotinamide molecules within the chain all face the same direction with the amide groups 
alternating between pointing up and down. 
7. Structure solution from X-ray powder diffraction Page 229 
 
 
Figure 7.7: A view of the chain formed by alternating nicotinamide and succinic acid 
molecules. Hydrogen bonds are shown as dashed lines 
 
These infinite chains are linked through a second complementary N-H…O interaction formed 
by N7 through H8 to O9 resulting in the formation of a corrugated hydrogen bonded sheet 
(figure 7.8). In the different chains of this corrugated sheet the nicotinamide molecules face 
the opposite way from one another. 
 
Figure 7.8: A view of the hydrogen bonded sheet formed by the chains linking via hard 
hydrogen bonds. Hydrogen bonds are represented by dashed lines 
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All hydrogen bond donors and acceptors are utilised within this structure, which contains the 
acid-pyridine and acid-amide synthons expected for a 1:1 nicotinamide : dicarboxylic acid 
cocrystal (chapter 6). 
 
7.3 Nicotinamide : fumaric acid 
Upon the success of the structure solution of the unknown nicotinamide : succinic acid 1:1 
cocrystal, structure solution of the known nicotinamide : fumaric acid structure was 
attempted. 
 
7.3.1 Pattern decomposition 
A good quality pawley fit was obtained from room temperature data of nicotinamide : 
fumaric acid. The specific sample used was one that was synthesised with maleic acid, 
undergoing isomerisation in the cocrystallisation process (section 6.3). The cell parameters 
after the pawley fit refinements are shown in table 7.9. 
 
Table 7.9: The refined pawley fit unit cell for nicotinamide : fumaric acid, 1:1  
Parameter Nicotinamide : fumaric acid 
a (Å) 5.5629 
b (Å) 13.8113 
c (Å) 14.3808 
α (º) 90 
β (º) 93.5493 
γ (º) 90 
Space group P21/c 
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7.3.2 Structure solution 
The structure of nicotinamide : fumaric acid 1:1 has previously been reported1 and is known 
to form infinite chains of alternating nicotinamide and acid molecules that link to form 
hydrogen bonded sheets (appendix 22.4). 
Sixteen different conformational models were identified for nicotinamide : fumaric acid 1:1 
(figure 7.9), though it is known from the previously reported single crystal structure that it is 
a cocrystal with the conformation of the nicotinamide and fumaric acid being that of model 
11. 
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Figure 7.9: The sixteen possible cocrystal and salt conformations for nicotinamide : fumaric 
acid 1:1 
 
All of the conformational models above were used as Z-matrices in sixteen different structure 
solutions with R factors collected (table 7.10). Like with nicotinamide : succinic acid, 
restraints were placed on all of the bond lengths and angles. 
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Table 7.10: A table of R factors for all sixteen nicotinamide : fumaric acid 1:1 conformations 
Model 
 
R
wp
  Model R
wp
 
Cocrystal 1 
 
9.89  Salt 1 9.76 
Cocrystal 2 
 
10.50  Salt 2 10.31 
Cocrystal 3 
 
10.41  Salt 3 10.55 
Cocrystal 4 
 
11.22  Salt 4 11.42 
Cocrystal 5 
 
9.63  Salt 5 9.57 
Cocrystal 6 
 
10.14  Salt 6 10.08 
Cocrystal 7 
 
10.43  Salt 7 10.52 
Cocrystal 8 
 
11.13  Salt 8 11.36 
 
As previously mentioned, it is known from the single crystal structure that nicotinamide : 
fumaric acid is a cocrystal and has the conformation seen in model 1. The resultant R factors 
do not fully represent this, with cocrystal and salt 5 having lower values than model 1 and 
that of the salt being slightly lower, although the R factors of these four models (cocrystals 1 
and 5 and salts 1 and 5) are all very close. Once again the bond lengths were studied and 
bond length restraints removed to further confirm the conformation of nicotinamide and to 
obtain a clearer idea about the fumaric acid molecule (tables 7.11 and 7.12 respectively). 
 
 
 
 
 
7. Structure solution from X-ray powder diffraction Page 234 
 
Table 7.11: The amide and pyridine bond lengths for the different conformations of the 
nicotinamide molecule once the restraints on bond lengths were removed 
Model Amide bond 
length (Å) 
Pyridine bond length (Å) Conformation 
 
 
Cocrystal 
1 
 
 
C=O 
 
C-N 
 
 
1.220 
 
1.330 
 
C-C 
 
C-C 
 
C-C 
 
1.399 
 
1.360 
 
1.360 
 
C-N 
 
C-N 
 
1.310 
 
1.350 
 
 
 
Cocrystal 
2 
 
 
C=O 
 
C-N 
 
 
1.160 
 
1.133 
 
 
 
 
Cocrystal 
3 
  
C-C 
 
C-C 
 
C-C 
 
1.195 
 
1.307 
 
1.329 
 
C-N 
 
C-N 
 
1.448 
 
1.354 
 
 
Table 7.12: The carboxylic acid bond lengths for the different conformations of the fumaric 
acid molecule once the restraints on bond lengths were removed 
Model Carboxylic acid bond 
length (Å) 
Conformation 
 
 
Cocrystal 1 
 
 
 
C=O 
 
C-OH 
 
 
1.215 
 
1.290 
 
 
 
 
 
Cocrystal 5 
 
 
C=O 
 
C-OH 
 
 
1.199 
 
1.290 
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The bond lengths for the nicotinamide molecule have shown the same elongation and 
contraction that was found in the nicotinamide : succinic acid structure solution in which the 
bond length becomes more representative of its opposite. When inspecting the bond lengths 
of the fumaric acid molecule, we do not see this, concluding that with this dataset the method 
has not been as conclusive on the conformation of the acid molecule or the placement of the 
acidic proton. 
 
7.3.3 Rietveld refinement 
The final call parameters for nicotinamide : fumaric acid 1:1 after rietveld refinement are 
given in table 7.13 along with a comparison of the cell parameters obtained from single 
crystal analysis. 
 
Table 7.13: The refined unit cell parameters for nicotinamide : fumaric acid, 1:1 compared to 
those obtained from single crystal analysis of the cocrystal 1 model 
Parameter Nicotinamide : fumaric acid from 
powder diffraction analysis 
Nicotinamide : fumaric acid 
from single crystal analysis3 
a (Å) 5.5627 5.550(1) 
b (Å) 13.8108 13.792(1) 
c (Å) 14.3811 14.360(2) 
α (º) 90 90 
β (º) 93.5549 93.41(1) 
γ (º) 90 90 
Space group P21/c P21/c 
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As the structure solution resulted in an incorrect model being the preferred one, R factors 
were obtained for all of the different conformational possibilities of nicotinamide : fumaric 
acid by entering the known atomic coordinates from the single crystal structure1 and allowing 
them to refine within tight restraints. New atomic coordinates for the atoms that will be in 
different positions were calculated so that all sixteen models could be used. The results of this 
are given in table 7.14 
 
Table 7.14: A table of R factors for all sixteen nicotinamide : fumaric acid 1:1 conformations 
using atomic coordinates 
Model 
 
R
wp
  Conformation R
wp
 
Cocrystal 1 
 
9.32  Salt 1 9.27 
Cocrystal 2 
 
9.74  Salt 2 9.73 
Cocrystal 3 
 
9.77  Salt 3 9.67 
Cocrystal 4 
 
10.51  Salt 4 10.41 
Cocrystal 5 
 
9.79  Salt 5 9.75 
Cocrystal 6 
 
9.82  Salt 6 9.80 
Cocrystal 7 
 
10.36  Salt 7 10.10 
Cocrystal 8 
 
10.63  Salt 8 10.52 
 
This has resulted in the correct conformational model of both the nicotinamide and fumaric 
acid molecules having the lowest R factors, though the salt versus cocrystal result is still 
questionable.  
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7.3.4 Low temperature data 
The room temperature data resulted in the best R factor for a model with the correct 
conformation of nicotinamide molecule but incorrect fumaric acid conformation therefore 
both of the above methods (z matrix of all conformations as method 1 and refinement of 
atomic positions from single crystal structure being method 2) were applied to the low 
temperature high resolution data. The resulting R factors for both methods are given in table 
7.15. 
 
Table 7.15: A table of R factors for all sixteen nicotinamide : fumaric acid 1:1 conformations 
using method 1 (z matrices of all conformational models) and method 2 (atomic positions 
from the single crystal structure) 
Model 
 
R
wp 
method 1 
R
wp 
method 2 
 Model R
wp 
method 1 
R
wp 
method 2 
Cocrystal 1 
 
8.34 9.54  Salt 1 8.33 9.53 
Cocrystal 2 
 
9.17 10.49  Salt 2 9.08 10.39 
Cocrystal 3 
 
8.83 10.10  Salt 3 8.99 10.29 
Cocrystal 4 
 
9.87 11.30  Salt 4 10.04 11.49 
Cocrystal 5 
 
8.35 9.55  Salt 5 8.37 9.58 
Cocrystal 6 
 
9.03 10.34  Salt 6 9.04 10.34 
Cocrystal 7 
 
9.04 10.35  Salt 7 9.16 10.49 
Cocrystal 8 
 
9.92 11.35  Salt 8 9.96 11.40 
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As can be seen from these results the R factors for models 1 and 5 are again very close, 
though this data has a better R factor for model 1 compared to 5 in both structure solution 
methods. Both the nicotinamide and fumaric acid conformations are correct though the 
position of the acidic proton is unconfirmed as the structure is known to be a cocrystal and 
these results indicate a salt. The refined unit cell parameters for the low temperature data are 
shown in table 7.16 along with those obtained from the room temperature data and single 
crystal structure. 
 
Table 7.16: The refined unit cell parameters for nicotinamide : fumaric acid, 1:1 compared to 
those obtained from single crystal analysis  
Parameter Nicotinamide : fumaric 
acid low temperature 
Nicotinamide : fumaric acid 
room temperature 
Nicotinamide : fumaric 
acid from single crystal 
analysis1 
a (Å) 5.5221 5.5627 5.550(1) 
b (Å) 13.7652 13.8108 13.792(1) 
c (Å) 14.1250 14.3811 14.360(2) 
α (º) 90 90 90 
β (º) 92.2912 93.5549 93.41(1) 
γ (º) 90 90 90 
Space 
group 
P21/c P21/c P21/c 
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7.4 Discussion 
Several conclusions can be drawn from this initial work in solving crystalline adducts from 
powder diffraction. The nicotinamide : succinic acid structure solution has shown the 
importance of collecting powder X-ray diffraction data from a synchrotron source and how 
much extra detail can be obtained from it particularly when comparing the results of this to 
the results obtained from the laboratory X-ray diffraction data. 
It is clear from both systems studied that the location of the acidic proton is not able to be 
reliably confirmed from this method alone, it will require further analysis by either solid state 
infrared spectroscopy, studying the COOH and NH bands or NMR spectroscopy. 
The nicotinamide : fumaric acid system shows the differences between low temperature and 
room temperature, in this case with the low temperature data being more reliable. 
 
7.5 Footnote 
The nicotinamide : succinic acid, 1:1 structure will be drafted into a communication paper for 
publication. 
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8. Conclusions and further work 
The work presented and discussed in this thesis has covered a variety of areas within 
crystallography, more specifically, molecular crystallography. A number of results have been 
generated that have enabled better understanding and provided advances in certain subject 
areas. 
It has been shown that in certain structures studied within this project that it is possible to link 
the properties of the crystalline adduct with their relative coformers, a significant advantage 
for the pharmaceutical industry in which the requirement of optimal physical properties is 
vital. The continuation of this section of the project will include obtaining measurements for 
other physical properties (e.g. solubility) and comparing the results to that of their relative 
coformers, providing further evidence that the properties of a cocrystal can be tuned from 
those of the coformers. 
Chapter four presented the structures of several new adenine cocrystals and salts to add to the 
relatively short list of previously reported adenine adducts. It yielded some very interesting 
results with the adenine undergoing tautomerisation in some structures and the existence of a 
vast number of hydrogen bonding motifs. This area of research has room for further 
developments. Single crystals were not obtained for all adducts, therefore there are still 
structures yet to be solved. It would also be interesting to try multiple different 
cocrystallisation methods to investigate whether it is possible to obtain anhydrous forms of all 
of the structures and to determine whether tautomerisation would occur in different 
conditions.  
It has been shown from the initial work completed in this project that it is possible to solve a 
cocrystal structure from powder diffraction data, though it did have some problems. In both 
8. Conclusions and further work Page 242 
 
the nicotinamide : succinic acid and nicotinamide : fumaric acid structure the relative placing 
of the acidic proton was not easily obtained. The nicotinamide : fumaric acid dataset had 
further problems with the wrong model being obtained in the initial stages. This work needs 
to be continued with significantly more datasets to ensure that this method is reliable and 
other complementary techniques need to be utilised to aide the salt or cocrystal problem. 
In conclusion this project has been successful in making advances and further confirming 
certain hypotheses that have been previously reported along with initiating exciting areas of 
research within small molecule crystallography.  
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9. Appendices 
Appendix 1: 
1.1: Table of adenine complexes known to date and their relative tautomeric forms 
9H 
CSD code Chemical Tauto
mers 
Refere
nces 
ADRBFT10 Adenine-riboflavin trihydrate 9H 1 
BETNOD tris(Adenine) phthalic acid hexahydrate 9H 
1H9H 
2 
BIGHIJ Diaqua-bis(quinoline-2-carboxylato)-manganese 
bis(adenine) 
9H 3 
  
CODYOJ Adenine hydrochloride hemihydrate 9H 4 
 
COFBUU Adenine bis(N-methyl-2-pyrrolidone) 9H 5 
COFBUU10 Adenine bis(N-methyl-2-pyrrolidone) 9H 6 
DXCADM10 Deoxycorticosterone-adenine monohydrate 9H 7 
EVIFIY Adeninium adenine perchlorate dihydrate 9H 
1H9H 
8 
 
FUSVAQ Adenine trihydrate 9H 9 
FUSVAQ01 Adenine trihydrate 9H 9 
GUNQUB bis(Adenine) hexahydroxytellurium tetrahydrate 9H 10 
JOZZED Adenine hydrogen peroxide 9H 11 
LAFSUH catena-(bis((m2-Oxalato)-aqua-adenine-cobalt(ii)) 
adenine solvate dihydrate) 
9H 12 
LAFTAO catena-(bis((m2-Oxalato)-aqua-adenine-zinc(ii)) adenine 
solvate dihydrate) 
9H 12 
LOLCUL bis(9H-Purin-6-amine) adipic acid methanol solvate 9H 13 
MUBRAD tris(2-Hydroxybenzoic acid) 9H-purin-6-amine 9H 14 
NILNUS (Adenin-7-yl)-(tris(2-aminoethyl)amino)-(perchlorato-O)-
nickel adenine solvate 
9H 15 
 
TAZWOH 9H-purin-6-amine benzoic acid 9H 16 
TAZWOH01 9H-Purin-6-amine bis(benzoic acid) 9H 13 
VIGVEM Adenine-adeninium tetrafluoroborate dihydrate 9H 
1H9H 
17 
 
VILLIM Hexa-aqua-magnesium(ii) diperchlorate bis(adenine) 9H 18 
WUPGOE 5-Methylpyrimidine-2,4(1H,3H)-dione 9H-purin-6-amine 
dihydrate 
9H 19 
 
WUPGUK 5-Methylpyrimidine-2,4(1H,3H)-dione 9H-purin-6-amine 
tetrahydrate 
9H 19 
 
YUWMUY Adenine 7-oxide monohydrate 9H 20 
 
ZZZEGG Adenine 1-N-oxide 9H 21 
OYEFUU Adeninium 2,6-dihydroxybenzoate monohydrate 9H 22 
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7H 
CSD code Chemical Tauto
mers 
Refer
ences 
SEGCOX catena-(bis(m2-oxalato)-tetraaqua-di-manganese(ii) 
bis(adenine) dihydrate)Trichloroguaninium zinc 
7H 23 
VILLAE Hexa-aqua-magnesium(ii) dichloride bis(adenine)  7H 18 
VILLEI Hexa-aqua-magnesium(ii) dibromide bis(adenine)  7H 18 
PANSAA 6-Amino-9H-purin-1-ium hydrogen maleate hemikis(9H-
purin-6-amine) monohydrate 
7H 
1H9H 
24 
ADAQCU Diaqua-tetrakis(m2-adenine-N,N')-di-copper(ii) 
tetraperchlorate dihydrate 
7H 25 
PEKPEA 3-Adenyl-tris((2-aminoethyl)amine)-chloro-nickel(ii) 
chloride 
7H 26 
VILLOS Tetra-aqua-bis(adenine)-manganese(ii) diperchlorate 7H 18 
VILLUY bis((m2-Aqua)-(m2-adenine-N,N'))-tetra-aqua-di-
manganese(ii) tetranitrate dihydrate 
7H 18 
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1.2: Table of adeninium complexes known to date and their relative tautomeric forms 
1H,9H 
CSD code Chemical Tauto
mers 
Refere
nces 
ADALEW Adenine (46,63-di-t-butyl-44,65-dimethyl-4,6(1,2)-
dibenzena-1,3,2-dioxaphosphacyclohexaphane 2,2-
dioxide) methanol solvate 
1H9H 1 
 
ADENBH Adeninium hydrobromide hemihydrate 1H9H 2 
ADENCH Adenine hydrochloride hemihydrate 1H9H 3 
ADENCH01 Adenine hydrochloride hemihydrate 1H9H 4 
ADENCH02 Adenine hydrochloride monohydrate 1H9H 5 
ADENCH03 Adenine hydrochloride hemihydrate 1H9H 6 
ADENOH bis(Adeninium nitrate) monohydrate 1H9H 7 
ADENOH10 bis(Adeninium) dinitrate monohydrate 1H9H 7 
ADENPH Adeninium phosphate 1H9H 8 
ADESUL Adeninium hemisulfate monohydrate 1H9H 9 
ADNCHG10 Adeninium catena(trichloro-mercury(ii)) sesquihydrate 1H9H 10 
BOTSIN 9H-Adenin-1-ium oxalate hemikis(oxalic acid) 
monohydrate 
1H9H 11 
BUDJAM Adeninium 3-carboxyanilinium diperchlorate trihydrate 1H9H 12 
BUDVUR Adenine 1-(2-carboxyethyl)-uracil 1H9H 13 
BUDVUR10 Adenine 1-(2-carboxyethyl)-uracil 1H9H 14 
CADENZO2 Trichloro-adeninium-zinc(ii) 1H9H 15 
CADENZ10 Trichloro-adeninium-zinc 1H9H 16 
CADENZ20 (Adeninium-N)-trichloro-zinc(ii) 1H9H 17 
COFBUU10 Adeninium chloroacetate chloroacetic acid solvate 1H9H 18 
EGOWIG Adeninium aqua-(ethylenediamine-N,N,N'-triacetato-N'-
acetic acid)-copper(ii) dihydrate 
1H9H 19 
GADPOS catena-(bis(6-amino-9H-purine-1,7-diium) bis(m2-
pyridine-2,3-dicarboxylato)-manganese(ii) tetrahydrate) 
1H9H 20 
IKAFOQ 6-amino-9H-purin-1-ium perchlorate 1H9H 21 
LEZHIH bis(Adenine) 7-hydroxy-8-(phenylazo)-1,3-naphthalene-
disulfonate pentahydrate 
1H9H 22 
 
LICGIO bis(adeninium) phthalate phthalic acid hydrate 1H9H 23 
LOLDAS Adeninium 2,6-dihydroxybenzoate 1H9H 24 
LOLDEW Adeninium 2,6-dihydroxybenzoate monohydrate 1H9H 24 
LOLDIA Adeninium 2-hydroxybenzoate methanol solvate 1 H9H 24 
LOLDOG Adeninium hydroxonium 3,5-dihydroxybenzoate 
hydroxide 
1H9H 24 
MUCCOD Adeninium cytosinium sulphate 1H9H 25 
RIGMEA Adeninium phenylacetate phenylacetic acid monohydrate 1H9H 26 
RIGMIE Adeninium 3-carboxypropionate monohydrate 1H9H 26 
SOLCOM bis(Adeninium) aqua-bis(2-methylmalonato)-copper 1H9H 27 
SOLCOM01 bis(adeninium) aqua-bis(methylmalonato)-copper(ii) 1H9H 28 
SOLDAZ catena-(bis(Adeninium) bis(m2-malonato)-copper 
dihydrate) 
1H9H 27 
SOLDAZ01 catena-[bis(Adeninium) bis(m2-malonato)-copper(ii) 1H9H 28 
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dihydrate] 
TINYIZ Bis(adeninium) chloranilate dihydrate 1H9H 29 
TUDLOT 2-Aminopurinium 2-fluorobenzoate monohydrate 1H9H 30 
UDIJEX bis(1H,9H-Adeninium) aqua-bis(oxalato)-copper(ii) 1H9H 31 
ZETGOU bis(1H-Adeninium) pentachloroantimonate monohydrate 1H9H 32 
ZETGUA 1H-Adeninium (propylen-1,2-diaminetetra-acetato)-
antimony dihydrate 
1H9H 32 
 
3H,7H 
CSD code Chemical Tauto
mers 
Refer
ences 
UDIJIB Bis(3H,7H-adeninium) diaqua-bis(oxalate)-cobalt (ii) 
dehydrate 
3H7H 33 
UDIJOH Bis(3H,7H-adeninium) diaqua-bis(oxalate)-zinc (ii) 
dehydrate 
3H7H 33 
 
 
1H,7H 
CSD code Chemical Tauto
mers 
Refere
nces 
CUZGOT 6-Amino-8-mercaptopurinium chloride 1H7H 34 
CUZGUZ bis(6-Amino-8-mercaptopurinium) (6-amino-8-
mercaptopurinium-S)-pentachloro-bismuth chloride 
pentahydrate 
1H7H 34 
CUZHAG (6-Amino-8-mercaptopurinium) (6-amino-8-
mercaptopurinium-S)-pentachloro-bismuth dihydrate 
1H7H 34 
 
OCIQUM Adeninium tri-iodide di-iodine monohydrate 1H7H 35 
PIDQIC tetrakis(Adeninium) p-sulfonatocalix(4)arene 
tetradecahydrate clathrate 
1H7H 36 
 
BRADCU Dibromo-di(adeninium) copper(ii) dibromide 1H7H 37 
 
6H,9H 
CSD code Chemical Tauto
mers 
Refere
nces 
BEZSII bis(Adeninium) hydrogen phosphate dihydrate NH3 
9H 
38 
 
FESWUW bis(Adeninium) (m2-hydrogen phosphato)-
tetracosakis(m2-oxo)-dodecaoxo-dodeca-tungsten 
dimethylformamide solvate dihydrate 
NH3 
9H 
39 
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Mixture of tautomers 
CSD code Chemical Tauto
mers 
References 
ADHCOS1
0 
bis(Adeninium) trans-tetra-aqua-
bis(adenine-N9)-cobalt(ii) sulfate 
hexahydrate 
1H9H 
7H 
40 
 
PANSAA 6-Amino-9H-purin-1-ium hydrogen 
maleate hemikis(9H-purin-6-amine) 
monohydrate 
1H9H 
7H 
41 
 
BETNOD tris(Adenine) phthalic acid 
hexahydrate 
1H9H 
9H 
42 
 
EVIFIY Adeninium adenine perchlorate 
dihydrate 
1H9H 
9H 
43 
 
VIGVEM Adenine-adeninium tetrafluoroborate 
dihydrate 
1H9H 
9H 
44 
ADENZN Trichloro-adeninium-zinc(ii) N7-H-
adeninium chloride monohydrate 
1H9H 
1H7H 
45 
QUTJAR (1H,9H)-Adeninium (3H,7H)-
adeninium bis(pyridine-2,6-
dicarboxylato)-copper(ii) trihydrate 
1H9H 
3H7H 
46 
 
QUTJEV (1H,9H)-Adeninium (3H,7H)-
adeninium bis(pyridine-2,6-
dicarboxylato)-manganese(ii) 
trihydrate 
1H9H 
3H7H 
46 
 
QUTKEW (1H,9H)-Adeninium (3H,7H)-
adeninium tris(pyridine-2,6-
dicarboxylato)-cerium tetrahydrate 
1H9H 
3H7H 
46 
 
APUHEZ tris(adeninium) hexafluoro-aluminium 
hydrate 
1H9H 
3H7H 
47 
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Appendix 2: 
2.1.1: 1H NMR spectra of adenine : malonic acid adduct synthesised from methanol (solvent 
– DMSO) 
 
Adenine:   7.10 (2H,s),   8.10 (2H,d),   12.80 (1H,s),                                                         
Malonic acid:   3.2 (2H, s) 
 
2.1.2: 1H NMR spectra of adenine : malonic acid adduct synthesised from ethanol (solvent – 
DMSO) 
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Adenine:   7.25 (2H,s),   8.20 (2H,d),   12.80 (1H,s)                                                        
Malonic acid:   3.25 (2H, s) 
2.2: The diffraction pattern simulated from the single crystal structure compared to that of the 
laboratory experimental powder diffraction pattern of adeninium : hydrogen malonate 
 
 
 
 
 
2.3: Ortep of adeninium : hydrogen malonate, 1:1 
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2.4: Crystallographic details of adeninium : hydrogen malonate, 1:1 
Empirical formula C8 H9 N5 O4 
Formula weight 239.20 
Temperature 120(2) K 
Wavelength 1.54184 Å 
Crystal system Triclinic 
Space group  P -1 
Unit cell dimensions a = 4.8942(3) Å 
b = 8.1034(4) Å 
c = 12.5052(6) Å 
α = 82.944(3)° 
β = 86.677(3) ° 
γ = 79.855(4)° 
Volume 484.17(4) Å3 
Z 2 
Density (calculated) 1.641 Mg/m3 
Absorption coefficient 1.159 mm-1 
F(000) 248 
Crystal size  0.15 x 0.08 x 0.04 mm3 
Theta range for data collection 6.97 to 70.03°. 
Index ranges -5<=h<=5, -9<=k<=9, -14<=l<=14 
Reflections collected 4730 
Independent reflections 1725 [R(int) = 0.0288] 
Completeness to theta = 70.03° 94.6 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9551 and 0.8453 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1725 / 0 / 155 
Goodness-of-fit on F2 1.168 
Final R indices [I>2sigma(I)] R1 = 0.0991, wR2 = 0.2512 
R indices (all data) R1 = 0.1097, wR2 = 0.2680 
Largest diff. peak and hole 2.005 and -0.567 e.Å-3 
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2.5: Intramolecular bond lengths (Å) and angles (°) in adeninium : hydrogen malonate, 1:1 
Bond length (Å) Bond length (Å) Bond length (Å) 
C10-O11     1.248(4) 
C10-O10     1.267(4) 
C10-C11     1.525(4) 
C11-C12     1.518(5) 
C11-H11A     0.990 
C11-H11B     0.990 
C12-O13     1.205(5) 
C12-O12     1.319(4) 
O12-H12     0.840 
C1-N9                1.302(4) 
C1-N2                1.370(4) 
C1-H1                0.950 
C3-N2                1.349(5) 
C3-N4                1.368(4) 
C3-C8                1.394(5) 
C5-N4                1.310(4) 
C5-N6      1.346(4) 
C5-H5                0.950 
C7-N7                1.302(4) 
C7-N6                1.379(4) 
C7-C8                1.426(5) 
C8-N9                1.375(4) 
N2-H2     0.880 
N6-H6     0.880 
N7-H7A     0.880 
N7-H7B     0.880 
 
Bond angle (°) Bond angle (°) Bond angle (°) 
O11-C10-O10          124.4(3) 
O11-C10-C11           118.0(3) 
O10-C10-C11           117.6(3) 
C12-C11-C10           117.5(3) 
C12-C11-H11A        107.9 
C10-C11-H11A        107.9 
C12-C11-H11B        107.9 
C10-C11-H11B        107.9 
H11A-C11-H11B     107.2 
O13-C12-O12          120.7(3) 
O13-C12-C11           122.4(3) 
O12-C12-C11           116.9(3) 
C12-O12-H12           109.5 
N9-C1-N2           113.5(3) 
N9-C1-H1           123.3 
N2-C1-H1           123.3 
N2-C3-N4           128.0(3) 
N2-C3-C8           105.4(3) 
N4-C3-C8           126.5(3) 
N4-C5-N6           126.1(3) 
N4-C5-H5           117.0 
N6-C5-H5           117.0 
N7-C7-N6           120.5(3) 
N7-C7-C8           126.6(3) 
N6-C7-C8           113.0(3) 
N9-C8-C3                 110.5(3) 
N9-C8-C7           131.2(3) 
C3-C8-C7           118.2(3) 
C3-N2-C1           106.6(3) 
C3-N2-H2           126.7 
C1-N2-H2           126.7 
C5-N4-C3           112.2(3) 
C5-N6-C7           123.9(3) 
C5-N6-H6           118.0 
C7-N6-H6           118.0 
C7-N7-H7A           120.0 
C7-N7-H7B           120.0 
H7A-N7-H7B           120.0 
C1-N9-C8           104.0(3) 
 
Torsion angle (°) Torsion angle (°) 
O11-C10-C11-C12           -166.6(3) 
O10-C10-C11-C12            14.8(5) 
C10-C11-C12-O13            166.9(3) 
C10-C11-C12-O12           -15.1(5) 
N2-C3-C8-N9                    0.6(4) 
N4-C3-C8-N9                   -178.6(3) 
N2-C3-C8-C7                   -178.2(3) 
N4-C3-C8-C7                    2.6(5) 
N7-C7-C8-N9                   -2.0(6) 
N6-C7-C8-N9                    178.3(3) 
N7-C7-C8-C3          176.5(3) 
N6-C7-C8-C3                   -3.2(4) 
N4-C3-N2-C1                    178.8(3) 
C8-C3-N2-C1                   -0.5(4) 
N9-C1-N2-C3                     0.1(4) 
N6-C5-N4-C3        -0.7(5) 
N2-C3-N4-C5                   -179.6(3) 
C8-C3-N4-C5                   -0.5(5) 
N4-C5-N6-C7                   -0.2(5) 
N7-C7-N6-C5                   -177.4(3) 
C8-C7-N6-C5                     2.2(5) 
N2-C1-N9-C8                     0.2(4) 
C3-C8-N9-C1                    -0.6(4) 
C7-C8-N9-C1                     178.0(3) 
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Appendix 3: 
3.1: 1H NMR spectra of adenine : succinic acid adduct (solvent – DMSO) 
 
 
 
Adenine:   7.10 (2H,s),   8.10 (2H,d),   12.80 (1H,s)                                                        
Succinic acid:  2.42 (4H, s),   12.20 (2H, s) 
 
3.2: The diffraction pattern simulated from the single crystal structure compared to that of the 
laboratory experimental powder diffraction pattern of adenine : succinic acid 
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3.3: Ortep of adenine : succinic acid, 1:1 
 
3.4: Crystallographic details of adenine : succinic acid, 1:1 
Empirical formula C9 H11 N5 O4 
Formula weight 253.23 
Temperature 120(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group P21/n 
Unit cell dimensions a = 9.4902(4) Å 
b = 5.3041(3) Å 
c = 21.2846(8) Å 
β = 92.398(3) ° 
Volume 1070.46(9) Å3 
Z 4 
Density (calculated) 1.471 Mg/m3 
Absorption coefficient 0.126 mm-1 
F(000) 528 
Crystal size  0.10 x 0.08 x 0.06 mm3 
Theta range for data collection 3.52 to 27.48°. 
Index ranges -12<=h<=12, -6<=k<=6, -27<=l<=27 
Reflections collected 8933 
Independent reflections 2426 [R(int) = 0.0485] 
Completeness to theta = 27.48° 99.1 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9925 and 0.9875 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2426 / 0 / 165 
Goodness-of-fit on F2 1.114 
Final R indices [I>2sigma(I)] R1 = 0.0586, wR2 = 0.1123 
R indices (all data) R1 = 0.0817, wR2 = 0.1257 
Largest diff. peak and hole 0.278 and -0.276 e.Å-3 
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3.5: Intramolecular bond lengths (Å) and angles (°) in adenine : succinic acid, 1:1 
Bond length (Å) Bond length (Å) Bond length (Å) 
C1-N9                1.324(3) 
C1-N2                1.351(3) 
C1-H1                0.9500 
C3-N4                1.352(3) 
C3-N2                1.370(3) 
C3-C8                1.382(3) 
C5-N4                1.325(3) 
C5-N6                1.340(3) 
C5-H5                0.9500 
C7-N7                1.333(3) 
C7-N6                1.362(3) 
C7-C8                1.407(3) 
C8-N9                1.390(3) 
N2-H2                0.8800 
N7-H7A             0.8800 
N7-H7B             0.8800 
C10-O11            1.220(3) 
C10-O10            1.304(3) 
C10-C11            1.498(3) 
C11-C12            1.526(3) 
C11-H11A         0.9900 
C11-H11B         0.9900 
C12-C13            1.509(3) 
C12-H12A         0.9900 
C12-H12B         0.9900 
C13-O14            1.206(3) 
C13-O13            1.330(3) 
O10-H10            0.8400 
O13-H13            0.8400 
 
Bond angle (°) Bond angle (°) Bond angle (°) 
N9-C1-N2                 13.5(2) 
N9-C1-H1                 123.2 
N2-C1-H1                 123.2 
N4-C3-N2                 27.4(2) 
N4-C3-C8                 126.8(2) 
N2-C3-C8                 105.8(2) 
N4-C5-N6                 28.6(2) 
N4-C5-H5                 115.7 
N6-C5-H5                 115.7 
N7-C7-N6           119.9(2) 
N7-C7-C8                 122.8(2) 
N6-C7-C8                 117.2(2) 
C3-C8-N9                 110.3(2) 
C3-C8-C7                 116.9(2) 
N9-C8-C7                 132.7(2) 
 
C1-N2-C3                 106.7(2) 
C1-N2-H2                 126.7 
C3-N2-H2                 126.7 
C5-N4-C3           111.1(2) 
C5-N6-C7                 119.2(2) 
C7-N7-H7A              120.0 
C7-N7-H7B              120.0 
H7A-N7-H7B           120.0 
C1-N9-C8                 103.7(2) 
O11-C10-O10           122.8(2) 
O11-C10-C11           124.0(2) 
O10-C10-C11           113.1(2) 
C10-C11-C12           113.5(2) 
C10-C11-H11A        108.9 
C12-C11-H11A        108.9 
 
C10-C11-H11B        108.9 
C12-C11-H11B        108.9 
H11A-C11-H11B     107.7 
C13-C12-C11           111.7(2) 
C13-C12-H12A        109.3 
C11-C12-H12A        109.3 
C13-C12-H12B        109.3 
C11-C12-H12B        109.3 
H12A-C12-H12B     107.9 
O14-C13-O13           119.8(2) 
O14-C13-C12           123.2(2) 
O13-C13-C12           117.0(2) 
C10-O10-H10           109.5 
C13-O13-H13           109.5 
 
 
Torsion angle (°) Torsion angle (°) 
N4-C3-C8-N9                   -179.3(2) 
N2-C3-C8-N9                   0.0(3) 
N4-C3-C8-C7                   -1.1(4) 
N2-C3-C8-C7                   178.2(2) 
N7-C7-C8-C3                   -178.8(2) 
N6-C7-C8-C3                   0.7(3) 
N7-C7-C8-N9                   -1.2(4) 
N6-C7-C8-N9                   178.3(2) 
N9-C1-N2-C3                   -0.6(3) 
N4-C3-N2-C1                   179.6(2) 
C8-C3-N2-C1                   0.3(3) 
N6-C5-N4-C3                   0.5(4) 
N2-C3-N4-C5                   -178.6(2) 
C8-C3-N4-C5                   0.6(3) 
N4-C5-N6-C7                   -0.9(4) 
N7-C7-N6-C5                   179.7(2) 
C8-C7-N6-C5                   0.2(3) 
N2-C1-N9-C8                   0.6(3) 
C3-C8-N9-C1                   -0.4(3) 
C7-C8-N9-C1                   -178.1(3) 
O11-C10-C11-C12           3.7(3) 
O10-C10-C11-C12           -176.4(2) 
C10-C11-C12-C13           177.0 (2) 
C11-C12-C13-O14           12.6(3) 
C11-C12-C13-O13           -168.0(2) 
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Appendix 4:  
4.1: 1H NMR spectra of adenine : fumaric acid adduct (solvent – DMSO) 
 
Adenine:   7.10 (2H,s),   8.10 (2H,d),  12.80 (1H,s)   
Fumaric acid:   6.62 (2H, s),   13.20 (2H, s) 
 
4.2: The diffraction pattern simulated from the single crystal structure compared to that of the 
laboratory experimental powder diffraction pattern of adeninium : hydrogen fumarate 
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4.3: Ortep of  adeninium : hydrogen fumarate, 1:1 
 
4.4: Crystallographic details of adeninium : hydrogen fumarate, 1:1 
Empirical formula C9 H9 N5 O4 
Formula weight 251.21 
Temperature 120(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group P21/c 
Unit cell dimensions a = 3.6160(1) Å 
b = 13.0730(6) Å 
c = 22.0296(9) Å 
β = 94.633(3) ° 
Volume 1037.98(7) Å3 
Z 4 
Density (calculated) 1.608 Mg/m3 
Absorption coefficient 0.130 mm-1 
F(000) 520 
Crystal size  0.16 x 0.02 x 0.01 mm3 
Theta range for data collection 3.25 to 25.02°. 
Index ranges -4<=h<=4, -15<=k<=15, -26<=l<=26 
Reflections collected 10663 
Independent reflections 1872 [R(int) = 0.0778] 
Completeness to theta = 25.02° 99.6 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9987 and 0.9795 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1872 / 0 / 166 
Goodness-of-fit on F2 1.114 
Final R indices [I>2sigma(I)] R1 = 0.0574, wR2 = 0.1071 
R indices (all data) R1 = 0.0813, wR2 = 0.1206 
Largest diff. peak and hole 0.303 and -0.360 e.Å-3 
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4.5: Intramolecular bond lengths (Å) and angles (°) in adeninium : hydrogen fumarate, 1:1 
Bond length (Å) Bond length (Å) Bond length (Å) 
C1-N9                1.324(3) 
C1-N2                1.351(3) 
C1-H1                0.9500 
C3-N4                1.352(3) 
C3-N2                1.370(3) 
C3-C8                1.382(3) 
C5-N4                1.325(3) 
C5-N6                1.340(3) 
C5-H5                0.9500 
C7-N7                1.333(3) 
C7-N6                1.362(3) 
C7-C8                1.407(3) 
C8-N9                1.390(3) 
N2-H2                0.8800 
N7-H7A             0.8800 
N7-H7B             0.8800 
C10-O11            1.220(3) 
C10-O10            1.304(3) 
C10-C11            1.498(3) 
C11-C12            1.526(3) 
C11-H11A         0.9900 
C11-H11B         0.9900 
C12-C13            1.509(3) 
C12-H12A         0.9900 
C12-H12B         0.9900 
C13-O14            1.206(3) 
C13-O13            1.330(3) 
O10-H10            0.8400 
O13-H13            0.8400 
 
Bond angle (°) Bond angle (°) Bond angle (°) 
C1-N9                1.311(5) 
C1-N2                1.370(5) 
C1-H1                0.950 
C3-N2                1.356(5) 
C3-N4                1.366(5) 
C3-C8                1.381(5) 
C5-N4                1.315(5) 
C5-N6                1.348(5) 
C5-H5                0.950 
C7-N7                1.309(5) 
C7-N6                1.386(5) 
C7-C8                1.395(5) 
C8-N9                1.380(4) 
N2-H2                0.880 
N7-H7A             0.880 
N6-H6                0.880 
N7-H7B             0.880 
C10-O11            1.246(4) 
C10-O10            1.280(4) 
C10-C11            1.489(5) 
C11-C12            1.316(5) 
C11-H11            0.950 
C12-C13            1.481(5) 
C12-H12            0.950 
C13-O14            1.215(5) 
C13-O13            1.324(5) 
O13-H13            0.840 
 
Torsion angle (°) Torsion angle (°) 
N2-C3-C8-N9                    0.3(4) 
N4-C3-C8-N9                    179.8(4) 
N2-C3-C8-C7                   -179.4(3) 
N4-C3-C8-C7                     0.1(6) 
N7-C7-C8-N9                     0.1(7) 
N6-C7-C8-N9                   -180.0(4) 
N7-C7-C8-C3                     179.7(4) 
N6-C7-C8-C3                    -0.4(5) 
N4-C3-N2-C1                   -179.6(4) 
C8-C3-N2-C1                     0.0(4) 
N9-C1-N2-C3                   -0.3(5) 
N6-C5-N4-C3                    0.3(5) 
N2-C3-N4-C5                    179.4(4) 
C8-C3-N4-C5                   -0.1(6) 
N4-C5-N6-C7                   -0.6(6) 
N7-C7-N6-C5                   -179.4(4) 
C8-C7-N6-C5                     0.6(5) 
N2-C1-N9-C8                     0.4(5) 
C3-C8-N9-C1                    -0.4(4) 
C7-C8-N9-C1                    179.2(4) 
O11-C10-C11-C12            13.6(6) 
O10-C10-C11-C12           -165.6(4) 
C10-C11-C12-C13            177.5(4) 
C11-C12-C13-O14            10.3(6) 
C11-C12-C13-O13           -168.7(4) 
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Appendix 5:  
5.1.1: 1H NMR spectra of adenine : maleic acid adduct (synthesised in EtOH) (1) (solvent – 
DMSO) 
 
Adenine:   7.95 (2H,s),   8.25 (2H,s)                                                                                    
Maleic acid:   6.2 (2H, s),                                                                                          
Impurity:   1.25 (t) 
 
5.1.2: 1H NMR spectra of adenine : maleic acid adduct (synthesised in MeOH) (2) (solvent – 
DMSO) 
 
Adenine:   7.60 (2H,s),   8.20 (2H,d)                                                                                   
Maleic acid:   6.2 (2H, s) 
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5.2.1: The diffraction pattern simulated from the single crystal structure compared to that of 
the laboratory experimental powder diffraction pattern of anhydrous adeninium : hydrogen 
maleate (1) 
 
 
 
5.2.2: The diffraction pattern simulated from the single crystal structure compared to that of 
the laboratory experimental powder diffraction pattern of adeninium : hydrogen maleate 
methanolate (2) 
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5.3: Ortep of anhydrous adeninium : hydrogen maleate (1), 1:1 
 
 
5.4: Crystallographic details of anhydrous adeninium : hydrogen maleate (1), 1:1 
Empirical formula C9 H9 N5 O4 
Formula weight 251.21 
Temperature 100(2) K 
Wavelength 0.68890 Å 
Crystal system Monoclinic 
Space group P21/c 
Unit cell dimensions a = 3.610(3) Å 
b = 13.323(11) Å 
c = 22.187(19) Å 
β = 92.258(7) ° 
Volume 1066.3(15) Å3 
Z 4 
Density (calculated) 1.565 Mg/m3 
Absorption coefficient 0.126 mm-1 
F(000) 520 
Crystal size  0.09 x 0.01 x 0.01 mm3 
Theta range for data collection 2.96 to 26.56°. 
Index ranges -4<=h<=4, -17<=k<=17, -28<=l<=28 
Reflections collected 10172 
Independent reflections 2401 [R(int) = 0.0556] 
Completeness to theta = 26.56° 98.1 % 
Max. and min. transmission 0.9987 and 0.9887 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2401 / 0 / 164 
Goodness-of-fit on F2 1.052 
Final R indices [I>2sigma(I)] R1 = 0.0416, wR2 = 0.1020 
R indices (all data) R1 = 0.0582, wR2 = 0.1108 
Largest diff. peak and hole 0.234 and -0.255 e.Å-3 
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5.5: Intramolecular bond lengths (Å) and angles (°) in anhydrous adeninium : hydrogen 
maleate (1), 1:1 
 
Bond length (Å) Bond length (Å) Bond length (Å) 
O13-C13               1.309(2) 
O13-H13               0.8400 
O14-C13               1.226(2) 
O11-C10               1.280(2) 
O10-C10               1.254(2) 
C10-C11               1.496(2) 
C11-C12               1.342(2) 
C11-H11               0.9500 
C12-C13               1.501(2) 
 
C12-H12               0.9500 
N6-C5                   1.311(2) 
N6-C7                   1.375(2) 
N7-C7                   1.316(2) 
N7-H7A                0.8800 
N7-H7B                0.8800 
N9-C1                   1.345(2) 
N9-C8                   1.392(2) 
N9-H9                   0.8800 
 
N4-C5                   1.348(2) 
N4-C3                   1.369(2) 
N4-H4                   0.8800 
C8-C3                   1.379(2) 
C8-C7                   1.419(2) 
N2-C1                   1.340(2) 
N2-C3                   1.363(2) 
C1-H1                   0.9500 
C5-H5                   0.9500 
 
 
Bond angle (°) Bond angle (°) Bond angle (°) 
C13-O13-H13              109.5 
O10-C10-O11          122.4(1) 
O10-C10-C11           117.2(1) 
O11-C10-C11           120.4(1) 
C12-C11-C10           130.0(2) 
C12-C11-H11      115.0 
C10-C11-H11              115.0 
C11-C12-C13           131.8(2) 
C11-C12-H12              114.1 
C13-C12-H12              114.1 
O14-C13-O13           121.2(2) 
O14-C13-C12           118.9(1) 
O13-C13-C12           120.0(1) 
C5-N6-C7           120.1(1) 
C7-N7-H7A              120.0 
C7-N7-H7B              120.0 
H7A-N7-H7B              120.0 
C1-N9-C8           106.4(1) 
C1-N9-H9              126.8 
C8-N9-H9              126.8 
C5-N4-C3           116.2(1) 
C5-N4-H4              121.9 
C3-N4-H4               121.9 
C3-C8-N9           104.6(1) 
C3-C8-C7           120.0(1) 
N9-C8-C7           135.4(1) 
C1-N2-C3           103.4(1) 
N7-C7-N6           118.2(1) 
N7-C7-C8           125.1(1) 
N6-C7-C8           116.7(1) 
N2-C1-N9           113.4(1) 
N2-C1-H1              123.3 
N9-C1-H1              123.3 
N2-C3-N4            126.9(1) 
N2-C3-C8                 112.1(1) 
N4-C3-C8           121.0(1) 
N6-C5-N4           126.0(1) 
N6-C5-H5              117.0 
N4C5-H5              117.0 
C13B-C12B-H12B  114.2 
O14B-C13B-O13B  121.1(3) 
O14B-C13B-C12B   118.1(1) 
O13B-C13B-C12B 20.6(1) 
C13B-O13B-H13B  109.5 
O16-C15-H15A  109.5 
O16-C15-H15B  109.5     
H15A-C15-H15B  109.5 
O16-C15-H15C  109.5 
H15A-C15-H15C  109.5 
H15B-C15-H15C  109.5 
C15-O16-H16              109.5 
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Torsion angle (°) Torsion angle (°) 
O10-C10-C11-C12                    177.6(2) 
O11-C10-C11-C12                   -1.2(2) 
C10-C11-C12-C13                     2.4(3) 
C11-C12-C13-O14                    177.2(2) 
C11-C12-C13-O13                   -2.1(3) 
C1-N9-C8-C3                           -0.1(2) 
C1-N9-C8-C7                            179.1(2) 
C5-N6-C7-N7                          -178.7(1) 
C5-N6-C7-C8)                           1.6(2) 
C3-C8-C7-N7                            177.9(1) 
N9-C8-C7-N7                           -1.2(3) 
C3-C8-C7-N6                           -2.4(2) 
N9-C8-C7-N6                            178.5(2) 
C3-N2-C1-N9                            0.4(2) 
C8-N9-C1-N2                           -0.2(2) 
C1-N2-C3-N4                            179.0(1) 
C1-N2-C3-C8                           -0.5(2) 
C5-N4-C3-N2                          -179.2(1) 
C5-N4-C3-C8                            0.3(2) 
N9-C8-C3-N2                            0.4(2) 
C7-C8-C3-N2                           -179.0(1) 
N9-C8-C3-N4                          -179.1(1) 
C7-C8-C3-N4                            1.5(2) 
C7-N6-C5-N4                            0.2(2) 
C3-N4-C5-N6                           -1.2(2) 
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5.6: Ortep of adeninium : hydrogen maleate methanolate (2), 1:1:0.5 
 
 
5.7: Crystallographic details of adeninium : hydrogen maleate methanolate (2), 1:1:0.5 
Empirical formula C9.5 H11 N5 O4.5 
Formula weight 267.23 
Temperature 120(2) K 
Wavelength 1.54184 Å 
Crystal system Triclinic 
Space group P -1 
Unit cell dimensions a = 5.2815(1) Å 
b = 10.0506(2) Å 
c = 22.0125(4) Å 
α = 78.1910(1) ° 
β = 85.1600 (1) ° 
γ = 80.0170(1)° 
Volume 1124.98(4) Å3 
Z 4 
Density (calculated) 1.578 Mg/m3 
Absorption coefficient 1.100 mm-1 
F(000) 556 
Crystal size  0.15 x 0.05 x 0.05 mm3 
Theta range for data collection 6.71 to 66.59°. 
Index ranges -6<=h<=6, -11<=k<=11, -25<=l<=24 
Reflections collected 7965 
Independent reflections 3745 [R(int) = 0.0212] 
Completeness to theta = 66.59° 94.0 % 
Max. and min. transmission 0.9470 and 0.8524 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3745 / 0 / 347 
Goodness-of-fit on F2 1.064 
Final R indices [I>2sigma(I)] R1 = 0.0345, wR2 = 0.0901 
R indices (all data) R1 = 0.0404, wR2 = 0.0938 
Largest diff. peak and hole 0.256 and -0.346 e.Å-3 
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5.8: Intramolecular bond lengths (Å) and angles (°) in adeninium : hydrogen maleate 
methanolate (2), 1:1:0.5 
 
Bond length (Å) Bond length (Å) Bond length (Å) 
C7A-N7A             1.312(2) 
C7A-N6A             1.367(2) 
C7A-C8A             1.407(2) 
C5A-N4A             1.309(2) 
C5A-N6A             1.363(2) 
C5A-H5A             0.9500 
C3A-N2A             1.358(2) 
C3A-N4A             1.364(2) 
C3A-C8A             1.389(2) 
C1A-N9A             1.315(2) 
C1A-N2A             1.374(2) 
C1A-H1A             0.9500 
C8A-N9A             1.375(2) 
N7A-H7AA          0.8800 
N7A-H7AB)         0.8800 
N6A-H6A             0.8800 
N2A-H2A             0.8800 
C13A-O14A         1.241(2) 
C13A-O13A         1.288(2) 
C13A-C12A         1.494(2) 
C12A-C11A         1.336(2) 
C12A-H12A         0.9500 
C11A-C10A         1.497(2) 
C11A-H11A        0.9500 
C10A-O11A        1.248(2) 
C10A-O10A        1.276(2) 
O13A-H13A        0.8400 
C7B-N7B             1.308(2) 
C7B-N6B             1.372(2) 
C7B-C8B             1.408(2) 
C5B-N4B             1.301(2) 
C5B-N6B             1.358(2) 
C5B-H5B             0.9500 
C3B-N4B             1.360(2) 
C3B-N2B             1.362(2) 
C3B-C8B             1.387(2) 
C1B-N9B             1.313(2) 
C1B-N2B             1.365(2) 
C1B-H1B             0.9500 
C8B-N9B             1.390(2) 
N7B-H7BA          0.8800 
N7B-H7BB          0.8800 
N6B-H6B             0.8800 
N2B-H2B             0.8800 
C10B-O11B         1.249(2) 
C10B-O10B         1.281(2) 
C10B-C11B         1.492(2) 
C11B-C12B         1.332(2) 
C11B-H11B         0.9500 
C12B-C13B         1.492(2) 
C12B-H12B         0.9500 
C13B-O14B         1.230(2) 
C13B-O13B         1.303(2) 
O13B-H13B         0.8400 
C15-O16               1.406(2) 
C15-H15A            0.9800 
C15-H15B            0.9800 
C15-H15C            0.9800 
O16-H16              0.8400 
 
 
 
Bond angle (°) Bond angle (°) Bond angle (°) 
N7A-C7A-N6A        121.1(1) 
N7A-C7A-C8A        125.3(2) 
N6A-C7A-C8A        113.5(1) 
N4A-C5A-N6A        125.6(2) 
N4A-C5A-H5A            117.2 
N6A-C5A-H5A            117.2 
N2A-C3A-N4A        128.0(1) 
N2A-C3A-C8A        105.1(1) 
N4A-C3A-C8A        126.9(1) 
N9A-C1A-N2A        113.7(1) 
N9A-C1A-H1A            123.2 
N2A-C1A-H1A            123.2 
N9A-C8A-C3A        111.6(1) 
N9A-C8A-C7A        129.9(1) 
C3A-C8A-C7A        118.5(1) 
C7A-N7A-H7AA   120.0 
C7A-N7A-H7AB          120.0 
H7AA-N7A-H7AB       120.0 
C5B-N4B-C3B         111.8(1) 
C3B-N2B-C1B         106.1(1) 
O14A-C13A-O13A 21.1(1) 
O14A-C13A-C12A  117.7(1) 
O13A-C13A-C12A  121.3(1) 
C11A-C12A-C13A  131.3(2) 
C11A-C12A-H12A       114.4 
C13A-C12A-H12A       114.4 
C12A-C11A-C10A  129.8(2) 
C12A-C11A-H11A       115.1 
C10A-C11A-H11A   115.1 
O11A-C10A-O10A  123.4(1) 
O11A-C10A-C11A  117.7(1) 
O10A-C10A-C11A  118.9(1) 
C13A-O13A-H13A      109.5 
N7B-C7B-N6B        119.6(1) 
N7B-C7B-C8B         127.0(1) 
N6B-C7B-C8B         113.4(1) 
N4B-C5B-N6B        125.5(1) 
N4B-C5B-H5B             117.2 
N6B-C5B-H5B             117.2 
N4B-C3B-N2B        126.3(1) 
C7B-N7B-H7BB          120.0 
H7BA-N7B-H7BB       120.0 
C5B-N6B-C7B         123.8(1) 
C5B-N6B-H6B             118.1 
C7B-N6B-H6B             118.1 
C1B-N2B-H2B             126.9 
C1B-N9B-C8B         103.7(1) 
O11B-C10B-O10B  123.1(1) 
O11B-C10B-C11B   116.9(1) 
O10B-C10B-C11B   120.0(1) 
C12B-C11B-C10B   130.0(1) 
C12B-C11B-H11B       115.0 
C10B-C11B-H11B       115.0 
C11B-C12B-C13B   131.6(2) 
C11B-C12B-H12B       114.2 
C13B-C12B-H12B       114.2 
O14B-C13B-O13B  121.3(1) 
O14B-C13B-C12B   118.1(1) 
O13B-C13B-C12B   120.6(1) 
C13B-O13B-H13B       109.5 
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C3B-N2B-H2B             126.9 
C5A-N6A-C7A        123.6(1) 
C5A-N6A-H6A            118.2 
C7A-N6A-H6A            118.2 
C5A-N4A-C3A        111.9(1) 
C3A-N2A-C1A        106.4(1) 
C3A-N2A-H2A            126.8 
C1A-N2A-H2A            126.8 
C1A-N9A-C8A        103.2(1) 
N4B-C3B-C8B         127.6(1) 
N2B-C3B-C8B         106.1(1) 
N9B-C1B-N2B        113.9(1) 
N9B-C1B-H1B             123.0 
N2B-C1B-H1B             123.0 
C3B-C8B-N9B         110.2(1) 
C3B-C8B-C7B         117.8(1) 
N9B-C8B-C7B         132.0(1) 
C7B-N7B-H7BA          120.0 
O16-C15-H15A            109.5 
O16-C15-H15B            109.5 
H15A-C15-H15B          109.5 
O16-C15-H15C            109.5 
H15A-C15-H15C          109.5 
H15B-C15-H15C          109.5 
C15-O16-H16               109.5 
 
 
Torsion angle (°) Torsion angle (°) 
N2A-C3A-C8A-N9A              - 0.08(17) 
N4A-C3A-C8A-N9A                180.0(1) 
N2A-C3A-C8A-C7A               -179.7(1) 
N4A-C3A-C8A-C7A                0.4(2) 
N7A-C7A-C8A-N9A                1.6(3) 
N6A-C7A-C8A-N9A               -178.2(2) 
N7A-C7A-C8A-C3A               -178.9(2) 
N6A-C7A-C8A-C3A                1.3(2) 
N4A-C5A-N6A-C7A                2.0(2) 
N7A-C7A-N6A-C5A                177.8(1) 
C8A-C7A-N6A-C5A               -2.5(2) 
N6A-C5A-N4A-C3A              -0.1(2) 
N2A-C3A-N4A-C5A                179.0(2) 
C8A-C3A-N4A-C5A               -1.1(2) 
N4A-C3A-N2A-C1A               -179.9(2) 
C8A-C3A-N2A-C1A                 0.2(2) 
N9A-C1A-N2A-C3A               -0.2(2) 
N2A-C1A-N9A-C8A                0.2(2) 
C3A-C8A-N9A-C1A               -0.04(2) 
C7A-C8A-N9A-C1A                179.5(2) 
O14A-C13A-C12A-C11A       -178.5(2) 
O13A-C13A-C12A-C11A         0.9(3) 
C13A-C12A-C11A-C10A        -0.6(3) 
C12A-C11A-C10A-O11A       -179.0(2) 
C12A-C11A-C10A-O10A        1.1(3) 
N4B-C3B-C8B-N9B                 179.6(1) 
N2B-C3B-C8B-N9B                -0.7(2) 
N4B-C3B-C8B-C7B                -0.9(2) 
N2B-C3B-C8B-C7B                 178.6(1) 
N7B-C7B-C8B-C3B                -176.4(2) 
N6B-C7B-C8B-C3B                  2.6(2) 
N7B-C7B-C8B-N9B                  2.9(3) 
N6B-C7B-C8B-N9B                -178.0(2) 
N4B-C5B-N6B-C7B                 0.9(2) 
N7B-C7B-N6B-C5B                 176.4(1) 
C8B-C7B-N6B-C5B                -2.7(2) 
N6B-C5B-N4B-C3B                 1.0(2) 
N2B-C3B-N4B-C5B                 179.4(2) 
C8B-C3B-N4B-C5B                -1.0(2) 
N4B-C3B-N2B-C1B                -179.7(2) 
C8B-C3B-N2B-C1B                  0.6(2) 
N9B-C1B-N2B-C3B                 -0.3(2) 
N2B-C1B-N9B-C8B                 -0.2(2) 
C3B-C8B-N9B-C1B                  0.5(2) 
C7B-C8B-N9B-C1B                -178.8(2) 
O11B-C10B-C11B-C12B        -178.0(2) 
O10B-C10B-C11B-C12B          2.3(3) 
C10B-C11B-C12B-C13B          1.5(3) 
C11B-C12B-C13B-O14B         178.5(2) 
C11B-C12B-C13B-O13B        -1.1(3) 
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Appendix 6: 
6.1: 1H NMR spectra of adenine : glutaric acid adduct (solvent – DMSO) 
 
Adenine:   7.15 (2H,s),   8.10 (2H,d)                                                                                        
Glutaric acid:   1.7 (2H, t),   2.25 (4H, q) 
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6.2: Indexing results for adenine : glutaric acid 1:1, with the preferred unit cell highlighted in 
orange 
I20 Merit Volume V/V1 a b c alpha beta gamma 
20 6.8 2037.407 1 20.615 5.7732 17.4311 90 100.859 90 
20 6.8 2037.407 1 20.615 5.7732 17.4311 90 100.859 90 
20 6 2038.286 1 24.3661 5.7742 17.4288 90 123.775 90 
20 6 2038.286 1 24.3661 5.7742 17.4288 90 123.775 90 
20 5.2 2348.391 1.15 24.0992 5.4323 17.9441 90 91.442 90 
20 5.2 2348.391 1.15 24.0992 5.4323 17.9441 90 91.442 90 
20 5 5889.011 2.89 51.8098 24.0917 4.7181 90 90 90 
20 5 5889.011 2.89 51.8098 24.0917 4.7181 90 90 90 
19 7 597.735 0.29 5.6897 8.7289 14.2471 57.883 89.827 93.411 
19 6 644.747 0.32 5.7013 9.4646 15.2963 128.062 92.411 83.171 
19 6 644.747 0.32 5.7013 9.4646 16.5475 127.652 112.547 83.171 
19 6 597.233 0.29 5.6882 8.727 12.1144 84.653 87.379 86.64 
19 5.1 1609.59 0.79 10.7059 15.5258 10.1946 102.638 90.999 102.64 
19 4.7 1582.66 0.78 10.5341 15.1722 10.2637 102.276 97.606 93.258 
18 10 703.162 0.35 5.2672 11.1084 18.1065 137.836 84.602 89.534 
18 9 699.146 0.34 5.2658 11.0702 12.3288 100.439 81.853 89.323 
18 8 1256.415 0.62 11.1715 12.0195 10.0587 90 111.528 90 
18 7 1853.641 0.91 17.6333 16.282 6.4563 90 90 90 
18 7 1853.641 0.91 17.6333 16.282 6.4563 90 90 90 
18 7 1256.964 0.62 11.9828 12.0191 10.0671 90 119.895 90 
18 7 701.865 0.34 5.2661 11.0977 12.3582 100.676 81.729 89.463 
18 6 1468.344 0.72 17.4553 17.8027 5.0683 90 111.205 90 
18 6 1468.343 0.72 16.321 17.8027 5.0683 90 94.376 90 
18 6 1468.343 0.72 16.7164 17.8027 5.0683 90 103.22 90 
18 6 948.076 0.47 9.0767 9.9572 19.4002 131.803 133.416 60.879 
17 7 1703.444 0.84 17.8042 16.2749 5.8788 90 90 90 
17 7 1336.301 0.66 24.5266 10.3271 5.3716 90 100.833 90 
17 7 1336.301 0.66 24.1015 10.3271 5.3716 90 91.811 90 
17 7 1085.32 0.53 12.1834 9.3567 9.5256 90 91.825 90 
17 6.9 1039.31 0.51 10.8244 11.1459 9.6294 106.623 110.972 83.207 
17 6 1263.348 0.62 11.1957 12.0044 9.5773 90 101.04 90 
17 6 931.51 0.46 15.0059 6.299 10.1561 90 103.989 90 
17 5.6 1390.75 0.68 10.8718 12.7984 10.5764 106.483 93.794 80.312 
16 9.7 730.047 0.36 8.1431 12.4884 7.846 101.315 108.37 76.604 
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Appendix 7: 
7.1: 1H NMR spectra of adenine : adipic acid adduct (solvent – DMSO) 
 
 
Adenine:   7.15 (2H,s),   8.15 (2H,d)                                                                                           
Adipic acid:   1.5 (4H, q),   2.2 (4H, t)  
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7.2: Indexing results for adenine : adipic acid 1:1, with the preferred unit cell highlighted in 
orange 
I20 Merit Volume V/V1 a b c alpha beta gamma 
20 12.34 782.437 1 11.5146 11.8849 6.483 100.388 103.01 65.44 
20 9.63 2082.011 2.66 11.8124 21.9384 8.2288 94.862 95.989 99.249 
20 9.16 1542.753 1.97 12.6436 19.4839 6.3074 95.88 93.055 91.371 
20 6.9 2462.008 3.15 17.6189 13.0139 12.962 90 124.067 90 
20 6.9 2462.008 3.15 17.6189 13.0139 12.962 90 124.067 90 
20 6.8 2462.43 3.15 14.9199 13.0154 12.9618 90 101.956 90 
20 6.8 2462.43 3.15 14.9199 13.0154 12.9618 90 101.956 90 
20 5.4 1495.23 1.91 11.8334 20.3964 6.4982 100.085 100.642 78.587 
20 5.3 2553.391 3.26 26.4084 9.2588 12.805 90 125.36 90 
20 5.3 2553.391 3.26 26.4084 9.2588 12.805 90 125.36 90 
20 5.2 2553.396 3.26 23.8849 9.2588 12.805 90 115.618 90 
20 5.2 2553.396 3.26 23.8849 9.2588 12.805 90 115.618 90 
20 5.2 2553.384 3.26 21.6789 9.2588 12.805 90 96.563 90 
20 5.2 2553.384 3.26 21.6789 9.2588 12.805 90 96.563 90 
19 10 901.713 1.15 12.2863 12.8879 13.1215 63.899 62.886 29.336 
19 9.94 908.44 1.16 7.0909 21.532 6.6711 92.471 116.774 89.521 
19 9.45 1417.206 1.81 12.6297 19.4109 5.7931 93.045 91.227 88.192 
19 8.3 1301.26 1.66 11.3726 19.169 6.4402 101.717 98.743 71.978 
19 7.26 1759.631 2.25 12.7391 21.7388 6.4706 96.273 98.041 92.951 
19 7.2 1315.52 1.68 11.401 19.0565 6.4328 96.108 99.036 105.255 
19 7 1729.1 2.21 12.7725 14.1837 10.2489 91.188 101.265 107.626 
19 7 2721.417 3.48 17.8809 13.4445 11.3204 90 90 90 
19 7 2721.417 3.48 17.8809 13.4445 11.3204 90 90 90 
19 6 2410.917 3.08 15.7927 11.8849 12.9707 90 97.986 90 
19 6 2335.181 2.98 19.1791 11.3373 11.6722 90 113.062 90 
19 6 1170.261 1.5 16.0937 10.7503 7.0159 90 105.398 90 
19 6 1170.261 1.5 15.7565 10.7503 7.0159 90 100.024 90 
19 6 1170.261 1.5 16.0937 10.7503 7.0159 90 105.398 90 
19 5.9 1894.29 2.42 14.3358 21.3241 6.3669 97.612 90.63 100.715 
19 5.5 1629.44 2.08 11.8715 21.8213 6.4968 97.589 101.006 82.984 
18 14.19 1427.077 1.82 12.7432 19.3788 5.8439 93.395 97.673 91.247 
18 13 1257.157 1.61 22.0742 9.3018 6.2978 90 103.543 90 
18 13 1257.157 1.61 21.4901 9.3018 6.2978 90 93.011 90 
18 11.07 848.203 1.08 6.623 21.5226 6.2313 91.169 107.209 90.452 
18 10 1438.091 1.84 15.18 7.1497 13.3867 90 98.183 90 
18 9.96 1214.944 1.55 8.8066 22.0775 6.5877 99.078 103.458 79.238 
18 9.88 1049.069 1.34 7.5883 22.1721 6.8902 100.557 111.33 78.065 
18 9.76 1439.609 1.84 15.1821 7.1496 13.4015 90 98.257 90 
18 9.6 946.235 1.21 7.2245 21.672 6.8571 89.094 117.458 96.272 
18 9.33 940.744 1.2 6.9939 21.7081 6.8218 88.54 113.804 96.761 
18 9.16 1455.473 1.86 12.7676 19.4263 5.961 95.399 98.405 90.889 
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18 8 1438.09 1.84 18.7561 7.1497 13.3867 90 126.765 90 
18 7 1542.944 1.97 23.791 6.1889 11.574 90 115.124 90 
18 7 1542.944 1.97 23.791 6.1889 11.574 90 115.124 90 
18 7 1542.944 1.97 23.791 6.1889 11.574 90 115.124 90 
18 6.2 2493.95 3.19 33.4401 11.3355 6.5946 90 93.904 90 
18 6.2 2493.95 3.19 33.4401 11.3355 6.5946 90 93.904 90 
18 6 1158.208 1.48 15.5267 5.6828 13.2442 90 97.651 90 
17 11 896.72 1.15 13.2285 13.7278 13.0783 57.353 55.516 27.402 
17 10.15 1082.077 1.38 7.9621 21.5885 6.7362 89.63 110.535 93.557 
17 10 996.052 1.27 11.9824 14.6456 6.3157 90 116.014 90 
17 9 1238.211 1.58 10.7046 18.3838 6.3179 90 95.194 90 
17 9 1221.964 1.56 12.7548 13.4399 8.0152 90 117.208 90 
17 9 996.052 1.27 10.8205 14.6456 6.3157 90 95.624 90 
17 8.77 1723.761 2.2 12.7017 21.543 6.3541 91.187 97.38 89.079 
17 7.72 1765.895 2.26 12.799 21.9844 6.4401 97.527 95.952 80.562 
17 6 2592.608 3.31 21.2757 11.3475 10.7387 90 90 90 
17 6 1205.455 1.54 15.7991 10.7142 7.1895 90 97.9 90 
17 6 1205.454 1.54 16.434 10.7142 7.1895 90 107.779 90 
16 15.08 896.718 1.15 6.8719 21.6855 6.5011 92.488 111.149 95.242 
16 14.67 918.717 1.17 11.4928 13.5113 6.4316 99.849 98.785 69.799 
16 10.89 1475.89 1.89 12.8568 19.4541 6.0306 94.706 100.825 87.465 
16 10.65 945.038 1.21 7.1807 21.5679 6.941 92.603 118.339 89.599 
16 10.44 1922.006 2.46 14.139 21.829 6.382 89.493 98.597 99.261 
16 10.22 1476.208 1.89 10.8609 21.7034 6.3407 91.616 96.027 83.37 
16 8.47 1523.372 1.95 11.2084 22.1539 6.3392 92.233 95.741 76.606 
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Appendix 8:  
8.1: 1H NMR spectra of adenine : pimelic acid adduct (solvent – DMSO) 
 
Adenine:   7.15 (2H,s),   8.15 (2H,d)                                                                                             
Pimelic acid:   1.25 (2H, q),   1.5 (4H, q),   2.2 (4H, t)  
 
 
8.2: The diffraction pattern simulated from the single crystal structure compared to that of the 
laboratory experimental powder diffraction pattern of adenine : pimelic acid, 1:1 
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8.3: Ortep of adenine : pimelic acid, 1:1 
 
8.4: Crystallographic details for adenine : pimelic acid, 1:1 
Empirical formula C12 H17 N5 O4 
Formula weight 295.31 
Temperature 100(2) K 
Wavelength 0.71075 Å 
Crystal system Monoclinic 
Space group P21/c 
Unit cell dimensions a = 12.44 (1) Å 
b = 31.49(3) Å 
c = 7.237(6) Å 
β = 102.64(1) ° 
Volume 2766(4) Å3 
Z 8 
Density (calculated) 1.419 Mg/m3 
Absorption coefficient 0.109 mm-1 
F(000) 1248 
Crystal size  0.05 x 0.01 x 0.01 mm3 
Theta range for data collection 3.07 to 24.95°. 
Index ranges -11<=h<=14, -37<=k<=37, -8<=l<=7 
Reflections collected 11224 
Independent reflections 4802 [R(int) = 0.1653] 
Completeness to theta = 24.95° 98.9 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9989 and 0.9946 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4802 / 0 / 385 
Goodness-of-fit on F2 0.832 
Final R indices [I>2sigma(I)] R1 = 0.0757, wR2 = 0.1443 
R indices (all data) R1 = 0.2554, wR2 = 0.2055 
Largest diff. peak and hole 0.422 and -0.330 e.Å-3 
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8.5: Intramolecular bond lengths (Å) and angles (°) for  adenine : pimelic acid, 1:1 
 
Bond length (Å) Bond length (Å) Bond length (Å) 
N6BC5B            1.348(8) 
N6BC7B            1.350(8) 
N4BC5B            1.323(8) 
N4BC3B            1.367(8) 
N2BC3B            1.357(8) 
N2BC1B            1.363(8) 
N2BH2B            0.8800 
N9BC1B            1.307(8) 
N9BC8B            1.398(8) 
N7BC7B            1.342(8) 
N7BH7BB         0.8647 
N7BH7BA         0.8641 
N6AC5A            1.349(8) 
N6AC7A            1.369(7) 
N4AC5A            1.328(8) 
N4AC3A            1.347(7) 
N2AC3A            1.347(7) 
N2AC1A            1.369(8) 
N2AH2A            0.8800 
N9AC1A            1.322(7) 
N9AC6A            1.383(7) 
N7AC7A            1.363(8) 
N7AH7AA         0.8621 
N7AH7AB         0.8623 
O17BC16B        1.243(7) 
O16BC16B        1.333(7) 
 
 
O16BH16B        0.8400 
O11BC10B        1.239(7) 
O10BC10B        1.319(7) 
O10BH10B        0.8400 
O11AC10A        1.237(7) 
O10AC10A        1.344(7) 
O10AH10A        0.8400 
O17AC16A        1.236(7) 
O16AC16A        1.327(7) 
O16AH16A        0.8400 
C16BC15B         1.486(8) 
C15BC14B         1.543(8) 
C15BH15BA      0.9900 
C15BH15BB      0.9900 
C14BC13B         1.525(8) 
C14H14BA         0.9900 
C14H14BB         0.9900 
C13BC12B         1.535(8) 
C13BH13BA      0.9900 
C13BH13BB      0.9900 
C12BC11B         1.513(8) 
C12BH12BA      0.9900 
C12BH12BB      0.9900 
C11BC10B         1.509(8) 
C11BH11BB      0.9900 
 
C11BH11BA      0.9900 
C5BH5B             0.9500 
C3BC8B             1.426(9) 
C1BH1B             0.9500 
C8BC7B             1.402(9) 
C10AC11A        1.500(8) 
C11AC12A        1.499(8) 
C11AH11AA     0.9900 
C11AH11AB     0.9900 
C12AC13A        1.549(8) 
C12AH12AA     0.9900 
C12AH12AB     0.9900 
C13AC14A        1.525(8) 
C13AH13AA     0.9900 
C13AH13AB     0.9900 
C14AC15A        1.544(8) 
C14AH14AA     0.9900 
C14AH14AB     0.9900 
C15AC16S         1.493(8) 
C15AH15AA     0.9900 
C15AH15AB     0.9900 
C5AH5A            0.9500 
C3AC8A            1.411(8) 
C1AH1A            0.9500 
C6AC7A            1.403(8) 
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Bond angle (°) Bond angle (°) Bond angle (°) 
C5BN6BC7B       119.7(6) 
C5BN4BC3B       110.6(6) 
C3BN2BC1B       106.9(6) 
C3BN2BH2B           126.5 
C1BN2BH2B           126.5 
C1BN9BC8B       104.8(6) 
C7BN7BH7BB         111.6 
C7B-N7BH7BA         107.2 
H7BBN7BH7BA      108.3 
C5AN6AC7A      117.2(6) 
C5AN4AC3A      112.1(6) 
C3AN2AC1A      107.1(5) 
C3AN2AH2A          126.5 
C1AN2AH2A          126.5 
C1AN9AC8A      105.0(5) 
C7AN7AH7AA       108.6 
C7AN7AH7AB       108.8 
H7AAN7AH7AB     109.3 
C16BO16BH16B     109.5 
C10BO10BH10B   109.5 
C10AO10AH10A   109.5 
C16AO16AH16A     109.5 
O17BC16BO16B 122.9(6) 
O17BC16BC15B 124.9(6) 
O16BC16BC15B 112.2(6) 
C16BC15BC14B 116.0(5) 
C16BC15BH15BA   108.3 
C14BC15BH15BA   108.3 
C16BC15BH15BB  108.3 
C14BC15BH15BB   108.3 
H15BAC15BH15BB107.4 
C13BC14BC15B 109.5(5) 
C13BC14BH14BA   109.8 
C15B C14BH14BA  109.8 
C13BC14BH14BB   109.8 
C15B C14BH14BB  109.8 
H14BAC14BH15BB108.2 
C14BC13BC12B 113.3(5) 
C14BC13BH13BA   108.9 
C12BC13BH13BA    108.9 
C14BC13BH13BB   108.9 
C12BC13BH13BB    108.9 
 
H13BAC13BH13BB107.7 
C11BC12BC13B 111.7(5) 
C11BC12BH12BA   109.3 
C13BC12BH12BA   109.3 
C11BC12BH12BB   109.3 
C13BC12BH12BB   109.3 
H12BAC12BH12BB107.9 
C10BC11BC12B 115.7(5) 
C10BC11BH11BA   108.4 
C12BC11BH11BA   108.4 
C10BC11BH11BB   108.4 
C12BC11BH11BB   108.4 
H11BAC6H11BB    107.4 
O11BC10BO10B 124.1(6) 
O11BC10BC11B 121.9(5) 
O10BC10BC11B 113.9(5) 
N4BC5BN6B       129.2(6) 
N4BC5BH5B           115.4 
N6BC5BH5B           115.4 
N2BC3BN4B       127.9(6) 
N2BC3BC8B       105.8(6) 
N4BC3BC8B       126.3(7) 
N9BC1BN2B       114.0(6) 
N9BC1BH1B           123.0 
N2BC1BH1B           123.0 
N9BC8BC7B       135.4(7) 
N9BC8BC3B       108.5(6) 
C7BC8BC3B       116.1(7) 
N7BC7BN6B       120.9(6) 
N7BC7BC8B       120.9(7) 
N6BC7BC8B        118.1(6) 
O11AC10AO10A122.3(6) 
O11AC10AC11A124.3(6) 
O10AC10AC11A113.4(5) 
C12AC111AC10A113.9(5) 
C12AC11AH11AA   108.8 
C10AC11AH11AA   108.8 
C12AC11AH11AB    108.8 
C10AC11AH11AB    108.8 
H11AAC11AH11AB 107.7 
C11AC12AC13A 112.7(5) 
 
C11AC12AH12AA     109.0 
C13AC12AH12AA     109.0 
C11AC12AH12AB     109.0 
C13AC12AH12AB     109.0 
H12ABC12AH12AB  107.8 
C14AC13AC12A      13.3(5) 
C14AC13AH13AA     108.9 
C12AC13AH13AA     108.9 
C14AC13AH13AB     108.9 
C12AC13AH13AB     108.9 
H13AAC13AH13AB  107.7 
C13AC14AC15A    109.9(5) 
C13AC14AH14AA     109.7 
C15AC14AH14AA     109.7 
C13AC14AH14AB      109.7 
C15AC14AH14AB      109.7 
H14AAC14AH14AB   108.2 
C16AC15AC14A    115.9(5) 
C16AC15AH15AA     108.3 
C14AC15AH15AA     108.3 
C16AC15AH15AB      108.3 
C16AC15AH15AB      108.3 
H15AAC15AH15AB  107.4 
O17AC16AO16A  122.6(6) 
O17AC16AC15A  125.5(6) 
O16AC16AC15A  111.9(6) 
N4AC5AN6A         129.4(6) 
N4AC5AH5A              115.3 
N6AC5AH5A              115.3 
N2AC3AN4A         127.9(6) 
N2AC3AC8A         106.4(5) 
N4AC3AC28A       125.7(6) 
N9AC1AN2A         112.6(6) 
N9AC1AH1A              123.7 
N2AC1AH1A              123.7 
N9AC8AC7A         134.8(6) 
N9AC8AC3A         108.9(5) 
C7AC8AC3A         116.3(6) 
N7AC7AN6A        119.2(6) 
N7AC7AC8A        121.5(6) 
N6AC7AC8A        119.3(6) 
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Torsion angle (°) Torsion angle (°) 
O17BC16BC15BC14B         8.5(12) 
O16B C16BC15BC14B      170.9(6) 
C16BC15BC14BC13B         179.6(7) 
C15BC14BC13B C12B        178.0(6) 
C14BC13B C12BC11B      179.8(6) 
C13B C12BC11B C10B       179.1(7) 
C12BC11B C10 BO11B    6.6(10) 
C12BC11B C10 BO10B      175.8(7) 
C3BN4BC5BN6B       0.3(12) 
C7BN6BC5BN4B     0.7(13) 
C1BN2BC3BN4B      178.8(8) 
C1BN2BC3BC8B               0.8(9) 
C5BN4BC3BN2B    179.7(7) 
C5BN4BC3BC8B    0.2(11) 
C8BN9BC1BN2B    0.1(10) 
C3BN2BC1BN9B      0.6(10) 
C1BN9BC8BC7B    179.4(9) 
C1BN9BC8BC3B    0.4(9) 
N2BC3BC8BN9B      0.8(9) 
N4BC3BC8BN9B    178.9(7) 
N2BC3BC8BC7B      180.0(7) 
N4BC3BC8BC7B      0.3(12) 
C5BN6BC7BN7B      176.8(7) 
C5BN6BC7BC8B      0.8(11) 
N9BC8BC7BN7B      2.3(15) 
C3BC8BC7BN7B    176.6(7) 
N9BC8BC7BN6B      178.3(8) 
C3BC8BC7BN6B    0.7(11) 
O11AC10AC11AC12A      3.3(10) 
O10A C10AC11AC12A     177.3(6) 
C10A C11AC12A C13A    178.4(6) 
C11AC12A C13A C14A      178.5(6) 
C12A C13A C14A C15A   179.5(6) 
C13A C14A C15AC16A      172.6(7) 
C14A C15AC16A O17A      4.4(12) 
C14A C15AC16A O16A    173.4(6) 
C3AN4AC5AN6A       0.8(11) 
C7AN6AC5AN4A     0.9(12) 
C1AN2A C3 AN4A    178.7(8) 
C1A N2A C3AC8A     0.3(8) 
C5A N4AC3AN2A      178.1(7) 
C5A N4AC3AC8A      0.0(11) 
C8A N9AC1AN2A      2.7(8) 
C3AN2AC1AN9A    1.6(9) 
C1AN9AC8AC7A      178.4(8) 
C1AN9AC8AC3A    2.8(8) 
N2AC3AC8AN9A      1.9(9) 
N4AC3AC8AN9A    179.6(7) 
N2AC3AC8AC7A    179.0(6) 
N4AC3AC8AC7A    0.5(12) 
C5AN6AC7AN7A    176.8(6) 
C5AN6AC7AC8A      0.2(10) 
N9AC8AC7AN7A    3.9(13) 
C3AC8AC7AN7A      177.4(7) 
N9AC8AC7AN6A      179.1(8) 
C3AC8AC7AN6A      0.4(10) 
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Appendix 9: 
9.1: 1H NMR spectra of adenine : suberic acid adduct (solvent – DMSO) 
 
 
Adenine:   7.15 (2H,s),   8.10 (2H,d)                                                                                           
Suberic acid:   1.25 (4H, q),   1.5 (4H, q),   2.2 (4H,t)  
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9.2: Indexing results for adenine : suberic acid, 1:1.5 
I20 Merit Volume V/V1 a b c alpha beta gamma 
20 6.1 3562.37 1 46.2512 24.3184 3.1672 90 90 90 
20 6.1 3562.37 1 46.2512 24.3184 3.1672 90 90 90 
20 5.6 2801.482 0.79 20.1099 8.9383 19.2881 90 126.095 90 
20 5.6 2801.482 0.79 20.1099 8.9383 19.2881 90 126.095 90 
20 5.6 2801.478 0.79 20.1099 8.9383 17.8721 90 119.301 90 
20 5.6 2801.478 0.79 20.1099 8.9383 17.8721 90 119.301 90 
20 5.1 2801.211 0.79 19.2862 8.9394 17.874 90 114.631 90 
20 5.1 2801.211 0.79 19.2862 8.9394 17.874 90 114.631 90 
20 5 1972.54 0.55 10.042 16.2016 13.0826 92.802 111.899 88.955 
20 5 1972.54 0.55 10.042 16.2016 13.0826 92.802 111.899 88.955 
20 4.7 2019.73 0.57 13.0173 16.2223 10.2657 91.209 111.105 92.063 
20 4.7 2019.73 0.57 13.0173 16.2223 10.2657 91.209 111.105 92.063 
20 4.2 1953.39 0.55 13.1227 15.8363 10.1163 91.761 111.608 88.47 
19 10.27 2325.452 0.65 13.6309 17.2214 11.2827 102.138 110.702 70.722 
19 8 484.123 0.14 6.2146 8.2752 11.6128 88.845 56.026 79.319 
19 8 484.122 0.14 6.2146 8.2752 9.6343 95.467 91.635 100.681 
19 5.2 1974.48 0.55 10.0599 16.1452 13.102 92.662 111.744 89.014 
18 11 657.985 0.18 6.6449 10.4081 12.2347 57.011 88.452 107.391 
18 11 657.985 0.18 6.6449 10.5423 14.0795 50.2 60.302 70.414 
18 11 657.985 0.18 6.6449 10.5423 12.2347 56.319 88.452 70.414 
18 9.46 1792.196 0.5 11.2963 16.8112 10.4859 104.203 110.964 79.324 
18 9 483.235 0.14 6.1995 9.3875 9.6291 95.921 91.787 60.131 
18 9 483.235 0.14 6.1995 9.3875 9.6291 95.921 88.213 119.868 
18 9 483.235 0.14 6.1995 9.3875 9.6291 84.079 88.213 60.131 
18 9 483.234 0.14 6.1995 8.2821 9.6291 95.37 91.787 100.607 
18 7 1333.113 0.37 24.3792 6.0865 9.5791 90 110.299 90 
18 7 657.619 0.18 6.6393 10.3907 13.7724 51.135 62.749 72.733 
18 6 1996.473 0.56 12.6243 16.6678 10.2381 90 112.067 90 
18 6 1996.473 0.56 12.6243 16.6678 10.2381 90 112.067 90 
18 6 1449.478 0.41 11.1944 13.1206 16.0972 58.005 122.444 130.811 
18 6 1449.478 0.41 11.1944 13.1206 16.0972 58.005 57.556 49.189 
18 6 1449.478 0.41 11.1944 13.1206 16.0972 121.995 57.556 130.811 
18 6 1449.478 0.41 11.1944 13.1206 16.0972 121.995 122.444 49.189 
18 5.2 3175.88 0.89 24.6237 6.4796 20.2522 90 100.625 90 
18 4.8 2729.74 0.77 15.0354 14.3653 13.5375 90 111 90 
17 13.82 482.507 0.14 8.2732 9.6267 6.1942 91.729 100.47 95.272 
17 11 579.495 0.16 8.8575 7.454 14.5763 65.207 42.022 66.82 
17 10.37 979.181 0.27 10.7641 13.0041 7.4825 96.646 89.715 109.641 
17 10.28 1761.357 0.49 10.5402 16.7024 10.3136 102.543 89.494 96.317 
17 10 1510.255 0.42 12.208 15.2745 10.367 90 128.626 90 
17 10 1510.254 0.42 12.208 15.2745 9.9249 90 125.31 90 
17 10 1240.418 0.35 9.0695 18.9898 21.5724 26.34 51.481 49.214 
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17 10 786.801 0.22 9.427 8.7709 11.2454 99.991 59.448 91.796 
17 10 558.047 0.16 6.6806 8.9471 10.9188 66.537 79.756 102.623 
17 9 1511.281 0.42 12.213 15.2742 10.3629 90 128.576 90 
17 9 1211.491 0.34 9.5941 15.2786 8.3325 90 97.308 90 
17 9 915.185 0.26 8.1615 10.7663 11.786 117.123 93.387 93.724 
17 9 915.183 0.26 8.1615 10.7662 11.786 62.877 86.613 93.724 
17 9 915.183 0.26 8.1615 10.7662 11.786 62.877 93.387 86.276 
17 9 568.956 0.16 6.3367 9.4518 11.272 119.137 79.547 85.541 
17 9 484.523 0.14 8.2777 6.2182 13.2785 84.54 46.24 79.3 
17 8 1742.187 0.49 15.7719 11.9729 9.2329 90 92.227 90 
17 8 580.464 0.16 7.4734 8.8657 9.9461 101.31 74.752 113.378 
17 7 1472.132 0.41 12.0314 16.3612 13.6045 125.27 69.978 137.116 
17 7 1390.382 0.39 18.575 8.9739 9.5738 90 119.396 90 
17 6 1970.237 0.55 19.2272 15.2711 6.7555 90 96.646 90 
17 6 1970.237 0.55 21.1043 15.2711 6.7555 90 115.185 90 
17 6 1807.811 0.51 16.0464 9.5073 12.3299 90 106.038 90 
17 6 1769.916 0.5 18.1976 11.7877 9.5788 90 120.527 90 
17 6 1512.516 0.42 10.3773 15.2867 9.9175 90 105.974 90 
17 6 1509.421 0.42 10.4036 15.2721 9.897 90 106.282 90 
17 6 1390.383 0.39 16.1898 8.9739 9.5738 90 91.615 90 
16 10.56 711.434 0.2 8.3711 11.9336 7.3615 89.799 98.96 101.543 
16 10.17 1985.639 0.56 11.6058 16.3478 10.8745 97.032 103.682 84.858 
16 10.14 727.459 0.2 9.737 10.3394 7.4967 102.804 97.209 83.651 
16 9.32 3662.345 1.03 16.4389 13.7614 16.4114 90 99.44 90 
16 7.82 1830.393 0.51 10.7227 16.4244 10.7047 97.084 100.188 82.63 
16 7.03 1882.295 0.53 11.0614 16.3281 11.0123 94.236 107.388 94.495 
 
9.3: The diffraction pattern simulated from the single crystal structure compared to that of the 
laboratory experimental powder diffraction pattern of adenine : suberic acid : hydrate, 2:2:1 
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9.3: Ortep for adenine : suberic acid : hydrate, 2:2:1 
 
9.4: Crystallographic details for adenine : suberic acid : water, 2:2:1 
Empirical formula C13 H21 N5 O5 
Formula weight 327.35 
Temperature 100 K 
Wavelength 0.71075 Å 
Crystal system Triclinic 
Space group P -1 
Unit cell dimensions a = 8.08(2) Å 
b = 9.76(2) Å 
c = 10.49(2) Å 
α = 104.43(4)° 
β = 99.88(4) ° 
γ = 92.01(2)° 
Volume 786(3) Å3 
Z 2 
Density (calculated) 1.383 Mg/m3 
Absorption coefficient 0.108 mm-1 
F(000) 348 
Crystal size  0.15 x 0.15 x 0.12 mm3 
Theta range for data collection 3.22 to 23.81°. 
Index ranges -9<=h<=9, -11<=k<=11, -11<=l<=11 
Reflections collected 4634 
Independent reflections 2343 [R(int) = 0.2197] 
Completeness to theta = 23.81° 97.4 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000  and 0.667 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2343 / 3 / 216 
Goodness-of-fit on F2 1.479 
Final R indices [I>2sigma(I)] R1 = 0.0415, wR2 = 0.3573 
R indices (all data) R1 = 0.1600, wR2 = 0.38408 
Largest diff. peak and hole 0.656 and -0.484 e.Å-3 
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9.5: Intermolecular bond lengths (Å) and angles(°) for adenine : suberic acid : hydrate 2:2:1 
Bond length (Å) Bond length (Å) Bond length (Å) 
C1-N9                   1.320(7) 
C1-N2                   1.341(6) 
C1-H1                   0.9500 
C3-N4                   1.357(6) 
C3-N2                   1.368(7) 
C3-C8                   1.389(9) 
C5-N6                   1.317(8) 
C5-N4                   1.353(8) 
C5-H5                   0.9500 
C7-N7                   1.359(8) 
C7-C8                   1.384(9) 
C7-N6               1.396(7) 
C8-N9                   1.381(6) 
N2-H2        0.8800 
N7-H7A        0.8800 
N7-H7B        0.8800 
C10-O11        1.202(7) 
C10-O10        1.289(8) 
C10-C11        1.514(9) 
C11-C12        1.493(9) 
C11-H11A        0.9900 
C11-H11B        0.9900 
C12-C13        1.547(9) 
C12-H12A        0.9900 
C12-H12B        0.9900 
C13-C13i        1.501(1) 
C13-H13A        0.9900 
C13-H13B        0.9900 
O10-H10        0.8400 
C14-O15        1.223(6) 
C14-O14        1.307(7) 
C14-C15        1.510(7) 
C15-C16        1.516(8) 
C15-H15A        0.9900 
C15-H15B        0.9900 
C16-C17        1.520(7) 
C16-H16A        0.9900 
C16-H16B        0.9900 
C17-C17ii        1.540(1) 
C17-H17A        0.9900 
C17-H17B        0.9900 
O14-H14        0.8400 
O18-H18A        0.86(2) 
O18-H18B        0.85(2) 
 
Bond angle (°) Bond angle (°) Bond angle (°) 
N9-C1-N2                113.0(5) 
N9-C1-H1              123.5 
N2-C1-H1              123.5 
N4-C3-N2                127.5(5) 
N4-C3-C8                 128.6(5) 
N2-C3-C8           103.9(4) 
N6-C5-N4           128.9(5) 
N6-C5-H5              115.6 
N4-C5-H5              115.5 
N7-C7-C8           121.7(5) 
N7-C7-N6           120.9(5) 
C8-C7-N6           117.4(6) 
N9-C8-C7           132.3(6) 
N9-C8-C3           111.3(5) 
C7-C8-C3           116.4(5) 
C1-N2-C3           108.2(5) 
C13i-C13-H13A          108.9 
C12-C13-H13A  108.9 
C13i-C13-H13B          108.9 
C12-C13-H13B  108.9 
H13A-C13-H13B  107.7 
C10-O10-H10              109.5 
O15-C14-O14           123.3(5) 
C1-N2-H2              125.9 
C3-N2-H2              125.9 
C3-N4-C5           109.4(5) 
C5-N6-C7           119.3(5) 
C7-N7-H7A              120.0 
C7-N7-H7B              120.0 
H7A-N7-H7B              120.0 
C1-N9-C8           103.6(5) 
O11-C10-O10           122.0(6) 
O11-C10-C11           121.1(6) 
O10-C10-C11           116.8(5) 
C12-C11-C10           111.0(5) 
C12-C11-H11A  109.4 
C10-C11-H11A  109.4 
C12-C11-H11B  109.4 
C10-C11-H11B  109.5 
H11A-C11-H11B  108.0 
C11-C12-C13           111.6(5) 
C11-C12-H12A  109.3 
C13-C12-H12A  109.3 
C11-C12-H12B  109.3 
C13-C12-H12B  109.3 
H12A-C12-H12B  108.0 
C13i-C13-C12           113.4(6) 
O15-C14-C15           124.1(5) 
O14-C14-C15           112.7(4) 
C14-C15-C16           115.6(4) 
C14-C15-H15A  108.4 
C16-C15-H15A  108.4 
C14-C15-H15B  108.4 
C16-C15-H15B  108.4 
H15A-C15-H15B  107.4 
C15-C16-C17           113.0(4) 
C15-C16-H16A  109.0 
C17-C16-H16A  109.0 
C15-C16-H16B  109.0 
C17-C16-H16B  109.0 
H16A-C16-H16B  107.8 
C16-C17-C17i          114.3(5) 
C16-C17-H17A  108.7 
C17ii-C17-H17A  108.7 
C16-C17-H17B  108.7 
C17ii-C17-H17B  108.7 
H17A-C17-H17B  107.6 
C14-O14-H14              109.5 
H18A-O18-H18B  110(4) 
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Torsion angle (°) Torsion angle (°) 
N7-C7-C8-N9               -2.1(8) 
N6-C7-C8-N9                           178.2(4) 
N7-C7-C8-C3                           179.2(4) 
N6-C7-C8-C3                          -0.5(7) 
N4-C3-C8-N9                          -178.9(4) 
N2-C3-C8-N9                           0.8(5) 
N4-C3-C8-C7                           0.1(7) 
N2-C3-C8-C7                           179.8(4) 
N9-C1-N2-C3                          -0.5(5) 
N4-C3-N2-C1                           179.5(4) 
C8-C3-N2-C1                          -0.2(5) 
N2-C3-N4-C5                -178.5(4) 
C8-C3-N4-C5                           1.1(6) 
N6-C5-N4-C3                          -2.1(6) 
N4-C5-N6-C7                           1.8(7) 
N7-C7-N6-C5                           180.0(4) 
C8-C7-N6-C5                          -0.3(7) 
N2-C1-N9-C8                           1.0(5) 
C7-C8-N9-C1                         -179.8(5) 
C3-C8-N9-C1                         -1.1(5) 
O11-C10-C11-C12               97.0(7) 
O10-C10-C11-C12             -80.2(7) 
C10-C11-C12-C13             -178.3(5) 
C11-C12-C13-C13i             -176.7(6) 
O15-C14-C15-C16             -0.6(6) 
O14-C14-C15-C16              179.5(4) 
C14-C15-C16-C17              177.4(3) 
C15-C16-C17-C17ii              177.0(4) 
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Appendix 10:  
10.1: 1H NMR spectra of adenine : azelaic acid adduct (solvent – DMSO) 
 
Adenine:   Not present                                                                                                   
Azelaic acid:   1.2 (6H,s),   1.4 (4H,t),   2.2 (4H,t)  
 
10.2: The diffraction pattern simulated from the single crystal structure compared to that of 
the laboratory experimental powder diffraction pattern of the azelaic acid polymorph 
 
0
200
400
600
800
1000
1200
1400
1600
1800
5 10 15 20 25 30 35 40 45
In
te
n
si
ty
 
2-theta 
Simulated diffraction pattern from
single crystal structure
Laboratory experimental powder
diffraction pattern
Appendices Page 285 
 
10.3: Ortep of the azelaic acid polymorph 
 
10.4: Crystallographic details for the azelaic acid polymorph 
Empirical formula C9 H16 O4 
Formula weight 188.22 
Temperature 120(2) K 
Wavelength 1.54184 Å 
Crystal system Monoclinic 
Space group P21/c 
Unit cell dimensions a = 5.5114(1) Å 
b = 9.4563(2) Å 
c = 18.8814(4) Å 
β = 95.994(2) ° 
Volume 978.67(3) Å3 
Z 4 
Density (calculated) 1.277 Mg/m3 
Absorption coefficient 0.832 mm-1 
F(000) 408 
Crystal size  0.23 x 0.18 x 0.08 mm3 
Theta range for data collection 6.64 to 66.59°. 
Index ranges -6<=h<=6, -11<=k<=11, -22<=l<=22 
Reflections collected 13150 
Independent reflections 1697 [R(int) = 0.0358] 
Completeness to theta = 66.59° 98.0 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9364 and 0.8317 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1697 / 0 / 122 
Goodness-of-fit on F2 1.069 
Final R indices [I>2sigma(I)] R1 = 0.0472, wR2 = 0.1217 
R indices (all data) R1 = 0.0525, wR2 = 0.1288 
Largest diff. peak and hole 0.304 and -0.203 e.Å-3 
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10.5: Intramolecular bond lengths (Å) and angles (°) for the azelaic acid polymorph 
Bond length (Å) Bond length (Å) Bond length (Å) 
O3-C9                   1.322(2) 
O3-H3                   0.8400 
O2-C1                   1.308(2) 
O2-H2                   0.8400 
O4-C9                   1.221(2) 
C7-C6                   1.525(2) 
C7-C8                   1.525(2) 
C7-H7A                0.9900 
C7-H7B                0.9900 
C5-C6                   1.524(2) 
C5-C4                   1.525(2) 
C5-H5A                0.9900 
C5-H5B                0.9900 
C3-C2                   1.525(2) 
C3-C4                   1.530(2) 
C3-H3A                0.9900 
C3-H3B                0.9900 
C6-H6A                0.9900 
C6-H6B                0.9900 
O1-C1                   1.230(2) 
C9-C8                   1.498(2) 
C4-H4A                0.9900 
C4-H4B                0.9900 
C8-H8A                0.9900 
C8-H8B                0.9900 
C1-C2                   1.499(2) 
C2-H2A                0.9900 
C2-H2B                0.9900 
 
 
Bond angle (°) Bond angle (°) Bond angle (°) 
C9-O3-H3               109.5 
C1-O2-H2              109.5 
C6-C7-C8           111.0(1) 
C6-C7-H7A              109.4 
C8-C7-H7A                 109.4 
C6-C7-H7B              109.4 
C8-C7-H7B              109.4 
H7A-C7-H7B              108.0 
C6-C5-C4           112.5(1) 
C6-C5-H5A              109.1 
C4-C5-H5A              109.1 
C6-C5-H5B              109.1 
C4-C5-H5B              109.1 
H5A-C5-H5B              107.8 
C2-C3-C4           111.1(1) 
C2-C3-H3A              109.4 
C4-C3-H3A              109.4 
C2-C3-H3B              109.4 
C4-C3-H3B              109.4 
H3A-C3-H3B              108.0 
C5-C6-C7           114.1(1) 
C5-C6-H6A              108.7 
C7-C6-H6A              108.7 
C5-C6-H6B              108.7 
C7-C6-H6B              108.7 
H6A-C6-H6B              107.6 
O4-C9-O3           123.0(1) 
O4-C9-C8           124.4(1) 
O3-C9-C8             112.(1) 
C5-C4-C3           114.0(1) 
C5-C4-H4A              108.8 
C3-C4-H4A              108.8 
C5-C4-H4B              108.8 
C3-C4-H4B              108.8 
H4A-C4-H4B              107.6 
C9-C8-C7           115.3(1) 
C9-C8-H8A              108.5 
C7-C8-H8A              108.5 
C9-C8-H8B              108.5 
C7-C8-H8B              108.5 
H8A-C8-H8B              107.5 
O1-C1-O2           122.8(1) 
O1-C1-C2           122.1(1) 
O2-C1-C2           115.1(1) 
C1-C2-C3           116.3(1) 
C1-C2-H2A              108.2 
C3-C2-H2A               108.2 
C1-C2-H2B               108.2 
C3-C2-H2B               108.2 
H2A-C2-H2B               107.4 
 
 
Torsion angle (°) Torsion angle (°) 
C4-C5-C6-C7                            174.4(1) 
C8-C7-C6-C5                            179.7(1) 
C6-C5-C4-C3                            179.6(1) 
C2-C3-C4-C5                            170.3(1) 
O4-C9-C8-C7                           -2.0(2) 
O3-C9-C8-C7                            178.7(1) 
C6-C7-C8-C9                            174.0(1) 
O1-C1-C2-C3                            145.8(2) 
O2-C1-C2-C3                           -36.5(2) 
C4-C3-C2-C1                            177.9(1) 
 
     
 
 
 
    
     
Appendices Page 287 
 
10.6.1: 1H NMR spectra of adenine : azelaic acid adduct (product of crystallisation from 
methanol) repeat (solvent – DMSO) 
 
Adenine:   7.15 (2H,s),   8.15 (2H,d)                                                                                     
Azelaic acid:   1.25 (6H,s),   1.5 (4H,t),   2.25 (4H,t)  
 
10.6.2: 1H NMR spectra of adenine : azelaic acid adduct (product of crystallisation from 
ethanol) repeat (solvent – DMSO) 
 
Adenine:   7.15 (2H,s),   8.15 (2H,d),                                                                                        
Azelaic acid:   1.25 (6H,s),   1.45 (4H,t),   2.20 (4H,t)  
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10.7: Indexing results for adenine : azelaic acid adduct, with the unit cell highlighted in 
orange 
I20 Merit Volume V/V1 a b c alpha beta gamma 
17 7.1 1789.405 1 21.914 5.0149 20.9548 90 129.01 90 
17 7.1 1789.405 1 21.914 5.0149 20.9548 90 129.01 90 
17 7 1269.422 0.71 9.8836 10.8608 18.0716 95.918 60.624 58.814 
17 6.3 4394.352 2.46 34.0165 28.0501 4.6054 90 90 90 
17 6.3 4394.352 2.46 34.0165 28.0501 4.6054 90 90 90 
17 6 1451.132 0.81 20.9083 9.3719 9.1299 90 125.792 90 
17 6 1451.132 0.81 20.9083 9.3719 9.1299 90 125.792 90 
17 5.4 4392.873 2.45 56.0465 17.0131 4.607 90 90 90 
17 5.4 4392.873 2.45 56.0465 17.0131 4.607 90 90 90 
17 4.31 2855.517 1.6 6.7166 8.5774 49.5658 90 90 90 
16 12 547.189 0.31 7.1659 9.8778 9.8163 60.293 84.204 66.06 
16 6 1297.161 0.72 18.2318 4.6715 16.3596 90 111.414 90 
16 6 1297.161 0.72 18.2318 4.6715 16.3596 90 111.414 90 
16 6 1297.161 0.72 18.2318 4.6715 16.3596 90 111.414 90 
15 14 937.496 0.52 9.2242 10.8125 13.4039 91.446 63.374 57.137 
15 14 530.951 0.3 6.837 9.3069 9.7017 114.5 79.493 80.16 
15 14 530.95 0.3 6.837 9.3069 10.8016 118.727 62.019 99.84 
15 12 1267.571 0.71 15.7558 10.8657 18.0229 95.93 146.835 63.687 
15 12 1267.566 0.71 15.7557 14.8981 18.0228 60.956 33.165 38.816 
15 12 945.183 0.53 12.5235 13.4668 10.8483 91.981 63.997 138.586 
15 11 933.852 0.52 9.6918 10.8227 13.3423 91.762 117.3 53.108 
15 9 1420.623 0.79 12.9814 11.2215 9.7834 90 94.574 90 
15 9 1381.674 0.77 12.5685 12.9505 10.9615 90 129.249 90 
15 9 932.169 0.52 13.3212 12.3582 12.346 52.089 44.16 41.951 
15 9 932.167 0.52 13.3212 12.3582 9.6906 103.86 117.431 41.951 
15 7 1657.955 0.93 11.1208 11.1513 23.6491 103.52 50.655 69.662 
15 7 1314.606 0.73 17.6969 4.6902 16.544 90 106.795 90 
15 7 1241.622 0.69 17.0757 14.0443 5.2171 90 97.076 90 
15 7 1241.621 0.69 17.2294 14.0443 5.2171 90 100.412 90 
15 7 932.166 0.52 9.2363 9.6906 13.3212 117.431 116.562 69.885 
15 6 1310.357 0.73 16.9677 14.0157 5.5135 90 92.027 90 
15 6 1275.021 0.71 14.3799 10.476 9.4307 90 116.172 90 
14 22 531.392 0.3 6.9563 12.6683 10.4781 54.226 69.104 45.429 
14 18 530.72 0.3 6.955 9.2161 14.4922 60.961 42.489 77.963 
14 12 526.485 0.29 6.8975 9.1966 10.4215 58.123 110.275 101.476 
14 11 1038.697 0.58 15.0559 8.1405 9.4591 90 116.37 90 
14 9 1153.632 0.64 18.8301 5.2088 13.0157 90 115.357 90 
14 8 1221.631 0.68 13.6737 10.4689 9.0015 90 108.547 90 
14 8 1221.63 0.68 13.7731 10.4689 9.0015 90 109.741 90 
14 7 2587.561 1.45 20.2569 13.6947 9.3275 90 90 90 
14 7 1038.376 0.58 10.5462 16.2351 6.4298 90 109.404 90 
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14 6 1363.161 0.76 18.184 4.9204 16.3474 90 111.255 90 
14 6 1350.881 0.75 18.2618 4.5408 17.537 90 111.732 90 
14 6 1199.534 0.67 19.2476 7.5494 9.3638 90 118.164 90 
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Appendix 11: 
11.1.1: 1H NMR spectra of adenine : sebacic acid adduct (product of crystallisation from 
MeOH) (solvent – DMSO) 
 
 
Adenine: 7.1 (2H,s), 8.10 (2H,d),  Sebacic acid: 1.3 (8H, s), 1.55 (4H, q), 2.25 (4H,t)  
 
11.1.2: 1H NMR spectra of adenine : sebacic acid adduct (product of crystallisation from 
EtOH) (solvent – DMSO) 
 
Adenine: 7.1 (2H,s), 8.10 (2H,d),  Sebacic acid: 1.25 (8H, s), 1.5 (4H, q), 2.2 (4H,t)  
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11.2: The diffraction pattern simulated from the single crystal structure compared to that of 
the laboratory experimental powder diffraction pattern of adenine : sebacic acid : hydrate, 
4:3:4 
 
 
11.4: Ortep of adenine and sebacic acid hydrated cocrystal 
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11.5: Crystallographic details for the adenine : sebacic acid : hydrate, 4:3:4 
Empirical formula C25 H41 N10 O8 
Formula weight 609.68 
Temperature 120(2) K 
Wavelength 1.54184 Å 
Crystal system Trioclinic 
Space group P -1 
Unit cell dimensions a = 10.3417(2) Å 
b = 12.4896(3) Å 
c = 12.7894(3) Å 
α = 101.134(2) ° 
β = 95.994(2) ° 
γ = 104.620(1) ° 
Volume 1460.92(6) Å3 
Z 2 
Density (calculated) 1.386 Mg/m3 
Absorption coefficient 0.881mm-1 
F(000) 650 
Crystal size  0.19 x 0.12 x 0.10 mm3 
Theta range for data collection 6.49 to 66.60°. 
Index ranges -12<=h<=12, -14<=k<=14, -15<=l<=15 
Reflections collected 14245 
Independent reflections 5019 [R(int) = 0.0254] 
Completeness to theta = 66.60° 97.2 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9170 and 0.8504 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5019 / 6 / 403 
Goodness-of-fit on F2 1.044 
Final R indices [I>2sigma(I)] R1 = 0.0360, wR2 = 0.0877 
R indices (all data) R1 = 0.0429, wR2 = 0.0918 
Largest diff. peak and hole 0.286 and -0.214 e.Å-3 
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11.6: Intramolecular bond lengths (Å) and angles (°) for the adenine : sebacic acid : hydrate, 
4:3:4 
Bond length (Å) Bond length (Å) Bond length (Å) 
N2-C1         1.353(2) 
N2-C3                   1.369(2) 
N2-H2                   0.880 
N7-C7                   1.330(2) 
N7-H7A        0.880 
N7-H7B                0.880 
C1-N9                   1.320(2) 
C1-H1                   0.950 
N4-C5                   1.333(2) 
N4-C3                   1.345(2) 
C5-N6                   1.334(2) 
C5-H5                   0.950 
C3-C8                   1.387(2) 
C7-N6                   1.358(2) 
C7-C8                   1.409(2) 
N9-C8                   1.387(2) 
O10-C10               1.309(2) 
O10-H10               0.840 
O11-C10               1.222(2) 
C11-C10               1.503(2) 
C11-C12               1.518(2) 
C11-H11A            0.990 
C11-H11B       0.990 
C15-C16               1.518(2) 
C15-C14               1.526(2) 
C15-H15A        0.990 
C15-H15B             0.990 
C16-C17        1.526(2) 
C16-H16A            0.990 
C16-H16B        0.990 
O20-C19        1.226(2) 
O19-C19        1.302(2) 
O19-H19        0.840 
C14-C13        1.525(2) 
C14-H14A        0.990 
C14-H14B       0.990 
C12-C13        1.522(2) 
C12-H12A        0.990 
C12-H12B        0.990 
C19-C18        1.505(2) 
C18-C17        1.518(2) 
C18-H18A        0.990 
C18-H18B       0.990 
C17-H17A        0.990 
C17-H17B        0.990 
C13-H13A        0.990 
C13-H13B        0.990 
N26-C25        1.340(2) 
N26-C27        1.368(2) 
C22-N24        1.355(2) 
C22-N21        1.363(2) 
C22-C28        1.386(2) 
N24-C25        1.326(2) 
N29-C20        1.314(2) 
N29-C28               1.380(2) 
N27-C27        1.324(2) 
N27-H27A            0.880 
N27-H27B        0.880 
C20-N21        1.364(2) 
C20-H20        0.950 
N21-H21        0.880 
C25-H25        0.950 
C27-C28        1.411(2) 
O30-C30        1.312(2) 
O30-H30        0.840 
O31-C30        1.222(2) 
C32-C33        1.522(2) 
C32-C31        1.523(2) 
C32-H32A        0.990 
C32-H32B        0.990 
C31-C30        1.502(2) 
C31-H31A       0.990 
C31-H31B        0.990 
C34-C34i        1.520(3) 
C34-C33        1.521(2) 
C34-H34A        0.990 
C34-H34B        0.990 
C33-H33A        0.990 
C33-H33B        0.990 
O35-H35A        0.873(2) 
O35-H35B        0.881(2) 
O36-H36A        0.845(2) 
O36-H36B        0.860(2) 
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Bond angle (°) Bond angle (°) Bond angle (°) 
C1-N2-C3           106.6(1) 
C1-N2-H2              126.7 
C3-N2-H2              126.7 
C7-N7-H7A              120.0 
C7-N7-H7B              120.0 
H7A-N7-H7B              120.0 
N9-C1-N2           113.7(1) 
N9-C1-H1              123.2 
N2-C1-H1              123.2 
C5-N4-C3           110.5(1) 
N4-C5-N6           129.4(1) 
N4-C5-H5              115.3 
N6-C5-H5              115.3 
N4-C3-N2           127.4(1) 
N4-C3-C8           126.9(1) 
N2-C3-C8           105.7(1) 
N7-C7-N6           119.2(1) 
N7-C7-C8           123.4(1) 
N6-C7-C8           117.3(1) 
C5-N6-C7           118.8(1) 
C1-N9-C8           103.8(1) 
C3-C8-N9           110.2(1) 
C3-C8-C7           117.0(1) 
N9-C8-C7           132.8(1) 
C10-O10-H10              109.5 
C10-C11-C12           115.0(1) 
C10-C11-H11A  108.5 
C12-C11-H11A  108.5 
C10-C11-H11B  108.5 
C12-C11-H11B  108.5 
H11A-C11-H11B  107.5 
C16-C15-C14           114.3(1) 
C16-C15-H15A  108.7 
C14-C15-H15A  108.7 
C16-C15-H15B  108.7 
C14-C15-H15B  108.7 
H15A-C15-H15B  107.6 
C15-C16-C17           112.0(1) 
C15-C16-H16A  109.2 
C17-C16-H16A  109.2 
C15-C16-H16B  109.2 
C17-C16-H16B  109.2 
H16A-C16-H16B  107.9 
C19-O19-H19              109.5 
C13-C14-C15           112.9(1) 
C13-C14-H14A  109.0 
C15-C14-H14A  109.0 
C13-C14-H14B  109.0 
C15-C14-H14B  109.0 
H14A-C14-H14B  107.8 
C11-C12-C13           112.1(1) 
C11-C12-H12A  109.2 
C13-C12-H12A  109.2 
C11-C12-H12B  109.2 
C13-C12-H12B  109.2 
H12A-C12-H12B  107.9 
O20-C19-O19           123.4(1) 
O20-C19-C18           123.0(1) 
O19-C19-C18           113.6(1) 
C19-C18-C17           114.4(1) 
C19-C18-H18A  108.7 
C17-C18-H18A  108.7 
C19-C18-H18B  108.7 
C17-C18-H18B  108.7 
H18A-C18-H18B  107.6 
C18-C17-C16           112.8(1) 
C18-C17-H17A  109.0 
C16-C17-H17A  109.0 
C18-C17-H17B  109.0 
C16-C17-H17B  109.0 
H17A-C17-H17B  107.8 
C12-C13-C14           112.9(1) 
C12-C13-H13A  109.0 
C14-C13-H13A  109.0 
C12-C13-H13B  109.0 
C14-C13-H13B  109.0 
H13A-C13-H13B  107.8 
O11-C10-O10           123.0(1) 
O11-C10-C11           123.5(1) 
O10-C10-C11           113.5(1) 
C25-N26-C27           120.7(1) 
N24-C22-N21           127.5(1) 
N24-C22-C28           127.4(1) 
N21-C22-C28           105.2(1) 
C25-N24-C22           111.1(1) 
C20-N29-C28           103.6(1) 
C27-N27-H27A  120.0 
C27-N27-H27B  120.0 
H27A-N27-H27B  120.0 
N29-C20-N21           113.4(1) 
N29-C20-H20              123.3 
N21-C20-H20              123.3 
C22-N21-C20           106.7(1) 
C22-N21-H21              126.6 
C20-N21-H21              126.6 
N24-C25-N26           127.8(1) 
N24-C25-H25              116.1 
N26-C25-H25              116.1 
N27-C27-N26           119.8(1) 
N27-C27-C28           124.1(1) 
N26-C27-C28           116.2(1) 
N29-C28-C22           111.1(1) 
N29-C28-C27           132.0(1) 
C22-C28-C27           116.9(1) 
C30-O30-H30              109.5 
C33-C32-C31           111.3(1) 
C33-C32-H32A  109.4 
C31-C32-H32A           109.4 
C33-C32-H32B  109.4 
C31-C32-H32B  109.4 
H32A-C32-H32B  108.0 
C30-C31-C32           117.1(1) 
C30-C31-H31A  108.0 
C32-C31-H31A  108.0 
C30-C31-H31B  108.0 
C32-C31-H31B           108.0 
H31A-C31-H31B  107.3 
C34i-C34-C33          113.5(2) 
C34i-C34-H34A  108.9 
C33-C34-H34A  108.9 
C34i-C34-H34B  108.9 
C33-C34-H34B  108.9 
H34A-C34-H34B  107.7 
C34-C33-C32           114.3(1) 
C34-C33-H33A  108.7 
C32-C33-H33A  108.7 
C34-C33-H33B  108.7 
C32-C33-H33B  108.7 
H33A-C33-H33B  107.6 
O31-C30-O30           123.0(1) 
O31-C30-C31           122.1(1) 
O30-C30-C31           114.9(1) 
H35A-O35-H35       104.3(2) 
H36A-O36-H36B     108.6(2) 
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Torsion angle (°) Torsion angle (°) 
C3-N2-C1-N9                          -0.9(2) 
C3-N4-C5-N6                           0.0(2) 
C5-N4-C3-N2                           179.3(1) 
C5-N4-C3-C8                           1.2(2) 
C1-N2-C3-N4                          -177.5(1) 
C1-N2-C3-C8                           1.0(2) 
N4-C5-N6-C7                          -1.3(2) 
N7-C7-N6-C5                          -178.5(1) 
C8-C7-N6-C5                           1.3(2) 
N2-C1-N9-C8                           0.4 (2) 
N4-C3-C8-N9                           177.7(1) 
N2-C3-C8-N9                          -0.8(2) 
N4-C3-C8-C7                          -1.1(2) 
N2-C3-C8-C7                          -179.5(1) 
C1-N9-C8-C3                           0.3(2) 
C1-N9-C8-C7                           178.8(2) 
N7-C7-C8-C3                           179.6(1) 
N6-C7-C8-C3                          -0.3(2) 
N7-C7-C8-N9                           1.1(2) 
N6-C7-C8-N9                         -178.7(1) 
C14-C15-C16-C17             -179.0(1) 
C16-C15-C14-C13             -177.4(1) 
C10-C11-C12-C13             -175.2(1) 
O20-C19-C18-C17              -8.2(2) 
O19-C19-C18-C17               172.6(1) 
C19-C18-C17-C16              -179.7(1) 
C15-C16-C17-C18              -178.1(1) 
C11-C12-C13-C14               180.0(1) 
C15-C14-C13-C12               177.8(1) 
C12-C11-C10-O11               4.1(2) 
C12-C11-C10-O10              -177.1(1) 
N21-C22-N24-C25               179.7(1) 
C28-C22-N24-C25               1.1(2) 
C28-N29-C20-N21              -0.2(2) 
N24-C22-N21-C20               -178.3(1) 
C28-C22-N21-C20               0.5(2) 
N29-C20-N21-C22              -0.2(2) 
C22-N24-C25-N26               1.0(2) 
C27-N26-C25-N24              -1.8(2) 
C25-N26-C27-N27              -179.8(1) 
C25-N26-C27-C28               0.5(2) 
C20-N29-C28-C22               0.5 (2) 
C20-N29-C28-C27              -179.0(2) 
N24-C22-C28-N29                178.2(1) 
N21-C22-C28-N29               -0.6(2) 
N24-C22-C28-C27               -2.2(2) 
N21-C22-C28-C27                178.9(1) 
N27-C27-C28-N29                1.0(3) 
N26-C27-C28-N29              -179.2(1) 
N27-C27-C28-C22              -178.5(1) 
N26-C27-C28-C22               1.3(2) 
C33-C32-C31-C30               167.2(1) 
C34i-C34-C33-C32               176.2 (2) 
C31-C32-C33-C34              -174.6(1) 
C32-C31-C30-O31              -157.9(2) 
C32-C31-C30-O30                23.0(2) 
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Appendix 12: 
 
12.1: Crystalline structure of adenine : adipic acid 2:1 
 
 
 
12.2: Crystalline structure of adenine : azelaic acid 1:1 
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Appendix 13: 
The supramolecular behaviour of adenine with 
succinic, fumaric and maleic acids; tautomerism, 
cocrystallisation, salt formation and solvation 
Laura J. Thompson, Norhanida Elias, Louise Male & Maryjane Tremayne* 
School of Chemistry, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK  
Email: m.tremayne@bham.ac.uk 
ABSTRACT 
The powerful hydrogen bonding capability of adenine makes it a key component of the DNA 
double helix, while as a crystalline molecular material, these hydrogen bond donors and 
acceptors make it a good potential cocrystal component possessing distinct physical 
properties.  Here we report the preparation and structure determination of four adenine-based 
multicomponent adducts formed with a number of dicarboxylic acids; an anhydrous cocrystal 
with succinic acid (1), anhydrous salts with fumaric acid (2) and maleic acid (3), and a 
methanolated salt with maleic acid (4).  The supramolecular behavior of adenine in these 
materials is discussed in terms of strong hydrogen bonded bidentate motifs formed between 
the adenine and acid components and the homomeric adenine synthons retained in these 
structures.  The additional formation of an CH…N interaction on the Watson-Crick site in (3) 
enables the stabilization of the unusual 3H,7H adeninium tautomer within a purely molecular 
material. 
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INTRODUCTION 
 
Adenine (6-aminopurine) is a principal component of DNA and an important constituent of 
adenosine triphosphate (ATP), making it essential for the release of energy to be used by cells 
in living organisms.  The structural aspects and supramolecular behaviour of adenine are 
diverse and intriguing.  The multiple strong hydrogen bond donor and acceptor sites in the 
neutral adenine molecule make it a good potential cocrystal component able to form robust 
heteromeric synthons with other molecules.  It forms a number of crystalline complexes, 
some with metals present 1-5 and other molecular cocrystal materials 6,7 including 
methanolated adenine : adipic acid 8 and anhydrous forms of adenine : benzoic acid 8,9 and 
adenine : 2-hydroxybenzoic acid 10.  In all these structures, adenine is present in its most 
stable and natural tautomeric 9H form (Scheme 1), although other less common adenine 
tautomers have been stabilised in structures in which metal ions are bound to the adenine 
5,11,12  and the 7H tautomer found within the hydrogen bonding network of a molecular adduct 
13.  The existence of multiple tautomeric forms of a nucleobase such as adenine can be 
problematic in spontaneous mutations in DNA 14, but may also be crucial, along with 
protonated adenine forms, in terms of high photostability and protection of DNA from UV 
damage 15.   
Adenine also forms crystalline salts in which the adeninium cation itself can adopt a variety 
of tautomeric forms.  A combined theoretical and experimental study placed the relative 
stability of the adeninium tautomers in their ground state as 1H,9H > 3H,7H > 3H,9H >> 
7H,9H > 1H,7H 16,17 (Scheme 1) and hence it is unsurprising that the majority of crystalline 
adeninium salts contain the 1H,9H tautomer.  It is this tautomer that is present in all the 
molecular adeninium : carboxylate salts reported to date, including oxalate 18, maleate 19 and 
hydroxybenzoate salts 8, and in combination with the non-canonical neutral 7H tautomer in a 
second hydrated maleate form 13.  Occurrence of the less stable 3H,7H adeninium tautomer in 
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the solid state is much less common.  There are a few examples in which this tautomer exists 
in combination with the 1H,9H form in metal salts 20,21, but only in cobalt and zinc-oxalato 
frameworks 22 has the 3H,7H tautomer been reported as the only adeninium component 
present within the crystal structure.  As far as we are aware, the anhydrous hydrogen maleate 
structure reported in this paper (3) is the first example in which the 3H,7H tautomer is 
stabilised within the hydrogen-bonding network of a purely molecular salt.   
 
Scheme 1.  Tautomers of adenine (top row) and the adeninium ion (bottom row) reported in 
the crystalline state and discussed in this work.  
 
 
Combination of molecular components in the form of cocrystals or salts provides us with 
an alternative source of solid crystalline materials with the potential to provide optimal 
physical properties whilst retaining the chemical properties of the cocrystal components 23-26.  
Physical properties can be changed dramatically by formulation in one of these alternative 
solid forms 27 and it has been shown that properties such as the transfer of melting point 
behaviour of pure aliphatic dicarboxylic acids can be tuned within a homologous series of 
cocrystals 28-31.  Although these effects are not always predictable 27,32, the ability to address 
poor hydration stability 33 and undesirable low or high solubility 28,34,35 by formulation in 
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cocrystal or salt form, makes these materials an essential tool in pharmaceutical material 
design and formulation. 
Predictable synthesis of a cocrystal or a salt relies on the preferential formation of 
heteromeric synthons rather than the formation of strong intermolecular interactions between 
molecules within the individual components.  Adenine contains several strong hydrogen bond 
donor and acceptor sites which are potentially available for interaction with suitable 
coformers containing complementary hydrogen bonding functionalities such as carboxylic 
acids.  In this paper we report the synthesis and crystal structures of four new crystalline 
adducts formed by adenine and three dicarboxylic acids; adenine : succinic acid 1:1 (1), 
adeninium : hydrogen fumarate 1:1 (2), adeninium : hydrogen maleate 1:1 (3), and adeninium 
: hydrogen maleate : methanolate 2:2:1 (4).  The supramolecular behaviour of adenine within 
these materials will be discussed in detail including the adoption of tautomeric form, 
formation of predicted hydrogen bond motifs, identification of any packing trends across the 
series and preference for cocrystal or salt formation. 
Possible hydrogen bonding motifs in these adducts mimic the hydrogen bonding network in 
adenine itself 36 based primarily on the formation of strong bidentate synthons.  In the pure 
9H form, adenine forms two motifs through complementary N-H...N interactions along the 
base of two molecules giving an )8(22R ring 
37 (motif I) and between the Watson-Crick and 
Hoogsteen edges of neighbouring adenine molecules giving an )9(22R ring (motif II) (Scheme 
2).  Other adenine-adenine motifs include a Hoogsteen pairing generating an )10(22R  ring 
(motif III), a Watson-Crick pairing generating an )8(22R ring (motif IV) and interaction of the 
Watson-Crick edge with the base of a neighbouring adenine forming another )8(22R ring 
(motif V).  Adenine-acid motifs formed by N-H...O=C and O-H...N interactions include an 
)8(22R ring on the Watson-Crick edge (motif VI) and an )9(
2
2R ring on the Hoogsteen edge 
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(motif VII).  Maleic acid provides a possible alternative adenine-acid motif in which an 
)8(22R ring on the Watson-Crick site is formed by N-H...O(H) and C-H...N interactions rather 
than through the carboxylic group (motif VIII).  In order to simplify the discussion and to aid 
identification of supramolecular trends within this series of structures, alternative motifs 
arising from tautomeric variation or proton transfer will be given a notation based on the 9H 
form (as described above) but with an extension describing the hydrogen position within the 
motif.  E.g:  In scheme 2, the 3H,7H adeninium tautomer is shown forming the motif I(3H) 
which denotes the )8(22R ring motif I with the hydrogen donated from the base of the adenine 
molecule on the 3H position rather than 9H; VII(7H+) denotes an additional proton on 7H of 
the adeninium ion in the )9(22R  ring motif VII. 
Five adenine : dicarboxylic acid salts or cocrystals have been reported; chlorinated and 
hydrated adeninium : oxalate structures 18, an adenine : adipic acid methanolate cocrystal 8, 
and two hydrated adeninium : maleate structures, including a mixed adenine-adeninium 
system 13 and a second hydrated maleate salt (which was incorrectly reported as adenine : 
succinate) 19.  All these structures contain one or more of the above motifs, but the hydrogen 
bonding network is disrupted by the presence of water, solvent or an additional ionic 
component resulting in the 
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Scheme 2.  Bidentate hydrogen bond motifs found in adenine or adenine:carboxylic acid 
adducts.  Motifs I, II, III, IV and V formed between adenine units, VI and VII formed by 
adenine with acids and VIII formed by adenine-maleic acid.  Motifs I(3H) and VII(7H+) 
denote alternative tautomer and adeninium motifs respectively. 
 
 
formation of single adenine-acid carboxylic O-H...N(hetero) (or C=O...H-N(adeninium) in 
salt form) and solvent-centred intermolecular interactions in addition to the bidentate motifs 
described above.  As anhydrous adducts, structures (1), (2) and (3) reported in this paper, 
may display the formation of more predictable bidentate hydrogen bond motifs, whereas 
structure (4) is another new maleate adduct in which the solvent is retained.  The hydrogen 
bonding network adopted by all these new materials will be analysed and the structural 
behaviour of all four maleate adducts discussed. 
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EXPERIMENTAL 
 
Preparation of compounds (1) to (4) 
All starting materials were purchased from Sigma Aldrich and used without purification.  
Equi-millimolar amounts of the two starting materials (approximately 0.6mmol), adenine and 
the respective dicarboxylic acid, were dissolved in warm solvent (10ml).  The filtered 
solutions were mixed and allowed to cool to room temperature.  On slow evaporation of the 
solvent, crystals were formed and obtained by filtration.  For (1), (2) and (4), the crystals 
were obtained from methanol whereas (3) was obtained from an ethanolic solution. 
 
Single crystal structure determination and refinement 
Single crystal X-ray diffraction data were collected from suitable crystals of all four 
adducts. Data from crystals (1) and (2) were collected on a Bruker APEX II CCD 
diffractometer at the window of a Bruker FR591 rotating anode (λMo-Kα=0.71073 Å) at 120K 
by the UK National Crystallography Service38.  The data collections were driven by 
COLLECT39 and processed by DENZO40.  Absorption corrections were applied using 
SADABS41.  Data for adduct (3) were collected on a Crystal Logic 4-circle kappa 
diffractometer equipped with a Rigaku Saturn 724 CCD detector using synchrotron radiation 
(λ = 0.68890 Å) at beamline I19 at the Diamond Light Source, UK.  The data were collected 
at 100K and the data collection was driven and processed (including absorption correction) 
by CrystalClear-SM Expert 2.0 r542.  Data for (4) were collected on a Bruker SMART 6000 
diffractometer (λ CuKα = 1.54184 Å) at 120K in the School of Chemistry at the University of 
Birmingham.  The data collection was driven by SMART43 and processed by SAINT44.  An 
absorption correction was applied using SADABS41. 
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All four structures were solved by direct methods and refined on F2 by full-matrix least-
squares refinement using SHELXS97 and SHELXL9745 respectively.  All non hydrogen atoms 
were refined with anisotropic displacement parameters.  Electron density maps were used to 
locate the positions of the hydrogen atoms thus confirming tautomeric form and whether or 
not proton transfer had taken place between the molecular components.  All H atoms were 
then added at calculated positions and refined by use of a riding model with isotropic 
displacement parameters based on the equivalent isotropic displacement parameter (Ueq) of 
the parent atom.  WinGX46 was used to prepare the material for publication.  The graphics 
were produced using DIAMOND47 and ORTEP348 with details of intermolecular interactions 
analysed with the aid of PLATON49 and geometrical analysis carried out in MERCURY50.  
The data from (2) are subject to merohedral twinning by 180 about the [100] direct lattice 
direction with the refined ratio of fractional contributions of the two components being 
0.54:0.46.  Crystallographic data for all four structures are given in Table 1. 
 
RESULTS 
The crystal structures of all four materials (1)-(4) contain extensive hydrogen bond 
networks in which the adenine and acid components form a range of possible synthons shown 
in Scheme 2.  In these structures, adenine is present in both neutral form ((1)) and protonated 
forms ((2), (3) and (4)) in which two distinct tautomers are displayed.  X-ray powder 
diffraction patterns were simulated from each single crystal structure and comparison with 
the experimental diffraction data showed a clear match between the crystals chosen for 
structural analysis and the bulk sample, although in (3) there is evidence of some excess 
maleic acid present (see Supplementary Information).  Details of selected intramolecular 
bond lengths and angles for (1)-(4) confirming tautomeric form and acid conformation are 
given as Supplementary Information. 
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Crystal structure of adenine:succinic acid 1:1 (1) 
In the crystal structure of (1), the neutral adenine molecule is in the most stable and 
expected 9H tautomeric form confirmed by the endocyclic C4-N9-C8 angle being 
approximately 3 larger than the unprotonated nitrogen site C5-N7-C8 (Supplementary 
Information).  There is also clear discrimination between the C-OH and C=O bonds in the 
succinic acid molecule indicating that both carboxyl groups have retained their acidic protons 
(Figure 1). 
 
 
Figure 1.  The asymmetric unit of adenine:succinic acid (1) showing the atom-numbering 
scheme and intermolecular hydrogen bonds (shown as dashed lines).  Displacement ellipsoids 
are drawn at the 50% probability level.  
 
The two coformer molecules are connected through two hydrogen bonds; N6-H6B…O11 
and O10-H10…N7, together creating an )9(22R ring formed along the adenine Hoogsteen 
edge (Scheme 2, motif VII).  Each adenine forms a dimer through complementary hydrogen 
donation from N9 via H9 to N3 resulting in an )8(22R ring.  This dimer motif (motif I) is 
common to other  
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Table 1. Crystallographic data for adducts (1) to (4). 
 
Cocrystal (1) (2)  (3) (4) 
Formula C9H11N5O4 C9H9N5O4 C9H9N5O4 C9.5H11N5O4.5 
Mr 253.23 251.21 251.21 267.23 
T (K) 120 120 100 120 
Crystal system Monoclinic Monoclinic Monoclinic Triclinic 
Space group P21/n P21/c P21/c P -1 
a (Å) 9.4902(4) 3.6160(1) 3.610(3) 5.2815(1) 
b (Å) 5.3041(3) 13.0730(6) 13.323(11) 10.0506(2) 
c (Å) 21.2846(8) 22.0296(9) 22.187(19) 22.0125(4) 
α (˚) 90 90 90 78.191(1) 
β (˚) 92.398(3) 94.633(3) 92.258(7) 85.160(1) 
γ (˚) 90 90 90 80.017(1) 
Volume (Å3) 1070.46(9) 1037.98(7) 1066.3(15) 1124.98(4) 
Z 4 4 4 4 
Dcalc (Mg/m
3) 1.571 1.608 1.565 1.578 
μ (mm-1) 0.126 0.130 0.126 1.100 
Crystal Shape Fragment Needle Needle Rod 
Colour Colourless Colourless Colourless Colourless 
Melting Pt (°C) 241-242 242-244 133-135 193-194 
θ (˚)  3.52 – 27.48 3.25 – 25.02 2.96 – 26.56 6.71 – 66.59 
Range of h -12 – 12 -4 – 4 -4 – 4 -6 – 6 
Range of k -6 – 6 -15 – 15 -17 – 17 -11 – 11 
Range of l -27 – 27 -26 – 26 -28 – 28 -25 – 24 
Reflections 
collected 
8933 10663 10172 7965 
Independent 
reflections 
2426 1872 2401 3745 
Goodness of fit 1.114 1.093 1.052 1.064 
Final R1 and wR2 
(I>2(I)) 
0.0586, 0.1123 0.0552, 0.1045 0.0416, 0.1020 0.0345, 0.0901 
Final R1 (all data) 0.0817 0.0792 0.0582 0.0404 
crystalline adenine structures, and acts to form a small supramolecular building block containing 
alternating ring motifs (Figure 2a).  These units are linked through two C-H…O interactions in which 
O14 acts as a double acceptor forming )8(23R rings above and below the adenine dimer (Figure 2a).  
The result is a hydrogen-bonded ribbon running in the [-120] direction, linked to two others running 
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in the same direction through a ‘layer’ of other ribbons running in the [120] direction in a sandwich-
type arrangement (Figure 2b).  This architecture is formed by the two remaining hydrogen bonds; N6-
H6A…O11 and O13-H13…N1.  In this extensive hydrogen bond network, each adenine molecule is 
involved in eight intermolecular interactions such that all hydrogen bond donors and acceptor sites are 
used, while in each succinic acid molecule, both carboxylic OH groups act as donors and both C=O 
groups as double acceptors (Table 2).   
 
Table 2. Intermolecular hydrogen bonding and weak interactions (Å and ˚) in (1). 
D-H…A d(D-H) d(H…A) d(D…A) <(DHA) 
N6-H6A…O11i 
N6-H6B…O11 
N9-H9…N3ii 
O10-H10…N7 
O13-H13…N1iii 
C2-H2…O14iv 
C8-H8…O14v 
0.88 
0.88 
0.88 
0.84 
0.84 
0.95 
0.95 
2.04 
2.05 
1.96 
1.80 
1.87 
2.43 
2.38 
2.875(2) 
2.924(3) 
2.825(3) 
2.630(3) 
2.686(2) 
3.213(3) 
3.077(3) 
157.3 
171.7 
166.4 
167.0 
162.9 
140.0 
129.9 
Symmetry transformations used to generate equivalent atoms: 
(i) –x+0.5, y+0.5, -z+0.5  (ii) –x, -y+3, -z (iii) –x+0.5, y-1.5, -z+0.5 
(iv) x-1, y+2, z   (v) –x+1, -y+1, -z 
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Figure 2.  The hydrogen bond network of adenine and succinic acid molecules in (1) 
showing (a) the infinite ribbon of adenine dimers and succinic acid molecules, and (b) 
alternating perpendicular layers of these infinite hydrogen-bonded ribbons. Intermolecular 
hydrogen bonds are shown as dashed lines.  
 
Crystal structure of adeninium : hydrogen fumarate 1:1 (2) 
The asymmetric unit of (2) shows that in this case proton transfer has taken place and the 
adeninium ion is in the common 1H,9H tautomeric salt form, confirmed by the larger 
endocyclic angle around the protonated nitrogen sites.  There is clear discrimination again 
between the C-OH and C=O bond lengths at the protonated C13 end of the hydrogen 
fumarate ion, but not at the carboxylate C10 end (Figure 3).   
(a) 
(b) 
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Figure 3.  The asymmetric unit of adeninium : hydrogen fumarate (2) showing the atom-
numbering scheme and intermolecular hydrogen bonds (shown as dashed lines).  
Displacement ellipsoids are drawn at the 50% probability level.  
The coformers are linked by the hydrogen bonds N6-H6A…O11 and N1-H1…O10 
forming an )8(22R ring on the Watson-Crick edge giving motif VI(1H
+) (Figure 3).  The 
adeninium dimer )8(22R ring motif (motif I) is also formed in this structure, via 
complementary N9-H9…N3 interactions.  This creates a supramolecular building block of 
alternating acid-adeninium and adeninium-adeninium ring motifs, distinct from that seen in 
(1), linked to form an infinite chain by complementary N6-H6B…O11 hydrogen bonds 
creating an additional )8(24R  ring (Figure 4a).  Unlike in the crystal structure of (1), this 
chain is not planar, with the hydrogen fumarate ion bent out of plane with intramolecular 
carboxylate-to-carboxyl torsion angles of -149.5° and  
-161.3° (Supplementary Information).  This marked geometric distortion of the hydrogen 
fumarate ion means that rather than the formation of strong interactions with the N7 or C8 in 
the adeninium units within the chain, each fumarate links to three neighbouring perpendicular 
chains (Figure 4b); the first through hydrogen bonds O13-H13…O10 and C2-H2…O14 
which create a further )9(33R  ring; the second also via a C2-H2…O14 interaction with an 
adeninium dimer but with a shorter H...A distance; finally, interaction with a third chain 
through a complementary O13-H13...O10 hydrogen bond (Table 3).  In a similar way to (1), 
these chains form a sandwich-type structure with alternating ‘layers’ of chains running in 
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opposing directions. While there are the same total number of intermolecular interactions in 
structures (1) and (2), the coformer molecules play a different role in the network.  In (2), 
each adeninium is involved in seven interactions including a bifurcated C-H donation, but 
with N7 and C8 not used.  Each hydrogen fumarate ion is also involved in seven interactions 
with all three unprotonated oxygens acting as double acceptors and the carboxylic OH acting 
as a donor (Table 3).   
 
Figure 4.  The hydrogen bond network of adeninium dimers and hydrogen fumarate ions in 
(2) showing (a) the infinite hydrogen-bonded chain of dimers and alternating ions, and (b) the 
criss-cross chains that form the alternating layer structure.  Intermolecular hydrogen bonds 
are shown as dashed lines and selected atom labels are included in (b) to aid discussion.  
 
(b) 
(a) 
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Table 3. Intermolecular hydrogen bonding and weak interactions (Å and ˚) in (2). 
D-H…A d(D-H) d(H…A) d(D…A) <(DHA) 
N1-H1…O10 
N6-H6A…O11 
N6-H6B…O11i 
N9-H9…N3ii 
O13-H13…O10iii 
C2-H2...O14iv 
C2-H2...O14v 
0.88 
0.88 
0.88 
0.88 
0.84 
0.95 
0.95 
1.77 
1.92 
2.07 
2.06 
1.77 
2.42 
2.54 
2.639(4) 
2.795(4) 
2.810(4) 
2.892(4) 
2.604(3) 
3.172(5) 
3.238(5) 
171.3 
170.9 
140.8 
158.5 
172.0 
135.5 
130.9 
Symmetry transformations used to generate equivalent atoms: 
(i) –x+1, -y+1, -z+1  (ii) –x-1, -y+2, -z+1  (iii) –x+1, y-0.5, -z+0.5 
(iv) –x, y+0.5, –z+0.5  (v) –x+1, y+0.5, -z+0.5 
 
Crystal structure of adeninium : hydrogen maleate 1:1 (3) 
The crystal structure of (3) has an asymmetric unit containing an adeninium cation and a 
hydrogen maleate anion, the latter displaying the planar acid conformation stabilised by the 
short intramolecular hydrogen bond O13-H13...O11 commonly found in other hydrogen 
maleate structures 13,19 (Figure 5).  However, the adeninium ion in (3) is in the unusual 3H,7H 
tautomeric form with the endocyclic angles around N3 and N7 larger than the unprotonated N 
sites (Supplementary Information).  The two components form an )8(22R  ring on the adenine 
Watson-Crick edge which is similar to that seen in the fumarate structure (2) although the 
synthon itself is formed by an alternative combination of interactions N6-H6A…O10 and 
C11-H11…N1(Scheme 2, motif VIII) (Figure 5).   
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Figure 5.  The asymmetric unit of adeninium : hydrogen maleate (3) showing the atom-
numbering scheme and hydrogen bonds (shown as dashed lines).  Displacement ellipsoids are 
drawn at the 50% probability level.  
The adeninium dimer )8(22R motif is formed through complementary N3-H3…N9 
interactions and differs in nature from the synthon in (1) and (2) due to the alternative 
tautomeric form giving the motif I(3H).  Each adeninium ion is hydrogen bonded to a second 
hydrogen maleate through N6-H6B…O11 and N7-H7…O10 interactions forming an )9(22R
ring motif on the Hoogsteen edge (motif VII(7H+)) (Figure 6a).  The result is the formation 
of chains of alternating adeninium and hydrogen maleate ions linked through alternating 
hydrogen bonded rings in the Watson-Crick and Hoogsteen modes, running parallel to the b-
axis.  These chains are linked by the adeninium dimers to give an infinite hydrogen bonded 
sheet (Figure 6a).  The protonated end of the hydrogen maleate lies either above or below the 
sheet and is involved in interactions with adeninium dimers in neighbouring sheets;  a 
combination of C8-H8…O13 and C2-H2…O14 generating a puckered )10(33R  ring (Figure 
6b).  All strong hydrogen bond donors and acceptors are used in this structure (Table 4), with 
each adeninium ion involved in nine intermolecular interactions (including N7 acting as a 
bifurcated donor) and each hydrogen maleate ion forming eight hydrogen bonds with O10 as 
a double acceptor, O11 as a triple acceptor and O13 as both a donor and acceptor. 
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Figure 6.  A view of the crystal structure of (3) showing (a) the chains of alternating )8(22R  
and )9(22R rings linked together in an infinite hydrogen-bonded sheet.  Hydrogen bonds are 
shown as dashed lines and (b) interactions between the adeninium dimer and maleate anions 
above and below the plane shown as dashed pink and blue lines (hydrogen bonds within the 
layer are shown as green dashed lines).  
(a) 
(b) 
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Table 4. Intermolecular hydrogen bonding and weak interactions (Å and ˚) in (3). 
D-H…A d(D-H) d(H…A) d(D…A) <(DHA) 
N3-H3...N9i 
N6-H6A...O10 
N6-H6B...O11ii 
N7-H7...O10ii 
N7-H7...O11ii 
O13-H13...O11 
C2-H2...O14iii 
C8-H8...O13iv 
C11-H11...N1 
0.88 
0.88 
0.88 
0.88 
0.88 
0.84 
0.95 
0.95 
0.95 
1.95 
2.07 
2.07 
1.87 
2.56 
1.62 
2.39 
2.35 
2.43 
2.808(2) 
2.946(3) 
2.922(2) 
2.721(2) 
3.288(2) 
2.464(2) 
3.154(3) 
3.231(3) 
3.374(3) 
162.9 
171.3 
163.2 
161.6 
140.1 
177.4 
137.8 
153.9 
170.9 
Symmetry transformations used to generate equivalent atoms: 
(i) -x+1, -y+3, -z (ii) -x+2, y+1/2, -z+1/2 (iii) -x, -y, -z (iv) x+1, y+1, z 
 
Crystal structure of adeninium : hydrogen maleate : methanolate 2:2:1 (4) 
In the crystal structure of (4) the asymmetric unit contains two independent adeninium 
cations, two independent hydrogen maleate anions and one methanol molecule (Figure 7).  
Both adeninium ions (A and B with atom labels a and b respectively) are in the more 
common 1H,9H tautomeric form and both hydrogen maleate ions are stabilised by 
intramolecular O13-H13…O10 hydrogen bonds.  Both adeninium cations (A and B) are 
hydrogen bonded to the hydrogen maleate anions (A and B respectively) through the 
formation of )8(22R  rings on each Watson-Crick site but via N1-H1…O11 and N6-
H6A…O10 interactions within each pair (Figure 7 and Table 5) forming the VI(1H+) motif, 
similar to that in the adeninium hydrogen fumarate structure (2) rather than the anhydrous 
maleate (3).   
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Figure 7.  The asymmetric unit of adeninium : hydrogen maleate : methanolate (4) showing 
the atom-numbering scheme and hydrogen bonds (shown as dashed lines).  Displacement 
ellipsoids are drawn at the 50% probability level.  
The two adeninium ions are linked through N9A-H9A…N7B (reinforced by C8B-
H8B…N3A, not shown in Figure 7), and hence the typical base edge dimer motif (I) is not 
formed here.  The methanol is linked to adeninium B by N9B-N9B…O16.  
The asymmetric unit is linked to others generating an infinite hydrogen bonded sheet that 
can be viewed as parallel ladders of )8(22R  rings running in the [2-10] direction, formed 
independently by the adeninium and hydrogen maleate A and B pairs (Figure 8).  These 
ladders contain alternating )16(46R  and )10(
2
4R  rings formed by complementary N6-
H6…O14 and C2-H2…O11 hydrogen bonds respectively.  Two further interactions, C8A-
H8A…O14B and O16-H16…O14 (the latter linking the methanol to hydrogen maleate A) 
bring together the ‘A’ and ‘B’ ladders to form an infinite sheet (Figure 8).  In both hydrogen 
maleate ions all strong hydrogen bond donors and acceptors are used with the C-O groups 
acting as double acceptors.  Both adeninium ions are involved in the six intermolecular 
interactions marked in Figure 8, whereas the heterocyclic N and C-H groups that are not 
marked as involved in intermolecular interactions are in positions conducive to the formation 
of weak interactions with neighbouring maleate or adeninium ions or methanol hydrogens. 
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Figure 8.  A view of the crystal structure of (4) showing the hydrogen-bonded sheet formed 
by the crystallographically independent adeninium (A and B) and the hydrogen maleate (A 
and B) ions with methanol.  Hydrogen bonds are shown as dashed lines (black lines denote 
interactions within the asymmetric unit, green lines those between asymmetric units). 
 
DISCUSSION 
 
The structures presented in this paper illustrate the role that small dicarboxylic acids can 
play in disruption of the strong hydrogen bonding network in adenine in the crystalline solid 
state, resulting in the preferential formation of cocrystals or salts.  There is general 
acceptance that if the pKa difference (ΔpKa = pKa(base) - pKa(acid)) is greater than 2-3 then 
the salt will form, whereas if ΔpKa < 0 then the cocrystal product should predominate
51
.  
With aqueous pKa 
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Table 5. Intermolecular hydrogen bonding and weak interactions (Å and ˚) in (4). 
D-H…A d(D-H) d(H…A) d(D…A) <(DHA) 
N1A-H1A...O11A 
N6A-H6AA...O10A 
N6A-H6AB...O14A
i 
N9A-H9A...N7B 
O13A-H13A...O10A 
C2A-H2A…O11Aiii 
C8A-H8A...O14B
ii
 
0.88 
0.88 
0.88 
0.88 
0.84 
0.95 
0.95 
1.90 
1.93 
2.01 
2.05 
1.59 
2.39 
2.33 
2.772(2) 
2.801(2) 
2.865(2) 
2.921(2) 
2.430(2) 
3.329(2) 
3.130(2) 
174.3 
169.3 
163.7 
171.5 
173.1 
172.4 
141.7 
N1B-H1B...O11B 
N6B-H6BA...O10B 
N6B-H6BB...O14B
ii 
N9B-H9B...O16 
O13B-H13B...O10B 
O16-H16...O14A
iii 
C2B-H2B…O11Biv 
C8B-H8B…N3A 
0.88 
0.88 
0.88 
0.88 
0.84 
0.84 
0.95 
0.95 
1.82 
2.00 
1.97 
1.83 
1.61 
1.82 
2.35 
2.79 
2.688(2) 
2.875(2) 
2.808(2) 
2.697(2) 
2.448(2) 
2.658(2) 
3.292(2) 
3.608(2) 
168.9 
170.2 
158.1 
168.4 
176.5 
173.6 
169.7 
144.9 
Symmetry transformations used to generate equivalent atoms: 
(i) -x, -y+2, -z   (ii) –x+3, -y+2, -z+1  (iii) –x+2, -y+1, -z   
(iv) –x+5, -y+1, -z+1 
 
differences of -0.06, 1.13 and 2.23 between adenine and succinic, fumaric and maleic acids 
respectively
52
, cocrystal formation is indeed expected in the case of adenine : succinic acid 
(1), and the maleic acid adducts (3) and (4) are most likely to be predicted as salts. However, 
with a ΔpKa value within the range 0 to 3, the formation of an adenine fumarate salt (2) could 
not be predicted using this parameter.  Although the difference in aqueous pKas is a useful 
indicator of adduct form when values are at the extremes, an alternative indicator based on 
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features in the solid form or even consideration of pKa behavior in the solvent of 
cocrystallization may prove to be more reliable in this narrow unpredictable region.   
In (2) and (4), a single proton transfer from the acid takes place at the N6 position giving 
rise to the most common 1H,9H adeninium tautomer.  However, in the anhydrous hydrogen 
maleate structure (3), protonation of the natural 9H adenine form is not observed, and 
generation of the less stable 3H,7H adeninium tautomer is preferred.  As far as we are aware, 
this is the first example in which the 3H,7H  tautomer is stabilized within the crystalline 
structure of a purely molecular material.  The hydrogen-bonding network in (3) arises from a 
combination of intermolecular interactions that differs from the other reported structures and 
results in a crystalline arrangement that stabilizes this energetically unfavourable tautomer.  
The lack of protonation at the N1 position enables the formation of an additional C-H…N 
intermolecular interaction within motif VIII on the Watson-Crick site.  The presence of a 
hydrogen on N3 necessitates movement of the proton from N9 to N7 so that the expected 
complementary adeninium dimer (motif I(3H)) can form.  The overall combination of these 
structural requirements results in the adoption and stabilization of the unusual 3H,7H 
tautomer.  This tautomeric variation further illustrates the potential structural diversity 
displayed by adenine-based molecular adducts.  This is evident even within the four hydrogen 
maleate structures that have now been reported; our work has produced the anhydrous 
hydrogen maleate (3) containing the 3H,7H tautomer from ethanolic solution and the 
methanolate (4), based on the 1H,9H tautomer from methanol.  This 1H,9H tautomer is also 
present in the hydrated form
19
 from aqueous solution, whereas a second hydrate
13
 from 
methanol in an open beaker has both 1H,9H adeninium and neutral 7H adenine forms present. 
The supramolecular behaviour of (1)-(4) is dominated by strong bidentate motifs, similar to 
other adenine:carboxylic acid adducts (Table 6).  All these structures contain either the 
)8(22R  heterosynthon (motif VI) formed by NH…O=C and OH…N(hetero) interactions on 
Appendices Page 319 
 
the Watson-Crick site, or the )9(22R  heterosynthon (motif VII) on the Hoogsteen edge.  
Although adenine adducts containing monocarboxylic acids form both motifs8, Table 6 
highlights a preference for formation of the Hoogsteen-acid motif VII by cocrystals and the 
Watson Crick-acid motif VI(1H+) by salts.  This trend is also observed in the hydrated 
maleate structure
13
 with the VII(7H
+
) motif formed by the adenine 7H tautomer and the 
VI(1H+) motif generated by the adeninium ion.  The only exception is structure (3), where 
the unusual 3H,7H tautomer forms alternative interactions at the Watson-Crick site and 
protonation of the 7H position gives the VII(7H
+
) motif.  Distinct adenine or adeninium 
dimer supramolecular units are also found in structures [(1)-(4)], mostly as the common 
)8(22R  homosynthon (motif I).  Formation of motif I is disrupted when the structure is 
solvated or hydrated, when alternative interactions are formed by the base edge of the 
adenine unit, e.g: in the solvated hydrogen maleate (4), in which a single NH…N(hetero) 
hydrogen bond is formed from the base of the adeninium to the Hoogsteen edge and 
reinforced by a CH…N(hetero) hydrogen bond to give an )7(22R  ring.  Hence, although the 
supramolecular behavior of these materials is not yet predictable, there are common features 
that emerge from the structures studied to date.  All the dicarboxylic acid adduct structures in 
Table 6 contain at least two of the bidentate synthons discussed (although there may be some 
disruption to this network by solvation etc.), with the motif formed dependent on cocrystal, 
salt or tautomeric form.  Consideration of the anhydrous adducts shows that only structure (3) 
utilizes a combination of three bidentate motifs, while the Watson-Crick edge in (1) is 
involved in alternative interactions to neighbouring supramolecular chains and the Hoogsteen 
site in (2) is blocked by twisting of the hydrogen fumarate ion. 
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Table 6.  Intermolecular hydrogen bond motifs found in adenine: carboxylic acid adducts. 
Material Ad/Ad+ motif 
Bidentate Ad/Ad+: 
acid motif 
Single Ad/Ad+: 
acid interaction 
Reference 
Adenine I II    35 
Ad:benzoic acid I  VI VII  8 
Ad:hydroxy 
benzoic acid   VI VII 
OH…N(3)      
N(9)H…O 
8 
Ad:succinic acid I   VII 
OH…N(1)  
N(6)H…O   
C(2)H…O 
C(8)H…O 
this work (1) 
Ad:adipic acid 
methanolate  IV  VII 
 8 
Ad+:hydrogen 
fumarate I  VI(1H
+)  
N(6)H…O      
C(2)H…O 
C(2)H…O 
this work (2) 
Ad+:hydrogen 
maleate 
I(3H)  VIII VII(7H+) 
C(2)H…O 
C(8)H…O 
this work (3) 
Ad+:hydrogen 
maleate 
methanolate 
N(9)H…N(7) 
C(8)H…N(3) 
VI(1H+)  
N(6)H…O      
C(2)H…O 
C(8)H…O 
this work (4) 
Ad+:hydrogen 
maleate hydrate 
III  VI(1H+)  N(9)H…O 18 
Ad+:Ad:hydrogen 
maleate hydrate 
III 
IV 
V(1H) 
VI(1H+) VII(7H+) N(9)H…O 13 
Ad denotes neutral adenine and Ad+ denotes protonated adeninium species. 
Finally, it is worth a comment on the effect of cocrystallisation and salt formation on 
physical properties as the primary concern of pharmaceutical formulation is often to tailor the 
solubility or transfer other desirable physical properties to a multi-component material.  
Adenine is poorly soluble in water and has a melting point > 360°C at which point it 
Appendices Page 321 
 
decomposes, whereas succinic, fumaric and maleic acids have significantly lower melting 
points (184, 287 and 135°C respectively) and higher solubilities.  The adenine : succinic acid 
cocrystal (1) has a melting point between the two individual components (~242°C) behaving 
in a similar way to the majority of pharmaceutical cocrystals27.  The two anhydrous salts (2) 
and (3) display melting points lower than both the individual starting components, whereas 
the methanolated maleate salt (4) has a melting point between adenine and maleic acid (Table 
1).  Although the exact effect of cocrystallisation or salt formation on the physical properties 
of adenine is clearly unpredictable, this approach does provide a pathway to lowering the 
melting point and/or improving its poor solubility. 
 
 
CONCLUSION 
 
Adenine forms a variety of cocrystals and salts with small dicarboxylic acids.  Those 
reported here include an anhydrous cocrystal with succinic acid, an anhydrous fumarate salt, 
an anhydrous maleate salt in which the adeninium adopts the unusual 3H,7H tautomer and a 
methanolated maleate salt.  The supramolecular behavior of adenine across this range of 
adducts can be rationalized through the formation of strong bidentate hydrogen bond 
synthons based around a number of predicted motifs, which adapt to accommodate salt 
formation or stabilization of uncommon tautomeric form. 
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Appendix 14: 
 
14.1: Crystalline structure of isonicotinamide : oxalic acid 2:1 
 
 
14.2: Crystalline structure of isonicotinamide : malonic acid 2:1 
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14.3: Crystalline structure of isonicotinamide : succinic acid 2:1 
 
 
 
14.4: Crystalline structure of isonicotinamide : fumaric acid 2:1 
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14.5: Crystalline structure of isonicotinamide : hydrogen maleate 1:1 
 
 
14.6: Crystalline structure of isonicotinamide : glutaric acid 2:1 
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14.7: Crystalline structure of isonicotinamide : adipic acid 2:1 
 
 
14.8: Crystalline structure of isonicotinamide : glutaric acid 1:1 
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14.9: Crystalline structure of isonicotinamide : adipic acid 1:1 
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Appendix 15: 
15.1: 1H NMR spectra of isonicotinamide : pimelic acid (solvent – DMSO) 
 
Isonicotinamide:  7.75 (3H,dd and s),  8.25 (1H,s),  8.72 (2H,dd)                                
Pimelic acid:   1.25 (2H, q),   1.5 (4H, q),  2.2 (4H,t) 
 
15.2: The diffraction pattern simulated from the single crystal structure compared to that of 
the laboratory experimental powder diffraction pattern of isonicotinamide : pimelic acid, 1:1 
 
 
 
0
500
1000
1500
2000
2500
3000
3500
5 15 25 35 45
In
te
n
si
ty
 
2-theta 
Simulated diffraction pattern from single crystal
structure
Laboratory experimental powder diffraction
pattern
Appendices Page 334 
 
15.3: Ortep of isonicotinamide : pimelic acid, 1:1 
 
 
15.4: Crystallographic details for  isonicotinamide : pimelic acid, 1:1 
Empirical formula C13 H18 N2 O5 
Formula weight 282.29 
Temperature 120(2) K 
Wavelength 0.71073Å 
Crystal system Monoclinic 
Space group P2/c 
Unit cell dimensions a = 8.2223(5) Å 
b = 5.1437(3) Å 
c = 33.389(2) Å 
α = 90° 
β = 93.873(3) ° 
γ = 90° 
Volume 1408.9(2) Å3 
Z 4 
Density (calculated) 1.331 Mg/m3 
Absorption coefficient 0.103 mm-1 
F(000) 600 
Crystal size  0.10 x 0.08 x 0.05mm3 
Theta range for data collection 3.37 to 25.02°. 
Index ranges -9<=h<=9, -6<=k<=6, -39<=l<=39 
Reflections collected 13904 
Independent reflections 2480 [R(int) = 0.0742] 
Completeness to theta = 25.02° 99.6% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9949 and 0.9898 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2480 / 0 / 180 
Goodness-of-fit on F2 1.077 
Final R indices [I>2sigma(I)] R1 = 0.0557, wR2 = 0.1184 
R indices (all data) R1 = 0.0901, wR2 = 0.1337 
Largest diff. peak and hole 0.311 and -0.305 e.Å-3 
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15.5: Intramolecular bond lengths (Å) and angles (°) for isonicotinamide : pimelic acid, 1:1  
Bond length (Å) Bond length (Å) Bond length (Å) 
C2-N1                   1.333(3) 
C2-C3          1.390(3) 
C2-H2            0.9500 
C3-C4                   1.383(3) 
C3-H3          0.9500 
C4-C5                   1.385(3) 
C4-C7                   1.504(3) 
C5-C6                   1.380(3) 
C5-H5                   0.9500 
C6-N1                   1.338(3) 
C6-H6                   0.9500 
C7-O7           1.246(3) 
C7-N7                   1.322(3) 
N7-H7A        0.8800 
N7-H7B        0.8800 
C8-O9                   1.209(3) 
C8-O8                   1.322(3) 
C8-C9                   1.500(3) 
C9-C10        1.518(3) 
C9-H9A        0.9900 
C9-H9B        0.9900 
C10-C11        1.520(3) 
C10-H10A        0.9900 
C10-H10B        0.9900 
C11-C12        1.522(3) 
 
C12-C13        1.522(3) 
C12-H12A        0.9900 
C12-H12B        0.9900 
C13-C14        1.508(3) 
C13-H13A        0.9900 
C13-H13B        0.9900 
C14-O15        1.216(3) 
C14-O14        1.316(3) 
O8-H8        0.8400 
O14-H14        0.8400 
 
Bond angle (°) Bond angle (°) Bond angle (°) 
N1-C2-C3             122.9(2) 
N1-C2-H2             118.6 
C3-C2-H2             118.6 
C4-C3-C2             119.3(2) 
C4-C3-H3             120.4 
C2-C3-H3             120.4 
C3-C4-C5             117.9(2) 
C3-C4-C7             118.9(2) 
C5-C4-C7             123.2(2) 
C6-C5-C4             119.3(2) 
C6-C5-H5             120.4 
C4-C5-H5             120.4 
N1-C6-C5             123.2(2) 
N1-C6-H6             118.4 
C5-C6-H6             118.4 
O7-C7-N7             122.7(2) 
O7-C7-C4             118.8(2) 
N7-C7-C4             118.5(2) 
C2-N1-C6             117.5(2) 
C7-N7-H7A          120.0 
C7-N7-H7B          120.0 
H7A-N7-H7B          120.0 
O9-C8-O8.               123.8(2) 
O9-C8-C9                124.5(2) 
O8-C8-C9                111.6(2) 
C8-C9-C10              114.9(2) 
C8-C9-H9A             108.5 
C10-C9-H9A           108.5 
C8-C9-H9B          108.5 
C10-C9-H9B          108.5 
H9A-C9-H9B          107.5 
C9-C10-C11          112.2(2) 
C9-C10-H10A         109.2 
C11-C10-H10A       109.2 
C9-C10-H10B         109.2 
C11-C10-H10B       109.2 
H10A-C10-H10B    107.9 
C10-C11-C12          113.9(2) 
C10-C11-H11A       108.8 
C12-C11-H11A       108.8 
C10-C11-H11B        108.8 
C12-C11-H11B        108.8 
H11A-C11-H11B     107.7 
C13-C12-C11           112.1(2) 
C13-C12-H12A        109.2 
C11-C12-H12A   .    109.2 
C13-C12-H12B        109.2 
C11-C12-H12B        109.2 
H12A-C12-H12B     107.9 
C14-C13-C12           116.4(2) 
C14-C13-H13A        108.2 
C12-C13-H13A        108.2 
C14-C13-H13B        108.2 
C12-C13-H13B        108.2 
H13A-C13-H13B     107.3 
O15-C14-O14           122.7(2) 
O15-C14-C13           123.2(2) 
O14-C14-C13           114.1(2) 
C8-O8-H8           109.5 
C14-O14-H14           109.5 
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Torsion angle (°) Torsion angle (°) 
N1-C2-C3-C4                            0.0(4) 
C2-C3-C4-C5                            0.6(3) 
C2-C3-C4-C7                            179.9(2) 
C3-C4-C5-C6                           -0.9(3) 
C7-C4-C5-C6                            179.8(2) 
C4-C5-C6-N1                    0.7(4) 
C3-C4-C7-O7                            0.2(3) 
C5-C4-C7-O7                            179.5(2) 
C3-C4-C7-N7                 -178.9(2) 
C5-C4-C7-N7                  0.3(3) 
C3-C2-N1-C6                           -0.3(4) 
C5-C6-N1-C2                  0.0(4) 
O9-C8-C9-C10                12.4(4) 
O8-C8-C9-C10              -169.6(2) 
C8-C9-C10-C11              -169.9(2) 
C9-C10-C11-C12              -176.0(2) 
C10-C11-C12-C13              -174.9(2) 
C11-C12-C13-C14              -175.6(2) 
C12-C13-C14-O15              -146.7(2) 
C12-C13-C14-O14               35.4(3) 
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Appendix 16: 
16.1: 1H NMR spectra of isonicotinamide : suberic acid (solvent – DMSO) 
 
Isonicotinamide:  7.75 (3H,dd and s),  8.25 (1H,s),  8.70 (2H,dd)                                
Suberic acid:   1.25 (4H, q),   1.5 (4H, q),  2.2 (4H,t) 
 
16.2: The diffraction pattern simulated from the single crystal structure compared to that of 
the laboratory experimental powder diffraction pattern of isonicotinamide : suberic acid, 1:1 
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16.3: Ortep of isonicotinamide : suberic acid, 1:1 
 
 
16.4: Crystallographic details for isonicotinamide : suberic acid, 1:1 
Empirical formula C14 H20 N2 O5 
Formula weight 296.32 
Temperature 120(2) K 
Wavelength 0.71073Å 
Crystal system Triclinic 
Space group P -1 
Unit cell dimensions a = 8.941 (2) Å 
b = 9.537(1) Å 
c = 10.135(2) Å 
α = 86.65(1)° 
β = 66.031(7) ° 
γ = 66.57(1)° 
Volume 719.1(2) Å3 
Z 2 
Density (calculated) 1.369 Mg/m3 
Absorption coefficient 0.104 mm-1 
F(000) 316 
Crystal size  0.20 x 0.10 x 0.03mm3 
Theta range for data collection 2.97 to 25.02°. 
Index ranges -10<=h<=10, -11<=k<=11, -12<=l<=12 
Reflections collected 9503 
Independent reflections 2516 [R(int) = 0.0719] 
Completeness to theta = 25.02° 99.0% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9969 and 0.9794 
Refinement method Full-matrix least-squares on F
2 
Data / restraints / parameters 2516 / 0 / 192 
Goodness-of-fit on F2 1.105 
Final R indices [I>2sigma(I)] R1 = 0.0724, wR2 = 0.1604 
R indices (all data) R1 = 0.1055, wR2 = 0.1837 
Largest diff. peak and hole 0.281 and -0.306 e.Å-3 
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16.5: Intramolecular bond lengths (Å) and angles (°) for isonicotinamide : suberic acid, 1:1 
Bond length (Å) Bond length (Å) Bond length (Å) 
C2-N1         1.332(4) 
C2-C3                   1.381(5) 
C2-H2                   0.9500 
C3-C4                   1.385(5) 
C3-H3          0.9500 
C4-C5         1.381(5) 
C4-C7                   1.500(5) 
C5-C6                   1.377(5) 
C5-H5                   0.9500 
C6-N1                   1.339(4) 
C6-H6                   0.9500 
C7-O7                   1.241(4) 
C7-N7                   1.326(4) 
N7-H7A        0.8800 
N7-H7B        0.8800 
C8-O9                   1.214(4) 
C8-O8                   1.321(4) 
C8-C9                   1.497(5) 
C9-C10        1.506(5) 
C9-H9A        0.9900 
C9-H9B        0.9900 
C10-C11        1.528(4) 
C10-H10A        0.9900 
C10-H10B        0.9900 
C11-C12        1.517(5) 
C11-H11A        0.9900 
C11-H11B        0.9900 
C12-C13        1.520(4) 
C12-H12A        0.9900 
C12-H12B        0.9900 
C13-C14        1.516(5) 
C13-H13A        0.9900 
C13-H13B        0.9900 
C14-C15        1.500(5) 
C14-H14A        0.9900 
C14-H14B        0.9900 
C15-O16        1.215(4) 
C15-O15        1.309(4) 
O8-H8        0.8400 
O15-H15        0.8400 
 
Bond angle (°) Bond angle (°) Bond angle (°) 
N1-C2-C3                 123.6(3) 
N1-C2-H2           118.2 
C3-C2-H2           118.2 
C2-C3-C4           118.4(3) 
C2-C3-H3           120.8 
C4-C3-H3           120.8 
C5-C4-C3           118.5(3) 
C5-C4-C7           118.3(3) 
C3-C4-C7           123.2(3) 
C6-C5-C4           119.2(3) 
C6-C5-H5           120.4 
C4-C5-H5           120.4 
N1-C6-C5                 122.9(3) 
N1-C6-H6           118.6 
C5-C6-H6           118.6 
O7-C7-N7           122.0(3) 
O7-C7-C4                 119.2(3) 
N7-C7-C4                 118.7(3) 
C2-N1-C6                 117.4(3) 
C7-N7-H7A           120.0 
C7-N7-H7B           120.0 
H7A-N7-H7B           120.0 
O9-C8-O8                123.4(3) 
O9-C8-C9                125.8(3) 
O8-C8-C9          110.8(3) 
C8-C9-C10          116.7(3) 
C8-C9-H9A          108.1 
C10-C9-H9A          108.1 
C8-C9-H9B          108.1 
C10-C9-H9B          108.1 
H9A-C9-H9B          107.3 
C9-C10-C11          110.2(3) 
C9-C10-H10A         109.6 
C11-C10-H10A       109.6 
C9-C10-H10B         109.6 
C11-C10-H10B       109.6 
H10A-C10-H10B    108.1 
C12-C11-C10          115.5(3) 
C12-C11-H11A       108.4 
C10-C11-H11A       108.4 
C12-C11-H11B       108.4 
C10-C11-H11B       108.4 
H11A-C11-H11B    107.5 
C11-C12-C13          112.0(3) 
C11-C12-H12A        109.2 
C13-C12-H12A        109.2 
C11-C12-H12B        109.2 
C13-C12-H12B        109.2 
H12A-C12-H12B     107.9 
C14-C13-C12           112.8(3) 
C14-C13-H13A        109.0 
C12-C13-H13A        109.0 
C14-C13-H13B        109.0 
C12-C13-H13B        109.0 
H13A-C13-H13B     107.8 
C15-C14-C13           114.5(3) 
C15-C14-H14A        108.6 
C13-C14-H14A        108.6 
C13-C14-H14B        108.6 
H14A-C14-H14B     107.6 
O16-C15-O15           122.8(3) 
O16-C15-C14           124.8(3) 
O15-C15-C14           112.4(3) 
C8-O8-H8           109.5 
C15-O15-H15           109.5 
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Torsion angle (°) Torsion angle (°) 
N1-C2-C3-C4                         -1.5(5) 
C2-C3-C4-C5                           0.4(5) 
C2-C3-C4-C7                          179.8(3) 
C3-C4-C5-C6                           0.6(5) 
C7-C4-C5-C6                          -178.7(3) 
C4-C5-C6-N1                          -0.8(5) 
C5-C4-C7-O7                          -6.5(5) 
C3-C4-C7-O7                           174.1(3) 
C5-C4-C7-N7                           172.2(3) 
C3-C4-C7-N7                           -7.1(5) 
C3-C2-N1-C6                           1.4(5) 
C5-C6-N1-C2                  -0.2(5) 
O9-C8-C9-C10               -2.0(5) 
O8-C8-C9-C10                179.2(3) 
C8-C9-C10-C11                175.7(3) 
C9-C10-C11-C12                178.0(3) 
C10-C11-C12-C13                178.7(3) 
C11-C12-C13-C14                178.6(3) 
C12-C13-C14-C15                179.6(3) 
C13-C14-C15-O16               -3.4(5) 
C13-C14-C15-O15                176.8(3) 
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Appendix 17 
17.1: 1H NMR spectra of isonicotinamide : azelaic acid (solvent – DMSO) 
 
Isonicotinamide:  7.71 (3H,dd and s),  8.21 (1H,s),   8.68 (2H,dd)                                
Azelaic acid:   1.2 (6H, s),  1.42 (4H, q),   2.15 (4H,t) 
 
17.2: The diffraction pattern simulated from the single crystal structure compared to that of 
the laboratory experimental powder diffraction pattern of isonicotinamide : azelaic acid, 1:1 
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17.3: Ortep of isonicotinamide : azelaic acid, 1:1 
 
 
17.4: Crystallographic details for isonicotinamide : azelaic acid, 1:1 
Empirical formula C15 H22 N2 O5 
Formula weight 310.35 
Temperature 120(2) K 
Wavelength 0.71073Å 
Crystal system Monoclinic 
Space group P2/c 
Unit cell dimensions a = 8.212 (1) Å 
b = 5.068(7) Å 
c = 38.683(5) Å 
α = 90° 
β = 93.264(6) ° 
γ = 90° 
Volume 1604.3(4) Å3 
Z 4 
Density (calculated) 1.283 Mg/m3 
Absorption coefficient 0.097 mm-1 
F(000) 664 
Crystal size  0.13 x 0.07 x 0.04mm
3 
Theta range for data collection 3.16 to 25.03°. 
Index ranges -9<=h<=9, -6<=k<=6, -46<=l<=45 
Reflections collected 11278 
Independent reflections 2761 [R(int) = 0.0748] 
Completeness to theta = 25.03° 97.3% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9961 and 0.9876 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2761/ 0 / 201 
Goodness-of-fit on F2 1.186 
Final R indices [I>2sigma(I)] R1 = 0.0879, wR2 = 0.1966 
R indices (all data) R1 = 0.1217, wR2 = 0.2217 
Largest diff. peak and hole 0.391 and -0.289 e.Å-3 
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17.5: Intramolecular bond lengths (Å) and angles (°) for isonicotinamide : azelaic acid, 1:1 
Bond length (Å) Bond length (Å) Bond length (Å) 
C6-N1                   1.339(5) 
C6-C5                   1.379(6) 
C6-H6                   0.9500 
C5-C4                   1.393(6) 
C5-H5                 0.9500 
C4-C3                   1.394(6) 
C4-C7                   1.501(6) 
C3-C2                   1.381(6) 
C3-H3                   0.9500 
C2-N1                   1.336(6) 
C2-H2          0.9500 
C7-O7                   1.248(5) 
C7-N7                   1.322(5) 
N7-H7A        0.8800 
N7-H7B        0.8800 
C8-O9                   1.216(5) 
C8-O8                   1.318(5) 
C8-C9                   1.481(6) 
C9-C10        1.521(6) 
C9-H9A        0.9900 
C9-H9B        0.9900 
C10-C11       1.523(6) 
C10-H10A        0.9900 
C10-H10B        0.9900 
C11-C12       1.526(6) 
C11-H11A        0.9900 
C11-H11B        0.9900 
C12-C13        1.523(6) 
C12-H12A        0.9900 
C12-H12B        0.9900 
C13-C14       1.520(6) 
C13-H13A        0.9900 
C13-H13B        0.9900 
C14-C15        1.521(6) 
C14-H14A        0.9900 
C14-H14B        0.9900 
C15-C16        1.506(6) 
C15-H15A        0.9900 
C15-H15B        0.9900 
C16-O17        1.222(5) 
C16-O16        1.313(5) 
O8-H8        0.8400 
O16-H16        0.8400 
 
 
Bond angle (°) Bond angle (°) Bond angle (°) 
N1-C6-C5                 123.5(4) 
N1-C6-H6           118.3 
C5-C6-H6           118.3 
C6-C5-C4           118.8(4) 
C6-C5-H5           120.6 
C4-C5-H5           120.6 
C5-C4-C3           118.0(4) 
C5-C4-C7           123.0(4) 
C3-C4-C7           119.0(4) 
C2-C3-C4           118.9(4) 
C2-C3-H3           120.6 
C4-C3-H3           120.6 
N1-C2-C3           123.4(4) 
N1-C2-H2           118.3 
C3-C2-H2           118.3 
O7-C7-N7                122.8(4) 
O7-C7-C4           118.9(4) 
N7-C7-C4           118.3(4) 
C2-N1-C6           117.4(4) 
C7-N7-H7A           120.0 
C7-N7-H7B           120.0 
H7A-N7-H7B           120.0 
O9-C8-O8           123.1(4) 
O9-C8-C9           124.2(4) 
 
O8-C8-C9           112.7(4) 
C8-C9-C10           115.3(4) 
C8-C9-H9A           108.4 
C10-C9-H9A           108.4 
C8-C9-H9B           108.4 
C10-C9-H9B           108.4 
H9A-C9-H9B           107.5 
C9-C10-C11           112.5(4) 
C9-C10-H10A          109.1 
C11-C10-H10A        109.1 
C9-C10-H10B           109.1 
C11-C10-H10B         109.1 
H10A-C10-H10B     107.8 
C10-C11-C12           113.3(4) 
C10-C11-H11A        108.9 
C12-C11-H11A        108.9 
C10-C11-H11B        108.9 
C12-C11-H11B        108.9 
H11A-C11-H11B     107.7 
C13-C12-C11           112.8(4) 
C13-C12-H12A        109.0 
C11-C12-H12A        109.0 
C13-C12-H12B        109.0 
C11-C12-H12B        109.0 
 
H12A-C12-H12B     107.8 
C14-C13-C12           113.3(4) 
C14-C13-H13A        108.9 
C12-C13-H13A        108.9 
C14-C13-H13B        108.9 
C12-C13-H13B        108.9 
H13A-C13-H13B     107.7 
C13-C14-C15           112.3(4) 
C13-C14-H14A        109.1 
C15-C14-H14A        109.1 
C13-C14-H14B        109.1 
C15-C14-H14B        109.1 
H14A-C14-H14B     107.9 
C16-C15-C14           116.4(4) 
C16-C15-H15A        108.2 
C14-C15-H15A        108.2 
C16-C15-H15B        108.2 
C14-C15-H15B        108.2 
H15A-C15-H15B     107.3 
O17-C16-O16          122.8(4) 
O17-C16-C15          122.7(4) 
O16-C16-C15          114.5(4) 
C8-O8-H8          109.5 
C16-O16-H16         109.5 
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Torsion angle (°) Torsion angle (°) 
N1-C6-C5-C4                           -0.4(7) 
C6-C5-C4-C3                   0.4(6) 
C6-C5-C4-C7                          -179.5(4) 
C5-C4-C3-C2                           -0.4(6) 
C7-C4-C3-C2                            179.6(4) 
C4-C3-C2-N1                            0.3(7) 
C5-C4-C7-O7                            179.9(4) 
C3-C4-C7-O7                       -0.1(6) 
C5-C4-C7-N7                  -1.7(6) 
C3-C4-C7-N7                            178.4(4) 
C3-C2-N1-C6                           -0.3(7) 
C5-C6-N1-C2                            0.3(7) 
O9-C8-C9-C10               -9.6(7) 
O8-C8-C9-C10                171.5(4) 
C8-C9-C10-C11                169.3(4) 
C9-C10-C11-C12                175.7(4) 
C10-C11-C12-C13                173.6(4) 
C11-C12-C13-C14                174.2(4) 
C12-C13-C14-C15                176.7(4) 
C13-C14-C15-C16                175.8(4) 
C14-C15-C16-O17                150.4(4) 
C14-C15-C16-O16               -30.6(6) 
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Appendix 18: 
18.1: 1H NMR spectra of the isonicotinamide : sebacic acid adduct (cocrystallised from 
ethanol) (solvent – DMSO) 
 
 
Isonicotinamide:  7.75 (3H,dd and s),  8.25 (1H,s),  8.72 (2H,dd)                                
Sebacic acid:   1.25 (8H, s),   1.47 (4H, t),  2.17 (4H,t),   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendices Page 346 
 
Appendix 19: 
19.1: 1H NMR spectra of the isonicotinamide : undecanedioic acid adduct (solvent – DMSO) 
 
 
Isonicotinamide:  7.6 (3H,dd and s),  8.25 (1H,s),  8.70 (2H,dd)                                     
Undecanedioic acid:  1.25 (10H, s),   1.47 (4H, t),  2.19 (4H,t), 12.0 (2H, s) 
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Appendix 20: 
20.1: Table of values comparing density and packing fraction of the isonicotinamide : alkanediacid cocrystals and their respective pure acids 
Pure alkanediacid 1:1 isonicotinamide : alkanediacid cocrystal 2:1 isonicotinamide : alkanediacid cocrystal 
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189.5 1.948 0.802          243 1.584 77.1 9 16.573 
 
4.887 
Malonic  
 
135.6 1.669 0.749          170 1.490 73.1    
Succinic  
 
188 1.624 0.777 4 6.924 
 
2.311       206 1.480 74.1 9 (17.186 
 
4.712 
Glutaric  
 
99 1.484 0.741 4 6.832 
 
2.342 134 1.399 70.3    149 1.420 71.8    
Adipic  
 
153 1.398 0.726 4 6.728 
 
2.374 163 1.395 71.6 6 11.048 
 
3.259 178 1.425 73.0 9 17.495 
 
4.630 
Pimelic  
 
106 1.372 0.727 4 6.853 
 
2.335 112 1.331 69 
 
6 11.566 
 
3.112 
 
      
Suberic  
 
144 1.319 0.714 4 6.676 
 
2.397 165 1.369 72 6 11.698 
 
3.077       
Azelaic 106.5 1.303 0.720 4 6.816 
 
2.347 142 1.283 68.3 6 11.483 
 
3.134       
Sebacic 
 
134.5 1.257 0.704 4 6.616 
 
2.419       156      
Undecan
edioic 
109 1.181 0.254 2 4.15 0.964 123            
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Appendix 21: 
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Appendix 22: 
22.1: Crystalline structure of nicotinamide : hydrogen oxalate 1:1 
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22.2: Crystalline structure of nicotinamide : malonic acid 2:1 
 
22.3: Crystalline structure of nicotinamide : hydrogen maleate 1:1 
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22.4: Crystalline structure of nicotinamide : fumaric acid 1:1 
 
 
22.5: Crystalline structure of nicotinamide : fumaric acid 2:1 
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22.6: Crystalline structure of nicotinamide : glutaric acid 1:1 
 
 
22.7: Crystalline structure of nicotinamide : adipic acid 1:1 
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22.8: Crystalline structure of nicotinamide : adipic acid 2:1 
 
 
22.9: Crystalline structure of nicotinamide : pimelic acid 1:1 
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22.10: Crystalline structure of nicotinamide : suberic acid 1:1 
 
22.11: Crystalline structure of nicotinamide : suberic acid 2:1 
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22.12: Crystalline structure of nicotinamide : azelaic acid 1:1 
 
 
22.13: Crystalline structure of nicotinamide : sebacic acid 2:1 
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Appendix 23 
23.1: 1H NMR spectra of nicotinamide : succinic acid (experimental method 3.1) (solvent – 
DMSO) 
 
 
Nicotinamide: 7.50 (1H,q), 7.62 (1H,s), 8.20 (2H,dt), 8.71 (1H,dd), 9.30 (1H,d)       
Succinic acid: 2.42 (2H, s), 12.20 (2H, s) 
 
23.2: 1H NMR spectra of nicotinamide : succinic acid (experimental method 3.2) (solvent – 
DMSO) 
 
 
Nicotinamide: 7.50 (1H,q), 7.61 (1H,s), 8.20 (2H,dt), 8.71 (1H,dd), 9.40 (1H,d),         
Succinic acid: 2.41 (2H, s), 12.19 (2H, s) 
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23.3: Ortep of nicotinamide : succinic acid, 2:1 
 
23.4: Crystallographic details of nicotinamide : succinic acid, 2:1 
Empirical formula C16H18N4O6 
Formula weight 362.34 
Temperature 120(2)K 
Wavelength 0.71073 Å 
Crystal system Triclinic 
Space group P -1 
Unit cell dimensions a = 5.0872(2)Å 
b = 11.5569(5)Å 
c = 14.2784(5)Å 
α = 77.433(2)° 
β = 86.726(2) ° 
γ = 89.418(2)° 
Volume 818.01(6)Å3 
Z 2 
Density (calculated) 1.471 Mg/m3 
Absorption coefficient 0.115 mm-1 
F(000) 380 
Crystal size  0.17 x 0.03 x 0.01 mm3 
Theta range for data collection 3.59 to 26.02° 
Index ranges -6<=h<=6, -14<=k<=14, -17<=l<=17 
Reflections collected 12664 
Independent reflections 3205 [R(int) = 0.0610] 
Completeness to theta = 26.02° 99.3% 
Max. and min. transmission 0.9989 and 0.9808 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3205/0/237 
Goodness-of-fit on F2 1.106 
Final R indices [I>2sigma(I)] R1 = 0.0555, wR2 = 0.1162 
R indices (all data) R1 =0.0803, wR2 = 0.1320 
Largest diff. peak and hole 0.244 and -0.267 e.Å-3 
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23.5: Intramolecular bond lengths (Å) and angles (°) in nicotinamide : succinic acid, 2:1  
Bond length (Å) Bond length (Å) Bond length (Å) 
C2A-N1A    1.339(3) 
C2A-C3A     1.384(4) 
C2A-H2A     0.9500 
C3A-C4A     1.382(3) 
C3A-H3A     0.9500 
C4A-C5A     1.390(3) 
C4A-H4A     0.9500 
C5A-C6A     1.391(3) 
C5A-C7A     1.491(3) 
C6A-N1A     1.341(3) 
C6A-H6A     0.9500 
C7A-O7A     1.241(3) 
C7A-N7A     1.332(3) 
N7A-H7AA     0.8800 
N7A-H7AB     0.8800 
C8A-O9A     1.213(3) 
C8A-O8A     1.328(3) 
C8A-C9A     1.500(3) 
C9A-C9Ai     1.516(5) 
C9A-H9AA     0.9900 
C9A-H9AB     0.9900 
O8A-H8A     0.8400 
C2B-N1B     1.344(3) 
C2B-C3B     1.379(3) 
C2B-H2B     0.9500 
C3B-C4B     1.382(4) 
C3B-H3B     0.9500 
C4B-C5B     1.392(3) 
C4B-H4B     0.9500 
C5B-C6B     1.387(3) 
C5B-C7B     1.494(3) 
C6B-N1B     1.338(3) 
C6B-H6B     0.9500 
C7B-O7B     1.242(3) 
C7B-N7B     1.331(3) 
N7B-H7BA     0.8800 
N7B-H7BB     0.8800 
C8B-O9B     1.212(3) 
C8B-O8B     1.334(3) 
C8B-C9B     1.498(3) 
C9B-C9Bii     1.528(5) 
C9B-H9BA     0.9900 
C9B-H9BB     0.9900 
O8B-H8B     0.8400 
 
 
Bond angle (°) Bond angle (°) Bond angle (°) 
N1A-C2A-C3A        122.8(2) 
N1A-C2A-H2A            118.6 
C3A-C2A-H2A            118.6 
C4A-C3A-C2A        119.0(2) 
C4A-C3A-H3A            120.5 
C2A-C3A-H3A            120.5 
C3A-C4A-C5A        119.0(2) 
C3A-C4A-H4A            120.5 
C5A-C4A-H4A            120.5 
C4A-C5A-C6A        118.2(2) 
C4A-C5A-C7A        124.4(2) 
C6A-C5A-C7A        117.4(2) 
N1A-C6A-C5A        123.0(2) 
N1A-C6A-H6A            118.5 
C5A-C6A-H6A            118.5 
O7A-C7A-N7A        121.8(2) 
O7A-C7A-C5A        120.6(2) 
N7A-C7A-C5A        117.6(2) 
C2A-N1A-C6A        118.0(2) 
C7A-N7A-H7AA         120.0 
C7A-N7A-H7AB         120.0 
H7AA-N7A-H7AB     120.0 
O9A-C8A-O8A        123.6(2) 
O9A-C8A-C9A        124.2(2) 
O8A-C8A-C9A        112.2(2) 
C8AC9A-C9Ai           112.7(2) 
C8A-C9A-H9AA          109.1 
C9A#1-C9A-H9AA      109.1 
C8A-C9A-H9AB          109.1 
C9A#1-C9A-H9AB      109.1 
H9AA-C9A-H9AB       107.8 
C8A-O8A-H8A            109.5 
N1B-C2B-C3B         123.1(2) 
N1B-C2B-H2B             118.5 
C3B-C2B-H2B             118.5 
C2B-C3B-C4B         118.8(2) 
C2B-C3B-H3B            120.6 
C4B-C3B-H3B            120.6 
C3B-C4B-C5B        119.0(2) 
C3B-C4B-H4B            120.5 
C5B-C4B-H4B            120.5 
C6B-C5B-C4B         118.2(2) 
C6B-C5B-C7B         122.3(2) 
C4B-C5B-C7B        119.4(2) 
N1B-C6B-C5B         123.1(2) 
N1B-C6B-H6B            118.4 
C5B-C6B-H6B            118.4 
O7B-C7B-N7B        122.2(2) 
O7B-C7B-C5B         120.0(2) 
N7B-C7B-C5B         117.8(2) 
C6B-N1B-C2B         117.7(2) 
C7B-N7B-H7BA   120.0 
C7B-N7B-H7BB   120.0 
H7BA-N7B-H7BB       120.0 
O9B-C8B-O8B          23.3(2) 
O9B-C8B-C9B         124.9(2) 
O8B-C8B-C9B         111.8(2) 
C8B-C9B-9Bii          112.2(2) 
C8B-C9B-H9BA   109.2 
C9B#2-C9B-H9BA      109.2 
C8B-C9B-H9BB   109.2 
C9B#2-C9B-H9BB       109.2 
H9BA-C9B-H9BB   107.9 
C8B-O8B-H8B   109.5 
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Torsion angle (°) Torsion angle (°) 
N1A-C2A-C3A-C4A            1.7(4) 
C2A-C3A-C4A-C5A          -1.6(3) 
C3A-C4A-C5A-C6A            0.3(3) 
C3A-C4A-C5A-C7A          -180.0(2) 
C4A-C5A-C6A-N1A           1.2(3) 
C7A-C5A-C6A-N1A          -178.6(2) 
C4A-C5A-C7A-O7A           153.6(2) 
C6A-C5A-C7A-O7A          -26.7(3) 
C4A-C5A-C7A-N7A          -27.8(3) 
C6A-C5A-C7A-N7A           151.9(2) 
C3A-C2A-N1A-C6A           -0.3(3) 
C5A-C6A-N1A-C2A           -1.2(3) 
O9A-C8A-C9A-C9Aiii              -3.5(4) 
O8A-C8A-C9A-C9Aiii           176.4(2) 
N1B-C2B-C3B-C4B          -1.2(4) 
C2B-C3B-C4B-C5B           0.8(4) 
C3B-C4B-C5B-C6B           0.4(3) 
C3B-C4B-C5B-C7B          -175.7(2) 
C4B-C5B-C6B-N1B          -1.5(4) 
C7B-C5B-C6B-N1B           174.4(2) 
C6B-C5B-C7B-O7B          -152.2(2) 
C4B-C5B-C7B-O7B           23.7(3) 
C6B-C5B-C7B-N7B           26.5(3) 
C4B-C5B-C7B-N7B          -157.6(2) 
C5B-C6B-N1B-C2B           1.3(4) 
C3B-C2B-N1B-C6B           0.1(4) 
O9B-C8B-C9B-C9Biv               2.9(4) 
O8B-C8B-C9B-C9Biv             -176.6(2) 
     
     
     
Symmetry transformations used to generate equivalent atoms:  
i) -x+3,-y+2,-z+1    ii) -x,-y+1,-z+1  iii) -x+3,-y+2,-z+1    iv) -x,-y+1,-z+1 
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Appendix 24 
24.1: 1H NMR spectra of nicotinamide : undecanedioic acid (solvent – DMSO) 
 
 
Nicotinamide:  7.50 (1H,q), 7.63 (1H,s), 8.19 (2H,dt), 8.71 (1H,dd), 9.20 (1H,d) 
Undecanedioic acid: 1.25 (10H, s), 1.47 (4H, t), 2.18 (4H, t) 
 
24.2: The diffraction pattern simulated from the single crystal structure compared to that of 
the laboratory experimental powder diffraction pattern of nicotinamide : undecanedioic acid 
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24.3: Ortep of nicotinamide : undecanedioic acid, 1:1  
 
24.4: Crystallographic details of nicotinamide : undecanedioic acid, 1:1  
Empirical formula C17H26N2O5 
Formula weight 338.40 
Temperature 120(2)K 
Wavelength 1.54184 Å 
Crystal system Triclinic 
Space group P -1 
Unit cell dimensions a = 9.1939(1)Å 
b = 11.6336(2)Å 
c = 17.6109(3)Å 
α = 106.738(1)° 
β = 90.588(1) ° 
γ = 105.479(1)° 
Volume 1730.63(5)Å3 
Z 4 
Density (calculated) 1.299 Mg/m3 
Absorption coefficient 0.788  mm-1 
F(000) 728 
Crystal size  0.24 x 0.10 x 0.04 mm3 
Theta range for data collection 6.45 to 66.60° 
Index ranges -10<=h<=10, -13<=k<=13, -20<=l<=20 
Reflections collected 15786 
Independent reflections 5925 [R(int) = 0.0288] 
Completeness to theta = 66.60° 97.0% 
Max. and min. transmission 0.9691 and 0.8333 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5925/0/437 
Goodness-of-fit on F2 1.040 
Final R indices [I>2sigma(I)] R1 = 0.0373, wR2 = 0.0985 
R indices (all data) R1 = 0.0442, wR2 = 0.1047  
Largest diff. peak and hole 0.196 and -0.262 e.Å-3 
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24.5: Intramolecular bond lengths (Å) and angles (°) in nicotinamide : undecanedioic acid, 
1:1 
Bond length (Å) Bond length (Å) Bond length (Å) 
N1B-C2B          1.337(2) 
N1B-C6B          1.344(2) 
C2B-C3B           1.377(2) 
C2B-H2B           0.9500 
C3B-C4B           1.387(2) 
C3B-H3B           0.9500 
C4B-C5B           1.387(2) 
C4B-H4B           0.9500 
C5B-C6B           1.395(2) 
C5B-C7B           1.514(2) 
C6B-H6B           0.9500 
C7B-O7B          1.237(2) 
C7B-N7B          1.329(2) 
N7B-H7BA        0.8800 
N7B-H7BB        0.8800 
O8A-C8A          1.316(2) 
O8A-H8A          0.8400 
O9A-C8A          1.214(2) 
O18A-C18A      1.335(2) 
O18A-H18A      0.8400 
O19A-C18A      1.207(2) 
C8A-C9A          1.504(2) 
C9A-C10A        1.517(2) 
C9A-H9AA       0.9900 
C9A-H9AB       0.9900 
C10A-C11A      1.526(2) 
C10A-H10A      0.9900 
C10A-H10C      0.9900 
C11A-C12A      1.522(2) 
C11A-H11A      0.9900 
C11A-H11C      0.9900 
C12A-C13A      1.525(2) 
C12A-H12A      0.9900 
C12A-H12C      0.9900 
C13A-C14A      1.522(2) 
C13A-H13A      0.9900 
C13A-H13C      0.9900 
C14A-C15A      1.524(2) 
C14A-H14A      0.9900 
C14A-H14C      0.9900 
C15A-C16A      1.525(2) 
C15A-H15C      0.9900 
C15A-H15A      0.9900 
C16A-C17A      1.521(2) 
C16A-H16C      0.9900 
C16A-H16A      0.9900 
C17A-C18A      1.500(2) 
C17A-H17A      0.9900 
C17A-H17C      0.9900 
N1A-C2A          1.336(2) 
N1A-C6A          1.337(2) 
C2A-C3A          1.381(2) 
C2A-H2A          0.9500 
C3A-C4A          1.385(2) 
C3A-H3A          0.9500 
C4A-C5A          1.391(2) 
C4A-H4A          0.9500 
C5A-C6A          1.395(2) 
C5A-C7A          1.512(2) 
C6A-H6A          0.9500 
C7A-O7A          1.238(2) 
C7A-N7A          1.329(2) 
N7A-H7AA       0.8800 
N7A-H7AB       0.8800 
O8B-C8B          1.309(2) 
O8B-H8B          0.8400 
O9B-C8B          1.220(2) 
O18B-C18B      1.334(2) 
O18B-H18B      0.8400 
O19B-C18B      1.209(2) 
C8B-C9B           1.502(2) 
C9B-C10B         1.515(2) 
C9B-H9BA        0.9900 
C9B-H9BB        0.9900 
C10B-C11B       1.526(2) 
C10B-H10D       0.9900 
C10B-H10B       0.9900 
C11B-C12B       1.521(2) 
C11B-H11D       0.9900 
C11B-H11B       0.9900 
C12B-C13B       1.524(2) 
C12B-H12D       0.9900 
C12B-H12B       0.9900 
C13B-C14B       1.522(2) 
C13B-H13D       0.9900 
C13B-H13B       0.9900 
C14B-C15B       1.525(2) 
C14B-H14D       0.9900 
C14B-H14B       0.9900 
C15B-C16B       1.524(2) 
C15B-H15D       0.9900 
C15B-H15B       0.9900 
C16B-C17B       1.523(2) 
C16B-H16B       0.9900 
C16B-H16D       0.9900 
C17B-C18B       1.497(2) 
C17B-H17D       0.9900 
C17B-H17B       0.9900 
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Bond angle (°) Bond angle (°) Bond angle (°) 
C2B-N1B-C6B         118.7(1) 
N1B-C2B-C3B         122.9(1) 
N1B-C2B-H2B             118.5 
C3B-C2B-H2B             118.5 
C2B-C3B-C4B         118.3(1) 
C2B-C3B-H3B             120.8 
C4B-C3B-H3B             120.8 
C5B-C4B-C3B         119.8(1) 
C5B-C4B-H4B             120.1 
C3B-C4B-H4B             120.1 
C4B-C5B-C6B         118.0(2) 
C4B-C5B-C7B         117.8(1) 
C6B-C5B-C7B         124.2(1) 
N1B-C6B-C5B         122.2(1) 
N1B-C6B-H6B             118.9 
C5B-C6B-H6B             118.9 
O7B-C7B-N7B        122.5(1) 
O7B-C7B-C5B         118.8(1) 
N7B-C7B-C5B         118.9(1) 
C7B-N7B-H7BA          120.0 
C7B-N7B-H7BB          120.0 
H7BA-N7B-H7BB       120.0 
C8A-O8A-H8A            109.5 
C18A-O18A-H18A      109.5 
O9A-C8A-O8A        122.2(1) 
O9A-C8A-C9A        125.1(1) 
O8A-C8A-C9A        112.7(1) 
C8A-C9A-C10A      115.6(1) 
C8A-C9A-H9AA          108.4 
C10A-C9A-H9AA        108.4 
C8A-C9A-H9AB          108.4 
C10A-C9A-H9AB        108.4 
H9AA-C9A-H9AB      107.4 
C9A-C10A-C11A    110.7(1) 
C9A-C10A-H10A        109.5 
C11A-C10A-H10A       109.5 
C9A-C10A)-H10C        109.5 
H13A-C13A-H13C       107.7 
C13A-C14A-C15A  111.9(1) 
C13A-C14A-H14A       109.2 
C15A-C14A-H14A       109.2 
C13A-C14A-H14C       109.2 
C15A-C14A-H14C       109.2 
H14A-C14A-H14C       107.9 
C14A-C15A-C16A  114.1(1) 
C14A-C15A-H15C       108.7 
C16A-C15A-H15C       108.7 
C14A-C15A-H15A       108.7 
C16A-C15A-H15A       108.7 
H15C-C15A-H15A       107.6 
C17A-C16A-C15A111.56(1) 
C17A-C16A-H16C       109.3 
C15A-C16A-H16C       109.3 
C17A-C16A-H16A       109.3 
C15A-C16A-H16A       109.3 
H16C-C16A-H16A       108.0 
C18A-C17A-C16A  113.8(1) 
C18A-C17A-H17A       108.8 
C16A-C17A-H17A       108.8 
C18A-C17A-H17C       108.8 
C16A-C17A-H17C       108.8 
H17A-C17A-H17C       107.7 
O19A-C18A-O18A  122.6(1) 
O19A-C18A-C17A  124.4(1) 
O18A-C18A-C17A  113.0(1) 
C2A-N1A-C6A        119.0(1) 
N1A-C2A-C3A        122.5(1) 
N1A-C2A-H2A            118.8 
C3A-C2A-H2A            118.8 
C2A-C3A-C4A        118.6(1) 
C2A-C3A-H3A             120.7 
C4A-C3A-H3A             120.7 
C3A-C4A-C5A        119.7(1) 
C3A-C4A-H4A             120.1 
C8B-C9B-H9BA          108.4 
C10B-C9B-H9BA        108.4 
C8B-C9B-H9BB          108.4 
C10B-C9B-H9BB         108.4 
H9BA-C9B-H9BB        107.4 
C9B-C10B-C11B     111.1(1) 
C9B-C10B-H10D         109.4 
C11B-C10B-H10D       109.4 
C9B-C10B-H10B         109.4 
C11B-C10B-H10B       109.4 
H10D-C10B-H10B       108.0 
C12B-C11B-C10B   114.3(1) 
C12B-C11B-H11D       108.7 
C10B-C11B-H11D       108.7 
C12B-C11B-H11B       108.7 
C10B-C11B-H11B       108.7 
H11D-C11B-H11B       107.6 
C11B-C12B-C13B   113.0(1) 
C11B-C12B-H12D       109.0 
C13B-C12B-H12D       109.0 
C11B-C12B-H12B       109.0 
C13B-C12B-H12B       109.0 
H12D-C12B-H12B       107.8 
C14B-C13B-C12B   113.9(1) 
C14B-C13B-H13D       108.8 
C12B-C13B-H13D       108.8 
C14B-C13B-H13B       108.8 
C12B-C13B-H13B       108.8 
H13D-C13B-H13B      107.7 
C13B-C14B-C15B   112.5(1) 
C13B-C14B-H14D       109.1 
C15B-C14B-H14D       109.1 
C13B-C14B-H14B       109.1 
C15B-C14B-H14B       109.1 
H14D-C14B-H14B       107.8 
C16B-C15B-C14B   114.0(1) 
C16B-C15B-H15D       108.8 
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C11A-C10A-H10C       109.5 
H10A-C10A-H10C       108.1 
C12A-C11A-C10A  114.0(1) 
C12A-C11A-H11A       108.8 
C10A-C11A-H11A       108.8 
C12A-C11A-H11C       108.8 
C10A-C11A-H11C       108.8 
H11A-C11A-H11C       107.7 
C11A-C12A-C13A  112.9(1) 
C11A-C12A-H12A       109.0 
C13A-C12A-H12A       109.0 
C11A-C12A-H12C       109.0 
C13A-C12A-H12C       109.0 
H12A-C12A-H12C       107.8 
C14A-C13A-C12A  113.9(1) 
C14A-C13A-H13A       108.8 
C12A-C13A-H13A       108.8 
C14A-C13A-H13C       108.8 
C12A-C13A-H13C       108.8 
C5A-C4A-H4A             120.1 
C4A-C5A-C6A        117.7(1) 
C4A-C5A-C7A        117.7(1) 
C6A-C5A-C7A        124.7(1) 
N1A-C6A-C5A        122.6(1) 
N1A-C6A-H6A            118.7 
C5A-C6A-H6A            118.7 
O7A-C7A-N7A        122.8(1) 
O7A-C7A-C5A        118.5(1) 
N7A-C7A-C5A        118.7(1) 
C7A-N7A-H7AA         120.0 
C7A-N7A-H7AB         120.0 
H7AA-N7A-H7AB      120.0 
C8B-O8B-H8B             109.5 
C18B-O18B-H18B       109.5 
O9B-C8B-O8B        122.4(1) 
O9B-C8B-C9B         124.5(1) 
O8B-C8B-C9B         113.1(1) 
C8B-C9B-C10B       115.7(1) 
C14B-C15B-H15D       108.8 
C16B-C15B-H15B       108.8 
C14B-C15B-H15B       108.8 
H15D-C15B-H15B       107.7 
C17B-C16B-C15B   111.1(1) 
C17B-C16B-H16B       109.4 
C15B-C16B-H16B       109.4 
C17B-C16B-H16D       109.4 
C15B-C16B-H16D       109.4 
H16B-C16B-H16D       108.0 
C18B-C17B-C16B   113.8(1) 
C18B-C17B-H17D       108.8 
C16B-C17B-H17D       108.8 
C18B-C17B-H17B       108.8 
C16B-C17B-H17B       108.8 
H17D-C17B-H17B       107.7 
O19B-C18B-O18B  122.6(1) 
O19B-C18B-C17B   124.8(1) 
O18B-C18B-C17B.  112.7(1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendices Page 372 
 
Torsion angle (°) Torsion angle (°) 
C6B-N1B-C2B-C3B               -0.1(2) 
N1B-C2B-C3B-C4B               -0.3(2) 
C2B-C3B-C4B-C5B                 0.7(2) 
C3B-C4B-C5B-C6B               -0.7(2) 
C3B-C4B-C5B-C7B             178.2(1) 
C2B-N1B-C6B-C5B                0.1(2) 
C4B-C5B-C6B-N1B                0.3(2) 
C7B-C5B-C6B-N1B           -178.6(1) 
C4B-C5B-C7B-O7B                3.5(2) 
C6B-C5B-C7B-O7B           -177.7(1) 
C4B-C5B-C7B-N7B           -175.5(1) 
C6B-C5B-C7B-N7B                3.4(2) 
O9A-C8A-C9A-C10A            -2.1(2) 
O8A-C8A-C9A-C10A          178.7(1) 
C8A-C9A-C10A-C11A      -179.8(1) 
C9A-C10A-C11A-C12A      179.4(1) 
C10A-C11A-C12A-C13A    179.8(1) 
C11A-C12A-C13A-C14A  -179.1(1) 
C12A-C13A-C14A-C15A    179.0(1) 
C13A-C14A-C15A-C16A    177.5(1) 
C14A-C15A-C16A-C17A    177.4(1) 
C15A-C16A-C17A-C18A  -178.0(1) 
C16A-C17A-C18A-O19A      -6.8(2) 
C16A-C17A-C18A-O18A    174.1(1) 
C6A-N1A-C2A-C3A              -0.3(2) 
N1A-C2A-C3A-C4A              -0.2(2) 
C2A-C3A-C4A-C5A                0.6(2) 
C3A-C4A-C5A-C6A              -0.5(2) 
C3A-C4A-C5A-C7A            179.9(1) 
C2A-N1A-C6A-C5A              0.28(2) 
C4A-C5A-C6A-N1A                0.1(2) 
C7A-C5A-C6A-N1A            179.7(1) 
C4A-C5A-C7A-O7A               2.5 (2) 
C6A-C5A-C7A-O7A         -177.0 (1) 
C4A-C5A-C7A-N7A          -178.3(1) 
C6A-C5A-C7A-N7A                2.2(2) 
O9B-C8B-C9B-C10B            11.2(2) 
O8B-C8B-C9B-C10B         -170.4(1) 
C8B-C9B-C10B-C11B       -179.5(1) 
C9B-C10B-C11B-C12B       178.4(1) 
C10B-C11B-C12B-C13B     175.8(1) 
C11B-C12B-C13B-C14B   -177.4(1) 
C12B-C13B-C14B-C15B   -176.6(1) 
C13B-C14B-C15B-C16B     179.7(1) 
C14B-C15B-C16B-C17B   -178.1(1) 
C15B-C16B-C17B-C18B   -179.0(1) 
C16B-C17B-C18B-O19B       -5.1(2) 
C16B-C17B-C18B-O18B    175.6(1) 
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Appendix 25: 
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